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Investigating the role of higher order chromatin structure and DNA damage 
complexity on ATM signalling and G2/M checkpoint arrest 
SUMMARY 
In response to DNA double stranded breaks (DSBs), mammalian cells have evolved two major 
repair pathways, DNA Non Homologous End Joining (NHEJ) and Homologous Recombination 
(HR). The majority of DSB repair in G1 and G2 phase is repaired with fast kinetics by NHEJ in a 
pathway that involves the core NHEJ factors: Ku, DNA-PKcs, XLF, DNA Ligase IV and XRCC4. A 
subset of slow repairing DSBs also requires ATM and Artemis (Riballo et al, 2004). This slow 
component of repair represents DSBs that reside within highly compacted regions of the 
genome known as heterochromatin (HC) (Goodarzi et al, 2008).  ATM functions at HC to 
mediate relaxation by phosphorylating the HC building factor KAP-1 (Goodarzi et al, 2008). 
Here I provide evidence that DSBs dependent upon Artemis for their repair also reside within 
regions of HC. However, unlike ATM, Artemis functions downstream of the HC relaxation 
process. In response to DSBs, ATM phosphorylates the histone variant H2AX (γH2AX). γH2AX 
acts as a docking site for the localized recruitment and activation of DNA Damage Response 
(DDR) proteins. The expansion of γH2AX can spread over megabases of DNA. Here I have 
shown that highly compacted KAP-1, MeCP2 and DNMT3B enriched chromatin acts as a barrier 
to IR induced γH2AX expansion. In patient cells deficient for MeCP2 or DNMT3B proteins, such 
as Rett syndrome (MeCP2 deficient) and Immunodeficiency centromeric-instability facial-
anomalies syndrome (DNMT3B deficient), ATM and Chk2 signalling is heightened, which is 
reflected in a hypersensitive and prolonged G2/M checkpoint arrest. These findings suggest 
that higher order chromatin complexity is a barrier to ATM signalling to the checkpoint 
machinery. In the final section of my thesis, I addressed what affect DNA damage complexity 
exerts on checkpoint arrest. Using exposure to heavy ion irradiation, which induces complex 
DSBs, I observed larger γH2AX foci and prolonged G2/M checkpoint arrest.  
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1 Introduction 
 
1.1 The importance of the DNA damage response 
On a daily basis our genetic material is exposed to a variety of DNA damaging agents. Exposure 
to these agents poses a threat to the faithful transmission of our genetic material and to the 
survival of the individual. In response to these threats, mammalian cells have evolved an 
assortment of repair mechanisms which mechanistically preserve the genetic information 
encoded by DNA. The failure to repair or the misrepair of DNA alterations or lesions can result 
in apoptosis or chromosomal alterations including deletions, translocations, and chromosome 
fusions, which decrease genome stability and can subsequently lead to the development of 
cancer. Mammalian cells potentially experience 105 spontaneous DNA lesions per day 
(Hoeijmakers, 2009). Sources of DNA damage can arise both endogenously and exogenously. 
Endogenous sources of DNA damage include hydrolysis, oxidation, alkylation, and inaccurate 
replication of DNA (Lindahl and Barnes, 2000). Environmental sources of DNA damaging agents 
include ionizing radiation (IR), ultraviolet (UV) radiation and various chemotherapeutic drugs 
(Hakem, 2008) (Table 1.1).  Given the range of DNA alterations potentially inflicted on a cell on 
a daily basis, it is no surprise that a variety of repair mechanisms specific for lesion type have 
evolved to counteract the DNA damage (Table 1.2). The most potentially threatening lesions 
posed to mammalian cells are DNA Double Stranded Breaks (DSBs). The signaling and repair 
mechanisms that are activated in response to these lesions will be the main focus of this thesis.  
 Activation of DNA repair pathways is a highly regulated process that ensures DNA 
repair at the right time and place. In response to replication stress and DNA damage the DNA 
Damage Response (DDR) signaling transduction pathway is activated (Jackson and Bartek, 
2009). The DDR is primarily activated by members of the PIKK family – ATM, ATR and DNA-PK, 
and members of the poly (ADP-ribose) polymerase (PARP) family. ATM and DNA-PK respond to 
DSBs. ATR in complex with ATRIP is activated following recruitment to RPA coated single 
stranded (ss) DNA regions which can occur at stalled replication forks and resected DSBs 
(Cimprich and Cortez, 2008a). PARP is activated in response to single stranded breaks (SSBs) 
and catalyzes the addition of poly (ADP-ribose) chains on proteins to recruit DDR factors to 
chromatin at single stranded (ss) breaks (Schreiber et al., 2006). The PARP family has 16 
members, but only PARP1 and PARP2 have been implicated in the DDR (Schreiber et al., 2006).  
ATM and ATR are required for DSB repair as well as repair of replication associated damage. In 
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this general introduction I have given a mechanistic overview of points relevant to my thesis. 
Each chapter has a more specific and detailed discussion of arguments significant to each 
chapter.  
 
1.2 DSB repair 
At least 4 independent pathways of DSB repair exist, these being NHEJ, HR, alternative NHEJ 
(alt-NHEJ) and single strand annealing (SSA). A factor mainly influencing pathway choice is the 
extent of DNA end processing. NHEJ does not require end processing or resection, whereas alt-
NHEJ, HR and SSA are dependent on DSB end resection prior to repair (Hartlerode and Scully, 
2009). Four different DSB sensors also exist: Ku70/Ku80, Mre11/Rad50/Nbs1 (MRN) and RPA, 
which direct repair down different repair pathways. The major pathways of DSB repair that 
predominate are NHEJ and HR.  
 
1.2.1 Non Homologous End joining (NHEJ) 
In mammalian cells the majority of DSBs in both G1 and G2 phases of the cell cycle are 
repaired by NHEJ (Beucher et al., 2009). The initiating step of NHEJ involves the binding of the 
heterodimer Ku70/80, which forms a ring like structure around each end of the broken DNA 
molecule (Walker et al, 2001). Ku70/80 binds DSB ends with high affinity and localizes at the 
site of damage within seconds (Smith et al., 1999). The DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs), a serine/threonine protein kinase, is activated following recruitment to 
the DSB by Ku70/80 (Gottlieb and Jackson, 1993). This interaction between Ku and DNA-PKcs is 
thought to be mediated by the Ku80 carboxyl-terminus (Singleton et al., 1999). DNA-PKcs 
contains two clusters of autophosphorylation, known as the ABCDE (aa 2609 – 2647) and PQR 
(aa 2023 – 2056) (Cui et al., 2005). The DNA-PK holoenzyme (DNA-PKcs and Ku70/80) is 
thought to be important for tethering DNA ends. The initial presence of the unphosphorylated 
DNA-PK effectively blocks access to DNA termini by processing enzymes and ligases. It has 
been postulated that this blocking event functions to regulate repair pathway choice between 
NHEJ and HR, since an increased incidence of HR was observed in DNA-PK deficient cells (Allen 
et al., 2003). Autophosphorylation of DNA-PK on the ABCDE cluster results in destabilization of 
DNA-PKcs interaction with the DNA ends thus relieving this blockage (Chan et al., 2002). If the 
DSB termini are refractory to direct ligation, nucleases are subsequently recruited to process 
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the DNA ends prior to ligation. A 10-25% sub-fraction of DSBs are specifically dependent on 
processing by the endonuclease Artemis, in an ATM dependent NHEJ repair pathway. One 
question I wish to address in my thesis is the nature of these lesions dependent on Artemis for 
repair. Ligation of blunt or processed ends is catalyzed by the ATP utilizing Ligase IV, XRCC4 
and XLF complex. The carboxy terminus of ligase IV contains two regions that harbor BRCA1 
carboxy-terminus like (BRCT) motifs, a sequence known to be involved in protein-protein 
interactions, especially with BRCT domains in other proteins (Zhang et al., 1998). It has been 
suggested that the BRCT motifs of ligase IV may be involved in the interaction of ligase IV/ 
XRCC4/ XLF complex with Ku70/80 (Costantini et al., 2007), resulting in its recruitment to the 
DSB. Ligation is mediated by the donation of an AMP onto the exposed 5’ phosphate by the 
DNA ligase-adenylate complex. It has been proposed that XLF re-adenylates ligase IV following 
the ligation event, which recharges ligase IV for further ligations (Riballo et al., 2009) (Figure 
1.1). The majority of NHEJ repair is ATM independent and repaired with fast kinetics (Riballo et 
al., 2004b). Only 10-25 % of ionizing radiation (IR) induced DSBs in G0/G1 phase of the cell 
cycle require ATM activity and this sub-fraction represents the slow repair component of NHEJ. 
This slow component of DSB repair also requires the mediator protein 53BP1, γH2AX, the 
Mre11/Rad50/Nbs1 (MRN) complex and the endonuclease Artemis (Riballo et al., 2004). 
Further details of the slow and fast repair kinetics of DSB repair are given in chapter 4. 
Extensive characterization of ATM and Artemis has shown that cells lacking either of these two 
proteins manifest an epistatic repair defect whereby 10-20% of IR induced DSB remain un-
repaired (Riballo et al., 2004), strongly suggesting that they function within a common 
pathway. The role of Artemis in DSB repair is evaluated in chapter 5.  
 
1.2.2 Homologous Recombination (HR) 
DSBs can be recognised by the Mre11/Rad50/Nbs1 complex, which promotes activation of 
ATM (Williams and Tainer, 2007). MRE11 has endonuclease and exonuclease activities that are 
important for the initial steps of DNA end resection, which are essential to initiate HR repair 
(Williams et al., 2007) (Figure 1.1). The NBS1 subunit of the MRN complex interacts with ATM 
via its C-terminal region, which promotes the recruitment of ATM to DSBs (Jazayeri et al., 
2008). DNA resection, which is required to mediate HR, is regulated by ATM dependent 
phosphorylation and subsequent activation of CtIP (Shibata et al., 2011). CtIP interacts with 
BRCA1 and the MRN complex, interactions of which are likely to be important for CtIP 
recruitment to damage sites (Huen et al., 2010). CtIP is an endonuclease that promotes DNA 
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end resection (Sartori et al., 2007). CtIP activity is regulated by CDK2 phosphorylation, levels of 
which are low in G1 phase cells (You and Bailis, 2010). Since HR is dependent on resection and 
a homologous sister chromatid to act as a template for repair, this repair pathway is restricted 
to S and G2 phases of the cell cycle (You & Boulis, 2010). In S and G2, CtIP associates with 
BRCA1, which ubiquitinates CtIP and facilitates its association with damaged sites (Huen et al., 
2010). Repair pathway choice is thought to be regulated by resection. Indeed DSB resection 
promoted by CtIP and ATM can be inhibited by 53BP1 in BRCA1 deficient cells (Bunting et al., 
2010). 53BP1 was shown to block HR by preventing end resection. Here the knockdown of 
53BP1 in BRCA1 deficient cells rescued the sensitivity of BRCA1 cells to PARPi, suggesting that 
53BP1 blocks HR. BRCA1 and 53BP1 deficient cells inhibited for ATM were also sensitive to 
PARPi, since ATM cannot initiate CtIP mediated resection despite DNA ends being available for 
resection. BRCA1 is known to possess ubiquitin ligase activity, but this function is not essential 
for maintaining genomic stability (Reid et al., 2008). Bunting et al (2010), propose that BRCA1 
may function to remove proteins which are inhibitory to HR. For example the retention of Ku 
(Postow et al., 2008) and 53BP1 (Watanabe et al., 2009) is dependent on DSB induced 
ubiquitination of these factors. Following DSB resection and formation of 3’ssDNA ends, the 
heterotrimeric RPA complex, which is composed of 3 tightly associated subunits of 70, 32 and 
14 KDa, binds the ssDNA region (Wold, 1997). RPA is required for NER, BER, MMR and DSB 
repair (Wold, 1997). RPA is hyperphosphorylated in response to UV or IR (Liu and Weaver, 
1993). The unstressed cell cycle dependent phosphorylation of RPA occurs during G1/S 
transition and in M phase at CDK phosphorylation sites Ser23 and Ser29 at the N-terminus of 
RPA32 subunit (Din et al., 1990). Stress induces RPA hyperphosphorylation. RPA coated single 
stranded DNA regions recruit the PIKK family member ATR. ATR binds RPA via the ATR 
interacting protein (ATRIP) (Zou and Elledge, 2003). ATR phosphorylates components of the 
replication fork including the MCM helicase complex, which facilitates DNA strand opening 
(Cortez et al., 2004). ATR also phosphorylates Chk1 at the site of a DSB (Lukas et al., 2003). 
Chk1 phosphorylates protein involved in HR repair, including RAD51. Chk1 dependent RAD51 
phosphorylation at Thr309 is essential for RAD51 foci formation after replication associated 
damage (Sorensen et al., 2005). Rad51 filaments assemble on RPA coated ssDNA a process 
which is mediated through BRCA2 leading to HR repair (West, 2003). RPA and Rad51 form IR 
induced foci, which have been suggested to represent sites of resected DSBs (Miyazaki et al., 
2004). The interaction between Rad51 and BRCA2 C-terminus is dependent on CDK dependent 
phosphorylation of BRCA2, and is therefore limited to S and G2 phases of the cell cycle (Esashi 
et al., 2005). Rad51 filaments mediate the process of strand invasion, a process which searches 
the sister chromatid for homologous sequences to use as a template for repair. There are 
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several outcomes from this process, including extension of the 3’ invading strand by DNA 
polymerase followed by reannealing to the processed second strand of the break (West, 2003). 
Alternatively, Holiday junction intermediates can be formed after ligation of the invading 
strand with the second DNA end following branch migration (West, 2003). A variety of process 
can function to resolve the Holliday junction intermediate structures (Wechsler et al., 2011).  
Proteins involved in Holiday junction resolution include MUS81-EME1 (Chen et al., 2001), SLX1-
SLX4 (Andersen et al., 2009) and GEN1 (Rass et al., 2010), which function in endonucleolytic 
cleavage. Topological DNA problems that arise during DNA replication or repair can be 
resolved by topoisomerase enzyme I or II. Topoisomerases are enzymes that bind single or 
double stranded DNA and induce a transient nick in the DNA phosphate backbone. This allows 
the DNA to unwind and relax around the nick and subsequently removes the topological 
problem.  
 A role for CtIP has recently been established in the removal of DNA interstrand 
crosslinks. CtIP functions in G1 phase cells along with the MRN complex to remove etoposide 
induced lesions (Quennet et al., 2010). Knockdown of CtIP in XLF deficient cells was not 
additive suggesting that CtIP directed repair of etoposide (a drug which inhibits topoisomerase 
II) induced DSBs via NHEJ. It was proposed that CtIP functions in G1 with the MRN complex to 
remove topoisomerase II from DSBs prior to repair by NHEJ (Quennet et al., 2010).  
 Loss of ATRIP leads to an almost identical phenotype as observed when ATR is deleted 
(Cortez et al., 2001). ATRIP binds to RPA coated ssDNA directly (Zou and Elledge, 2003). γH2AX 
after UV is dependent on ATR (O'Driscoll et al., 2003b; Ward and Chen, 2001). CtIP is not 
phosphorylated after UV (Foray et al., 2003). ATM is not activated in response to UV (Khanna 
et al., 2001). 
 
1.2.3 Alternative NHEJ 
PARP also senses DSBs and acts to promote alt-NHEJ, which functions as a “backup” repair 
pathway to classical NHEJ in the absence of Ku (Wang et al., 2006a). Alt-NHEJ is characterized 
by repair junctions bearing regions of microhomology, excessive deletions (Roth and Wilson, 
1986) and chromosomal translocations (Bennardo et al., 2008). Chromosomal translocations 
are characteristic of cancer cells, thus understanding translocation formation is important for 
preventing tumorigenesis. An alternative NHEJ pathway was suggested to function to promote 
translocation formation given that translocations are not observed with HR proficient cells 
(Zhang and Rowley, 2006) and the elimination of Ku or DNA ligase IV–XRCC4 promotes the 
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frequency that chromosomal translocations occur (Simsek and Jasin, 2010). Alt-NHEJ uses a 
region of microhomology to align the broken DNA strands before joining. To reveal a region of 
microhomology suitable to mediate alt-NHEJ, 5’-3’ nucleolytic resection is required to degrade 
the ends at the DSB which results in loss of DNA sequence (McVey and Lee, 2008). A candidate 
nuclease is CtIP, since CtIP depleted cells have a decreased frequency of chromosomal 
translocation (Li et al., 2000). Recently CtIP has been established to have an essential role in 
alt-NHEJ. CtIP depletion in Ku70-/- cells resulted in an 80% reduction in translocations. Ku 
normally suppresses chromosomal translocations by inhibiting the resection step of alt-NHEJ 
and directing repair by NHEJ. Additionally CtIP knockdown cells were observed to have shorter 
microhomology repair junctions (Zhang & Jasin, 2010). Therefore alt-NHEJ is a DSB repair 
pathway that is independent of Ku and XRCC4 but dependent on PARP and CtIP.  
 
1.3 Signalling molecules and modifications 
1.3.1 Phosphorylation 
Post translational modifications such as protein phosphorylation in response to DNA damage is 
an important mechanism which orchestrates and regulates the DDR. Phosphorylation is the 
addition of a phosphate (PO4) group onto a protein. Phosphorylation activates or deactivates 
many protein enzymes. Phosphorylation on serine is the most common residue modified by 
phosphate addition, followed by threonine, then tyrosine (Burnett and Kennedy, 1954). The 
addition of a phosphate group to a protein is carried out by protein kinases. Kinases are 
enzymes that transfer the phosphate group from donor molecules such as ATP to specific 
substrates. Eukaryotic protein kinases belong to an extensive protein family that share a 
conserved catalytic core (Hanks and Hunter, 1995). The N-terminal of the catalytic domain has 
a stretch of glycine residues with a lysine amino acid which is important for ATP binding. The 
catalytic domain also contains an aspartic acid which is important for the catalytic activity of 
the kinase (Knighton et al., 1991). Serine/Threonine protein kinases phosphorylate the OH 
group of serine or threonine. ATM, ATR, and DNA-PKcs are all serine/threonine protein kinases 
and are central to damage response signalling.  
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1.3.2 Ubiquitination and SUMOylation 
In addition to phosphorylation, ubiquitination and SUMOylation have recently been 
established as additional modifications important for DDR regulation. Ubiquitin is a small 
highly conserved regulatory protein. The ubiquitination of target proteins works using three 
functional components, namely an E1 ubiquitin activating enzyme, an E2 ubiquitin conjugating 
enzyme and an E3 ubiquitin ligase (Figure 1.3). The E1 ubiquitin ligase catalyzes the activation 
of ubiquitin by using ATP to transfer ubiquitin to the E2 enzyme. The E2 enzyme interacts with 
a specific E3. The E3 ligase is responsible for transferring the ubiquitin to a specific target by 
catalysing the attachment of ubiquitin to a lysine on a target protein via an isopepetide bond. 
Polyubiquitinated proteins are often targeted for degradation by the proteasome. Mono-
ubiquitinated proteins are not targeted for degradation, but instead are altered in their cellular 
location or function. Additionally, different lysine residues targeted for ubiquitination can 
direct events down different pathways, for example Lys48 polyubiquitin chains target proteins 
for proteosomal degradation, whereas Lys68 polyubiquitin chains are important for DSB repair 
(reviewed in A-Hakim et al., 2010). 
 SUMO is a small ubiquitin-like modifier. Although SUMO has very little sequence 
identity with ubiquitin at the amino acid level, it has a nearly identical structural fold. Three 
SUMO isoforms in humans exists: SUMO1, SUMO2 and SUMO3. SUMO2 and SUMO3 are highly 
similar (Saitoh and Hinchey, 2000). Mixed chains of SUMO1 and SUMO2/3 can be formed. 
SUMO1 lacks the internal SUMO consensus site found in SUMO2/3, and is thought to 
terminate polySUMO chains (Matic et al., 2008). SUMOylation is directed by an enzymatic 
cascade analogous to that involved in ubiquitination. First the C-terminal peptide of SUMO is 
cleaved by a sentrin-specific (SENP) protease using ATP to reveal a di-glycine motif. Next 
SUMO becomes bound to an E1 SUMO activating enzyme (SAE). SUMO is then passed to an E2 
conjugating enzyme, Ubc9 in mammalian cells. An E3 ligase, either protein inhibitor of 
activated STAT 4 (PIAS4) or PIAS1 in mammalian cells, then attaches the SUMO to a target 
protein (Hay, 2005).  
 
1.4 Protein–protein interacting motifs: 14-3-3, FHA and BRCT domains 
Protein phosphate modifications are not only important for the activation of many proteins 
involved in the DDR but are also important for the formation of phosphopeptide signalling 
complexes and protein–protein interactions. Certain proteins and domains specifically 
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recognize short amino acid sequences surrounding a central phosphorylated serine or 
threonine residue. Three families of phosphoserine/threonine binding domains function in the 
DDR: 14-3-3 proteins, FHA domains and BRCT domains. The first phosphothreonine/serine 
binding protein identified was the 14-3-3 complex (Muslin et al., 1996). 14-3-3 proteins are 
highly conserved and are found in all eukaryotes (Mohammad and Yaffe, 2009). 14-3-3 
proteins mainly function in the cell cycle to supress cyclin-cdk activity through directly binding 
and sequestering the CDC25 family of phosphatases in the cytoplasm (Dalal et al., 2004) (see 
1.10.2 for details). FHA domains are phosphothreonine binding motifs found in hundreds of 
prokaryotic and eukaryotic proteins involved in transcription, DDR signalling and cell cycle 
control (Mohammad & Yaffe, 2009). DDR proteins MDC1, RNF8, NBS1 and Chk2 all contain an 
FHA domain. BRCT domains are found in multiple DDR proteins and are often in tandem arrays. 
There are roughly 30 BRCT domain containing proteins in mammalian cells (Callebaut and 
Mornon, 1997). The phosphopeptide binding activity of BRCT domains requires the presence 
of two BRCT domains in tandem. The N-terminal BRCT primarily stabilizes the phosphoserine, 
while the tandem BRCT domain fold forms a hydrophobic pocket which stabilizes the phosho-
ligand (Clapperton et al., 2004). Cancer associated mutations of BRCA1 often disrupt the BRCT 
domain of Breast cancer and ovarian type 1 (BRCA1) (Castilla et al., 1994), reflecting the 
importance of this domain in the DDR.  
 
1.5 The mediator proteins 
1.5.1 BRCA1 
BRCA1 is a multifunctional protein that functions to maintain genome stability primarily 
through its involvement in DSB repair and cell cycle control. BRCA1 contains a highly conserved 
RING domain and two BRCT domains (Figure 1.2). The RING domain is found in many E3 
ubiquitin ligases and mediates protein ubiquitination. The BRCT domains bind phosphorylated 
proteins and mediate protein-protein interactions (Manke et al., 2003), (Yu et al., 2003). The 
RING domain of BRCA1 mediates its stable association with BRCA1-associated RING domain 
protein 1 (BARD1) (Meza et al., 1999). BARD1 has a similar domain organization to BRCA1, 
comprising an N-terminal RING domain and tandem C-terminal BRCT domain. BRCA1 exists as 
a stable heterodimer with BARD1 (Wu et al., 1996). BRCA1 participates in G2/M checkpoint 
control partly by regulating Chk1 phosphorylation (Yarden et al., 2002). The mechanism is 
unclear; it is possible that BRCA1 may modify local chromatin architecture through substrate 
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ubiquitination surrounding a DSB to enhance ATM signalling. Alternatively BRCA1 may act as a 
scaffold for Chk1 phosphorylation (Huen et al., 2010).  BRCA1 is known to be required for CtIP 
dependent resection which leads to RPA recruitment and Chk1 activation. Therefore BRCA1 
may regulate G2/M checkpoint arrest indirectly by initiating resection which subsequently 
leads to Chk1 activation. For example, CtIP interacts with the BRCT domain of BRCA1 (Yu and 
Chen, 2004), and is modified with ubiquitin chains by BRCA1. CtIP promotes resection by 
stimulating the MRN complex (Sartori et al., 2007). CtIP is phosphorylated at Ser327 and 
interacts with BRCA1 during S and G2 phase (Yu & Chen, 2004). CtIP phosphorylation mutants 
that cannot bind BRCA1 exhibit defects in Chk1 phosphorylation and G2/M checkpoint arrest 
(Yu et al., 2006). Therefore it is possible that BRCA1 regulates the G2/M checkpoint by 
mediating CtIP dependent resection and subsequent Chk1 activation. BRCA1 also has a direct 
role in DSB repair through interacting with partner & localizer of BRCA2 (PALB2). PALB2 
recruits BRCA2 to sites of DSBs (Xia et al., 2006). BRCA2 loads Rad51 which forms filaments 
capable of performing a homology search in a sister chromatid to facilitate repair by HR.  
 
1.5.2 53BP1 
p53 binding protein 1 (53BP1) is another mediator protein that is important for relaying 
signalling between sensor and transducer proteins. 53BP1 also contains two BRCT domains 
which are involved in protein interactions. Upstream of the BRCT domain, 53BP1 contains a 
tudor domain (Charier et al., 2004) (Figure 1.2). Tudor domains interact with methylated 
histone residues, and are possibly used by 53BP1 for recruitment to regions of damaged DNA. 
53BP1 also contains a glycine/arginine-rich region (GAR), which is methylated by the enzyme 
PRMT1 (protein arginine N methyltransferase 1) and has been implicated as a possible DNA 
binding function for 53BP1 (Boisvert et al., 2005). 53BP1 contains 32 PIKK S/TQ consensus sites 
(Jowsey et al., 2007). Abrogation of 53BP1 results in a modest defect in G2/M checkpoint 
arrest which is only detectable after low doses IR and not after higher doses (DiTullio et al., 
2002), reflecting an essential role of 53BP1 in signal amplification after low doses IR. 53BP1 is 
necessary for efficient Chk2 phosphorylation (Wang et al., 2002). In DSB repair, 53BP1 is 
required for ATM dependent DSB repair (Riballo et al., 2004). These DSBs are repaired with 
slower kinetics and represent breaks that reside at regions of heterochromatin (Goodarzi et al., 
2008a), (Noon et al., 2010). 53BP1 also influences chromatin mobility at the environment 
surrounding a DNA damaged focus. For example, the presence of 53BP1 at deprotected 
telomeres increases chromatin mobility, thereby increasing the likelihood that two ends will 
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come together for repair by NHEJ (Dimitriva et al., 2008). 53BP1 also enhances the rate of class 
switch recombination (Manis et al., 2004; Ward et al., 2004) and long range V(D)J 
recombination (Difilippantonio et al., 2008), both end joining processes that involve DNA ends 
that are not in close proximity. Difilippantonio et al (2008), suggest that 53BP1 may promote 
chromatin mobility possibly via interacting with dynein motor proteins (Lo et al., 2005).  
 
1.5.3 MDC1 
Mediator of DNA damage checkpoint protein 1 (MDC1) is another mediator protein with a 
BRCT and FHA domain (Figure 1.2). MDC1 rapidly binds Ser139 phosphorylated H2AX to 
promote the recruitment of repair proteins to DSBs (Stewart et al., 2003). MDC1 deficient cells 
are sensitive to IR, and MDC1 controls the formation of 53BP1, BRCA1 and MRN by promoting 
efficient H2AX phosphorylation (Stewart et al., 2003) (see 1.6 for further discussion). 
 
1.6 γH2AX phosphorylation and DDR signalling cascade 
In response to DSBs, ATM and ATR phosphorylate a plethora of proteins that mediate the DDR 
signalling response. One initial target of these kinases is the histone variant H2AX. ATM, ATR 
and DNA-PKcs can directly phosphorylate H2AX at Ser139, a histone modification that is 
commonly referred to as γH2AX (Rogakou et al., 1998) (Figure 1.4). Following H2AX 
phosphorylation, MCD1 directly binds H2AX via its C-terminal BRCT repeat domain (Lukas et al., 
2004). MDC1 also binds the FHA and BRCT domains of the MRN complex subunit Nbs1 
(Chapman and Jackson, 2008). Nbs1 directly binds and tethers ATM at the site of a DSB, which 
functions to localize the kinase activity of ATM. MDC1 also binds ATM through its FHA domain 
which further propagates H2AX spreading (Lou et al., 2006). The initial localization of DDR 
proteins such as NBS1, BRCA1 and 53BP1 are not dependent on γH2AX phosphorylation, but 
sustained DDR signalling and maintenance of these factors at a DSB is dependent on extensive 
γH2AX spreading (Celeste et al., 2002). Additionally chromatin remodelling factors such as 
INO80 and SWI/SNF family are recruited to DSBs in a γH2AX dependent manner (Lee et al., 
2010). Recruitment of several DDR proteins is dependent on ubiquitination. The ubiquitin 
ligase RING finger containing nuclear factor 8 (RNF8) associates with MDC1 via an N-terminal 
FHA domain which propagates K63 linked ubiquitin (Ub) chains on neighbouring H2A and H2AX 
histones (Huen et al., 2007; Mailand et al., 2007). The E3 ligase RING finger containing nuclear 
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factor 168 (RNF168) binds these Ub chains and stimulates K63 ubiquitination (Stewart et al., 
2009). Heat domain & RLD 2 (HERC2), a recently identified E3 ubiquitin ligase interacts with 
RNF8 and facilitates the assembly of the RNF8 and ubiquitin conjugating enzyme 13 (UBC13) 
complex which further stimulates K63-linked ubiquitin chain synthesis (Bekker-Jensen and 
Mailand, 2010). K63 Ub chains generated by RNF8 are recognized by RAP80, which 
subsequently recruits the E3 ligase BRCA1 via an interaction with the scaffold protein ABRA1 
(Huen et al., 2007). RNF168 dependent ubiquitination is regulated by inhibition of UBC13 by 
the deubiquiting enzyme OTUB1 (Nakada et al., 2010).  
SUMO mediated modifications are also important for DDR protein recruitment. Protein 
inhibitor of activated STAT4 (PIAS4), an E3 SUMOylating protein kinase, has been shown to 
stimulate the Ub ligase activity of the RNF8/UBC13 complex (a ubiquitin E3 and SUMO E2 
complex respectively), thus promoting the recruitment of RNF168 and BRCA1 to site of 
damage (Galantly et al., 2009). A related kinase PIAS1 and PIAS4 are capable of directly 
SUMOylating BRCA1 to stimulate its Ub ligase activity (Galanty et al., 2009). A related protein, 
PIAS1 and PIAS4 are capable of directly SUMOylating BRCA1 to stimulate its Ub ligase activity 
(Galanty et al., 2009). Additionally 53BP1 recruitment is dependent on PIAS4 (Galantly et al., 
2009). However 53BP1 has no Ub binding domain. It has been proposed that RNF8/RNF168 
dependent ubiquitination events mediate chromatin relaxation which subsequently exposes 
dimethyl H4K20 and H3K79 residues, which are recognized by 53BP1 tudor domains 
(FitzGerald et al., 2009). The accumulation of these proteins into repair foci can be easily 
visualized under a microscope using fluorescently tagged antibodies to identify any one of 
these proteins. Monitoring the disappearance of these repair foci is commonly used as a 
biomarker for DSB repair and is a technique employed in this thesis.  
 
1.7 PIKK family 
The coordinated regulation of the DDR is controlled and initiated by three related kinases ATM, 
ATR and DNA-PK. These kinases belong to the PIKK (phospatidylionositol-3-kinase) related 
family (Shiloh, 2003). These enzymes phosphorylate proteins rather than lipids like the related 
PI3K family. All members are large proteins over 300 KDa’s in size with related domain 
structures. At the N-terminus all members have a large repeated domain known as a 
huntingtin, elongation factor3, protein phosphatase 2A & TOR1 (HEAT) domain, followed by a 
FRAP-ATM-TRRAP (FAT) domain, a catalytic domain homologous to the PI-3 kinase domain, a 
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PIKK regulatory domain (PRD) and a FATC domain at the C-terminus (Lovejoy and Cortez, 2009). 
The HEAT, FAT and FATC domains are involved in protein and substrate interaction (Lavin, 
2008). The consensus phosphorylation site for PIKK substrates is a serine or threonine residue 
followed by glutamine (SQ/TQ) motif. ATM and ATR have a wide substrate scope, with over 
900 substrates having been identified (Matsuoka et al., 2007). 
 
1.8 ATM activation  
Ataxia telangiectasia mutated (ATM) is central to the DSB signal transduction cascade. ATM 
exists as an inactive dimer in undamaged cells. In response to DSBs, ATM undergoes 
autophosphorylation, which results in dimer dissociation and kinase activation (Bakkenist and 
Kastan, 2003). 
 
1.8.1 ATM autophosphorylation and activation 
The most widely studied ATM auto-phosphorylation, Ser1981, is an SQ motif located in the 
amino-terminal region of the FAT domain and is rapidly phosphorylated in response to IR 
(Bakkenist & Kastan, 2003).  Other phosphorylation sites on ATM have also been 
demonstrated to be important for ATM activation such as Ser367 and Ser1893 (Kozlor et al., 
2006). Expression of mutated versions of ATM harboring nonphosphorylateable residues in 
cells from A-T patients resulted in increased radiosensitivity. However the literature remains 
controversial over the importance of ATM autophosphorylation events. Nussenweig and co-
workers demonstrated that expression of an S1987 (analogous to human S1981A) allele in 
ATM mouse yielded normal ATM dependent phosphorylation events after DNA damage and 
normal ATM localization at DSBs (Pellegrini et al., 2006). Furthermore, the Ser1981 
autophosphorylation site is not conserved in all ATM homologs, for example it is not present in 
Arabidopsis, Drosophila, budding yeast or fission yeast. Therefore the importance of ATM 
autophosphorylation in mediating ATM kinase activation may differ between species. Despite 
this distinction between species, ATM autophosphorylation in human cells does correlate with 
ATM activation and is used in this thesis to monitor ATM activation.  
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1.8.2 PP2A mediated dephosphorylation of ATM 
The de-activation of ATM’s kinase activity is also important for the down regulation of DSB 
induced signaling events and to allow cell cycle re-entry. Protein phosphatases have been 
demonstrated to affect ATM activity in vivo, in particular PP2A and PP5A (Ali et al., 2004; 
Goodarzi et al., 2004). PP2A is a member of the protein/threonine phosphatase family and is 
composed of a catalytic (C) subunit, a scaffolding (A) subunit and a regulatory (B) subunit. ATM 
directly interacts with the A subunit of PP2A, and in unirradiated cells, A and C subunits of 
PP2A directly co-immunoprecipitate with ATM (Goodarzi et al., 2004). Following IR these 
subunits dissociate from ATM, suggesting that ATM may be constitutively dephosphorylated 
by PP2A in undamaged cells (Goodarzi et al., 2004).  
 
1.8.3 ATM activation and signal amplification 
Ataxia telangiectasia like disorder (ATLD) and Nijmegen Breakage Syndrome (NBS) express 
hypomorphic alleles of Mre11 and Nbs1, respectively and are deficient in ATM activation. The 
clinical similarities between these syndromes and A-T suggest that the MRN complex plays an 
important role in ATM activation (Lee and Paull, 2005; Uziel et al., 2003). MRN is now an 
established upstream activator and substrate of ATM. Evidence of this was established from 
studies analyzing ATM signaling in Nbs1 or Mre11 deficient cell lines, where ATM 
autophosphorylation at Ser1981 was found to be compromised (Uziel et al., 2003).  MRN was 
later shown to interact with ATM via the C-terminus of Nbs1, which is required for the 
recruitment of ATM at the site of a DSB (Falck et al., 2005; Nakada et al., 2003). Cells 
expressing a complex which targets MRN for degradation known as endovine E1655k/E4crf6 
have abrogated ATM autophosphorylation, and BRCA1 and Chk2 phosphorylation, implying 
that MRN is required for ATM mediated phosphorylation of downstream repair factors (Carson 
et al., 2003). In Nbs1 defective cells, Chk2 phosphorylation is reduced or absent but p53 
phosphorylation by ATM is unaffected (Lee et al., 2003). This data suggests that the MRN 
complex is required for tethering ATM’s kinase activity at the break, whereas ATM targets 
which do not form IR induce foci, such as p53, can be readily phosphorylated in the absence of 
MRN mediated ATM tethering.  The mediator proteins MDC1 and 53BP1 have a dose 
dependent role in amplifying ATM signalling. After low doses of IR, cells deficient for 53BP1 or 
MDC1 are unable to initiate a full checkpoint response, however after doses above 6 Gy IR cells 
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are checkpoint proficient (Fernandez-Capetillo et al., 2002; Peng and Chen, 2003). This data 
presents a role for the mediator proteins in amplifying low dose damage signalling.  
 
1.8.4 ATM activation and chromatin remodeling  
In 2003 Kastan and Bakkenist (2003), reported that ATM activation following chloroquine 
induced chromatin relaxation independently of IR. A role for the chromatin modifying protein 
high-mobility group nucleosome binding domain 1 (HMGN1) has been shown to be important 
for ATM activation (Kim et al., 2009). HMGN1 is a member of the HMG superfamily of nuclear 
proteins that bind nucleosome core particles and affect chromatin superstructure (Bianchi and 
Agresti, 2005). Hmgn1-/- MEFs revealed that loss of HMGN1 significantly reduces the IR induced 
autophosphorylation of Ser1987 (Ser1981 homolog) (Kim et al., 2009). However the IR induced 
formation of Nbs1, MDC1, 53BP1 and γH2AX foci were all normal in Hmgn1-/- cells, implying 
that the reduced ATM activation observed in these cells was not due to defective recruitment 
of DSB mediator proteins to damaged sites. Loss of HMG1 reduced the amount of ATM 
Ser1987 phosphorylation found bound at chromatin. However, HMGN1 and ATM do not co-
localize when analyzed by immunofluorescence, indicating that ATM does not bind HMGN1 
enriched chromatin (Kim et al., 2009). This implied that defective ATM activation in Hmgn1-/- 
cells was due to global changes in chromatin organization rather than a direct interaction 
between HMGN1 and ATM. Additionally, global acetylation of Lys14 of histone H3 (H3K14) 
after IR increased in WT cells but less so in Hmgn1-/- cells. The authors suggest that HMGN1 
affects global organization of ATM throughout the nucleus through a mechanism involving 
H3K14 chromatin modification (Kim et al., 2009). 
 Tip60 is a histone acetyl transferase (HAT) which adds acetyl groups to lysine residues 
on histone tails. DSB induced activation of Tip60 leads to Tip60 dependent acetylation and 
activation of ATM (Sun et al., 2005; Sun et al., 2007). Mutations in the chromodomain, a 
conserved domain which interacts with methyl groups on methylated lysine residues, 
abolishes Tip60 dependent acetylation and autophosphorylation of ATM (Sun et al., 2009). 
Chk2 phosphorylation is also defective in Tip60 chromodomain mutants. Tip60 
acetyltransferase activity and ATM activation is also significantly impaired in Suv39H1/2 MEFs 
(Sun et al., 2009). Suv39H1 and H2 are histone methyltransferases responsible for tri-
methylating lysine 9 on histone H3, a chromatin modification associated with regions of 
heterochromatin.  Following treatment of cells with a demethylating drug which specifically 
demethylates H3K9me3 and H3K36me3 (Klose et al., 2006; Whetstine et al., 2006), the 
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demethylation of H3K9, H3K27 and H3K36 was found not to affect γH2AX foci or MRN 
recruitment to the site of a DSB. Tip60 was also recruited to DSBs in cells in which TriMeK9 H3 
was reduced, suggesting that the interaction of Tip60’s chromodomain and methylated 
histones is not required for Tip60 recruitment to a DSB (Sun et al., 2009). However 
demethylation of H3K9 sensitized cells to IR (Sun et al., 2009). Most TriMeK9 H3 has been 
shown by NMR spectroscopy to be bound by heterochromatin protein 1 (HP1), three isoforms 
of which exist (Nielsen et al., 2002). Following treatment with IR, the chromodomain of HP1β is 
phosphorylated by casein kinase 2 (Ck2), which results in the release of HP1β from TriMeK9 
histone H3 (Ayoub et al., 2008). Inhibiting cells for Ck2 prevents the release of HP1β from 
chromatin and results in defective Tip60 acetyltransferase activity and impairs Chk2 
phosphorylation (Ayoub et al., 2008). This implies that TriMeK9 histone H3 tail modifications 
are required for activation of Tip60 acetyltransferase activity. Tip60 acetyltransferase activity 
and acetylation of ATM is also reduced in MRN deficient cells (Sun et al., 2009). Sun et al 
(2009), proposed that ATM and Tip60 are recruited to DSBs via the MRN complex as an 
inactive complex. Price and co-workers have proposed a model for ATM activation that 
involves first the ejection of HP1β from chromatin exposing TriMeK9 H3, followed by MRN 
association with DSBs, the recruitment of inactive ATM-Tip60 complex to Nbs1, the localized 
recruitment of Tip60 and TriMeK9 resulting in activation of Tip60’s acetyltransferase activity, 
followed by acetylation and finally activation of ATM.  
 
1.9 ATR signaling 
The DDR is also stimulated by regions of ssDNA that can be generated at stalled or collapsed 
replication forks and by resected DSBs. The DDR in response to these lesions is coordinated by 
ATR. ATR responds to a wide range of DNA damage including replication stress, base adducts, 
UV induced nucleotide damage and DSBs. The response of ATR to IR, unlike ATM, is restricted 
to S and G2 phases of the cell cycle (Jazayeri et al., 2006). This is likely a consequence of 
resection mediated ssDNA generation being regulated by proteins which are regulated by CDK 
mediated stimulation, levels of which are low in G1 and M phase and high in S and G2 phase 
(Paull and Gellert, 1998; Sartori et al., 2007). The initiating step in ATR activation is the 
generation of ssDNA (Figure 1.5). ssDNA regions rapidly become coated in RPA which recruit 
the ATR-ATRIP (ATR-interacting protein) complex (Cortez et al., 2001). ATR and ATRIP are 
constitutively bound and loss of either complex results in the same DDR defect (Cimprich and 
Cortez, 2008b). To activate ATR kinase activity it must interact with TopBP1 (Kumagai et al., 
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2006). TopBP1 recruitment to ssDNA regions is also mediated by RPA (Majka et al., 2006). Here 
the clamp loader Rad17, which has homology to the replication factor C (RFC) that loads 
proliferating cell nuclear antigen (PCNA) at replication forks, is first recruited. Rad17 
subsequently loads the PCNA like heterotrimeric ring Rad9-Rad1-Hus1 (9-1-1) complex to 
damage sites (Yang and Zou, 2006). The 9-1-1 complex is responsible for recruiting 
topoisomerase binding protein 1 (TopBP1) bringing TopBP1 and ATR in close proximity leads to 
ATR activation (Lee et al., 2007). The mediator protein Claspin is also recruited via Rad17 
(Wang et al., 2006b). Claspin is required to mediate ATR kinase activity towards the check 
point kinase Chk1 (Kumagai and Dunphy, 2003). In G2 phase cells, ATM and MRN are required 
to initiate resection to form ssDNA substrates which lead to RPA recruitment and subsequent 
ATR activation. In this scenario, ATM phosphorylates and activates the exonuclease CtIP. 
 
1.10  Cell cycle checkpoint control 
An overview of cell cycle checkpoint arrest is given here. A more detailed discussion of how 
DNA damage and heterochromatin affect checkpoint arrest is given in chapter 3, 4 and 6. The 
cell cycle is monitored by surveillance mechanisms that arrest further progression if a crucial 
process has not been completed or if a cell has sustained DNA damage. The G1 and S phase 
checkpoints prevent replication of damaged DNA, whereas the G2 checkpoint prevents 
segregation of damaged chromosomes to daughter cells. Cell cycle checkpoint arrest is 
regulated by ATM and ATR. The downstream effector kinases that transduce ATM and ATR 
mediated signaling to initiate checkpoint arrest are the checkpoint kinases Chk2 and Chk1, 
respectively. Chk2 and Chk1 act as transducers of the DNA damage signal, phosphorylating a 
multitude of substrates in the DDR. Chk2 and Chk2 have a number of overlapping substrates, 
but have independent roles in directing the cellular response to DNA damage. ATM responds 
to DSBs and ATM and Chk2 can contribute to the regulation of all checkpoints. ATR responds 
to replication associated DNA damage, UV induced DNA damage, DNA crosslinks and resected 
DSBs. Given that DNA resection is restricted in G1 due to low CDK levels preventing the 
activation of endonucleases and that SSBs do not activate ATM or ATR, G1/S checkpoint arrest 
is dependent on ATM signaling only. Both ATM and ATR can function to initiate arrest at the 
intra-S phase and G2/M checkpoints. Similar to ATR, Chk1 activation is restricted to S and G2 
phase (Huertas and Jackson, 2009) (Figure 1.6). 
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1.10.1 Chk1 and Chk2 
Chk2 is a highly phosphorylated protein with more than 25 phosphorylation sites identified to 
date, some of which are important for regulation and stability (Ahn et al., 2004; Gabant et al., 
2008; Kass et al., 2007; Lovly et al., 2008). A well-studied Chk2 phosphorylation is the 
phosphorylation of Thr68 by ATM in response to DSBs (Ahn et al., 2000; Matsuoka et al., 2000). 
Phosphorylation at Thr68 promotes the binding of the SQ/TQ motif of one Chk2 to the FHA 
domain of another Chk2. This dimerization event initiates the autophosphorylation of Chk2’s T 
loop at Thr383 and Thr387 residues, resulting in full Chk2 activation (Ahn et al., 2002; Xu et al., 
2002). Protein phosphatases PP2A, PP2C and WIP1 bind and dephosphorylate Thr68 on Chk2. 
Once the T loop is phosphorylated, Thr68 is not required to maintain Chk2 activation (Ahn and 
Prives, 2002). Chk2 mice are viable and develop normally after birth (Hirao et al., 2000). 
Despite G2/M checkpoint initiation after IR being normal in Chk2 -/- deficient cells, conflicting 
results regarding G2/M checkpoint maintenance have been reported. At IR doses of 10 Gy, 
Chk2 deficient cells maintain checkpoint arrest for up to 6 hours (Takai et al., 2002). However 
at lower doses IR (5 Gy), Chk2 deficient cells are released from the G2/M checkpoint 
prematurely (Hirao et al., 2000). It is likely that at higher doses IR enough DDR signaling is 
generated to maintain arrest. At lower dose IR there is a role for the mediator proteins MDC1 
and 53BP1 to tether and amplifying the DDR. 
 Chk1 expression is largely restricted to S and G2 phase (Lukas et al., 2001) and is active 
as a kinase even in unperturbed cells (Gatei et al., 2003). Chk1 is characterized by 4 functional 
domains: an N-terminal kinase domain, followed by an SCD domain, a bipartite nuclear 
localization signal, and a PCNA interacting protein (PIP) motif (Scorah et al., 2008). The C-
terminal of Chk1 has been proposed to function as an auto-inhibitory region, as C-terminally 
truncated isoforms of Chk1 have increased activity (Katsuragi and Sagata, 2004). Chk1 
activation is primarily downstream of ATR in response to genotoxic insult. In undamaged cells 
a large proportion of Chk1 is chromatin bound (Smits et al., 2006). Phosphorylation of Chk1 
appears to affect its subcellular localization. For example, phosphorylation of Chk1 on Ser317 
is required for chromatin release as well as G2 checkpoint arrest, as Ser317 mutants and Chk1 
tethered to chromatin cannot activate G2/M checkpoint responses (Niida et al., 2007; Smits et 
al., 2006).  
 The checkpoint kinases phosphorylate numerous proteins that influence diverse 
aspects of the DDR to promote genome integrity. Chk1 and Chk2 influence diverse aspects of 
the DDR primarily, but not exclusively, via their influence on transcription. For example, 
Shimada et al (2008), reported a novel function for Chk1 in chromatin modification. Here Chk1 
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was shown to mediate phosphorylation of histone H3 on residue Thr11 (H3-Thr11). Using 
radiolabelled phosphorous, Chk1 but not kinase dead Chk1 incorporated phosphorous into H3 
in vivo. In addition, Chk1 chromatin dissociation after DNA damage correlated with H3-Thr11 
dephosphorylation and a reduction of Cdk1 and cyclin B1 transcript levels. GCN5 (a histone 
acetyltransferase (HAT) that promotes transcription) binds H3 peptides and phosphorylation of 
H3-Thr11 was found to enhance GCN5 chromatin binding (Shimada et al., 2008). The authors 
proposed a model whereby in unperturbed cells Chk1 is chromatin bound and histone H3 is 
phosphorylated at Thr11 in a Chk1 dependent manner. This phosphorylation event promotes 
the recruitment of GCN5 to specific genes. Following DNA damage, Chk1 is phosphorylated by 
ATR or ATM, resulting in Chk1 dissociation from chromatin and a subsequent reduction in H3-
Thr11 phosphorylation. GCN5 is no longer recruited to target genes and transcription is turned 
off (Shimada et al., 2008). 
 Chk1, unlike Chk2, is an essential gene, and Chk1-/- mice are embryonic lethal (Takai et 
al., 2000). Chk1-/- embryos fail to arrest in response to replication blocking agent aphidicolin or 
DNA damage induced by UV or X-ray. The lethality of these mice suggests that Chk2 cannot 
redundantly function to replace Chk1 and likely reflects the role of Chk1 activation in response 
to replication associated DNA damage. Human cells lacking Chk1 exhibit defects in both IR 
induced S and G2 phase checkpoints. 
 
1.10.2 G1/S checkpoint 
The G1/S checkpoint is essential to prevent any lesions that may arise in G0/G1 phase reaching 
the replication fork. If left undetected, these lesions could potentially become heritable 
mutations, which later compromise genetic integrity. In G1 phase cells the main protein 
regulating checkpoint arrest, identified by (Kastan et al., 1992), is p53. p53 levels vary 
throughout the cell cycle; levels are high in G1 but are low for the rest of the cells cycle (Kastan 
et al., 1992). The turnover of p53 is regulated by the murine double minute 2 (MDM2) protein, 
which binds the N-terminus of p53 and functions as a ubiquitin E3 ligase to promote p53 
degradation by proteosomes (Zhang and Xiong, 2001). MDM2 mono-ubiquitinates the C-
terminal of p53. This ubiquitination event exposes the leucine rich nuclear export signal (NES) 
of p53 stimulating the nuclear export and degradation of p53 in the cytoplasm (Boyd et al., 
2000; Stommel et al., 1999). Following damage induction, ATM phosphorylates p53 at Ser15 in 
vivo (Siliciano et al., 1997). This phosphorylation event precludes MDM2 binding of p53. 
Consequently p53 is not ubiquitinated and degradation is prevented (Chen et al., 2005). ATM 
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also directly phosphorylates MDM2, which inhibits the transport of p53 by MDM2 out of the 
nucleus for degradation (Maya et al., 2001). Furthermore, in addition to ATM phosphorylation 
of p53 on Ser15, both Chk1 and Chk2 phosphorylate p53 on Ser20, which adds to the 
disruption of p53’s association with the ubiquitin ligase MDM2, again promoting p53 stability 
(Banin et al., 1998; Canman et al., 1998; Shieh et al., 2000). 
 Following p53 stabilization and increased activation, transcriptional targets such as 
p21 are up-regulated. p21 is a cyclin dependent kinase (CDK) inhibitor (Xie et al., 1998). CDKs 
are serine-threonine kinases that only become active on association with cyclins. CDK-cyclin 
complexes regulate the progression through the cell cycle. IR induced enhanced expression of 
p21 inhibits activation of the CDK-cyclin complexes cyclin E/Cdk2 and cyclin D/cdk4. Failure to 
activate cyclin E/Cdk2 and cyclin D/cdk4 maintains E2F (a DNA binding transcription factor) 
sequestration by retinoblastoma (Rb) and impedes cell cycle progression through G1 (Elledge, 
1996). The Rb tumour suppressor protein binds to E2F preventing it from interacting with the 
transcription machinery. In the absence of Rb, E2F mediates the transcription of proteins 
involved in DNA replication (Chen et al., 2009). G1/S checkpoint arrest is also triggered by 
activated Chk2 following its phosphorylation at Thr68 by ATM. Phosphorylated dimers or 
monomers of Chk2 are active in phosphorylating substrates such as CDC25A. CDC25A is a 
protein phosphatase that removes phosphate groups from phosphorylated tyrosine or 
serine/threonine residues. Three isoforms of CDC25 exist: A, B and C. Phosphorylation of 
CDC25 isoforms targets them for degradation, preventing them from phosphorylating and 
activating of CDKs, and thereby inhibiting cell cycle progression (Boutros and Byrne, 2005). 
Phosphorylation of the effector protein CDC25A, primes it for ubiquitination and proteasome 
destruction (Mailand et al., 2002). The degradation of CDC25A allows the inhibitory 
phosphorylation on cyclin dependent kinase 4 (cdk4) at Tyr14 to be maintained, which 
prevents S-phase entry (Terada et al., 1995). ATM activation of Chk2 also activates and 
stabilizes p53. The p53 dependent block in G1 maintains arrest initiated by the CDC25A 
pathway to allow sufficient time for complete DNA repair. The high frequency of p53 
mutations in human cancers highlights its role as a tumour suppressor.  
 
1.10.3 The intra-S phase checkpoint 
The intra-S phase checkpoint results in a slowing of cell cycle progression rather than a 
complete arrest. In response to DNA damage in S phase, CDC25A is phosphorylated on Ser123, 
Ser178, Ser276 and Ser292 by ATM, Chk1 and Chk2, leading to its rapid degradation (Lukas et 
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al., 2001; Sorensen et al., 2003). Degradation of CDC25A during S phase is regulated by the F-
box protein β-TrCP, which is phosphorylated after DNA damage. β-TrCP binds CDC25A after its 
phosphorylation by Chk1/Chk2, marking it for ubiquitin mediated proteolysis (Busino et al., 
2003). This prevents the dephosphorylation of Thr14/Tyr15 on CDK2 by CDC25A. Maintenance 
of the inhibitory phosphorylations on CDK2 prevent loading of the origin binding factor CDC45. 
Lack of CDC45 loading at origins precludes recruitment of DNA polymerase and thereby blocks 
the initiation of DNA replication from unfired origins (Takisawa et al., 2000). Chk1 and CDC5A 
levels are positively regulated by E2F when cells enter S-phase.  
 
1.10.4 G2/M phase checkpoint arrest 
 
The G2/M checkpoint functions to prevent DNA damage caused during G2 phase being 
segregated into daughter cells during M phase. Regulation of the G2/M checkpoint is 
controlled by both Chk2 and Chk1 and depends on the inhibition of cyclin dependent protein 
kinase 1 (Cdk1) (Yu et al., 1998). Cdk1 prepares cells for entry into mitosis by phosphorylating 
key proteins required for replication including RNA polymerase II and histone H1 (Hartwell and 
Kastan, 1994). Regulation of Cdk1 activity involves Cdk1 catalytic subunits associating with 
cyclins. Activation of Cdk1 is a multistep process. First inhibitory Cdk1 phosphorylations on 
Thr14 and Tyr15, which are carried out by the protein kinase WEE1 (McGowan and Russell, 
1995) and Myt1 (Booher et al., 1997) respectively, must be removed prior to its association 
with cyclin B (Morgan, 1995). Cdk1 is inactive under these circumstances because 
phosphorylation of Thr14 and Tyr15 block the ATP binding site of the kinase. During G2/M 
transition, CDC25 activates the kinase by dephosphorylating Thr14 and Tyr15 (Morgan, 1995). 
In response to genotoxic stress, Chk1 and Chk2 both can function to phosphorylate CDC25 at 
serine 216 (Sanchez et al., 1997). Phosphorylation of CDC25 creates a binding site for 14-3-3 
proteins. 14-3-3 proteins are members of a phosphoserine binding family of proteins which, 
when bound to CDC25, sequester CDC25 in the cytoplasm. This sequestering event prevents 
CDC25 dephosphorylating and activating the mitotic cyclin B-Cdk1 kinase. Inactivation of 
cyclinB-Cdk1 kinase prevents damaged cells from entering mitosis. Despite both Chk2 and 
Chk1 functioning to phosphorylate CDC25, Chk1 appears to have a prominent role in this 
process. Jin et al (2008), found that, when the human colon cancer cell line HCT116 was 
engineered to lack Chk2, cells displayed no defects in CDC25 degradation in response to IR. In 
contrast depletion of Chk1 resulted in strong stabilization of CDC25 in response to IR and 
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continued cell cycle progression. Therefore Chk1 is believed to be the major kinase controlling 
CDC25 degradation in response to IR. 
 
1.11 ATM dependent apoptosis 
When the amount of damage in a cell is not repairable it can trigger apoptosis. Apoptosis is the 
process of programmed cell death. Biochemical events lead to characteristic cell changes such 
as loss of cell membrane asymmetry and attachment, cell shrinkage, nuclear fragmentation 
and chromatin condensation (Kerr et al., 1972). The process of apoptosis is controlled by a 
diverse range of cellular signals. There are two major pathways of apoptosis, one of which is 
mitochondrial based involving caspases (Fesik and Shi, 2001) and the other ligand based 
involving the attachment of receptors onto cell surfaces (Dejean et al., 2006; Kurose et al., 
2006). ATM defective cells are resistant to IR induced apoptosis (Duchaud et al., 1996; Takagi 
et al., 1998), implying that ATM is important for apoptotic signalling after IR. Here I will briefly 
mention some of the ATM dependent apoptotic pathways, but other pathways of apoptosis 
exist that are both dependent and independent of ATM. 
 ATM phosphorylation of p53 induces transcriptional activation of pro-apoptotic factors 
such as p53 up-regulated modulator of apoptosis (PUMA). PUMA is a member of the B-cell 
lymphoma 2 (Bcl-2) protein family which are a family of apoptotic regulatory proteins. p53 also 
up-regulates the Bcl-2 associated x (Bax) protein (Lane, 1992). Bax is believed to interact with 
and induce the opening of the mitochondrial voltage-dependent anion channel (VDAC). 
Alternatively Bax has been suggested to insert into the mitochondrial membrane to form a 
pore (Wolter et al., 1997). Opening of the mitochondrial membrane results in the release of 
cytochrome c (a protein associated with the inner mitochondrial membrane which is involved 
in electron transfer (Tafani et al., 2002) and other pro-apoptotic factors from the mitochondria 
leading to the activation of caspases. Caspases are a family of proteases that degrade proteins.  
 Chk2 can promote apoptosis independent of p53 in response to IR by phosphorylating 
Ser117 of the tumour suppressor pro myelocytic leukaemia (PML), which is another protein 
that functions to promote apoptosis. PML can also promote autophosphorylation and 
activation of Chk2 (Yang et al., 2006), resulting in an auto-activatory loop. ATM also 
phosphorylates nuclear factor kappa-light-chain-enhancer of activated B cells (NFKβ), a 
transcription factor which activates expression of the apoptotic FAS receptor (a receptor on 
the surface of cells that leads to apoptosis) (Stagni et al., 2008). The FAS receptor along with 
other proteins forms a complex on the cell surface which becomes internalized. On cellular 
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entry, the FAS receptor promotes the degradation of organelles via the action of caspases 
(Huang et al., 1996). 
 
1.12 Senescence 
Senescence is a form of permanent cell cycle arrest, evasion of which is a common theme in 
cancer cells. Solid tumors derived from epithelial cells show extensive resistance to apoptosis 
after IR (Dewey et al., 1995; Hendry et al., 1995; Ross, 1999). Senescent cells adopt a large and 
flattened morphology, positively stain for senescent associated β-galactosidase activity, 
terminate DNA synthesis and accumulate p53, p21 and p16 (Naka et al., 2004). p38 mitogen 
activated protein kinase (MAPK) signals to induce senescence. Senescence is mainly stimulated 
by RB and p16 (Kiyono et al., 1998). Oncogenic stress induced senescence results when 
overexpression of certain oncogenes such as Ras and Raf trigger a permanent and irreversible 
cell cycle arrest (Serrano and Blasco, 2001; Zhu et al., 1998). Growth inhibitors such as p53 and 
p16 are important for oncogenic suppression in the presence of oncogenic stimuli (Serrano 
and Blasco, 2001). DNA damage checkpoints can be permanently activated as a consequence 
of irreparable DNA damage or exposed telomeric ends.  
 
1.12.1 Replicative senescence 
The Hayflick limit describes the proliferative potential of human cells to a finite number of 
doublings (Hayflick and Moorhead, 1961). The replicative potential of a cell is dependent on 
the telomere length of each chromosome. Telomeric DNA is composed of tandem repeat DNA 
sequences, consisting of 6 bases (TTAGGG in humans) and a 3’ overhang ss telomeric DNA 
(~300 bases) (de Lange, 2004). The 3’ overhang is embedded in the telomeric DNA, and with 
the help of telomere repeat binding factors (TRF) forms a loop structure known as the t-loop. 
This capping event prevents telomere end fusions. Due to the end replication problem which 
results from incomplete DNA replication on either DNA end, telomeres gradually erode with 
each cell doubling, which eventually leads to critical shortening (Yang et al., 1998). Shortened 
telomeres eventually lose their cap and exposed telomere ends activate a DDR, leading to p53 
activation and permanent G1 arrest.  
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1.12.2 Stress induced premature senescence (SIPS) 
In addition to replicative senescence, normal diploid fibroblasts can undergo stress induced 
premature senescence (SIPS) in response to DNA damage. SIPS is not prevented by telomere 
elongation such as hTERT expression, therefore is not triggered by telomere shortening like 
replicative senescence (Gorbunova et al., 2002). SIPS is induced in various types of cancer 
(Chang et al., 2002). Normally after 6 hours after IR the p53 response wanes, however in SIPS, 
these responses have been observed for at least 10 days (Suzuki et al., 2001). Telomerase is 
expressed in ~ 90% of cancer cells; therefore replicative senescence is not normally induced 
(Kim et al., 1994). Lack of correct cell cycle regulation in cancer cells loses the ability to induce 
SIPS in cancer cells.  
 
1.13 The DDR and human disease 
Human diseases with defects in components of the DDR typically have defects associated with 
neuron homeostasis, immunity, fertility and aging (Table 1.3). 
 
1.13.1 Ataxia 
A common defect associated with loss of some components of the DDR is ataxia. Ataxia is a 
neurological symptom that involves lack of coordinated muscle movements. Cerebellar ataxia 
describes ataxia due to dysfunction of the cerebellum, as opposed to defects in peripheral 
neurons. Several DDR disorders have defects in the cerebellum, which is the part of the brain 
which controls motor coordination. The cerebellum is composed of 3 classes of neurons – 
granule cells, Purkinjie cells and interneurons, which is about 50% of neurons of the whole 
brain (Katyal and McKinnon, 2008). Ataxia normally correlates with defective SSB repair not 
DSB repair. However since neurons exhibit high mitochondrial respiration which can result in 
oxidative stress and subsequent DNA damage, the accumulation of SSBs in close proximity and 
on opposite DNA strands could produce DSB(s), in this sineario defective DSB repair would of 
particular risk to the maintenance of post-mitotic brain health. Additionally neurons do not 
divide therefore repair of DSBs is dependent on error prone NHEJ. Defects in regulation of 
oxidative stress and repair of DNA lesions often results in neuronal death and 
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neurodegeneration. Ataxia telangiectasia (A-T) patients which have mutations in ATM develop 
profound progressive ataxia due to progressive loss of granule and Purkinjie cells.  
 
1.13.2 Microcephaly 
The DDR also has a critical role during brain development. Consequently a large number of 
DDR disorders display microcephaly. Microcephaly is a neurodevelopmental disorder in which 
the circumference of the head is more than two standard deviations smaller than average for 
the individual’s age and sex. Defective proliferation of neurogenitor cells during fetal 
development accounts for microcephaly (O'Driscoll and Jeggo, 2008). Seckel syndrome 
patients with mutations in ATR typically display microcephaly. Nijmegen breakage syndrome 
(NBS) patients which have mutations in NBS1 display microcephaly; similarly Nijmegen 
breakage syndrome- like disorder (NBS-LD) patients who have mutations in RAD50 also display 
microcephaly. However some patients with mutations in Mre11, another component of the 
MRN complex, do not have microcephaly but instead display ataxia. This can be explained by 
the role of Mre11 in activating apoptosis. For example Mre11 defective mice which display a 
similar phenotype to A-TLD lose their ability to undergo ATM dependent apoptosis in the 
nervous system after DNA damage. This potentially results in the incorporation of damaged 
cells in the brain and subsequent neurodegeneration (Ciccia and Elledge, 2010). NBS mutants 
however still exhibit ATM dependent apoptosis which could consequently result in cell loss and 
microcephaly (Shull et al., 2009). Therefore residual ATM activity in the brain might determine 
the outcome between neurodegeneration and microcephaly.  
 
1.13.3 Ataxia telangiectasia (A-T) 
A-T is an autosomal recessive disorder caused by mutations in the ATM gene located on 
chromosome 11q22-23 (Savitsky et al., 1995). A-T patients have low or undetectable levels of 
ATM protein. A-T is characterized by early onset progressive cerebellar ataxia, ocular apraxia, 
telangiectasia of the eyes and skin (which is the appearance of prominent blood vessels), 
immunodeficiency and chromosomal instability.  Cells derived from A-T patients display severe 
radiosensitivity and defects in G1/S, S and G2/M phase checkpoint arrest following exposure to 
IR (Lavin, 1999).  
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1.13.4 ATR-Seckel 
Seckel syndrome is a genetically heterogeneous autosomal recessive disorder characterized by 
profound proportionate growth retardation, dwarfism, microcephaly and mental retardation. 
One type of Seckel syndrome is caused by mutations in the gene encoding ATR which maps to 
3q22.1-q24. ATR-SS patient cells exhibit increased sensitivity to DNA replication fork stalling, 
have a defective ATR-dependent G2/M checkpoint arrest specifically after UV-irradiation and 
contain cells with supernumerary centrosomes (Alderton et al., 2004). Centrosomes are 
organelles that function as microtubule organizing centres in the cell and are important for cell 
cycle regulation. The centrosome is normally replicated once per cell cycle in S phase (Stearns, 
2001). Cells containing multiple centrosomes incur difficulties in chromosome segregation 
during mitosis.  
Despite the complete knockout of ATR being lethal (de Klein et al., 2000), hypomorphic 
mutations in ATR which reduce the abundance of ATR but do not completely abolish it have 
been reported in Seckel syndrome patients (O'Driscoll et al., 2003a). Therefore low levels of 
ATR expression are compatible with survival. Murga et al (2009) took advantage of this 
mutation, and replaced the mouse genomic ATR fragment with the human counterpart 
containing the Seckel mutation to generate a humanized mouse model. These mice 
recapitulated many of the human Seckel syndrome phenotypes, such as severe dwarfism, 
microcephaly and premature aging. Interestingly an elevated incidence of malignancy is not 
observed in ATR knockout mice (Murga et al., 2009). Therefore below a certain threshold of 
ATR activity allows the accumulation of genomic instabilities that lead to tumor formation. It 
has been suggested that malignant transformation may depend on the amount of residual ATR 
activity (Murga et al., 2009).  
Pericentrin-mutated Seckel syndrome (PCNT-SS) is another form of Seckel syndrome 
where patients have a similar phenotype as ATR-SS patients, but the mutated gene is 
percentrin (PCNT). PCNT is a large protein that has a structural role in centrosome formation. 
Centrosome function is known to be essential for normal brain development by mediating the 
correct balance between symmetric and asymmetric division in the neuroepithelial stem cell 
layer (Lu et al., 2000). When dividing the neuroepithlial stem cells undergo a proliferative 
division producing two identical cells (symmetric divisions). After this division, the daughter 
cells produce another identical daughter cell as well as a non-stem cell progenitor cell which 
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forms a neuron (asymmetric division). Therefore impaired ATR signaling could potentially 
impair normal centrosome function and impact on brain development for example by 
exhausting neuroepithelial stem cells too early if symmetric and asymmetric divisions are 
unbalanced, potentially resulting in microcephaly (Kerzendorfer and O'Driscoll, 2009). 
Additionally, mitotic promoting factor Cdk1-cyclinB is activated at the centrosome and Chk1 
localization at the centrosome has been shown to be important for its ability to arrest cells 
following DNA damage (Kramer et al., 2004). Therefore irregular centrosome formation could 
potentially affect the activation of ATR’s downstream target kinase Chk1.  
 
1.13.5 Infertility and Immune deficiencies 
The generation of gametes during meiosis requires the exchange of genetic material between 
homologous chromosomes, which involves the formation of DSBs by the nuclease SPO11 and 
their subsequent repair by homologous recombination (Keeney and Neale, 2006). Therefore 
defective DSB repair during meiosis can result in infertility. A-T and FA patients display 
infertility (Biton et al., 2008).  
 To maintain immunity against the barrage of foreign pathogens a cell is exposed to 
each day, mammalian cells have developed an immune system which is capable of generating 
a wide number of unique immunoglobins and T cell receptors. B and T lymphocytes recognise 
foreign antigens through specialized receptors known as immunoglobins and TCR, respectively. 
These receptors are composed of V(D)J segments. Variation of these receptors is generated by 
recombination of these segments prior to antibody expression. Each V(D)J segment is flanked 
by a 12 or 23 bp recombination signal sequence (RSS). The process of recombination is 
initiated when Recombination Activating Gene 1 (RAG1) and Recombination Activating Gene 2 
(RAG2) along with Human Mobility Group 1 (HMG1) or Human Mobility Group 2 (HMG2) 
proteins form a complex known as the RAG complex, which binds RSS sequences (Hiom and 
Gellert, 1997). The RAG complex endonucleolytically nicks the DNA at the RSS. Mutations in 
RAG1 and RAG2 have been identified in patients with severe combined immunodeficiency 
(SCID) caused by profound lymphopenia with diminished or absent immunoglobins (Sobacchi 
et al., 2006). Following RAG cleavage, the free 3’ hydroxyl on each V, D, J coding end then 
attacks the antiparallel DNA strand and via transesterification a DNA hairpin is generated at 
each V, D and J coding end. The RSS end (signal end) is blunt. After generation of two 
hairpinned coding ends and two signal ends, the four DNA ends are held together by the RAG 
complex in a post-cleavage complex (Agrawal and Schatz, 1997). The hairpins are then cleaved 
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by Artemis (Ma et al., 2002). The loss of Artemis hairpin endonuclease activity results in the 
immunodeficient phenotype that is observed in Artemis patients. The subsequent re-joining of 
the V(D)J ends is carried out by NHEJ. Diversification of V(D)J variable domains is further 
achieved by class switch recombination (CSR) (Stavnezer et al., 2008a). CSR is triggered by the 
AID enzyme, which deaminates cytosines to uracil (Stavnezer et al., 2008b). DNA breaks are 
then generated by the combined action of the uracil DNA glycosylase UNG and the AP 
endonuclease APE1. NHEJ then leads to the exchange of the antibody constant regions. 
 
1.13.6 Premature aging and cancer 
Cancer is a major age-related disease in humans. In the absence of cancer, aging is mostly 
characterized by tissue atrophy and degeneration since older genomes have a higher incidence 
of accumulated DNA damage due to ongoing damage induction and less proficiency in repair 
(Weissman et al., 2007). p53 eliminates or arrests the proliferation of damaged or mutant cells 
by the process of apoptosis and senescence. Patients with inherited DDR defects often display 
features of premature aging. Most mammalian tissue can be described as being comprised of 
two major cellular components either: 1) stem or progenitor cells, which are responsible for 
regenerative capacity or repair after injury, or 2) differentiated somatic cells, which are 
responsible for adult stem cell support and specialized tissue/organ functions. Tissue 
degeneration with age can be accounted for by two major mechanisms: loss of stem cell pool 
division potential and loss of differentiated somatic cell function. Depending on cell type and 
damage amount, cellular senescence can be initiated by p53 signalling (Lowe et al., 1993). 
Senescent cells can no longer participate in tissue renewal and repair. Thus senescence can 
deplete both stem (Janzen et al., 2006) and stromal cell pools (Herbig et al., 2006). Unlike 
apoptotic cells, senescent cells persist, and have the ability to alter their surrounding tissue 
microenvironment (Campisi, 2005). Depletion of hematopoietic stem cells (HSC) has been 
observed in a variety of mouse models defective for DDR components, including ATM, BRCA2, 
Ku80 and LIG4. Ku80 null mice exhibit accelerated aging phenotypes, including skin atrophy, 
osteopenia, hepatocellular degeneration and shortened lifespan (Vogel et al., 1999). Ku80-/- 
MEFs undergo p53 dependent premature replicative senescence. However, loss of p53 in 
these cells was able to rescue the replicative senescence phenotype (Lim et al., 2000). This 
suggested that increased DNA damage and therefore p53 signalling was responsible for the 
accelerated aging phenotype of the Ku80-/- MEFs. Zmpste24 is a metalloproteinase that 
participates in the maturation of Lamin A, a protein component of the nuclear envelop. 
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Defects in Lamin A can cause premature aging phenotypes in humans and mice (Sullivan et al., 
1999). Some Hutchinson-Gilford progeria syndrome (HGPS) patients harbor mutations in 
ZMPST24 (Eriksson et al., 2003). Zmpste24-/- mice have upregulated activation of many p53 
targets (Varela et al., 2005), such as pChk1 and γH2AX (Liu et al., 2006). Analysis of DSB repair 
by neutral comet assay after IR revealed that Zmpste24-/- MEFs and HGPS cells repair DSBs 
with slower kinetics than wild type cells (Lui et al., 2005). Recruitment of Rad51 to DSBs is also 
impaired in these cells (Lui et al., 2005). It has been proposed that nuclear envelope 
abnormalities and defect in DSB repair in Zmpste24-/- mice and HGPS patients activate p53. 
Loss of p53 in the Zmpste24-/- background partially rescued the aging phenotype 
characteristic of Zmpste24 deficiency (Variela et al., 2005). Therefore despite p53 mediated 
apoptosis and senescence promoting tumor suppression, both can lead to aging phenotypes 
possibly by depleting important stem cells and other stroma cell pools. Therefore p53 
dependent signalling has been optimized to balance the beneficial effects of tumor 
suppression against the detrimental effects of tissue degeneration.  
 
1.14 Chromatin modification 
It is becoming increasingly clear that chromatin structure impacts the DDR and is modulated in 
response to DNA damage. The best characterized example of this is the ATM/ATR/DNA-PK 
mediated phosphorylation of Ser139 of the histone H2A variant H2AX on chromatin flanking 
DSBs. H2AX is a histone variant, comprising roughly 10% of the histone H2A complement in 
mammalian cells, on average being placed 1 in every 10 nucleosomes. The percentage of H2AX 
content varies depending on cell type. For example the H2AX complement in lymphocytes and 
Hela cells has been reported to be as little as 2%, whereas  20 % of nucleosomes in SF268 
human glioma cells contain H2AX (Rogakou et al., 1998). Following the induction of a DSB, 
within seconds, H2AX becomes rapidly phosphorylated at Serine 139 (Ser139). This 
phosphorylation event is mainly dependent on ATM, but DNA-PK can also play a redundant 
role (Stiff et al., 2004). ATR mediated phosphorylation of H2AX has been shown to be 
important during homologous recombination mediated repair in response to DNA damage that 
would slow or stall replication forks (Bonner et al., 2008). ATM independent H2AX 
phosphorylation also plays multiple roles during apoptosis. For example, DNA-PKcs mediated 
phosphorylation of H2AX at Ser139 mediates apoptotic DNA fragmentation (Rogakou et al., 
2000). Phosphorylation of H2AX by c-Jun N-terminus kinase (JNK) has also been associated 
with the induction of apoptosis (Lu et al., 2006).  
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1.15 Chromatin structure 
Genomic DNA and histones form a highly condensed structure known as chromatin. The major 
building blocks of chromatin are the histone proteins. These are small proteins containing a 
high proportion of basic amino acids (arginine and lysine) that facilitate binding to the 
negatively charged DNA molecule. There are five major types of histones, H1, H2A, H2B, H3, 
and H4 which assemble to form one octameric nucleosome core particle by wrapping 146 base 
pairs of DNA around the histone complex in a 1.65 left-handed super-helical turn (Suto et al., 
2000). The linker histone H1 binds the nucleosome and the entry and exit sites of the DNA, 
thus locking the DNA into place and allowing the formation of a higher order structure. 
Chromatin is organized into two major types in the cell, euchromatin and heterochromatin. 
Euchromatin is associated with transcriptionally active regions of the genome and is said to be 
in an “open” conformation, whereas heterochromatin is associated with silenced regions and 
is transcriptionally inactive. 
 
1.16 Types of heterochromatin  
There are two main types of heterochromatin: 
1.16.1 Constitutive heterochromatin   
Constitutive heterochromatin contains a particular type of DNA called satellite DNA, which 
consists of large numbers of short tandemly repeated sequences known as alpha-satellite DNA, 
DNA satellite I, II and III. These satellite DNA sequences are able to fold on themselves and may 
have an important role in the formation of the highly compact structure of the constitutive 
heterochromatin (Metzler-Guillemain et al., 2003). Constitutive heterochromatin is stable and 
conserves its heterochromatic properties during all stages of development and in all tissues. It 
is highly polymorphic, which is likely a consequence of the instability of the satellite DNA; this 
polymorphism can affect not only the size but also the localization of the heterochromatin 
(Metzler-Guillemain et al., 2003). 
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1.16.2 Facultative heterochromatin  
Facultative heterochromatin is reversible, its heterochromatic state depending on the stage of 
development or the cell type examined. 
Some examples of heterochromatic regions in mammalian cells include: 
(1) Centromeres – composed of tandem repeats known as satellite DNA. Centromeres are 
marked for epigenetic silencing by centromere protein–A (CENP-A), (Palmer et al., 
1991). CENP-A contains a histone H3 related histone fold which replaces one or both 
copies of H3 in the (H3-H4)2 tetrameric core of nucleosomes found at centromeres 
(Palmer et al., 1991). CENP-A is believed to confer conformational rigidity to 
nucleosomes, marking centromeres as constitutive heterochromatin (Black and 
Bassett, 2008). 
(2) Telomeres – composed of TTAGGG repeats. Epigenetic regulation of telomere length is 
maintained by suppressor of variegation 3-9 homolog 1 (Suv39h1) (an enzyme that 
adds methyl residues to chromatin) and Suv39h2 in mammalian cells (Garcia-Cao et al., 
2004). 
(3) Ribosomal DNA (rDNA) – In eukaryotes, there are hundreds of rDNA genes tandemly 
repeated head to tail within nucleolus organizer regions (NORs), (Preuss and Pikaard, 
2007). Their expression is in accordance with the physiological need for ribosomes 
(Preuss & Pikaard, 2007). One mechanism for transcriptional regulation is an 
epigenetic on/off switch which facilitates whether the rDNA sequences are silenced 
through heterochromatic formation (Preuss & Pikaard, 2007). A protein complex of 
eNoSc with sirtuin 1 (SIRT1) and Suv39h1has been described to sense both energy 
status and control rDNA transcription (Murayama et al., 2008). Low physiological 
energy levels induce the eNoSc/SIRT1/Suv39h complex to bind H3-K9 residues in rDNA, 
initiating methylation of these residues and consequently resulting in heterochromatin 
formation and gene silencing (Murayama et al., 2008). 
 
1.17 Heterochromatin modification 
To establish a highly compacted chromatin structure, chromatin must be modified. Two main 
classes of enzymes that modify chromatin structure have been identified: the first class 
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function through covalent modifications of histone tails. These modifications include 
methylation, acetylation, phosphorylation, ubiquitination, sumoylation, citrullination and ADP-
ribosylation (Marmorstein, 2001). The second class, are large multi protein ATP-hydrolyzing 
complexes that utilize ATP to charge the alteration of nucleosome structure (Lusser and 
Kadonaga, 2003) (Table 1.4). 
 
1.17.1 Histone Deacetylases (HDACs) 
Histone deacetylases (HDACs) are key players in heterochromatin formation and can be 
recruited by transcriptional repressors (which are sequence specific transcription factors that, 
following binding at promoter sequences, initiate the accumulation of repression specific 
factors), co-repressors, and proteins that methylate DNA (Richards and Elgin, 2002). HDACs 
function by catalyzing the removal of acetyl groups from ε-N-acetyl lysine amino acids on 
histones (de Ruijter et al., 2003). Their action is opposite to that of histone acetyltransferase. 
Histone acetylation plays an important role in the regulation of gene expression. 
Hyperacetylated chromatin is associated with transcriptionally active areas of the genome and 
hypoacetylated areas with transcriptional silencing (Strahl and Allis, 2000). 
 
1.17.2 Histone Methyltransferases (HMTs) 
Histone methylation at lysine residues is central to epigenetic regulation of gene expression 
and is carried out by histone methyltransferases (HMT) (Sims et al., 2003). Common histone 
residues involved in HMT associated repression include H3 lysine 9 (H3-K9), H3-K27 and H4-
K20 (Sims et al., 2003). At present the best understood histone modification is methylation of 
H3-K9, which is catalyzed by Suv39h1 and Suv39h2 in mammalian cells, and is responsible for 
most of the H3-K9 methylation at pericentric heterochromatin (Peters et al., 2001) 
 
1.17.3 DNA Methyltransferases (DNMTs) 
Mammalian DNA is modified by the addition of a methyl residue at position 5 of certain 
cytosine residues. This modification is predominantly carried out at CpG dinucleotides. 
Approximately 80% of CpG dinucleotides are modified in the human genome (Cooper & 
Krawczak, 1989). DNA methylation is important for embryonic development (Li et al., 1992), 
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imprinting (Sleutels et al., 2000) and X chromosome inactivation (Csankovski et al., 2001). DNA 
methyltransferases (DNMTs) are a family of enzymes that catalyze the transfer of a methyl 
group to DNA (Kaneda et al., 2004). Four active DNMTs have been identified in mammals, 
DNMT1, DNMT2, DNMT3A and DNMT3B. DNMT1 is the most abundant methyltransferase, 
which functions as a maintenance methyltransferase by copying DNA methylation patterns 
from the paternal to the daughter strand following DNA replication (Bestor, 2000). DNMT3A 
and DNMT3B are referred to as de novo DNA methyltransferases which are essential for 
methylation patterns established in the embryonic genome shortly after fertilization (Li, 2002). 
The function of DNMT2 is currently unknown. Heterochromatin, including centromeres, 
repetitive DNA sequences and telomeres tend to be hypermethylated and transcriptionally 
silent (Jenuwein, 2001) 
 
1.17.4 Heterochromatin Protein 1 (HP1) 
Heterochromatin protein 1 (HP1) is a structural component of heterochromatin which can bind 
both methylated histone residues and the HMTs responsible for the residue methylation (Craig, 
2005). HP1 is associated with many types of heterochromatin such as telomeres, centromeres, 
silenced gene promoters and triplet repeat expansions (Kellum, 2003). Mammals have 3 
isoforms – HP1α, HP1β and HP1γ (Craig, 2005). HP1 can bind to both Suv39h and H3-K9.  The 
recruitment of Suv39h results in methylation of adjacent nucleosomes and the spread of 
heterochromatin (Kellum, 2003).  
 
1.17.5 ATP-Dependent Chromatin Remodelers  
ATP-dependent chromatin remodelers can be recruited to chromatin by repressors and co-
repressors. However unlike the above proteins that alter chromatin structure through covalent 
modification, ATP-dependent remodelers use ATP to drive nucleosome remodeling.  ATP-
dependent remodelers function as ATP driven motors that translocate along DNA and 
destabilize protein-DNA interactions (Pazin and Kadonaga, 1997). One model suggests ATP 
hydrolysis is used to traverse a nucleosome in a wave like manner that results in partial 
disruption of the nucleosome (Pazin & Kadonaga, 1997). A well-known family of ATP-
dependent chromatin remodelers is the SWI/SNF (switch/sucrose non-fermentable) family. 
The SWI/SNF polypeptides contain seven conserved motifs that are characteristic of a large 
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group of nucleoside triphosphate (NTP) – binding proteins that include DNA and RNA helicases 
(Kruger et al., 1995). Many orthologs of the yeast SWI/SNF family are present in higher 
eukaryotes. Other known mammalian remodelers include: the ISWI containing RSF 
(remodeling and spacing factor) which mediates nucleosome deposition and generates 
regularly spaced nucleosome arrays (Loyola et al., 2003); and the nucleosome remodeling 
histone deacetylation (NuRD) complex, which has both ATP power nucleosome remodeling 
capabilities and histone deacetylation activity (Feng and Zhang, 2003). 
 
1.18 siRNA mediated protein knockdown 
Knockdown of protein expression by Small interfering RNAs (siRNA) mediated transfection is a 
useful tool for analysing protein function and is a technique employed in this thesis. siRNAs are 
a type of double stranded RNA molecule (typically 20-25 nucleotides in length) that play a 
variety of roles in biology including: gene silencing, transposon control, centromere function 
and silencing impaired sex chromosomes during meiosis. These small regulatory RNAs 
represent an ancient regulatory mechanism as mirrored by their presence in organisms 
ranging from plants to yeast and mammals. The source of the initial dsRNA can be either 
exogenous (e.g. from viral replication) or endogenous. Expression of endogenous siRNA is 
often tissue or developmental stage specific. siRNAs are generally derived from dsRNA, which 
is fragmented by Dicer an endonuclease in the RNase III family that cleaves dsRNA into ~21 
nucleotide siRNA. The siRNA is then bound by Argonaute protein. Argonaute proteins are small 
RNA binding proteins that are characterized by the presence of three domains: the 
PIWI/Argonaute/Zwille (PAZ) domain, the Middle (MID) domain and the P-element induced 
wimpy testis (PIWI) domain. The PAZ domain forms a binding pocket for the 3’ end of the small 
RNA, whereas the 5’ terminal nucleotide is bound by the MID domain (Boland et al., 2010). The 
PIWI domain has catalytic endonuclease activity referred to as slicing. The slicer activity allows 
Argonaute to degrade one of the strands of the dsRNA, thereby exposing the ssRNA and 
allowing it to detect its complementary target sequence (Leuschner et al., 2006; Matranga et 
al., 2005). The genomes of most organisms encode multiple Argonaute proteins, which 
typically bind to one specific type of siRNA either a microRNA (miRNA) which arise from 
imperfectly based paired miRNA hairpins, or siRNAs which arise from perfectly based paired 
long dsRNA, or PIWI interacting RNAs (piRNA) which is a germline enriched class of small RNA 
typically 24-30 nucleotides in length. The Argonoute and siRNA form the core RNA induced 
silencing complex (RISC) and target messenger RNA (mRNA) for silencing by mediating 
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transcript degradation. Targeting the mRNA by the RISC complex can induce the synthesis of 
secondary siRNA due to the formation of dsRNA on siRNA and mRNA association. In this 
sinareo RISC recruits RNA dependent RNA polymerase (RdRP), an enzyme that catalyzes the 
replication of RNA from an RNA template. RdRP synthesizes a new RNA that is antisense to the 
RNA template. The newly formed dsRNA is then fragmented by Dicer.  
 
1.19 Aims of this thesis 
The impact of higher order chromatin structure on DSB repair is now well established, but its 
impact on DDR signalling is less well understood. For example, can IR induced γH2AX foci 
expansion increase when heterochromatin associated barriers are reduced? What impact does 
this have on checkpoint arrest? Additionally do human disorders with known defects in 
chromatin organization respond hyperactively to IR? And if so, is this attributable to enhanced 
DDR signalling per γH2AX focus? Heavy ion radiotherapy is becoming of increasing importance 
for treating tumours that reside within vital organs which are not readily accessible by other 
means of radiotherapy, such as X-rays. For example, heavy charged particles offer a sharp 
increase in dose in a well-defined depth with a rapid loss of dose beyond the maximum output 
point, meaning that neighbouring tissues remain largely unaffected. This is of particular 
importance when treating brain tumours. However, given that heavy ion irradiation produces 
more complex DNA damage compared to X-ray, and complex DNA damage is more likely to 
take longer to repair, it is unknown whether this manifests as a prolonged checkpoint arrest? 
Also the number of heavy ion induced γH2AX clusters that are required to maintain checkpoint 
arrest is also unknown. A number of questions remain as to the mechanism by which Artemis 
functions to enable repair of a subset of ATM dependent DSBs in G0/G1. ATM and Artemis 
both have epistatic repair defects, but does Artemis like ATM function to repair HC associated 
DSBs? In this thesis I have addressed 3 main questions (see below) which all relate to the 
interplay between ATM signalling, checkpoint arrest and repair. How heterochromatin impacts 
on these endpoints is central to this work.  
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1.19.1 Addressing how human syndromes with disordered heterochromatin structure 
respond to IR. 
Previously global chromatin compaction induced by histone H1 has been shown to limit the 
strength of the DNA damage signalling response (Murga et al., 2007). Additionally, 
transcriptionally active regions have been shown to inhibit γH2AX expansion (Iacovoni et al., 
2010). However whether heterochromatin affects ATM signalling is yet to be examined. In 
chapters 3 and 4, I investigate how heterochromatin superstructure influences damage 
response signalling focussing on the impact of disordered chromatin found in human 
syndromes.  
 
1.19.2 Addressing the function of Artemis in DSB repair 
ATM and Artemis have an epistatic repair defect (Riballo et al., 2004a). The role of ATM in the 
repair of a subset of IR induced DSBs has recently been established. ATM was demonstrated to 
function in the repair of heterochromatin associated DSBs by mediating chromatin relaxation 
via phosphorylation of the heterochromatin building factor KAP-1 (Goodarzi et al., 2008b; Ziv 
et al., 2006). The function of Artemis in this process has not yet been established. In chapter 5, 
I address whether Artemis dependent DSBs also reside within regions of heterochromatin.  
 
1.19.3 Addressing checkpoint arrest after heavy ion irradiation 
Chapter 6 arose from an opportunity to visit the National Institute of Radiological Science 
(NIRS) in Chiba, Japan. The NIRS is home to one of three worldwide heavy ion accelerators. The 
ion accelerator at the NIRS is used for both patient radiotherapy treatments and scientific 
research. In chapters 3 and 4 of this thesis it was established that chromatin complexity 
influences the duration and sensitivity of G2/M checkpoint arrest. In this chapter I addressed 
how damage complexity after heavy ion irradiation influences this. The G2/M checkpoint has 
previously been shown to have a defined sensitivity threshold which requires at least 10-15 
DSS to initiate arrest (Deckbar et al., 2007; Fernet et al., 2010). As a consequence, cells 
released from checkpoint arrest harbour 1-2 chromosome breaks in mitosis. Since heavy ion 
irradiation produces more complex clustered DSBs, in this chapter I addressed whether 
checkpoint arrest could be maintained until only a few clustered γH2AX foci remained. 
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 Materials and Methods 
 
 
1.20 Cells and tissue culture 
 
1.20.1 Cell lines 
 
NIH 3T3 cells and mouse embryonic fibroblasts (MEFs): WT, AT, & Art-/-  were cultured in 
MEM supplemented with 10% v/v foetal calf serum (FCS), 1% v/v Penicillin/Streptomycin 
solution and 1% v/v L-Glutamine. 1BR (wildtype), 48BR (wildtype), PT3 (ICF/DNMT3B) and 
CJ179 (Art) transformed human fibroblasts (hTRETs) were cultured in MEM supplemented as 
above. 48BR (wildtype), 1BR3 (wildtype), GM11271 (Rett/MeCP2), GM11272 (Rett/MeCP2), 
and GM16548 (Rett/MeCP2) primary human fibroblasts were grown in MEM and 
supplemented with 15% FCS and 1% v/v Penicillin/Streptomycin solution and 1% v/v L-
Glutamine. GM02188 (wildtype), GM16848 (Rett/MeCP2), GM08714 (ICF/DNMT3B) & 
AG10801 (HGPS/Lamin A) are lymphoblastoid cell lines (LBLs) and were cultured in RPMI 
supplemented with 10% FCS, 1% v/v L-Glutamine and 1% v/v Penicillin/Streptomycin solution. 
All cells were grown at 37 oC in a humidified atmosphere containing 5% carbon dioxide.  
 
 
1.20.2 Tissue culture 
 
To maintain cells in a healthy and proliferating condition, cultures were divided every 4-5 days. 
For passaging, cells were washed once with 1X PBS followed by the addition of trypsin (200 
mg/ml trypsin dissolved is PBS, followed by filter sterilization). Cells were incubated with 
trypsin for 2-5 minutes in a 37°C incubator, and collected and pelleted by centrifugation at 
1500 rpm for 5 minutes at RT. The pellet was then resuspended in the desired volume of 
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media. To establish frozen cell stocks, a confluent 75 cm2 flask was trypsinized, pelleted and 
resuspended in 1 ml FCS with 10% v/v DMSO. Vials were slowly cooled to -80°C and 
transferred to liquid nitrogen tanks for permanent storage.  
 
1.20.3 Drug treatments and IR 
 
10 μM ATM inhibitor (Calbiochem) was added 30 minutes before IR. 4 μM aphidicolin was 
added immediately after IR to block entry of irradiated S phase cells into G2 during analysis. 
Cells were irradiated in medium using either a 137Cs gamma-source (dose rate, 7.5 Gy/min) or 
250kV X-rays delivered at 12 mA (dose rate 0.5 Gy/min). For irradiation with heavy ions cells 
were seeded into Nunc glass chamber slides. Heavy ion irradiation with Carbon (290 
MeV/nucleon, LET 70 KeV/μm) and Iron (500 MeV/nucleon, LET 200 KeV/μm) beams were 
performed at the Heavy Ion Medical Accelerator (HIMAC) facility at the National Institute of 
Radiological Sciences (NIRS), Chiba, Japan. Heavy ion irradiation was delivered at a dose rate of 
1 Gy/min.  
 
 
1.21 Immunofluorescence 
 
Cells grown on cover-slips were fixed for 10 minutes with fixative (3% (w/v) PFA, 2 % (w/v) 
sucrose and 1X PBS) and permeabilised for 3 minutes with 0.2% Triton X-100 in PBS. Cells were 
washed with PBS and incubated with primary antibody diluted in 2% (w/v) BSA + PBS, for one 
hour at room temperature. Cells were washed three times with PBS before incubating with the 
appropriate secondary antibody (diluted in 2 % (w/v) BSA + PBS (Green = FITC, red = cy3 or 
TRITC, conjugated antibodies), for 1 hour at room temperature in the dark. 4’, 6-diamidino-2-
phenylindole (DAPI) (1mg/ml) was then applied for 10 minutes followed by three washes with 
PBS. Cover-slips were then mounted on microscope slides using Vectashield. Slides were 
visualized on a Zeiss Axioplan microscope or An Applied Precision Delta Vision RT Lympus 1X70 
deconvolution microscope.  (See table 2.1 for antibody dilutions).  
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1.21.1 Sequential staining for pChk1, pChk2 and pATM 
 
Cells were fixed with 3 % PFA for 10 minutes, washed twice with PBS and incubated with 0.2 % 
Triton-X for 3 minutes. Cells were washed 2X with PSB and incubated with primary phospho-
antibodies for 30 minutes at 37°C. Cells were washed 3X with PBS before incubating with the 
secondary antibody rabbit Cy3 or mouse FITC for 30 minutes at 37°. Cells were washed 3X with 
PBS and incubated with primary CENP-F antibody for 30 minutes at 37°.  Cells were then 
washed 3X with PBS and incubated with secondary Alexa fluroflore 488 for 30 minutes at 37°. 
4’, 6-diamidino-2-phenylindole (DAPI) (1mg/ml) was then applied for 10 minutes followed by 
three washes with PBS. Cover-slips were then mounted on microscope slides using Vectashield 
and visualised using a Zeiss Axioplan microscope. (See table 2.1 for dilutions) 
 
 
1.21.2 Pre-extraction for RPA foci 
 
Before irradiating cells, aphidicolin was added to prevent S phase cells progressing into G2 
phase during analysis. Cells were irradiated and processed 1 hour later. Media was removed 
and cells were washed with 1X PBS. To pre-extract, 1 ml PBS + 0.2% Triton-X was added to 
each sample for 60 seconds. Triton-X solution was removed by aspiration and cells were fixed 
with 1 ml 3% PFA for 10 minutes. Staining was continued as described before. 
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Table 2.1 Antibodies used for Immunofluorescence (IF) and Western Blotting (WB) 
Antibody Size (KDa) Species and supplier Application 
CENP-F 330 Rabbit (Abcam) IF 1:1000 
pSer1981 ATM 330 Rabbit (Epitomics) IF 1:100, WB 1:500 
ATM 330 Rabbit  WB 1:500 
ATR  309 Goat WB 1:500 
53BP1 220 Rabbit (Abcam) IF 1:800, WB 1:1000 
KAP-1 100 Rabbit (Abcam) IF 1:800, WB 1:1000 
KAP-1 100 Mouse (Abcam) IF 1:800, WB 1:1000 
KAP-1 100 Goat (Abcam) IF 1:300 
pSer824 KAP-1  100 Rabbit (Noon et al, 2010) IF 1:200 (+ 1:1000 peptide) 
DNMT3B 98 Rabbit (Invitrogen) IF 1:800, WB 1:500 
Ku80 80 Rabbit (Sata Cruz) WB 1:2000  
pThr68 Chk2 68 Rabbit (Cell signalling) WB 1:500 
Chk2 68 Rabbit (cell signalling) WB 1:500 
pChk1 56 Rabbit (Cell signalling) WB 1:500 
Chk1 56 Rabbit (cell signalling) WB 1:500 
HDAC1 55 Mouse (Abcam) IF 1:300, WB 1:1000 
pP53 53 Mouse (Cell signalling) WB 1:1000  
MeCP2 53 Rabbit (Invitrogen) IF 1:800, WB 1:500 
P53 53 Mouse WB 1:1000  
pSer10 H3 16 Rabbit (upstate biotechnology) IF 1:400 
γH2AX 16 Mouse (Abcam/ Upstate) IF 1:800, WB 1:500 
TriMeK9 H3 ~16 Rabbit (Abcam) IF 1:800, WB 1:500 
RPA  34 Mouse  IF 1:100 
Actin 42 Mouse (Abcam) WB 1:3000 
A 
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Antibody Supplier Application 
Anti-Mouse FITC conjugated Sigma IF 1:200 
Anti-Rabbit Cy3 conjugated Sigma IF 1:200 
Anti-Goat Cy3 conjugated Sigma IF 1:200 
Anti-Mouse HRP conjugated Dako WB 1:2000 
Anti-Rabbit HRP conjugated Dako WB 1:2000 
 
 
(A) Primary antibodies used for immunofluorescence (IF) and western blotting (WB). 
(B) Secondary antibodies used for immunofluorescence (IF) and western blotting (WB). 
 
 
 
 
 
 
 
 
 
 
 
 
B 
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1.22 siRNA transfection 
 
siRNA transfections were carried out using HiPerfect (Qiagen) or Metafectene-Pro (Biontex) 
mediated transfection reagents according to the manufacturer’s instructions. 50-100 pmol of 
25 mM stock siRNA solutions were incubated with 2.5-5 μl of transfection reagent and 
optiMEM for 10 minutes at RT. Following incubation, the siRNA mix was applied onto glass 
coverslips in 3.5 cm dishes followed by 2 ml of 2 x 105 cell stocks. Cells were incubated for 48 
hours prior to conducting experiments. Where a double knock down was required to achieve 
efficient knockdown of protein expression, siRNA transfections were set up as described above. 
24 hours after incubation cells were trypsinized from the dishes, centrifuged at 1500 rpm for 5 
minutes and resuspended in 2 ml media/ dish. siRNA transfections were set up again and the 
previously transfected cells were incubated with a fresh siRNA transfection for a further 48 
hours. (See table 2.2 for siRNA sequences used for transfections). 
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Table 2.2 Oligonucleotides used for siRNA transfections 
siRNA target Sequence 5’-3’ Supplier 
HDAC1 (human cDNA nt 224-249) UCUUGCGCUCCAUCCGUCCAGAUAA Invitrogen 
HDAC2 (human cDNA nt 1381-1406) CACCUGGUGUCCAGAUGCAAGCUAU Invitrogen 
KAP-1 ‘A’ (human cDNA nt 450-475) CAGTGCTGCCACTAGCTGTGAGGATA Invitrogen 
KAP-1 ‘C’ (mouse cDNA nt 1297-1322) AAGATGCAGTGAGGAACCAACGTAA Invitrogen 
Artemis ‘A’ (mouse cDNA nt 684-709) CCACGUCGUGUGGCUGAACUGUAAA Invitrogen 
Artemis ‘B’ (mouse cDNA nt 1705-1729) UUUACAGUUCAGCCACACACGACGGUGG Invitrogen 
MeCP2 (mouse) CCUGAAGGUUGGACACGAA Dharmacon  
MeCP2 (human) GACACAUCCCUGGACCCUAAUGAUU Invitrogen 
DNMT3B (mouse) (SMARTpool) GAGGAGUGCAUUAUCGUUA 
UCAGGAUGAUAAAGAGUUU 
GCAAUGAUCUCUCUAACGU 
GGAAUGCGCUGGGUACAGU 
Dharmacon  
DNMT3B (human) CCACCUUCAAUAAGCUCGUCUCCUA Invitrogen 
siGENOME Non-targetting siRNA pools Cat. no. D-001206-13 Dharmacon  
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1.23 Protein techniques 
Stock solutions: 
 
Acrylamide gels: 
30% w/v Acrylamide 
2% w/v Bis-Acrylamide 
20% w/v sodium Dodecyl Sulphate (SDS) 
1M Tris pH 8.8 
10% Ammonium Persulphate 
ddH20 
TEMED 
 
Gel stack: 
30% w/v acrylamide 
20% w/v Bis-acrylamide 
1M Tris pH 6.8 
20% SDS 
10% APS 
TEMED 
ddH20 
 
NETN lysis buffer: 
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50 mM Tris pH 7.5 
150 mM NaCl 
0.2 mM EDTA 
1% NP-40 
ddH20 
1 protein phosphatase table 
 
6X SDS sample loading buffer (for 30 ml): 
15 ml Glycerol 
12 ml 1M Tris pH 6.8 
3g SDS 
Bromophenol Blue 
Gently warm to dissolve 
Add 1.5 ml β-mercaptoethanol 
 
 
1.23.1 Protein extraction 
 
Media was removed and cells were washed with PBS + 1 mM EDTA. Cells were trypsinized in 
500 μl trypsin (0.25%) for 3 minutes. Cell aggregates were removed by pipetting up and down, 
and transferred to eppendorfs. Samples were kept on ice. Cells were centrifuged at 2000 rpm 
for 2 minutes at 4°C. Pelleted cells were washed twice in 1 ml ice cold 1X PBS.  Cells were 
centrifuged at 2000 rpm for 4 minutes at 4°C. To the pellet a 5X Pellet cell volume (PCV) of 
NETN + NaCl + protease inhibitors + phosphatase inhibitors was added. Pellets were 
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suspended in the NETN by pipetting strongly. Samples were sonicated in a water bath for 5 
minutes. Samples were left on ice for 30 minutes.  BIO-RAD protein quantification was then 
carried out on the samples to determine protein concentrations. For quantification, 5 μl of 
each sample + 10 μl NETN + N buffer was added to 75 μl reagent A (BIO-RAD) + 600 μl reagent 
B (BIO-RAD), incubated at room temperature for 15 minutes and spectrophrometically 
quantified using a Beckman spectrophotometer.  For the blank standardization sample 15 μl of 
NETN + N buffer was used. Appropriate sample volumes were boiled for 3 minutes in 6X SDS 
loading buffer and centrifuged briefly before gel loading. Samples were loaded alongside a 250 
kDa Precision Plus Protein Standards marker from BIO-RAD. 
 
 
1.23.2 Poly-Acrylamide Gel Electrphoresis (PAGE) 
 
Acrylamide gels of appropriate percentage (see table 2.3) were made from stock solutions and 
polymerized at RT for at least 30 minutes. Gel stacks were then made fresh from stock 
solutions and added to the gel to polymerize for 15 minutes prior to removing the well comb. 
Gels were run in an Invitrogen Novex mini-cell tank. 
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Table 2.3: Loading concentrations for different percentage SDS-PAGE gels. 
 6 % 8 % 10 % 12 % 
dH2O 5.4 ml 4.7 ml 4.1 ml 3.4 ml 
30% Acrylamide  2 ml 2.7 ml 3.3 ml 4 ml 
1M Tris (8.8) 2.5 ml 2.5 ml 2.5 ml 2.5 ml 
20 % SDS 50 ul 50 ul 50 ul 50 ul 
10 % APS 50 ul 50 ul 50 ul 50 ul 
TEMED 5 ul 5 ul 5 ul 5 ul 
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1.23.3 Western blotting 
 
Transfer buffer (1L): 
5.8g Tris 
2.93g Glycine 
800 ml ddH20 
200 ml methanol 
(For high molecular weight proteins 1,8 ml 20% SDS was also added). 
 
10X Tris-buffered saline (TBS:1L): 
12.11g Tris 
81.82g NaCl 
ddH20 to 1L 
pH to 7.4 
 
Working 1X TBS/Tween-20 wash buffer: 
50 ml 10X TBS 
0.5 ml Tween 20 
450 ml ddH20 
 
Following protein separation by SDS-PAGE, samples were transferred onto a 0.45 μm 
nitrocellulose membrane using the BIO-RAD Mini Trans-Blot Cell. Proteins were transferred for 
1 hour at 100V in chilled electroblot buffer. To visualize that proteins had successfully 
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transferred to the membrane, a non-permanent Poceau stain (0.1% w/v Poceau S in 5% v/v 
acetic acid) was applied to the membrane for 1 minute. The stain was removed by washing in 
1X TBS/Tween. The membrane was then blocked for 1 hour in 5% BSA made up in 1X 
TBS/Tween. Primary antibodies (see table) were diluted in 5% BSA solution and incubated with 
the membrane at 4°C for 24 hours with gentle shaking. After incubation, the membrane was 
given three 20 minute washes in 1X TBS/Tween. Secondary HRP conjugated antibodies (see 
table) were diluted in 5% BSA and incubated with the membrane for 1 hour at RT with gentle 
shaking. The membrane was washed a further three times for 30 minutes (each wash) in 1X 
TBS/Tween. To visualize the protein bands, membranes were incubated with enhanced 
chemiluminescence (ECL) immunoblotting agent (Amersham Biosciences) for 2-5 minutes and 
exposed onto autoradiography blue sensitive film (GE healthcare). A Xograph Compact 4 
automatic X-ray film processor was used to develop the film. 
 
1.23.4 Stripping a western membrane for re-probing 
 
To reuse a membrane which had already been developed in ECL, it was first rinsed in water. 
The membrane was then incubated with 50 ml 1X stripping buffer (2X: 30 ml 1M Tris HCL pH 
6.8, 50 ml 2% SDS made to 250 ml with water) + 350 μl beta-merceptoethanol at 60° for 30 
minutes in the fume hood. The buffer was removed and the blot was washed twice for 10 
minutes with TBS/Tween in a fume hood. The membrane was re-blocked with 5% BSA for 1 
hour and incubated with primary antibody. The western blot procedure was then continued as 
before.  
 
1.24 Immunoprecipitation (IP) 
 
Nucleosome prep and chromatin segregation assay buffers: 
 
Low Salt Buffer (LSB) 
68 
 
10 mM HEPES pH 7.4 
25 mM KCl 
10 mM NaCl 
1 mM MgCl2 
0.1 mM EDTA 
 
High Salt Buffer (HSB) 
50 mM Tris-HCL pH 8 
5% glycerol 
1 mM EDTA  
10 mM MgCl2 
400 mM KCl 
1X protease inhibitor  
0.1 μM MC-LR 
 
Nuclease buffer 
10 mM HEPES 
10 mM KCl 
1 mM CaCl2 
1.5 mM MgCl2 
0.34 sucrose 
10% glycerol 
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1 mM DDT 
0.1% Triton X-100 
 
Wash Buffer 
Nuclease buffer   
1% NP-40,  
1% Triton X-100   
300 mM NaCl 
 
Solubilisation Buffer 
Nuclease buffer  
2% NP-40 
2% Triton X-100 
600 mM NaCl 
 
Denaturing Buffer 
50 mM Tris pH 6.8  
1% SDS 
100 mM DTT 
10% glycerol 
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1.24.1 Fixation trials for IP 
 
2 x T25 flasks were used per cell type. Cells were irradiated with 10 Gy IR and PFA treated 30 
minutes later. Cells were fixed with 2 ml fixative for 3 minutes under the following conditions: 
(1) No fixative (PBS), (2) 0.1% PFA, (3) 0.3% PFA, (4) 1% PFA, (5) 3% PFA. Fixative was poured 
off and cells were washed with 1X PBS.  Media was added back to the flask and the cells were 
collected by scraping. Collected cells were centrifuged at 2000 rpm for 2 minutes. The 
supernatant was removed and the pellets were washed with 1X PBS and transferred to 
eppendorfs. Pellets were then washed with 1X LSB (0.5 ml), centrifuged at 2000 rpm for 2 mins 
and resuspended in 5X pellet cell volume (PCV)) of LSB + Pl + PPl + Microcystin-LR (MCLR – 
protein phosphatase inhibitor). 
 
 
1.24.2 Nucleosome solubilization and γH2AX IP 
 
Cells were fixed with 0.1% PFA for 3 minutes, then washed with PBS and once with low salt 
buffer (LSB: 10 mM HEPES (pH 7.4), 25 mM KCl, 10 mM NaCl, 1 mM MgCl2, 0.1 mM EDTA). 
Pellet cells were resuspended in five times the packed cell volume (PCV) of LSB + 0.1 um MC-LR 
and 1X protease inhibitor cocktail (Sigma-Aldrich, UK) and snap frozen in liquid nitrogen. Cells 
were quick thawed and centrifuged at 10,000 rpm for 10 minutes. The pellet was resuspended 
in 2 times the PCV of nuclease buffer (10 mM HEPES (pH 7.9), 10 mM KCl, 1.0 mM CaCl2, 1.5 
mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, 0.1 % (v/v) Triton X-100) containing 
100U/ml MNase. Samples were incubated at 37 degrees for 45 minutes. A PCV of solubilization 
buffer (nuclease buffer + 2% (v/v) NP-40, 2% (v/v) Triton X-100, 600 mM NaCl) was then added. 
Samples were sonicated and centrifuged at 10,000 rpm for 10 minutes. The final supernatant 
was incubated with 2 µl of anti-γH2AX monoclonal antibody overnight at 4 degrees. 30 µl of 
protein G-sepharose was added and incubated overnight to pull down immunocomplexes 
followed by 3 washes with wash buffer (nuclease buffer + 1% (v/v) NP-40, 1% (v/v) Triton X-
100, 300 mM NaCl. Samples were boiled for 2 minutes following the addition of 20 µl 2X SDS 
sample buffer. Samples were separated on a 12.5 % SDS PAGE gel.  
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1.24.3 DNA extraction following γH2AX IP 
 
γH2AX IP was carried out as described above. 20 μg DNase-free RNase A was added to each 
sample and incubated at 37°C for 30 minutes. 250 μl IP elution buffer (1% SDS + 0.1 M NaHCO3) 
was added to each sample and incubated at room temperature for 15 minutes. Samples were 
vortexed occasionally throughout the incubation. The supernatant was collected in a screw cap 
eppendorf and the elution process repeated once. Supernatants were pooled. To revert the 
cross-linking, 200 mM NaCl was added to the eluted samples and samples were incubated at 
85°C for 2 hours. Protein and DNA samples were precipitated with the addition of 1 ml 99% 
ethanol. Samples were incubated with ethanol overnight at -20°C. 24 hours later, samples 
were centrifuged at 3000 rpm for 15 minutes at 4°C. Pellets were washed with cold 70% 
ethanol. Samples were centrifuged again at 3000 rpm for 15 minutes at 4°C. The pellet was air 
dried at room temperature. The pellet was then dissolved in 100 μl ddH2O pH 8. To each pellet, 
11 μl of 10X proteinase K buffer + 1 μl of 20 μg/μl of proteinase K was added and incubated at 
50°C for 30 minutes. DNA was then extracted with phenol/chloroform/isoamyl alcohol, using 
the same volume that was used to originally dissolve the pellet. Samples were shaken by hand 
and centrifuged at 3000 rpm for 10 minutes at room temperature. The upper aqueous layer 
(DNA) was removed. This was repeated 2X and the upper aqueous layers pooled. The DNA was 
ethanol precipitated in 1ml 99.9% ethanol at -20°C overnight. 24 hours later, samples were 
centrifuged at 10,000 rpm for 10 minutes.  The final pellet was dissolved in 50 – 100 μl of 
water. A fraction of the sample was loaded on an agarose gel.  
 
1.24.4 DNA agarose gel 
 
Stock solutions: 
1X TAE: 
0.4M Tris acetate 
1mM EDTA pH 8 
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6X loading buffer: 
25 mg Xylene cyanol FF 
25 mg Bromophenol blue 
3 ml Glycine 
Make up to 10 ml with ddH20 
Store at 4°C 
 
To prepare agarose gels the appropriate concentration (w/v) of agarose was dissolved in 1X 
TAE buffer by heating in a microwave. The agarose was cooled and ethidium bromide 
(0.5μg/ml) was added prior to pouring. Gels were left to polymerize at RT. Prior to sample 
loading the gel was immersed in TAE buffer for 10 minutes. Samples wer loaded with sample 
loading buffer alongside a 1Kb DNA marker (Invitrogen). Electrophoresis was carried out at 85V 
for 40 minutes. Ethidium bromide incorporated DNA was visualized with a UV light box.  
 
1.25 Chromatin fractionation assay  
 
Cells were irradiated with 40 Gy IR, trypsinzied and washed with 1ml PBS. Cells were 
centrifuged at 1500 rpm for 1 min. The cells pellet was resuspended in 1X PCV of nuclease 
buffer (no MNase). Sample were again spun at 1500 rpm for 1 min (supernatant = C0). The 
pellet was then resuspended in nuclease buffer (same V as PCV) containing 10 U/ml MNase 
and incubated at 37° for 10 mins. Samples were then centrifuged for 3 minutes at 2,000 rpm 
(supernatant = C1). The pellet was then resuspended in nuclease buffer (same V used for PCV) 
containing 100 U/ml MNase and incubated at 37°C for 45 minutes. The same volume of 
solublization buffer (nuclease buffer + 2% NP-40, 2% Triton X-100, 600 mM NaCl) was then 
added to the pellet. Samples were then briefly vortexed and centrifuged for 5 minutes at 
10,000 rpm (supernatant = C2). The remaining pellet was resuspended in solubilization buffer 
(same V as HSB) and an equal volume of denaturing buffer (50 mM Tris pH 6.8, 1% SDS, 100 
mM DTT, 10 % glycerol). Finally, the remaining sample was sonicated, boiled for 5 minutes and 
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centrifuged for 5 minutes at 10,000 rpm (supernatant = C3). (A very small pellet will remain 
which is the insoluble cell membrane) 
 
 
1.26 Flow cytometry  
 
Cells were grown in dishes at a concentration of 2 x 105 cells/ml for 48 hours. Cells were 
trypinized in 0.4% trypsin and centrifuged at 1500 rpm for 3 minutes. The cell pellet was 
washed in 10 ml PBS + 1mm EDTA and again centrifuged at 1500 rpm for 3 minutes. The PBS 
was then removed. The pellet was resuspended in 2 mls PBS with a pipette to have a 
population of single cells. 1 ml 2% PFA was added slowly to the sample while vortexing. 
Samples were fixed in PFA (2%) for 10 minutes. The pellet was centrifuged at 3000 rpm for 3 
minutes, resuspended in PBS and stored at 4°C.  200 μl PI buffer (20 μl 1 mg/ml Propidiun 
iodine (PI), 2 μl 30 mg/ml RNase, 180 μl PBS) was added to each sample. Samples were then 
transferred to a FACS tube. Samples were read using a FACS canto cell sorting calibrator.  
 
1.27 Clonogenic survival  
 
On day one, 1 x T25 flask was set up with 2 x 105 cells per cell line. 15 X 9 cm Petri dishes per 
cell line with 6 x 104 feeder cells were also set up. Feeder cells were irradiated with 35 Gy (IR) 
before plating into MEM + NBCS + supplements (10 ml/dish). On day two, the T25 flasks were 
trypsinized and counted. Serial dilutions were made from these cells. Cells were irradiated and 
plated onto feeder cells. On day 21, 1 ml of methylene blue was added to each dish for 45 
minutes. The solution was poured off and plates were left to dry at room temperature for 24 
hours. The plates were then gently washed with water and again left to dry.  Colonies with 
more than 50 cells were counted.  
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1.28 Delta vision microscope 
 
1.28.1 SoftWoRx® Suite software analysis  
 
Quantitative measurements of γH2AX and DAPI overlap were obtained and visualized as a red 
signal using softWoRx® Suite software. The size of overlapping regions per cell was quantified 
by ImageJ. The number of chromocentres was analysed. The size of overlap per chromocentre 
was normalized following these analyses. The volume of the interior signal was visualized and 
measured by Huygens Professional, Scientific Volume Imaging. Similar to the analysis of 
overlap, the volume per chromocentre was normalized to the number of chromocentres. 
 
1.28.2 Measuring fluroflore signal intensity using ImageJ software.  
 
The signal intensity of FITC and DAPI per YH2AX focus was quantified with ImageJ. To measure 
pATM signal intensity, the untreated nuclear intensity was subtracted from the IR induced 
nuclear signal intensity. The images were taken by the Zeiss Axioplan microscope with identical 
exposure time. The size of γH2AX foci at chromocentres was quantified with ImageJ after 
deconvolution with softWoRx® Suite software. 
 
1.28.3 softWoRx® Suite software analysis  
 
Quantitative measurements of γH2AX and DAPI overlap were obtained and visualized as a red 
signal using softWoRx® Suite software. The size of overlapping regions per cell was quantified 
by ImageJ. The number of chromocentres was analysed. The size of overlap per chromocentre 
was normalized following these analyses. The volume of the interior signal was visualized and 
measured by Huygens Professional, Scientific Volume Imaging. Similar to the analysis of 
overlap, the volume per chromocentre was normalized to the number of chromocentres.  
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1.29 γH2AX foci and G2/M checkpoint analysis  
 
DSB repair was monitored by disappearance of γH2AX foci (Lobrich et al., 2010). G1 and G2 
phase cells were identified using the cell cycle marker, anti-CENPF in human cells and anti- p-
H3 Ser10 in mouse cells, respectively (Beucher et al., 2009). For initiation of G2/M checkpoint 
analysis, cells were fixed 1 or 2 h after IR, and stained for p-H3 Ser10 and DAPI. p-H3 Ser10 
positive and condensed chromatin cells were scored as mitotic cells. >400 cells were scored 
per condition. For DSB repair in cycling cells and maintenance of G2/M checkpoint analysis, 4 
μM aphidicolin was added immediately after IR to block entry of irradiated S phase cells into 
G2 during analysis. Aphidicolin does not impact upon DSB repair and signaling in G1 and G2 
phase (Beucher et al., 2009; Lobrich et al., 2010; Shibata et al., 2010). The mitotic idex 
represents the number of mitotic cells per 100 cells.  
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The impact of higher order chromatin structure on G2/M 
checkpoint arrest and ATM signalling 
 
 
1.30 Introduction 
 
ATM is a DNA damage inducible protein kinase, which phosphorylates a plethora of substrates 
participating in the DNA damage response, including proteins involved in DNA repair and cell 
cycle checkpoint arrest. An early detectable ATM substrate is the histone variant γH2AX which 
acts as a docking site for the recruitment and retention of damage response proteins into 
repair foci. The accumulation and spread of these repair foci can travel over megabases of DNA. 
γH2AX foci formation is required for ATM-dependent DSB repair but its influence on ATM 
signalling appears to be modest since loss of H2AX confers only a mild defect in ATM 
phosphorylation of downstream substrates – most specifically impacting at low doses. Given 
that chromatin architecture plays an important role in regulating DNA replication, transcription, 
recombination and repair; the impact that heterochromatin poses to DDR signalling is 
unknown. This is of particular importance because there are human syndromes with 
disordered heterochromatin. In this chapter I will focus on how changes to heterochromatin 
that occur in human disorders influence ATM signalling. Specifically, I will focus on how 
reduced heterochromatin organization impacts upon the expansion of IR induced γH2AX foci 
and G2/M checkpoint initiation.  
 
 
1.30.1 The impact of chromatin on DSB repair 
 
Over two decades ago, changes in DNA packaging following DNA damage was recognized by 
changes in accessibility of DNA binding dyes and DNA nucleosome digestibility (Takahashi and 
Kaneko, 1985). The re-emergence of interest in this field has put heterochromatin in vogue, 
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and many recent publications analyzing the impact of chromatin structure on DSB repair have 
shed light on how the damage response machinery manoeuvres nucleosomes to allow access 
to the DNA repair machinery. It was first suggested in yeast that upon DNA damage histone 
remodelling complexes initiate structural changes at the site of a lesion (Downs et al., 2004). In 
yeast a subunit of the histone remodelling complex NuA4 was found to directly interact with 
H2A S129 (analogous to mammalian H2AX S139) following DNA damage (Downs et al., 2004), 
suggesting that nucleosome remodelling occurs at the site of a DSB. Further experiments in 
yeast found that the stability of histone H2B or H3 association with chromatin decreases after 
DSB induction (Tsukuda et al., 2005). Chromatin surrounding the DSB region also becomes 
more accessible to MNase digestion, implying that the chromatin superstructure at these 
localities relaxes (Tsukuda et al., 2005).  In mammalian cells, delayed recruitment and focal 
accumulation of 53BP1 and Rad51 has been observed in cells defective for the histone 
Acetyltransferase (HAT) co-factor Trrap (Murr et al., 2006). HATs typically modify histone tails 
with acetyl residues to promote nucleosomal relaxation. Using ChIP, a reduction of H4 
acetylation at the site of an I-Sce1 induced DSB in Trrap deficient cells was observed. Depletion 
of Trrap also abolished the association of another HAT known as Tip60 with the DSB site (Murr 
et al., 2006). Following chemically induced chromatin relaxation, mediated by either: 
chloroquine, sodium butyrate or hypotonic conditions, the accumulation of Rad51 at DSBs in 
Trrap deficient cells was rescued (Murr et al., 2006). These results suggested that the Trrap-
Tip60 complex functions to acetylate histones in the vicinity of a DSB, and that this remodelling 
is essential for the recruitment of repair proteins at the site of a lesion. In recent years several 
papers have demonstrated the importance of KAP-1 phosphorylation (pKAP-1) in response to 
DSBs to implement dynamic and localized chromatin changes necessary for DSB repair 
(Goodarzi et al., 2008; Ziv et al., 2006).  KAP-1 is a heterochromatin associated building protein 
that is phosphorylated by ATM at S824 (Goodarzi et al., 2008) (see 3.1.4.1 for further 
discussion on KAP-1). The importance of KAP-1 mobility for HC associated repair was first 
demonstrated by Ziv et al (2006) when MNase accessibility was found to increase following 
KAP-1 knockdown. Later Goodarzi et al (2008) demonstrated that the requirement for ATM in 
DSB repair could be overcome following HC mediated relaxation via KAP-1 knockdown or 
expression of a phosphomimetic KAP-1S824D, while the expression of a non-phosphorylatable 
KAP-1 conferred a constitutive HC DSB repair defect similar to that of A-T cells. The authors 
proposed that ATM dependent phosphorylation of KAP-1 functions to perturb 
heterochromatin at the site of a DSB. A later publication from the same laboratory established 
that the mediator proteins 53BP1, RNF8 and MDC1 promote KAP-1 phosphorylation and assist 
in DSB repair at heterochromatin (Noon et al., 2010).  At early time points after IR, pKAP-1 
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immunostaining appears pan-nuclear. This reflects the wide spread untethered activity of ATM 
at early time points after IR. At later time points when ATM activity is tethered by mediator 
proteins such as MDC1 and 53BP1, localized KAP-1 phosphorylation occurs, and these foci 
locate to slow repairing DSBs at regions of heterochromatin. Cells missing 53BP1 displayed 
largely normal pKAP-1 induction (pan-nuclear staining), but due to an inability to concentrate 
ATM they failed to form pKAP-1 IRIF overlapping with HC DSBs (Noon et al., 2010). The authors 
proposed that IRIF foci concentrate ATM activity at a DSB to promote localized alterations in 
regions of chromatin otherwise inhibitory to repair. Collectively these findings are consistent 
with the notion that the HC superstructure is a barrier to DSB repair and the importance of 
ATM phosphorylation in increasing the global accessibility of chromatin after DNA damage. In 
this chapter I will focus on whether heterochromatin influences DDR signalling. This is 
important because heterochromatin levels can vary between cell types and also there are 
patients with disordered heterochromatin.  
 
 
1.30.2 The impact of chromatin on DDR signalling 
 
One of the earliest detectable chromatin modifications to occur following DSB induction is the 
phosphorylation of H2AX on S139 (Rogakou et al., 1998). H2AX is a member of the H2A histone 
family, which is one of five histone families that package and organize DNA into chromatin (see 
1.15 for further discussion on chromatin). The importance of H2AX is not yet fully understood. 
H2AX-/- mice have a subtle DSB repair defect, are subject to increased genomic instability and 
male H2AX knockout mice are infertile; however, cell cycle checkpoints remain intact although 
they are impaired at low doses (Celeste et al., 2002). From these results it was concluded that 
H2AX is not required for the initial recognition of a DSB, but for the focal accumulation of 
repair proteins to the site of lesion (Celeste et al., 2002). In humans, the H2AX gene (H2AXFX), 
which maps to chromosome 11 at position 11q23, is a region frequently mutated or deleted in 
a large number of human cancers (Ghiassi-nejad et al., 2002). During DSB repair, 
phosphorylated H2AX (γH2AX) acts as a binding platform for the recruitment and retention of 
DSB signalling factors to the site of the lesion (as described in section 1.6). Damage induced 
phosphorylation of H2AX can spread over megabases of chromatin regions flanking the DSB. 
Local concentrations of γH2AX foci can be visualized at interphase cells by 
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immunofluorescence microscopy. γH2AX foci have been reported to be unevenly distributed 
throughout the nucleus and to form at the site of a DSB in a non-symmetrical fashion in both 
yeast (Cowell et al., 2007; Kim et al., 2007; Shroff et al., 2004) and mammals (Berkovich et al., 
2007; Meier et al., 2007; Savic et al., 2009). γH2AX foci are excluded from nuclear regions 
enriched for heterochromatic markers HP1 and H3K9Me3 following IR in MCF7 cells (Cowell et 
al., 2007). However, the treatment of S phase cells with HU lead to efficient H2AX 
phosphorylation at both euchromatin and heterochromatin, suggesting that ongoing 
replication partially relieves the heterochromatic barrier (Cowell et al., 2007). In human 
fibroblast cells, using immunoFISH techniques, Falk et al (2008), reported γH2AX induction 
following IR to be under-represented in the silenced chromatin of chromosome 18, in 
comparison to the gene rich uncondensed chromatin of chromosome 19. Following analysis of 
confocal microscopy images, the higher sensitivity of these regions to DNA damage was also 
observed to be accompanied by more efficient repair. Similar findings have been observed in 
the budding yeast Saccharomyces cerevisae, using an HO-inducible DSB system. The Haber 
laboratory used chromatin immunoprecipitation (ChIP) analysis to examine the spreading of 
phosphorylated H2AX along chromatin. Upon induction of a single DSB they could detect 
approximately 50 kilo bases (kb) of phosphorylated H2AX at either side of the HO induced 
break site. However, when the HO inducible break was situated in the vicinity of the 
heterochromatic, silenced HML and HMR loci, γH2AX expansion was inhibited (Kim et al., 
2007). In primary mouse fibroblasts a similar phenomenon was observed when cells were 
treated with the HDAC inhibitor trichostatin A (TSA), a drug which relaxes chromatin. Following 
relaxation, the total amount of H2AX phosphorylated at the site of a neocarzinostatin (NCS) 
induced DSB was found to increase (Kim et al., 2007). As well as these effects of HC, the impact 
of global chromatin relaxation has also been assessed in mouse embryonic stem cells 
expressing half the wild type complement of the linker histone H1 (Murga et al., 2007). Histone 
H1 depletion resulted in enhanced radioresistance and hyperactive checkpoint responses 
compared to WT or H1 complemented stem cells. γH2AX and Chk1 phosphorylation at Ser345 
was also found to be hyperactive in H1 depleted cells. This result was recapitulated following 
treatment with TSA (Murga et al., 2007). Collectively these findings suggest that processing of 
DSBs at heterochromatin might differ from that at euchromatin and that chromatin structure 
has a significant impact on damage response signalling.  In this chapter I sought to determine 
what impact reduced heterochromatin content would have on the expansion of IR induced 
γH2AX foci particularly at HC associated DSBs.  
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1.30.3 Model systems to analyze IR induced signalling in the context of reduced chromatin 
organization. 
 
Although numerous properties of HC differ, the molecular components constituting HC 
formation are largely shared by all. Chemical modifications on chromatin such as acetylation, 
methylation, phosphorylation, ubiquitination and SUMOylation are important in the epigenetic 
control of gene transcription (see 1.17 for further discussion). DNA modifications carried out 
by enzymes such as DNA methyltransferase (DNMTs) modify chromatin by addition or removal 
of these modifications. Other proteins bind and integrate with nucleosomes to form a higher 
order chromatin superstructure which is silenced from transcription. Such examples include 
the KRuppel Associated Box (KRAB) Associated Protein 1 (KAP-1) and Methyl CpG binding 
Protein 2 (MeCP2). Similarly, Lamin A which is a structural component of the lamina 
membrane, co-ordinates chromosomal location and silencing mediated partly through histone 
deacetylases (HDACs) (Han et al., 2008). Loss of these modifying enzymes or heterochromatin 
scaffolding proteins results in reduced higher order chromatin organization. Cells deficient in 
these proteins are ideal candidates for analyzing the effect of chromatin superstructure on 
ATM dependent DSB induced signalling. Similarly, patient cell lines with mutations in these 
proteins offer a similar advantage.  
 
 
1.30.3.1 KAP-1 
 
The transcription co-repressor KAP-1 is a critical heterochromatin building factor. KAP-1 
mediates DNA binding via association with a kruppel associated box (KRAB) domain. KRAB is a 
repression domain encoded by many transcription factors which contains a conserved amino 
terminal motif that contains multiple DNA binding Cys2-His2 zinc fingers (Bellefroid et al., 
1991). The C-terminus of KAP-1 contains a PHD finger and bromodomain, which typically are 
known as methyl-lysine or acetyl-lysine binding domains, respectively. The PHD-bromodomain 
of KAP-1 acts to control site specific KAP-1 SUMOylation (Li et al., 2007; Zeng et al., 2008). KAP-
1 SUMOylated residues serve as a recruitment platform for the nucleosome-remodelling and 
histone deacetylation (NuRD) chromatin remodelling complex (Ivanov et al., 2007). NuRD 
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mediates remodelling through the removal of acetyl residues via HDAC1/2. A second 
SUMOylated KAP-1 site interacts with SET domain, bifurcated 1 (SETDB1) histone 
methyltransferase via SUMO interacting motifs (Ivanov et al., 2007), and modifies chromatin 
via addition of methyl groups to histone tails (Figure 3.1) 
 
1.30.3.2 DNMTs 
 
Transcriptional silencing and HC formation can be mediated by the removal of methyl residues 
from histone tails. This is typically carried out by DNA methyltransferases (DNMTs). Human 
cells encode for 4 different DNMT’s, which are DNMT1, DNMT2, DNMT3A and DNMT3B. 
DNMT3B is a maintenance methyltransferase and predominantly methylates hemimethylated 
CpG dinucleotides in the mammalian genome. DNMT2 has strong sequence similarity with 
methyltransferases of both prokaryotes and eukaryotes, and has been shown to target small 
transfer RNA (Goll et al., 2006). DNMT3A and DNMT3B can methylate hemimethylated and 
unmethylated DNA and are described as de novo methyltransferases (Goll and Bestor, 2005). 
DNMT3B deficient mice are embryonic lethal, whereas DNMT3A deficient mice develop and 
appear normal at birth, implying that despite the similarities in function, the specific targets of 
each of the DNMT’s differs (Chen et al., 2003). DNMT3B knockout mice have marked 
demethylation or pericentric satellite repeats, which is a similar characteristic of 
Immunodeficiency Centromeric instability facial anomalies (ICF) syndrome patients (Hata et al., 
2002). 
 
 
1.30.3.3 ICF syndrome 
ICF (Immunodeficiency Centromeric instability Facial anomalies) syndrome is an autosomal 
recessive syndrome characterized by severe immunodeficiency and instability at pericentric 
heterochromatin. Typical ICF patients have mutations in the de novo DNA methyltransferase 
3B (DNMT3B) (Figure 3.2B). Loss of DNMT3B results in hypomethylation at constitutive 
heterochromatin, in particular at satellite regions on chromosomes 1, 9 and 16. Due to 
hypomethylation at these chromosomal locations gross chromosomal rearrangements, whole 
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arm deletions, chromosome breaks and multi-radial chromosome junctions can occur (Ehrlich, 
2003). 
 
1.30.3.4 MeCP2 
Methylation at CpG dinucleotides is one of the most abundant epigenetic modifications in 
mammalian genomes and plays an essential part in the control of gene expression. CpG islands 
are GC-rich regions of DNA stretching for an average of ~1kb and are coincident with the 
promoters of ~60% of human RNA pol transcribed genes. However methylation at these 
regions promotes the binding of the methyl binding domain (MBD) protein MeCP2. MeCP2 is a 
5-methyl cytosine binding protein that acts as a transcriptional repressor through recruitment 
of transcriptional co-repressors such as Sin3A and HDAC’s (Figure 3.3). Four functional domains 
comprise MeCP2: a MBD which binds methyl residues, a transcriptional repressor domain (TRD) 
which is responsible for recruiting silencing factors such as HDACs, a NLS and a large C-terminal 
domain (Figure 3.3). MeCP2 is expressed in all tissues, with highest levels of expression in the 
brain, lung and spleen and lower in the heart and kidney (Shahbazian et al., 2002). The broad 
spectrum of HC accessory factors capable of interacting with MeCP2 means that MeCP2 
contributes to a broad range of HC structures in the mammalian cell. For example HP1γ 
relocalization during myogenic differentiation correlates with the presence of MeCP2 (Agarwal 
et al., 2007). HP1γ and MeCP2 directly interact via the TRD of MeCP2, arguing that they co-
operate in the formation of repressive sub-nuclear compartments involved in epigenetic 
silencing. MeCP2 also interacts with the inner membrane protein Lamin B receptor (LBR), and 
this interaction has been suggested to contribute to heterochromatin formation at the nuclear 
periphery.  
 
 
1.30.3.5 Rett syndrome 
 
Rett syndrome is an X-linked progressive neurological disorder (Rett, 1966) caused by 
mutations in the MECP2 gene. Affected individuals develop normally until 6-18 months of age, 
thereafter regression of acquired skills begins. Individuals loose speech, develop microcephaly, 
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mental retardation and stereotypical hand movements (typically continuous clasping of hands) 
(Moog et al., 2003). Rett syndrome is the most common neurological disorder to affect 
females, with a penetrance in Europe of 1:15,000 (Hagberg et al., 1985). Approximately 1% of 
the total reported cases of Rett syndrome are inherited; the vast majority of cases are sporadic 
(Schanen et al., 1997). Almost all MeCP2 mutations are de novo, except for cases were the 
mutation has been inherited from a healthy or mildly affected mother, which either had 
gonadal mosacism or favourable X chromosome inactivation (XCI).  Around 60% of MeCP2 
mutations are caused by a C>T transition at 8 CpG dinucleotides (R106, R133, R158, R168, 
R255, R270, R294 and R306), located in the third and fourth exon (Matijevic et al., 2009) 
(Figure 3.2A). Frequently, nonsense, frameshift and splicing mutations occur after the MBD 
which result in premature termination and a truncated protein product. Although deletions 
occur frequently, identical deletions are rare. (Shahbazian and Zoghbi, 2001), suggest that 
truncated proteins still bind methylated DNA but cannot interact with the Sin3A co-repressor.  
 
 
1.30.3.6 HGPS 
 
Hutchinson-Gilford progeria syndrome (HGPS) is the most severe of the premature aging 
progeriod syndromes. Affected individuals have a mean life span of 13 years. It is an extremely 
rare condition with only 150 documented cases of HGPS worldwide. Affected individuals 
develop normally at birth, but prematurely display characteristics associated with aging, such 
as alopecia, severe lipodystropy, scleroderma and varied skin hyper-pigmentation (Kudlow et 
al., 2007). HGPS in the majority of cases is caused by aberrant splicing of LMNA, a gene that 
encodes A-type nuclear lamins.  A type lamins belong to a family of intermediate filament 
proteins that are the main components of the nuclear lamina (proteinacious meshwork that 
underlies the inner nuclear membrane). All A type lamins are encoded by a single LMNA locus 
through alternative splicing. The Lamin A protein is synthesized as a precursor protein called 
prelamin A (Rusinol and Sinensky, 2006) (Figure 3.4). The C-terminal of prelamin A undergoes 
farnesylation. Farnesylation is the addition of a 15-carbon isoprenoid farnesyl group to a four 
amino acid CAAX motif at the C-terminus of a protein. Farnesylated prelamin A undergoes two 
cleavage events, one of which removes the farnesyl. Hence, mature lamin A contains no 
farnesyl (Pendas et al., 2002). The most frequent HGPS associated mutation Gly608Gly, is a 
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silent base substitution that activates a cryptic spice donor in exon 11 of LMNA. The resulting 
mutant protein is called progerin. Progerin retains it’s C-terminal, and lacks the recognition 
sequence for the second cleavage, and therefore remains farnesylated (Dahl et al., 2006). The 
mutant protein localizes to the nuclear periphery, and cells from HGPS patients typically have 
irregular nuclear morphology. HGPS patient cells also show relocalization or decreased 
expression of heterochromatin protein-1 (HP1) (Scaffidi and Misteli, 2005). 
 
 
1.30.4 The crosstalk between ATM and ATR in G2/M checkpoint activation 
 
Despite structural similarities and stimulation by similar genotoxic stresses the target 
specificities and development requirements between Chk1 and Chk2 kinases differ. Chk1 is 
essential for mammalian development and viability (Takai et al., 2000), whereas Chk2 deficient 
mice are viable, fertile and only show tumour susceptibility when exposed to carcinogens 
(Hirao et al., 2000; Takai et al., 2002). Chk1 deficient mice have early embryonic lethality, 
making studies in knockout mice difficult. However RNAi mediated knockdown of Chk1 in 
human cells has revealed an essential role for Chk1 in control of Cdc25A protein turnover, 
supporting a role for Chk1 in S and intra-S phase checkpoints (see 1.10.3 for a further 
discussion on the S phase checkpoint). A-T patients and ATM knockout mice are sensitive to IR 
induced DSBs and are defective in activating checkpoint arrest. However, damage responses to 
UV and replication associated damage, which activates ATR, are normal in A-T cells. ATR 
dependent signalling is triggered by a range of DNA damaging agents including IR, UV light, 
interstrand crosslinking agents such as cis-platin, and replication inhibitors such as 
hydroxyurea. All of these agents pose the potential to induced replication fork stalling. The 
strict model of ATM to Chk2 and ATR to Chk1 mediated signalling has been expanded by 
evidence of cross-talk between these kinases. An overlapping role for ATM in the activation of 
Chk1 in response to IR was established after Chk1 phosphorylation at Ser317, which occurs 
normally after replication associated DNA damage, was compromised in ATM defective cells 
(Gatei et al., 2003). RPA focus formation after IR in ATM and Nbs1 deficient cells is also 
severely impaired (Jazayeri et al., 2006). ATLD (Mre11-/-) cells (which lack the nuclease 
component of the MRN complex) also have defective Chk1 phosphorylation after IR (Jazayeri 
et al., 2006). From this data it was proposed that after IR, ssDNA regions which are required for 
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ATR activation are generated via DNA end resection in a process that is regulated by ATM.  
ATM dependent Chk1 phosphorylation is inhibited by the CDK inhibitor roscovitine (Jazayeri et 
al., 2006). CDK phosphorylation regulates the activity of CtIP, a nuclease that has recently been 
established to regulate DSB repair pathway choice between HR and NHEJ (see 4.1.3 for further 
discussion). Furthermore ATM dependent CtIP phosphorylation at Ser664 and Ser745 regulates 
CtIP mediated resection. Therefore ATM has been proposed to promote resection via 
activation of CtIP. Thus Chk1 can contribute to G2/M checkpoint arrest via signalling from 
replication associated DNA damage in S phase (via ATR) or from resected DSBs in G2 (via ATM 
– ATR). Chk2 is activated at non-resected DSBs in G2 via ATM. Both Chk2 and Chk1 can 
contribute to G2/M checkpoint arrest (Figure 3.5). 
 
1.30.5 Sensitivity of the G2/M checkpoint 
 
Although ATM is sensitively activated by low numbers of DSBs (and likely by a single DSB), it is 
now evident that G2/M checkpoint arrest is less sensitive. It was first made apparent that the 
level of ATM activation does not directly correlate with the activation of Chk2 in 2004 when 
Buscemi et al reported that a phosphorylation dependent band shift of Chk2 was only 
observed after IR doses above 1 Gy, despite ATM phosphorylation being apparent after doses 
as little as 0.25 Gy IR (Bakkenist and Kastan, 2003; Buscemi et al., 2004). In accordance with 
this, the incorporation of radiolabelled isotopes during DNA synthesis was only inhibited after 
IR doses above 1 Gy (inducing roughly 19 DSBs). The authors concluded that the ATM 
dependent Chk2 pathway is only activated when ≥19 DSBs are present (Buscemi et al., 2004). 
This mechanism of checkpoint insensitivity was suggested to enable DSB repair to occur in the 
presence of less than ~ 19 DSBs without the activation of a Chk2 dependent checkpoint. The 
G2/M checkpoint can be activated by DSBs that are either generated in S phase and progress 
into G2 or DSBs induced directly in G2 phase. To study checkpoint induction and release 
following IR in G2, Deckbar et al (2006) irradiated cells 4 hours after pulse labelling with BrdU 
(a time at which cells were shown to progress into G2) and cell cycle progression was analysed 
by FACS. Checkpoint deficient cells, such as A-T, continuously progressed into mitosis. 
Wildtype cells initiated and sustained a checkpoint arrest for 4 hours after 1 Gy before 
progressing into mitosis. Checkpoint release in Artemis cells occurred later than compared to 
wildtype cells, which the authors concluded was likely reflective of their repair defect. To 
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evaluate whether DSB repair was completed upon G2/M checkpoint release, chromosome 
aberrations in mitotic cells were analysed in cells after checkpoint release. Unexpectedly the 
number of chromosome breaks in released wildtype and Artemis cells was similar despite the 
longer checkpoint arrest observed in Artemis cells. These results lead to the proposal of a 
threshold number of DSBs being required to initiate and sustain G2/M checkpoint arrest. Using 
premature chromosome condensation (PCC) analysis, wildtype and Artemis cells were both 
found to have 3-4 PCC breaks at the time of checkpoint release. Using PFGE, previous studies 
have established that 3-6 DSBs equate to 1 PCC break (Cornforth & Bedford, 1993). Given that 
1 PCC break represents between 3-6 DSBs, the sensitivity of the G2/M checkpoint was 
proposed to be 10-25 DSBs (Deckbar et al., 2007). This was further supported by γH2AX foci 
analysis showing that ~20 DSBs remained after checkpoint release and that the duration of 
G2/M checkpoint maintenance extended with increasing dose. Therefore G2/M checkpoint 
arrest is only sustained when the damage level remains above the threshold and the number 
of DSBs remaining directly influences the duration of arrest. The identification of a G2/M 
checkpoint threshold helped to explain the exaggerated sensitivity of G2 phase cells to low 
doses IR (Marples et al., 2004). Low dose hypersensitivity describes a phenomenon by which 
cells die from excessive sensitivity to small doses of IR. From survival experiments it became 
apparent that the dose of IR required to change from low-dose hyper-radiosensitivity to an 
increased radioresistant response corresponded to the activation point of the G2/M 
checkpoint (Marples et al., 2004). Since a certain number of DSBs are required to generate 
enough signalling to initiate arrest, doses of IR which fail to introduce enough DSBs to reach 
the threshold and activate a checkpoint arrest pose a threat to genomic stability or cell survival. 
Since DSBs arise endogenously following metabolic processes and replication stress, which if 
repaired correctly have no effect on survival, having a DSB threshold prevents unnecessary 
activation of the checkpoint.  
 
1.30.6 Aims of this chapter 
The impact of HC on the DSB damage responses is important to evaluate, not least 
because the HC content can differ between tissues and cell types. Additionally, human 
syndromes with disordered heterochromatin structure have been reported. These 
syndromes include Rett Syndrome, which harbours mutations in MeCP2, a methyl CpG-
binding protein, Immunodeficiency with Centromere instability and Facial anomalies (ICF), 
Syndrome which is mutated in the DNA methyl transferase, DNMT3B and Hutchinson 
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Gilford Progeria Syndrome (HGPS), which has mutations in Lamin A and displays 
progressive HC loss (Shumaker et al., 2006). Previous studies have shown that global 
chromatin compaction caused by histone H1 limits the strength of damage response 
signalling (Murga et al., 2007). Conversely, more recently transcription has been shown to 
restrict γH2AX expansion (Iacovoni et al., 2010). Interestingly, in addition to being 
inhibitory to DSB repair, studies have shown that HC also restricts the expansion of γH2AX, 
since they do not expand within chromocentres but rather on their periphery and HDAC 
inhibition leads to wider γH2AX foci (Cowell et al., 2007; Goodarzi et al., 2008; Kim et al., 
2007). However, whether this impacts upon ATM signalling since foci can expand on the 
chromocentre periphery and whether ATM-dependent modifications overcome any 
barrier to signalling as they do for DSB repair has not been examined. Here, I investigate 
how HC influences damage response signalling focusing on the impact of disordered 
heterochromatin found in human patients. 
 
1.31 Results 
 
1.31.1 The speed and size of IR induced γH2AX foci at heterochromatin regions is enhanced 
following KAP-1 knockdown. 
 
Previous publications have established that the heterochromatic building factor KAP-1 is 
phosphorylated by ATM at Ser824 in response to DSB induction (Ziv et al., 2006). This 
phosphorylation event alters KAP-1 association with nuclease resistant chromatin and has 
been proposed to induce nucleasomal remodelling to facilitate repair at otherwise inaccessible 
DSBs (Goodarzi et al., 2008; Ziv et al., 2006). As discussed in detail previously (see section 
3.1.2), γH2AX signalling has been demonstrated to be DNA sequence independent (Kim et al., 
2007), but in contrast, global chromatin compaction influences γH2AX foci formation (Kim et 
al., 2007; Murga et al., 2007). In consideration of this data, I sought to determine whether 
KAP-1 enriched chromatin impacts upon IR-induced γH2AX foci expansion at the site of 
heterochromatin DSBs (HC-DSBs) as it does for DSB repair (Goodarzi et al., 2008). To analyze 
IR-induced signalling at HC regions, I utilized murine NIH3T3 cells, which have chromocentres 
that correspond to pericentric and centromeric HC that can be readily identified as densely 
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staining DAPI regions (Goodarzi et al., 2008; Guenatri et al., 2004). I initially verified that the 
DAPI dense regions were enriched for the heterochromatic marker Histone H3 trimethylated 
at lys9 (H3K9me3) (Figure 3.6). NIH3T3 cells were treated with or without KAP-1 siRNA for 48 
hours, followed by irradiation with 3 Gy IR. 30 minutes post IR, cells were fixed and 
immunostained. It was important to select for G0/G1 phase cells only, because in G2 phase, 
DAPI regions become more diffuse and stain positively for KAP-1, as well as for both HC and EC 
markers, (H3K9me3 and H3K9Ac respectively) (Goodarzi et al., 2010). To select for G0/G1 
phase cells, cells were stained for pSer10 histone H3, a mitotic marker which also allows 
identification of G2 phase cells within an asynchronous population. G1 phase cells are selected 
by negative or weak pSer10 histone H3 staining. γH2AX and chromocentre overlap was 
quantified in G1 cells following KAP-1 knockdown using high resolution deconvolved z stacked 
images (Figure 3.7). I observed more than a 3-fold increase in γH2AX foci expansion at DAPI 
dense regions compared to control siRNA transfected cells. In order to analyze the volume of 
interior γH2AX signal expansion at the chromocentres, 3D models of representative high 
resolution deconvolved z stacked images were generated. The volume of interior γH2AX signal 
at the HC periphery was quantified using Hygens co-localization software (Figure 3.8, MeCP2 
will be discussed in 3.2.2). By this method, the volume of γH2AX expansion into 
heterochromatin was also found to be at least 3 fold greater following KAP-1 knockdown. 
From these results I concluded that KAP-1 enriched heterochromatin acts as a barrier to IR 
induced γH2AX foci expansion. Having established that KAP-1 enriched chromatin impacts on 
the size of IR induced γH2AX foci expansion at the site of a HC-DSB, I next sought to determine 
whether KAP-1 knockdown affects the intensity of γH2AX foci following IR at both euchromatin 
and heterochromatin DSBs. NIH3T3 cells were treated with control and KAP-1 siRNA using the 
conditions described above. 30 minutes post 3 Gy IR cells were fixed and immunostained for 
γH2AX, pSer10 histone H3 and DAPI. γH2AX and DAPI signal intensity was analyzed using 
ImageJ software (Figure 3.9). For control siRNA treated cells, 20% of DSBs induced after 3 Gy IR 
were found to locate at heterochromatic regions and the median γH2AX signal intensity was 
50 a.u.. For KAP-1 knockdown cells, there was an increase in the number of DSBs located or 
overlapping with regions of heterochromatin.  The γH2AX signal intensity for these breaks also 
increased with a median signal intensity of ~60 a.u.. Representative images used for analysis 
are shown in figure 3.9A. Importantly, the same number of DSBs were induced under each 
siRNA condition.  Therefore differences in γH2AX signal intensity between control and KAP-1 
siRNA treatment could not be accounted for by a difference in DSB induction. Considering that 
γH2AX foci expansion at HC regions increased following KAP-1 knockdown, I next analyzed 
what effect reduced chromatin organization had on the kinetics of DDR protein recruitment to 
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the site of a DSB. NIH3T3 cells were treated with control or KAP-1 siRNA for 48 hours. At 
indicated time-points post 1 Gy IR cells were fixed and immunostained for γH2AX, pSer10 
histone H3 and DAPI. The number of γH2AX foci overlapping/juxtaposing or non-overlapping 
with chromocentres were scored as HC and EC, respectively. As expected the formation of HC 
associated DSBs was slower than EC associated DSBs. Consistent with the notion that 
heterochromatin acts as a barrier to repair, the rate of γH2AX foci formation at 
heterochromatin was faster following KAP-1 knockdown (Figure 3.10). Collectively, these 
results demonstrate that depletion of the HC factor KAP-1, enhances the speed and signal 
expansion of γH2AX foci at HC regions. 
 
 
1.31.2 MeCP2 and DNMT3B knockdown cells show increased signal expansion and faster 
γH2AX foci formation in NIH 3T3 cells. 
 
DNA methylation is an important epigenetic modification. In particular methylation events on 
CpG islands regulate gene silencing through chromatin compaction. An important 
methyltransferase involved in DNA methylation is DNMT3B. DNMT3B is a de novo 
methyltransferase that is important for embryonic development, imprinting, heterochromatin 
formation and female inactivate X chromosome silencing (see 3.1.3.2 for further discussion on 
DNMT3B). MeCP2 is a methyl CpG binding protein which binds methylated promoter regions 
and is associated with transcriptional silencing (see 3.1.3.4 for further discussion on MeCP2).  
To consider whether loss of methylation dependent chromatin compaction affects signal 
expansion, NIH3T3 cells were treated with either DNMT3B or MeCP2 siRNA, irradiated with 3 
Gy IR and examined as described previously. Regions of γH2AX and chromocentre overlap 
were determined using high resolution deconvolved z stacked images (Figure 3.12, 3.13).  First 
I established whether loss of MeCP2 or DNMt3B affected the size or number of chromocentres 
per cell (KAP-1 knockdown was also included in this analysis) (Figure 3.11). In knockdown cells 
a small reduction in the number of chromocentres was observed. The size of chromocentres 
only significantly changed in MeCP2 knockdown cells. To account for these changes, γH2AX 
and DAPI overlap was calculated per chromocentre rather than per cell. Image analysis of 
γH2AX and DAPI overlap per chromocentre revealed almost a 3 fold increase in γH2AX foci 
expansion following DNMT3B or MeCP2 siRNA (Figure 3.12, 3.13).  Additionally, three 
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dimensional image analysis revealed a greater volume of overlap between γH2AX and HC with 
DNMT3B or MeCP2 knockdown compared to control cells (Figure 3.8). Similar to the results 
obtained in KAP-1 knockdown cells, DNMT3B and MeCP2 knockdown also enhanced the rate 
of γH2AX foci formation at HC regions (Figure 3.14). I subsequently analyzed whether γH2AX 
foci signal intensity increased following MeCP2 and DNMT3B knockdown. NIH 3T3 cells were 
treated as described previously. MeCP2 and DNMT3B siRNA caused a statistically significant 
increase in γH2AX signal intensity with the effect being greater on the foci associated with 
higher density DAPI regions (Figure 3.15). In somewhat distinction to the findings following 
KAP-1 loss, the impact, particularly following MeCP2 siRNA, was also upon regions of 
intermediate DAPI density possibly due to the role of methylation as a transcriptional 
repressor at CGIs at both constitutive and facultative HC. In contrast, KAP-1 is primarily 
enriched within constitutive HC and conferred a more specific enrichment at heterochromatin. 
Here I have demonstrated that reduced heterochromatin organization induced by MeCP2 or 
DNMT3B knockdown enhances the size of IR induced γH2AX expansion at regions of 
heterochromatin. Furthermore, knockdown of these heterochromatin associated factors also 
enhances the signal intensity of γH2AX in response to IR. Therefore MeCP2 and DNMT3B 
dependent chromatin organization also creates a barrier to IR induced γH2AX expansion at 
heterochromatin regions. 
 
 
1.31.3 IR induced ATM signalling is hyperactivated in Rett syndrome patient cells and 
MeCP2 knockdown cells  
 
γH2AX acts as a docking site for the recruitment of several different DNA repair factors, one of 
which is the ATM binding protein complex, MRN . MRN mediated binding of ATM tethers ATM 
at the site of the break and aids to maintain ATM in an active state (Chapman and Jackson, 
2008). ATM is also the main PIKK responsible for γH2AX phosphorylation in response to IR (Stiff 
et al., 2004). Therefore, in the context of reduced higher order chromatin structure, where the 
γH2AX response is enhanced, ATM activation would also be expected to be enhanced. 
Following my observation of enhanced γH2AX foci expansion and signal intensity in KAP-1, 
DNMT3B and MeCP2 knockdown cells, I next examined ATM activation in these cellular 
contexts. First I analyzed cells derived from Rett syndrome patents, which have mutations in 
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MeCP2. MeCP2 is a protein involved in transcriptional regulation and loss of this protein could 
potentially result in the up regulation of proteins involved in the DDR. Therefore, first I 
confirmed that Rett cell lines have normal levels of damage response protein expression and 
ATM dependent phosphorylation without DNA damage. For this and subsequent analysis I 
used three different Rett syndrome cell lines. This was to confirm that any differences 
observed between the Rett syndrome and wild type cells was a true phenotype observed with 
MeCP2 loss and not another patient specific mutation.  Cycling populations of 48BR (WT) and 
Rett syndrome patient (GM16548, GM11272, GM11272) primary fibroblast cells were 
harvested for whole cell protein extraction (as described in materials and methods). Extracts 
were resolved on an SDS denaturing PAGE gel and membranes were immunoblotted with 
indicated antibodies. The Rett syndrome cell lines analyzed had normal levels of damage 
response protein expression for the selected proteins analyzed (Figure 3.16A). To analyze IR 
induced ATM activation, cycling  48BR and Rett syndrome patient (GM16548, GM11272, 
GM11272)  cells were irradiated with either 0 or 0.5 Gy IR and harvested for whole cell extracts 
30 minutes later. 60 µg of each protein sample was resolved on an SDS denaturing PAGE gel 
and immunoblotted with the indicated antibodies. Low dose IR was used because at higher 
doses, such as 3 Gy IR, the DDR signalling responses appears saturated by western blotting 
analysis and any difference between WT and Rett syndrome cells might not be detectable. 
Strikingly, ATM activation as monitored by Ser1981 phosphorylation (pSer1981 ATM), was 2-3 
fold greater in the Rett cells compared to 48BR primary cells following 0.5 Gy IR (Figure 3.17). 
However the pSer1981 ATM signal obtained varied between each Rett syndrome cell line.  
ATM is activated at DSBs in G1 and G2 phase cells and replication dependent DSBs in S phase. 
Since G2 phase cells contain double the amount of DNA compared to G1 phase cells, the 
magnitude of ATM activation could differ. Further S phase cells activate ATM at IR induced 
DSBs as well as replication associated DSBs. Therefore differences in cell cycle distribution 
could impact upon the magnitude of ATM signalling. To confirm that the increased ATM 
activity observed in the Rett syndrome cells was a consequence of enhanced DDR signalling 
generated per DSB and not a consequence of a different cell cycle kinetics compared to control 
cells, cell cycle profiles were established for each cell line using FACS. For cell cycle profile 
analysis, cycling and contact inhibited G1 arrested 48BR and Rett syndrome (GM16548, 
GM11271, GM11272) primary fibroblast cells were prepared for FACS analysis (as described in 
materials and methods). The percentage of cells arrested at G1 was similar between WT and 
Rett syndrome (GM11271 & GM11272) primary fibroblast cells (Figure 3.16B). Analysis of 
cycling cell populations revealed that the S phase cell population of Rett syndrome (GM11271 
& GM11272) primary fibroblast cells was roughly double that observed in 48BR cells. However, 
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the S phase population contributed a relatively small fraction (<9%) of the total cell population. 
The S phase cell population in cycling Rett syndrome (GM16548) primary fibroblast cells 
however was almost four times greater than WT cells (Figure 3.16B). In consideration of cell 
cycle profile analysis I selected Rett syndrome (GM11271 & GM11272) primary fibroblast cell 
lines for subsequent western blotting analysis. However, since Rett syndrome (GM16548) 
primary fibroblast cells was found to have the greatest S phase population but the weakest 
ATM pS1981 activation, variation in pS1981 ATM activation could not be accounted for simply 
by differences in cell cycle distribution. Therefore, the hyperactivity in pS1981 ATM activation 
observed in the Rett syndrome cell lines compared to WT cells was unlikely to be a 
consequence of replication dependent repair. I next examined ATM activation in G1 arrested 
48BR and Rett syndrome (GM11271) primary fibroblast cells. 48BR and Rett syndrome 
(GM11271) fibroblast cells were grown in dishes for more than 10 days until completely 
confluent. Cells were irradiated with either 0, 0.5 or 3 Gy IR and harvested at indicated time 
points post IR. Whole cell protein extracts were prepared and immunoblotted for the indicated 
antibodies. Consistent with the results observed in the cycling cell populations, G1 arrested 
populations also showed enhanced pS1981 ATM and pThr68 Chk2 activation after 0.5 and 3 Gy 
IR (Figure 3.17B). However, the increase in ATM activity in G1 arrested cell populations was not 
as dramatic as that observed in cycling cell populations. To further substantiate my findings 
from western blot analysis, I next analysed pS1981 ATM activation by IF since this allows G1 
and G2 phase cells to be identified within an asynchronous population using the cell cycle 
marker, CENP-F.  pS1981 ATM antibody specificity was confirmed previously in Noon et al, 
2010. 48BR and Rett syndrome (GM11272) primary fibroblast cells were irradiated with 0, 0.5 
or 3 Gy IR. 30 minutes post IR, cells were fixed and immunostained for pS1981 ATM, CENP-F 
and DAPI. Pan nuclear pS1981 ATM signal intensity in G1 (CENP-F negative) or G2 (CENP-F 
positive) cells was analyzed using ImageJ software. Consistent with the results obtained by 
Western Blotting, IR induced pan nuclear pSer1981 ATM signal intensity showed >2 fold 
increase in the Rett patient cells compared to control cells in G1 phase (Figure 3.18). In G2 
phase there was only a modest increase in pSer1981 signalling between WT and Rett 
syndrome cells (Figure 3.18). I next analyzed whether MeCP2 knockdown in 48BR primary cells 
would result in an enhanced ATM signalling response. 48BR primary cells were treated with 
either control or MeCP2 siRNA for 48 hours. Cells were irradiated with 0, 0.5 or 3 Gy IR. 30 
minutes post IR cells were fixed and immunostained for pS1981 ATM, CENP-F and DAPI. Pan 
nuclear pS1981 ATM signal intensity in G1 and G2 phase cells was analyzed using ImageJ 
software. Strikingly, following MeCP2 knockdown, pS1981 ATM signal intensity in G1 and G2 
phase was enhanced more than 2 fold following 0.5 and 3 Gy IR (Figure 3.19). This data 
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suggests that the disordered chromatin present in Rett syndrome leads to enhanced ATM 
activation after IR. 
 
 
1.31.4 ATM activation is hyperactive in ICF syndrome patient cells  
 
To further analyze the effect of reduced higher order chromatin structure on DDR signalling, I 
next analyzed pSer1981 ATM in Immunodeficiency Centromeric instability and Facial 
anomalies (ICF) syndrome cells. ICF syndrome is caused by mutations in DNMT3B and since 
previously I observed greater signal expansion following DNMT3B knockdown, ICF syndrome 
cells are ideal candidates to analyze ATM signalling in the context of reduced chromatin 
organization. Contact inhibited G1 arrested 1BR and ICF hTERT fibroblast cells were irradiated 
with either 0 or 0.5 Gy IR. 30 minutes post IR, whole cell extracts were prepared and 
immunostained with the indicated antibodies. Conversely, ICF syndrome patient cells have 
been reported to have high levels of endogenous ATM activation even in the absence of DNA 
damage (Goldstine et al., 2006). Indeed, when the ICF syndrome hTERT immortalized 
fibroblasts western blots were overexposed, the 0 hour pS1981 ATM signal was as pronounced 
as that observed in the 1BR hTERT fibroblast cells after 0.5 Gy IR (Figure 3.20). Despite this, IR 
induced pS1981 ATM activation was also observed to be hyperactive in the ICF hTERT 
fibroblast cells compared to control cells (Figure 3.20). Taken together, these results 
demonstrate that greater signal expansion in cell lines with disordered or reduced chromatin 
formation, leads to an increase in ATM signalling which is greater than control cells. 
 
 
1.31.5 Rett syndrome patient cells and MeCP2 knockdown cells exhibit a hyperactive IR 
induced G/M checkpoint arrest 
 
The presence of hyperactive ATM activation in the context of reduced chromatin organization, 
led me to evaluate what impact this had on checkpoint initiation. It has previously been 
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reported that G2/M checkpoint arrest is not activated following exposure to low doses of IR 
(Krempler et al., 2007). Here an IR dose above 0.5 Gy IR (inducing roughly 15-20 DSBs in G2) 
was required to initiate and sustain checkpoint arrest. Since it is known that ATM and ATR 
activate Chk2 and Chk1 respectively, to initiate G2/M checkpoint arrest, if ATM dependent DSB 
induced signalling is enhanced in the context of reduced heterochromatin, it would be 
anticipated that the G2/M checkpoint arrest would be initiated at lower IR doses in chromatin 
defective cells compared to wild type cells. To analyze the sensitivity of G2/M checkpoint 
arrest Rett syndrome cell lines (GM16548, GM11271, & GM11272) were irradiated with the 
indicated low IR doses. One hour following IR cells were fixed and stained for the mitotic 
marker pSer10-histone H3, which is a distinctive marker for highly condensed metaphase 
chromosomes (Hans and Dimitrov, 2001). Strikingly, G2/M checkpoint initiation was observed 
at doses as low as 0.125 Gy IR in the Rett syndrome cell lines, where only 30% of the mitotic 
population (as identified by pSer10-histone H3) were in mitosis, compared to 80% in the 
control cells (Figure 3.21A). This dramatic difference in the percentage of cells entering mitosis 
between the Rett and WT populations was observed until 1 Gy IR. This is likely because 1 Gy IR, 
which induces roughly 40 DSBs in G2, generates a DDR signal sufficient to activate checkpoint 
arrest. To confirm that this dramatic difference in G2/M checkpoint sensitivity was not a 
phenotype only observed when comparing the Rett syndrome cell lines to 48BR primary cells, 
another primary fibroblast was analyzed in conjunction with the Rett syndrome cell lines. Here, 
1BR primary fibroblast and Rett syndrome cell lines (GM16548, GM11271, & GM11272) were 
treated and harvested as before. Consistent with the result observed when analysing 48BR 
primary cells, 1BR primary cells were also less sensitive to low doses IR in comparison to the 
Rett syndrome cell lines (Figure 3.21A). MeCP2 knockdown in the Rett syndrome cell lines did 
not show an additive affect (Figure 3.21B). Since NIH3T3 cells were previously exploited to 
visualize γH2AX foci expansion at heterochromatic regions in the context of reduced chromatin 
organization, I next analyzed whether MeCP2 knockdown in these cells affected G2/M 
checkpoint sensitivity. NIH3T3 mouse cells were transfected with MeCP2 siRNA for 48 hours 
and irradiated with the indicated doses of IR. One hour post IR, cells were fixed and stained for 
pSer10-histone H3. Similar to Rett syndrome patient cells, MeCP2 siRNA transfected cells also 
initiated G2/M arrest at IR doses as low as 0.125 Gy (Figure 3.22A).  Collectively, reduced 
MeCP2 levels results in a hypersensitive G2/M checkpoint arrest.  
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1.31.6 ICF syndrome cells and DNMT3B knockdown cells exhibit a hyperactive IR induced 
G2/M checkpoint arrest 
 
G2/M checkpoint initiation was next analyzed in ICF syndrome cells. Because of the slow 
growing nature of ICF fibroblast cell lines, G2/M checkpoint initiation was analyzed using a 
lymphoblastiod cell line derived from ICF syndrome patient (GM08714). ICF syndrome LBLs 
were irradiated with the indicated IR doses and 1 hour later harvested by cytospinning. Cells 
were fixed and stained for pSer10-histone H3. Again, the sensitivity of the G/M checkpoint was 
monitored by the presence of cells in mitosis as identified by pSer10-histone H3. Similar to my 
previous observation using MeCP2 deficient cells, ICF patient cells also exhibited a 
hypersensitive G2/M checkpoint compared to WT cells (Figure 3.23). After IR with 0.125 Gy, 
the ICF mitotic index was reduced to 40% of that of untreated cells, whereas the mitotic index 
of wildtype cells remained at 98% of that of untreated cells (Figure 3.23A). Similar analysis of 
an hTERT immortalized ICF syndrome fibroblast also revealed a hypersensitive checkpoint 
arrest (Figure 3.23B). ICF (PT3) hTERT cells were grown on cover-slips for 48 hours, irradiated 
with the indicated doses of IR and one hour later fixed and stained for pSer10-histone H3 
(Figure 3.23B). G2/M sensitivity was monitored by the percentage of cells in mitosis as 
identified by pSer10-histone H3. Consistent with the observation made with ICF syndrome 
patient GM08714, ICF syndrome hTERT line PT3 also initiated G2/M arrest at lower doses IR 
compared to WT cells. DNMT3B siRNA transfection in NIH3T3 cells gave a similar result (Figure 
3.22B). Despite having less than the required number of DSBs necessary to satisfy arrest in 
wildtype cells, Rett and ICF syndrome cells and MeCP2 and DNMT3B knockdown cells are able 
to initiate G2/M arrest at low doses IR. This could suggest that chromatin defective cells lines 
generate more DDR signalling per DSB compared to WT cells, suggesting that the barrier 
imposed by heterochromatin to repair also impacts on the strength of the DDR signalling 
response. To further investigate ATM signalling in the context of reduced heterochromatin, 
G2/M checkpoint initiation was analyzed in a further syndrome with disordered chromatin 
organization.  HGPS cells have mutations in the LMNA gene which encodes an intermediate 
filament protein that provides a scaffold for protein complexes regulating nuclear structure 
and function (see 3.1.3.6 for further discussion on HGPS). HGPS cells were irradiated with the 
indicated dose of IR. One hour following IR, cells were fixed and immunostained for the mitotic 
marker, pSer10 H3 (Figure 3.23C). As observed with Rett syndrome and ICF syndrome patient 
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cells, HGPS cells also responded hyperactively to low doses IR and initiated a G2/M checkpoint 
at IR doses as low as 0.25 Gy IR.  
 
 
1.32 Discussion 
 
1.32.1 Heterochromatin acts as a barrier to IR induced γH2AX signal expansion 
 
The possibility of higher order chromatin structure acting as a barrier to γH2AX expansion was 
first reported by Kim et al (2007) in yeast. The authors showed that γH2AX expansion was 
inhibited at an HO induced DSB at the silenced HML and HMR loci. Treatment of human cancer 
cells with the HDAC inhibitor, TSA, demonstrated that IR induced γH2AX foci can increase in 
size (Kim et al., 2007). Previous studies have demonstrated that depletion of the linker histone 
H1 in murine ES cells increases γH2AX and 53BP1 signal intensity per nucleus following IR 
(Murga et al., 2007). Furthermore, the signal intensity per γH2AX foci is enhanced in H1 
depleted cells compared to control (Murga et al., 2007). The reverse side of the coin, also 
provides examples, where the loss or inhibition of chromatin remodelling complexes reduces 
the magnitude of the IR induced DDR signalling cascade. For example, SWI/SNF depleted cells 
have reduced IR induced signalling and fail to initiate a G2/M checkpoint response following 
lower doses IR (Park et al., 2006). Loss of the chromatin remodeller SWI/SNF reduces the size 
of γH2AX foci (Park et al., 2006). Therefore reduced chromatin remodelling at the site of the 
DSB also inhibits γH2AX expansion. Here I have demonstrated that heterochromatic relaxation 
mediated by KAP-1, MeCP2 or DNMT3B knockdown enables IR induced γH2AX foci to expand 
at least three times more at heterochromatic regions compared to control cells. Like that 
observed in H1 depleted ES cells, γH2AX signal intensity per foci are also enhanced following 
KAP-1, MeCP2 or DNMT3B knockdown. In addition, the kinetics of γH2AX foci formation at 
heterochromatin occurs faster following KAP-1, MeCP2 or DNMT3B knockdown. The impact of 
KAP-1 siRNA was predominantly observed at DSBs with the highest DAPI-density consistent 
with KAP-1 being predominantly localised at highly compacted HC; the impact for MeCP2 was 
broader, possibly reflecting the presence of methylated CpGs in a wider range of compacted 
regions (although predominantly in HC-DNA). It is possible that higher order chromatin 
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structure may appear refractory to γH2AX expansion if the H2AX histone variant was of low 
abundance in heterochromatin. This would mean a heterochromatin associated DSB would not 
generate sufficient focal phospho-H2AX to generate a detectable γH2AX foci by 
immunofluorescence. However exposure of S phase cells, where heterochromatin structure is 
less condensed to enable replication, to HU, leads to abundant γH2AX foci at both 
euchromatin and heterochromatin (Cowell et al., 2007). From these experiments I postulate 
that KAP-1, MeCP2 and DNMT3B enriched higher order chromatin acts as a restrictive barrier 
to the expansion of IR induced γH2AX. Also, KAP-1, MeCP2 and DNMT3B enriched chromatin 
impedes the rate of DDR factor recruitment to the site of a lesion. Here one could envision that 
sufficient relaxation at the site of a DSB must first be initiated to expose local H2AX C-terminal 
tails, which, following phosphorylation by ATM, can bind MRN/MDC1. MRN then recruits and 
tethers ATM at the site of a break. This process stimulates an ATM auto-activation loop, 
whereby ATM is tethered at the break site to phosphorylate more H2AX and downstream DDR 
proteins. Hence if the chromatin structure around a DSB is already relaxed or partially relaxed, 
this above mentioned activation loop could happen more rapidly. Interestingly, despite 
observing an increase in γH2AX signal intensity for DSBs induced in both EC and HC, the most 
dramatic effect was observed at HC associated DSBs. This could possibly be explained by 
recent publications which describe transcriptionally active regions as being refractory to γH2AX 
expansion. Iacovoni et al, 2010, reported that following γH2AX profiling analysis by ChIP, RNA 
polymerase and γH2AX never overlap. Similarly, RNA polymerase has been described to 
function in chromosome decondensation immediately after transcription (Shanbhag et al., 
2010). 
 Analysis of pS1981 ATM activation in Rett syndrome cells by western blot and IF, 
revealed that ATM activation is increased at least two fold in the Rett syndrome cells 
compared to control cells. Despite all three Rett syndrome patient cells analyzed displaying 
enhanced ATM activation compared to control cells in response to IR, the magnitude of ATM 
activation varied. Since the MeCP2 gene is located on the X chromosome, skewed X 
chromosome inactivation may account for differences in MeCP2 expression between the Rett 
syndrome patients. Alternatively the location of the patients MeCP2 gene mutation may affect 
residual function. For example, a mutation in the transcriptional repressor domain (TRD) of the 
MeCP2 gene may enable the MeCP2 gene product to still functionally bind di-methylated CpG 
islands but not recruit co-repressors such as Sin3A or HDACs (Yusufzai and Wolffe, 2000). 
Whereas, a mutation in the methyl binding domain of the MeCP2 gene may prevent it from 
binding methylated DNA altogether. In this scenario a redundant DNA methyl binding protein 
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could possibly bind and functionally replace MeCP2. In this circumstance the impact of ATM 
signalling would be expected to be less dramatic since the chromatin architecture would be in 
a conformation resembling that which would contain a functional MeCP2 protein. Kudo et al, 
demonstrated that when mutants in the MeCP2 methyl binding domain (MBD) were 
transfected into cells, the mutant MeCP2 protein was unable to localize to heterochromatin 
and repress a reporter (Kudo et al., 2001). However, in the case where MeCP2 can bind CpG 
islands but not recruit silencing factors, the MBD would be blocked to other redundant factors, 
and the higher order silencing normally initiated by a functional MeCP2 would not result, 
hence a more open chromatin conformation would remain. Alternatively the promoter regions 
controlling MeCP2 expression may be less active or the MeCP2 transcript may be less stable. 
For example, deletions within the C-terminus of MeCP2, which are common mutations in 
classic RTT, significantly decrease protein stability (Yusufzai and Wolffe, 2000). In addition, 
MeCP2 mutants have been shown to offer varying levels of protection from MNase digestion 
depending on the type of mutation (Nikitina et al., 2007). 
 
 
1.32.2 The impact of higher order chromatin structure on checkpoint response signalling 
 
In all mammalian cells DSBs produce a damage response signalling cascade irrespective of their 
genomic or chromatic location that may be sufficient to initiate a checkpoint response.  The 
effect that chromatin compaction exerts on damage response signalling is an emerging field. 
Previously Murga et al (2007) reported hyperactive checkpoint response after low doses IR in 
ES cells with reduced linker histone H1 levels. Linker histone loss will affect both EC and HC. 
Here, I have focussed on the effect of HC superstructure on DDR signalling. A number of lines 
of evidence presented here would imply that higher order chromatin structure does indeed 
dampen the IR induced DDR. I have shown that pS1981 ATM activation is hyperactive in G0/G1 
and cycling cell populations of MeCP2 deficient Rett syndrome cells. In addition ICF (DNMT3B) 
syndrome cells display hyperactive ATM activation following low doses IR. γH2AX acts as a 
scaffold to recruit MDC1, MRN and 53BP1, which together serve to retain ATM at the DSB. 
Thus, it might be anticipated that foci size correlates with the magnitude of the downstream 
response. Yet, cells lacking γH2AX show efficient DDR signalling and checkpoint arrest except 
after low IR doses (Fernandez-Capetillo et al., 2002). I next analysed what impact enhanced 
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signalling has on checkpoint arrest in chromatin deficient cells. G2/M checkpoint sensitivity has 
been demonstrated to require at least 20 DSBs to initiate arrest (Deckbar et al., 2007). 
Therefore at low doses IR which produces less than 20 DSBs, G2/M checkpoint arrest would 
not be expected. Strikingly Rett syndrome, ICF syndrome, and HGPS cell lines exhibited a 
hypersensitive G2/M checkpoint arrest following low doses IR. The dramatic sensitivity of the 
G2/M checkpoint observed was unexpected as roughly only 25% of the genome is organised 
into heterochromatin (Goodarzi et al., 2008). Therefore after an IR dose of 0.25 Gy which 
induces ≤ 10 DSBs in G2, only ~ 3 of these DSBs would be expected to reside within 
heterochromatin. Therefore only 3 DSBs would be expected to contribute to the dramatic 
sensitivity observed. This might be possible if heterochromatin associated γH2AX foci were 
able to expand without any chromatin associated barriers. Since Rett and ICF syndrome cells 
still stain positively for heterochromatin associated markers such as TriMeK9 H3, it appears 
that heterochromatin structure is not completely abolished in these cells. It is more likely that 
other genomic regions such as facultative heterochromatin are also disorganized in Rett and 
ICF syndrome cells. Therefore a larger fraction of DSBs, not solely constitutive heterochromatin 
associated DSBs, are likely to contribute to IR induced G2/M checkpoint signalling. However I 
cannot fully exclude the possibility that KAP-1, MeCP2 or DNMT3B may contribute to γH2AX or 
ATM dependent signalling by regulating the expression of an as yet unidentified DSB repair 
protein. 
 Analysis of ATM activation in G1 phase ICF syndrome cells revealed that pSer1981 ATM 
activation is hyperactive in these cells compared to WT cells after IR. However, ATM activation 
at 0 hours in the absence of IR in the ICF syndrome cells was as pronounced as that observed 
in wildtype cells after 0.5 Gy IR. Endogenous ATM activation in ICF syndrome cells has 
previously been reported by Goldstine et al (2006). Downstream ATM targets, such as p53, 
NBS1 and SMC1 were not phosphorylated in ICF syndrome cells despite ATM activation 
(Goldstine et al., 2006). Endogenous ATM activation could not be accounted for by inefficient 
repair given that ICF syndrome cells subjected to IR produce normal numbers of γH2AX and 
repair with wildtype kinetics.  ATM activation has also been reported in the absence of DSBs 
following treatments that induce chromatin defects, such as chloroquine treatment (Bakkenist 
and Kastan, 2003; Kitagawa et al., 2004). However, most chromatin disordered cells do not 
display endogenous ATM activation. ATM displays little phosphorylation on pS1981 in 
Rubinstein-Taybi syndrome (RSTS) patients, Facioscapulohumeral muscular dystrophy (FSHD) 
patients (Goldstine et al., 2006) and importantly Rett syndrome patient cells in the absence of 
DNA damage. RSTS is caused by de novo mutations in the CREB binding gene, CBP (Bartsch et 
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al., 2005). CBP regulates the expression of the histone methyltransferase Suv39H1/2 which is 
responsible for hypermethylating histone H3 at lysine 9 (TrimeK9 H3)(Lee et al., 2008). 
TriMeK9 H3 promotes chromosome condensation and induces gene silencing (Lee et al., 2008). 
FSHD is caused by mutations at the sub-telomeric region of chromosome 4 (Wijmenga et al., 
1990). The disease is caused by molecular rearrangements that cause copy number variations 
of a 3.3 Kb tandem repeated microsatellite called D4Z4 (Wijmenga et al., 1992). D4Z4 units are 
normally heavily methylated, however FSHD patients have been shown to harbour 
euchromatin associated modifications, such as H3K4 diMe, at these units (Jiang et al., 2003; 
Zeng et al., 2009). TriMeK9 H3 modifications are also reduced in FSHD patients making 
chromatin organization in these cells less organized (Zeng et al., 2009). DNMT3B is responsible 
for maintaining large pericentric heterochromatin regions on chromosome 1, 9 and 16; 
therefore it is possible that large genomic disorganization is sufficient to active ATM 
surveillance mechanisms. Alternatively, endogenous ATM activation may be a consequence of 
chromosomal DNA instabilities reported for ICF syndrome cells which frequently arise after 
spindle mis-regulation at the disordered centromeric chromatin (Tuck-Muller et al., 2000).  
 The data presented here strongly suggests that higher order chromatin structure 
dampens the IR induced signalling at each heterochromatic associated DSB. Interestingly, Bao 
et al, reported that CD133 glioma stem cells activate a robust DNA damage response (Bao et 
al., 2006). Stem cells are an undifferentiated cell type characterized by their potential to self-
renew indefinitely and to differentiate into any cell type. Abundant histone modifications 
typically found in stem cells are those which are associated with transcriptional activity such as 
H3 and H4 hyperacetylation as well as global hypermethylation H3-K9 (Kimura et al., 2004). 
Repressive heterochromatic marks such as H3-triMeK9, H3-MeK27, H3diMeK20 and H4-
triMeK20 are greatly reduced in stem cells (Martens et al., 2005). The chromatin disordered 
cell line analyzed here, which have reduced higher order chromatin structure, are 
characteristically more stem cell like. This is potentially interesting when considering whether 
altered chromatin compaction could be exploited in the treatment of cancer cells to enhance 
their radiosensitivity to IR. Indeed, chromatin altering cancer therapeutics such as HDAC 
inhibitors, are at present in clinical use and trials. The most potent HDAC inhibitors are the 
hydroxamic acid derivatives, like SAHA, which have recently been approved for the therapy of 
T-cell lymphomas (Santini et al., 2007). Other classes of HDAC inhibitors include short chain 
fatty acids (SCFA) such as valproic acid, benzamides, epoxyketones and non-epoxyketone 
containing cyclic tetrapeptides, all of which function to increase the sensitivity of cells to IR 
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(Santini et al., 2007). MeCP2 and DNMT3B open an avenue for other drug developments which 
target these chromatin architecture proteins.  
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 Analysis of G2/M checkpoint maintenance and DSB repair in 
cell lines derived from patients with disordered chromatin.  
 
 
1.33 Introduction 
 
1.33.1 Fast and slow repair component of DSB repair 
 
The two major pathways of DSB repair are homologous recombination (HR) and Non 
homologous end joining (NHEJ). HR leads to accurate repair of the DSB by using a sister 
chromosome as a homologous template to re-replicate faithfully the damaged bases 
which require replacement. NHEJ is considered less accurate. Here the broken end is 
modified and ligated with no regard of homology. As a result insertions and deletions 
can be generated (Leiber, 2008). Given the different mechanisms underlying NHEJ and 
HR, it would seem plausible that the kinetics of repair would differ between the two 
mechanisms. Indeed, Mao et al (2008) found that NHEJ was completed within 30 
minutes after DSB induction, whereas HR was not completed until at least 7 hours 
after DSB induction. To monitor DSB repair fluorescent reporter constructs where 
chromosomally integrated into human fibroblasts. Following I-SceI endonuclease 
cutting, ligation was monitored by the reconstruction of fluorescent GFP. Interestingly 
the efficiency of repair varied between cell lines carrying identical constructs, which 
the authors speculated might be a consequence of the chromosomal location of the 
integrated construct (Mao et al., 2008). In G1 phase, since there is no sister homologue 
to mediate HR repair, all DSBs are repaired by NHEJ (Beucher et al., 2009). Despite the 
utilisation of a single DSB repair process, there is still a fast and slow component to 
repair (Goodarzi et al., 2008). The fast component requires the core NHEJ factors 
Ku70/80, DNA-PKcs, Ligase IV, XLF and XRCC4; the slow component additionally 
requires ATM and Artemis. It has recently been established that the slow component 
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of repair in G1 represents DSBs which reside within regions of HC (Goodarzi et al., 
2008). At HC DSBs ATM phosphorylates KAP-1 to mediate nucleosomal remodelling 
which likely facilitates access to repair proteins (Goodarzi et al., 2008; Ziv et al., 2006). 
Given that Artemis cleaves DNA hairpin intermediates during V(D)J recombination, the 
dependency on Artemis suggests a requirement for end processing (Ma et al., 2002). 
Thus, a working model is that HC DSBs, which are refractory to DSB repair, undergo 
limited end processing prior to re-joining. Given the highly repetitive nature of DNA 
associated at HC, damaged termini may form secondary structures or hairpins that 
require processing prior to ligation.  In G2, HR is the slow component that involves 
Rad51, Rad54, BRCA2, ATM and Artemis (Figure 4.1). Beucher et al (2009) observed 
that following KAP-1 knockdown in G2 phase cells, the requirement for ATM in DSB 
repair was relieved. This suggested that HR repair in G2 is associated with regions of 
heterochromatin (Beucher et al., 2009). 
 
 
1.33.2 Repair of heterochromatin associated DSBs by HR 
 
In mammalian cells, ATM and the endonuclease Artemis have been shown to be 
required for repair of a subset of DSBs in G1 (Riballo et al., 2004). Beucher et al (2009), 
later demonstrated that ATM and Artemis are also required for a similar sized subset in 
G2. ATM inhibition and Artemis knockdown resulted in a repair defect that was 
epistatic with Brca2, Rad52 and Rad54 after IR in G2. BrdU repair incorporation after IR 
was also dependent on ATM and Artemis in G2. However ATM and Artemis cells do not 
show sensitivity to crosslinking agents like HR mutants, and spontaneous SCEs and I-
Sce-I induced HR can occur without Artemis both implying that ATM and Artemis are 
not core HR factors (Beucher et al., 2009). Since the fast component of DSB repair 
(repair occurring within 2 hours of irradiation) is unaffected in HSC62 (Brca2- deficient) 
cells both in G1 and G2, Beucher et al (2009), suggests that HR specifically represents 
the slow component of DSB repair in G2. Following previous reports that knockdown 
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of the heterochromatic building factor KAP-1 alleviates the requirement for ATM in 
repair of the slow component of DSB repair in G1 (Goodarzi et al., 2008), KAP-1 
knockdown was subsequently tested in G2 and again found to overcome the 
requirement for ATM in DSB repair. This suggested that the slow repairing DSB fraction 
in G2, which is repaired by HR, represents those breaks which reside within regions of 
HC. The authors proposed that certain types of breaks dependent on location or 
nature may undergo resection.  
 
 
1.33.3 ATR and Chk1 activation at resected DSBs  
 
In G2 phase around 20% of DSBs undergo ATM dependent resection which represents 
the slow component of DSB repair in G2 (Beucher et al., 2009). Resected 3’ single 
stranded (ss) DNA overhangs (ssDNA) are rapidly bound by RPA which leads to ATR 
recruitment and Chk1 activation at the site of the lesion (Jazayeri et al., 2006; Wyman 
and Kanaar, 2006) (see 3.1.4 for further discussion). The C-terminal binding protein 
(CtIP) is essential to generate RPA coated ssDNA ends (Sartori et al., 2007). CtIP 
physically interacts with the MRN complex (Sartori et al., 2007) and is recruited with 
BRCA1 to control G2/M checkpoint arrest. ATM dependent phosphorylation of CtIP 
promotes CtIP relocation to MRN bound DSBs. Recently Kaidi et al (2010) identified a 
further step which is required to initiate CtIP dependent resection.  Here the authors 
found that impaired RPA foci formation reduced HR repair and caused sensitization to 
CPT following the depletion of the lysine deacetylase (KDAC) sirtuin1 (SIRT1). A model 
was proposed whereby CtIP is constitutively acetylated in undamaged cells, and that 
following replicative stress CtIP is deacetylated by SIRT6 to allow the initiation of 
resection. However CtIP is still phosphorylated and recruited to damage sites in SIRT6 
depleted cells following DNA damage (Kaidi et al., 2010). Generation of a constitutively 
deacetylated CtIP rescued SIRT6 loss, which lead to the proposal that SIRT6 promotes 
the process of resection rather than CtIP recruitment (Kaidi et al., 2010). RPA coated 
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ssDNA recruits and activates ATR/ATRIP/TopBP1 complexes and subsequently Chk1 
(Paulsen and Cimprich, 2007). In short, these studies demonstrate that in G2 phase, 
ATM is activated at unresected DSBs, which, if not repaired by NHEJ undergo resection 
in an ATM dependent manner to allow the activation of ATR. Hence there appears to 
be a hand over from ATM to ATR signaling as resection ensues. 
 
 
1.33.4 Checkpoint maintenance 
 
Following IR, ATM activates the G2/M checkpoint within one hour due to DSBs 
generated in G2 (Beamish et al., 1994). At later times post IR, G2/M arrest is ATR 
dependent due to ATR activation at resected DSB in S phase (Wang et al., 2003; Wang 
and Qin, 2003). As mentioned in section 4.1.2, ATR can also regulate a replication 
independent checkpoint in G2 which is dependent on ATM (Jazayeri et al., 2006). Here 
ATM functions upstream of ATR to initiate resection by phosphorylating the 
endonuclease CtIP. Therefore the G2/M checkpoint can be initiated by three 
mechanisms; ATM to Chk2 signalling at DSBs or ATM – ATR to Chk1 signalling at 
resected DSBs in G2 phase, or ATR to Chk1 signalling at replication associated damage 
in S phase. Since the majority of NHEJ will be completed after late time points after IR, 
the maintenance of G2/M checkpoint arrest is highly dependent on resected DSBs 
(Shibata et al., 2010). However, unrepaired non-resected DSBs will also sustain ATM to 
Chk2 signalling at later times (Shibata et al., 2010). Despite the fact that only 15% of 
DSBs undergoing resection in G2 at late time points after IR, the slow repairing 
component of repair represents DSBs which undergo resection. Therefore the majority 
of DSBs that signal at late time points after IR are resected DSBs since the majority of 
NHEJ will already be completed. Hence the maintenance of G2/M checkpoint arrest is 
mainly dependent on Chk1 in repair proficient cells. Shibata et al (2010) demonstrated 
a critical role of Chk1 in maintaining G2/M arrest by showing that in Chk1 depleted 
cells or in ATR-SS hTERT cells (which are mutated in ATR) there is premature release 
108 
 
from G2/M checkpoint arrest. APH was added during these experiments to prevent S 
phase cells from entering G2 during analysis. Thus, these findings provided evidence 
that Chk1 dependent signalling from resected DSBs in irradiated G2 rather than S 
phase contribute to maintain G2/M checkpoint arrest. 
 
 
1.33.5 The role of the mediator proteins in maintaining G2/M checkpoint arrest 
 
The mediator proteins 53BP1 and MDC1 are dispensable for G2/M checkpoint arrest, 
except after low doses IR (Fernandez-Capetillo et al., 2002; Lou et al., 2006). However 
both are required for maintenance of checkpoint arrest (Shibata et al., 2010). Despite 
the subtle roles of 53BP1 and MDC1 in DSB repair, MEFs lacking 53BP1 or MDC1 have 
increased genomic instability (Fernandez-Capetillo et al., 2002; Peng and Chen, 2003). 
This could be attributed to their role in maintaining and tethering active ATM at DSBs 
(Noon et al., 2010) and subsequently prolonging Chk1 and Chk2 activation (Shibata et 
al., 2010). Shibata et al (2010) found that 53BP1 deficient cells fail to activate Chk1 
normally after IR and have a diminished ability to sustain ATM to Chk2 signalling. 
Similarly, the BRCA1 deficient human carcinoma cell line HCC1987 is unable to activate 
a G2/M checkpoint even after 6 Gy IR (Xu et al., 2002). BRCA1 is also required for ATM 
and ATR dependent phosphorylation of p53, c-Jun, Nbs1 and Chk2 following exposure 
to IR or UV and for ATM phosphorylation of CtIP (Foray et al., 2003).  
 
 
1.33.6 Checkpoint recovery 
 
In budding yeast one DSB is sufficient to activate the G2/M checkpoint (Pellicioli et al., 
2001). Mec1 (ATR homolog) has a more prominent role than Tel1 (ATM homolog) in 
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activating the downstream target kinases, Chk1 and Rad53 (Chk2 homolog) (Harrison 
and Haber, 2006). In yeast the G2/M checkpoint can be resolved by two distinct 
phenomena known as checkpoint recovery or checkpoint adaptation. Recovery of the 
checkpoint occurs when DSB repair has been completed. Adaptation describes restart 
of the cell cycle despite incomplete DSB repair. 
 Following completion of DNA damage, cells exit the G2/M arrest and enter 
mitosis, a phenomenon known as checkpoint recovery. In mammalian cells, checkpoint 
recovery primarily involves the ubiquitin mediated proteasome degradation of the 
checkpoint mediator claspin and the mitosis inhibiting kinase WEE1 (Mailand et al., 
2006). After DNA damage, Claspin initiates G2/M checkpoint arrest by associating with 
replication forks where it interacts with the kinase domain of Chk1 (Lee et al., 2005). 
This interaction promotes Chk1 phosphorylation by ATR and enhances Chk1 
autophosphorylation (Lee et al., 2005).  To initiate G2/M checkpoint release, Claspin is 
degraded in a ubiquitin ligase SCF-dependent manner (Mailand et al., 2006). The 
adaptor protein β-TrCP links Claspin and WEE1 with the SCF ubiquitin ligase complex 
(Mailand et al., 2006). The interaction of Claspin with SCFβTrCP is dependent on the 
protein kinase, PIK1, phosphorylation of Claspin (Mailand et al., 2006). Disruption of 
Claspin removes Chk1 from the DSB and prevents Chk1 mediated inhibitory 
phosphorylation of Cdc25A; similarly WEE1 degradation eliminates a direct inhibition 
on cdk1 activity (Bartek et al., 2007). Hence both mechanisms converge on re-
activating cyclin-CDK complexes to enable entry into mitosis. Interestingly, SCFβTrCP acts 
as a regulatory ubiquitin switch where it functions both in checkpoint initiation and 
recovery. During checkpoint initiation SCFβTrCP promotes Cdc25C degradation (see 
1.10.4 for further discussion). 
 
 
1.33.7 Checkpoint adaptation 
Checkpoint adaptation occurs when cells divide following long checkpoint arrest 
despite the presence of irreparable DNA lesions. Adaptation was initially believed to be 
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restricted to single celled organisms such as yeast. However Syljuasen, 2006, reported 
the occurrence of checkpoint adaptation in human cells (Syljuasen, 2007). U20S cells 
exposed to 6 Gy IR were found to maintain a checkpoint arrest for up to 12 hours. 
However, at late times cells began to divide. At this dose clonogenic survival is only 4% 
and chromosome segregation is defective (Sandell et al., 1993), implying that DSBs 
may remain unrepaired. To test this, γH2AX foci were analyzed in mitotic cells released 
from the checkpoint. Indeed γH2AX foci were significantly increased in irradiated cells.  
However it is important to note that despite the fact that U2OS cells express p53 and 
Rb, they lack p16.  Therefore checkpoint function in these cells may not represent a 
wildtype phenotype.  In yeast we know that cells are released as a consequence of 
checkpoint adaptation. Whereas in mammalian cells, cells are released when less than 
20 DSBs remain (as discussed in detail in chapter 3) (Deckbar et al., 2007). Therefore 
checkpoint arrest in mammalian cells is dependent on dose rather than time.  
 
 
1.33.8 Aims of this chapter 
 
The maintenance of IR induced G2/M checkpoint arrest is known to require around 15- 
20 DSBs (Deckbar et al., 2007). At late time points after IR, the maintenance of arrest is 
heavily dependent on slow repairing resected DSBs since the majority of fast repairing 
NHEJ will have been completed (Shibata et al., 2010). Repair deficient cell lines such as 
Artemis or XLF maintain checkpoint arrest for longer than WT cells, implying a 
communication mechanism between the repair and checkpoint machinery – i.e. that 
the checkpoint machinery can sense the status of DSB repair. In chapter 3, I showed 
that cells with reduced HC organization are able to initiate a G2/M checkpoint at low IR 
doses, which in WT cells is insufficient to generate enough signalling to elicit arrest. 
This increase in damage response signaling was attributable to increased γH2AX 
expansion at HC associated DSBs and consequently hyperactive ATM activation. Based 
on the findings presented in chapter 3, in this chapter, I further explore how 
111 
 
disordered chromatin impacts upon the response to DNA damage. Firstly, I examine its 
impact on DSB repair and particularly on the repair of HC-DSBs by asking whether the 
need for ATM is diminished in the disordered HC syndromes. Next I wished to address 
whether amplified ATM dependent signaling in the context of reduced higher order 
chromatin structure would affect the duration of G2/M checkpoint arrest.  
 
 
1.34 Results 
 
1.34.1 Rett syndrome cell lines repair with normal DSB kinetics in G1 and G2. 
 
For sustained ATM activation, the initially activated ATM must be maintained in an 
active state at a DSB or ATM must be continuously recruited and activated at the DSB 
site. Sustained ATM activation is observed most markedly in cells with impaired NHEJ 
such as XLF or DNA-PKi treated cells (Shibata et al., 2010). Therefore, it was important 
to establish that DSB repair was normal in the chromatin disordered syndrome cells to 
rule out the possibility that prolonged ATM activation occurs as a consequence of 
incomplete or failed DSB repair. Firstly I monitored γH2AX foci disappearance in 
primary Rett fibroblasts after IR. Contact inhibited G1 arrested or cycling 48BR (WT) 
and Rett syndrome (GM16548, GM11271, & GM11272) cell lines were irradiating with 
3 Gy IR. Cells were fixed at the indicated time points post IR and immunostained for 
γH2AX, CENP-F and DAPI. γH2AX foci were scored in G1 (CENP-F negative) and G2 
(CENP-F positive) phase cells. Importantly, both wild type and Rett syndrome cell lines 
repaired DSBs with normal kinetics (Figure 4.2A, Figure 4.3). DSB repair was also 
monitored as described above in the ICF hTERT fibroblast line. Again, γH2AX foci 
disappeared with normal repair kinetics in the ICF (PT3) hTERT fibroblasts (Brunton et 
al., manuscript submitted). Therefore hyperactive ATM signalling as a consequence of 
slower or incomplete DSB repair could be ruled out.  
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1.34.2 MeCP2 knockdown alleviates the requirement for ATM in DSB repair although this is 
not observed in Rett Syndrome cell lines. 
A previous publication from our laboratory established a role for ATM in initiating 
nucleasomal remodelling at HC-DSBs via its phosphorylation of the heterochromatic 
building factor KAP-1 (Goodarzi et al., 2008). In addition knockdown of 
heterochromatin building proteins including HDAC1 and 2 and HP1, was shown to 
alleviate the requirement for ATM in DSB repair. It was postulated that ATM 
dependent DSBs in G1 are those which reside within heterochromatin. In consideration 
of this data, I tested whether Rett syndrome cell lines, which have a more relaxed 
chromatin configuration, would also overcome the requirement for ATM in DSB repair. 
Contact inhibited G1 arrested 48BR (WT) and Rett syndrome (GM16548, GM11271 & 
GM11272) cell lines were treated with or without ATMi 30 minutes prior to irradiating 
with 3 Gy IR. Cells were fixed at the indicated time points and immunostained for 
γH2AX, CENP-F and DAPI. γH2AX foci were scored in G1 (CENP-F negative) phase cells.  
ATMi treatment had no effect on DSB repair at early time points (< 2 hours) after IR in 
both 48BR and Rett syndrome cell lines consistent with previous findings (Figure 4.2A). 
However at late time points (> 8 hour) after IR, ATMi treated 48BR and Rett syndrome 
cells manifested a repair defect. After 24 hours recovery following 3 Gy IR, ATMi 
treated 48BR and Rett syndrome cells manifest a repair defect of ~ 8-10 DSBs. This was 
distinct to the findings observed following knock down of the heterochromatic building 
factors, KAP-1, HDAC1/2 or HP1, where there ceased to be a requirement for ATM for 
DSB repair (Goodarzi et al., 2008). This was somewhat surprising but suggested that 
MeCP2 loss in the patient cells does not sufficiently relax the chromatin structure to 
overcome ATM’s role in HC-DSB repair. Therefore it was possible that the residual 
MeCP2 expressed in the patient cells promotes sufficient chromatin compaction to 
necessitate a requirement for ATM for HC-DSB repair. To test this, 48BR and Rett 
syndrome (GM16548, GM11271 & GM11272) cell lines were treated with either 
control or MeCP2 siRNA for 48 hours and then exposed to 3 Gy IR. 30 minutes prior to 
irradiation, cells were treated with or without ATMi. Cells were fixed at the indicated 
time points and immunostained for γH2AX, CENP-F and DAPI. γH2AX foci were counted 
113 
 
in G1 (CENP-F negative) cells. Consistent with the data observed in KAP-1 knockdown 
cells, cells knocked-down for MeCP2 no longer required ATM for HC-DSB repair (Figure 
4.2B). This suggested that MeCP2 enriched chromatin does pose a barrier to DSB 
repair. However the MeCP2 mutations in the Rett syndrome cell lines do not 
sufficiently change heterochromatin to overcome this barrier. Similarly, ICF hTERT cell 
were unable to overcome the requirement for ATM in DSB repair, whilst DNMT3B 
knockdown in wildtype and ICF (PT3) hTERT cells did alleviate the heterochromatin 
associated barrier to DSB repair (Brunton et al., manuscript submitted). 
 
 
1.34.3 Chromatin disordered cells exhibit a prolonged G2/M checkpoint arrest 
 
After confirming that DSB repair was normal in the Rett syndrome cells, I next analyzed 
checkpoint maintenance in these cells. Based on previous analysis, checkpoint arrest is 
released when DDR signalling decreases as DSB repair ensues (Deckbar et al., 2007). 
Therefore a hyperactive checkpoint signalling response would be expected to manifest 
as prolonged checkpoint arrest. To examine checkpoint maintenance in irradiated G2 
phase cells only, the replicative polymerase inhibitor aphidicolin (APH) was added 
immediately after IR. 48BR and Rett syndrome (GM11272) cells were irradiated with 2 
Gy IR. Cells were harvested at the indicated time points and immunostained for the 
mitotic specific marker, pS10 histone H3 and DAPI. pS10 histone H3 positive mitotic 
cells were scored and expressed as a percentage of the mitotic population present in 
unirradiated cells (Figure 4.4A). Four hours post 1 Gy IR, both 48BR and Rett syndrome 
cells began to release from the G2/M checkpoint. However, Rett syndrome patient 
(GM11272) cells lagged behind wild type cells release from the checkpoint, with only 
40% of the mitotic population cycling in the Rett syndrome cells compared to 80% in 
control cells at 10 hours after IR demonstrating a prolonged maintenance of 
checkpoint arrest. To confirm that prolonged G2/M checkpoint maintenance is a 
consequence of reduced MeCP2 levels, MeCP2 was transiently knocked down in 1BR 
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hTERT cells. 1BR hTERT cells were treated with either control or MeCP2 siRNA for 48 
hours. Following transfection, cells were irradiated with 2 Gy IR and harvested at the 
indicated time points. Cells were immunostained as before. Consistent with the result 
observed in Rett syndrome (GM11272) cells, MeCP2 knockdown cells also maintained 
G2/M checkpoint arrest longer than control cells (Figure 4.4B). To further establish the 
effect that heterochromatin relaxation has on checkpoint maintenance, HGPS, ICF and 
Rett syndrome lymphoblastoid cells were treated as above, harvested by cytospinning  
and the mitotic index scored. Strikingly, cell lines from patients with impaired HC 
displayed prolonged G2/M checkpoint arrest up to 8 hours after 2 Gy IR whereas 
control cells are released by 6 hours (Figure 4.5).  
 
 
1.34.4 Chk1 phosphorylation is hyperactive in Rett syndrome and MeCP2 knockdown cells 
 
Chk2 and Chk1 both function to maintain checkpoint arrest, and loss of either kinase 
results in premature checkpoint release (Shibata et al., 2010). However, after high 
doses IR, either kinase alone can function to initiate checkpoint arrest. This is most 
likely because after a high dose there is a sufficient threshold signal generated by 
either kinase to activate checkpoint arrest. However, as DSB repair ensues and the 
number of DSBs diminishes, the combined function of both kinases is required – Chk2 
being activated at non-resected DSBs and Chk1 being activated at the resected DSBs 
(Shibata et al., 2010). DSB repair in G2 phase, like G1, has two components of repair 
one with fast kinetics involving the core NHEJ machinery (see 4.1.1 for further 
discussion) and the other occurring with slow kinetics involving ATM and Artemis and 
the HR proteins (Beucher et al., 2009). It is these slowly repaired DSBs that undergo 
resection. Thus, although only 15-20% of total DSBs undergo resection in G2, at late 
time points after IR the majority of DSBs that remain are those which have undergone 
resection since the majority of DSB repair by NHEJ is completed (fast component). 
Thus, Chk1 has a greater role in maintaining checkpoint arrest than Chk2 (Beucher et 
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al., 2009). In summary, the mechanisms that serve to maintain arrest represent either 
ATR dependent activation of Chk1 at resected DSBs or sustained ATM to Chk2 
signalling at un-repaired DSBs; with the former begin the most significant.  
 Given that DSB repair is normal in Rett syndrome and MeCP2 knock down cells 
(Figure 4.1) prolonged checkpoint maintenance as a consequence of sustained ATM to 
Chk2 signalling could be ruled out although initial checkpoint arrest is dependent on 
ATM-Chk2 signalling. I next wished to establish whether loss of MeCP2 activity affects 
resection to ATR/Chk1 signalling in irradiated G2 cells. To test this, pan nuclear Chk1 
phosphorylation at Ser345 (pSer345) was analysed by IF in 48BR and Rett syndrome 
patient (GM11272) cells. Cells were irradiated with 10 Gy IR. 1 hour post irradiation 
cells were fixed and immunostained for pSer345 Chk1, DAPI and the G2 marker CENP-F. 
Pan nuclear pSer345 Chk1 signal intensity in G2 phase (CENP-F positive) cells was 
analyzed using ImageJ software. Higher doses of IR were used to enable detection of 
Chk1 pSer345 induction. Strikingly, Rett syndrome (GM11272) cells activated pSer345 
almost 2 fold greater than control cells (Figure 4.6). Given that Chk1 can be activated 
by ATR at stalled or collapsed replication forks independently of ATM, and despite 
previously adding aphidicolin to prevent S phase cells entering G2 phase and 
contributing to signalling, it was important to confirm that hyperactive Chk1 activation 
in G2 was dependent on ATM mediated resected DSBs. To test this, 48BR (WT) and Rett 
syndrome (GM11272) cells were treated with or without ATMi 30 minutes prior to 
irradiating with 10 Gy IR. One hour post IR, cell were fixed and immunostained for 
pSer345 Chk1 and DAPI. Following ATMi treatment, Chk1 activation was dramatically 
reduced in both control and Rett syndrome 3 cells (Figure 4.6). This suggested that the 
majority of Chk1 activation observed was ATM dependent in G2 cells. To further 
consolidate that this result was a consequence of MeCP2 loss, 48BR (WT) cells were 
treated with either control or MeCP2 siRNA for 48 hours. Cells were irradiated with 
either 6 or 10 Gy IR and fixed and immunostained 1 hr later. As observed in the Rett 
syndrome cells, after 6 Gy IR, Chk1 pSer345 induction was almost 3 fold greater in 
MeCP2 knockdown cells. Similarly, following 10 Gy IR, Chk1 pSer345 activation was 2 
fold greater in MeCP2 knockdown cells (Figure 4.7).  
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1.34.5 RPA foci signal intensity is enhanced in Rett syndrome cells. 
 
Chk1 is activated at RPA coated resected DSBs in G2 by ATR. Therefore hyperactive 
Chk1 activation is likely to be indicative of enhanced resection. Having established that 
Chk1 activation is hyperactive in MeCP2 and Rett syndrome cells, I next analysed RPA 
foci in these cells. To exclude S phase cells from analysis, 48BR (WT) and Rett 
syndrome (GM11272) cells were treated with aphidicolin directly after IR. 30 minutes 
post 3 Gy IR, cell were fixed and immunostained for RPA, 53BP1 and DAPI. 53BP1 was 
used as a biomarker for DSBs. Signal intensity of RPA foci co-localizing with 53BP1 was 
quantified using ImageJ software. Consistent with the observation of hyperactive Chk1 
activation, RPA foci signal intensity was also enhanced in Rett syndrome cells (Figure 
4.8). This might suggest that Rett syndrome cells undergo larger scale ATM dependent 
resection. This is particularly interesting following reports that HR repair in G2 phase is 
associated with DSBs that reside within regions of heterochromatin (see 4.1.2 for 
further discussion).  
 
 
1.34.6 Rett syndrome cells have normal survival after IR. 
Having established that Rett syndrome cells initiate a hypersensitive G2/M checkpoint 
arrest i.e. they initiate arrest at a radiation dose which in wildtype cells is below the 
threshold number of DSBs required to initiate arrest (Figure 3.20), and maintain G2/M 
checkpoint arrest longer than wildtype cells despite having normal DSB repair (Figure 
4.3), I next analysed whether hyperactive ATM dependent Chk2 and Chk1 signalling 
impacts upon Rett syndrome cell survival. Following IR, radiosensitivity was assessed 
by colony survival analysis. 48BR and Rett syndrome cells were trypsinized, irradiated 
with the indicated doses IR and plated onto feeder cells prepared 24 hours earlier. 
Cells were left to form colonies for 3 weeks. At all doses of IR, Rett syndrome cells 
show a modest resistance but the significance of this result requires further 
investigation (Figure 4.9).  
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1.35 Discussion 
 
1.35.1 Chromatin disorganization prolongs G2/M checkpoint arrest 
 
The maintenance of G2/M checkpoint arrest following IR is dependent on Chk2 
signalling at non-resected DSBs, or Chk1 signalling at resected DSBs in G2 or collapsed 
replication forks in S phase (Shibata et al., 2010). A threshold of DDR signalling that 
accumulates from at least 15-25 DSBs is required to satisfy and maintain checkpoint 
arrest (Deckbar et al., 2007). In this chapter I have established that cell lines with 
reduced higher order chromatin organization show prolonged G2/M checkpoint arrest 
despite having normal DSB repair. Therefore late repairing DSBs which remain in a cell 
with reduced HC superstructure generate enough damage response signalling to 
sustain checkpoint arrest. Additionally, MeCP2 knockdown, like KAP-1 knockdown, 
overcomes the barrier to ATM dependent DSB repair. This further consolidates the 
notion that ATM dependent DSBs are those which reside within HC (Goodarzi et al., 
2008). 
1.35.2 Heterochromatin and homologous recombination 
 
In G2 phase cells at late time points after IR the fast component of DSB repair, namely 
NHEJ, is completed, and the majority of DSBs still signalling to maintain arrest are 
those dependent on HR (Beucher et al., 2009; Shibata et al., 2010). In this chapter I 
analysed whether prolonged checkpoint arrest was dependent on HR. Indeed I did not 
observe a significant change in Chk2 phosphorylation at later time points after IR, 
although ATM/Chk2 signalling was enhanced at initial time points. Importantly, Chk1 
phosphorylation was found to be hyperactive in G2 phase cells and this hyperactivity 
was dependent on ATM, demonstrating that Chk1 activation is dependent on DSB end 
resection. Additionally RPA signal intensity per foci was also enhanced in Rett 
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syndrome cells. In conclusion HC superstructure appears to act as a barrier to ATM 
dependent resection in G2, and removing this barrier by MeCP2 knockdown increases 
the magnitude of resection. It is still unclear whether loss of MeCP2 causes a longer 
length of DNA resection per DSB only by RPA foci analysis. However, importantly, this 
result suggests that relaxed HC superstructure following MeCP2 siRNA enhanced the 
number of RPA at DSB, which lead to a larger range of scaffold for ATR-Chk1 activation.  
Interestingly, Beucher et al (2009) reported that the dependency for ATM in the slow 
repair component of DSB repair in G2 could be overcome with KAP-1 knockdown. This 
suggested that HR repair in G2 occurs at regions of heterochromatin. Here I have 
shown that by removing the HC associated barrier resection at HC DSBs is enhanced. 
 It is interesting to speculate that a more accurate DSB repair mechanism such 
as HR would have a greater precedence to repair HC associated DSBs given the highly 
repetitive nature of DNA at these regions. Additionally resection mediated remodelling 
events such as those observed in yeast may be required to facilitate the access of 
repair proteins to HC associated DSBs. For example, in yeast, histone loss following 
DNA damage is tightly coupled to the rate of resection. Strains lacking the Arp8 
chromatin remodeling subunit, Ino80, have defective resection (Shimada et al., 2008). 
Consistent with this, chromatin disassembly is strongly reduced in strains lacking the 
nuclease, Mre11 (Shimada et al., 2008). Srs2 helicase mutant strains are also defective 
in checkpoint recovery, but deletion of Rad51 alleviates this defect (Vaze et al., 2002). 
Harrison and Haber proposed that the presence of Rad51 filaments promoted 
continuous DNA damage checkpoint signaling even after completion of repair 
(Harrison and Haber, 2006). In addition, displacement of repair factors following 
chromatin remodeling has also been shown to be sufficient to inactive the checkpoint 
(Soutoglou and Misteli, 2008). The observation that RPA foci signal intensity was 
enhanced in Rett syndrome cells suggests that a higher dependency on HR repair 
prolongs G2/M checkpoint arrest. If resection does function to remodel nucleosomes 
then complete HC relaxation would be expected to overcome the requirement for 
resection. Given that Rett syndrome cells still require ATM to complete DSB repair, and 
only after all MeCP2 expression has been abolished in these cells by siRNA is the 
requirement for ATM in DSB repair overcome suggest that the MeCP2 expressed in the 
119 
 
patient cells is still sufficient to maintain a barrier to a subcomponent of DSB repair. 
Hence G2 phase DSBs in Rett syndrome cells may still pose a barrier to repair which 
requires resection mediated remodelling. However, given the relaxed but not 
abolished HC superstructure of Rett syndrome cells, resection may progress with 
reduced HC restrictive barriers. Hence the dependency on resection may be dictated 
by how efficiently the HC superstructure is relaxed. It would be of interest in future 
experiments to establish whether loss of other HC associated factors also increase or 
reduce the magnitude of resection.  
 In this chapter I focused my attention on Rett syndrome cells because I 
observed the most dramatic impact in these cells and because they grew with similar 
kinetics to wildtype cells and had a low number of endogenous γH2AX foci. Rett 
syndrome cells showed a prolonged G2/M checkpoint arrest despite having normal 
DSB repair. Therefore lower numbers of γH2AX foci are sufficient to maintain 
checkpoint arrest in these cells. This data further consolidates the notion that more 
DDR signaling is generated per DSB in cells with reduced HC organization.  
 
 
1.35.3 Signalling the end of DSB repair 
 
Studies in yeast have suggested that chromatin reassembly, rather than the 
completion of DSB repair, is the signal to end DDR signaling and facilitate checkpoint 
release. Given that chromatin organization is perturbed in Rett, ICF and HPGS cell lines, 
reassembly of chromatin structure after DSB repair may be prolonged and 
subsequently checkpoint arrest maintained for longer. Kim and Haber tested whether 
loss of histone chaperones Asf1 and CAF-1 would affect recovery of the checkpoint 
after DNA damage. Chromatin assembly factor (CAF-1) and anti-silencing function 1 
(Asf1) are involved in replication-coupled nucleosome assembly via interactions with 
histone H3 and H4. Kim & Haber reported that DSB repair in asf1 and cac1 double 
mutant yeast strains was normal. However mutants maintained G2/M arrest and 
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Rad53 phosphorylation almost 4 hours longer than WT strains. In addition, asf1 
mutants lacking H3 H4 binding sites failed to suppress the G2/M checkpoint. The 
authors concluded that chromatin assembly is required for the termination of the 
damage induced G2/M checkpoint (Kim and Haber, 2009). The relevance of this to 
higher eukaryotes is less understood, but Asf1 proteins are highly conserved, and 
human Asf1 can functionally replace the yeast Asf1 protein (Tamburini and Tyler, 2005). 
CAF-1 also exists in mammalian cells and is recruited to sites of UV lesions (Green et al., 
2005) where is associates with histone H3.1 (Tagami et al., 2004). Following NER 
mediated repair of UV lesions, CAF-1 mediates the deposition of histone H3 and H4 
(Polo et al., 2006). It is interesting to speculate whether the process of chromatin 
reassembly, rather than DSB repair completion, signals the end of repair.  
 It is still unclear after DNA repair if nucleosomes are reassembled using pre-
existing histones or replaced with new histones. Histone modifying enzymes can be 
recruited to specific histone modifications which can allow spreading of these 
modifications to neighboring histones (Jenuwein, 2001; Jenuwein and Allis, 2001). 
Partial histone recycling may enable maintenance of epigenetic information by a 
semiconservative mechanism which is similar to the mechanism employed for DNA 
replication. Chromatin disordered cell lines could potentially have an epigenetic code 
which is less organized making the process of histone recycling during repair less 
efficient and as a consequence checkpoint arrest prolonged.  
 
Recently, γH2AX has been shown to inhibit neural stem cell (NSC) proliferation 
(Fernando et al., 2011). NCSs reside in particular regions of the brain and self-renew to 
generate neurons throughout life. The largest region of neurogenesis in the brain is 
known as the subventricular zone (SVZ) (Lim and Alvarez-Buylla, 1999). γH2AX 
phosphorylation at the SVZ slows NCS division, limits differentiation and reduces NCS 
niche size (Fernando et al., 2011). Therefore hyperactive and prolonged H2AX signaling 
in the SVZ would be expected to deplete NCS numbers and hence affect normal brain 
development. It is interesting to speculate whether the hyperactive signaling observed 
in Rett syndrome fibroblasts also occurs in neurons in response to replicative or 
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oxidative damage, and whether this signaling affects NCS differentiation. The Rett 
syndrome phenotype might be established later in development if the SVZ layer is depleted. 
Hence, early brain development is normal, but due to hyperactive ATM and hence gH2AX 
expansion, the SVZ layer is depleted due to either senescence or slow cycling. Therefore no 
NCS are available to acquire or maintain new skills such as speech.  
 
 
 
 
 
 
 
 
 
Chapter 5: DSBs dependent on Artemis 
for repair reside within regions of 
heterochromatin 
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DSBs dependent on Artemis for repair reside within regions of 
heterochromatin 
 
 
1.36 Introduction 
 
1.36.1 RS-SCID 
 
The Artemis gene was first identified in a small population of Athabascan-speaking Native 
Americans. Athabascan-type severe combined immunodeficiency (SCIDA) is characterised by a 
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failure to develop lymph nodes and a general failure to thrive (Moshous et al., 2001). A subset 
of SCID patients display sensitivity to ionizing radiation and are described as RS-SCID (radiation 
sensitive - severe combined immunodeficiency). In the majority of cases, patients are mutant 
for Artemis and are phenotypically characterised as T cell-negative (T-), B cell-negative (B-), 
natural killer cell-positive (NK+) (Moshous et al., 2001). The immunodeficient phenotype of 
these patients relates to the role of Artemis during V(D)J recombination a process which 
generates antibody diversity (see section 5.1.4 for details). The radiosensitivity experienced by 
these patients is a consequence of Artemis being required for the repair of a subset of DSBs. 
The nature of these lesions that are dependent on Artemis for repair is unknown. 
 
 
1.36.2 Gene location and family 
 
The Artemis gene encodes 685 amino acids with 14 exons and is located on chromosome 10. 
Sequence analysis revealed the murine protein to be 78 % identical to the human Artemis 
sequence (Moshous et al., 2001). Artemis, along with SNM1 (sensitive to nitrogen mustard 1), 
CPSF (cleavage and polyadenylation specificity factor), Pso2 and Apollo form a subgroup from 
the metallo-β-lactamase family which is characterised by the presence of a β-CASP (CPSF-
Artemis-Snml-Pso2) domain (Callebaut et al., 2002). Conserved residues between family 
members are predicted to be positioned in the vicinity of the catalytic centre formed by the 
metal binding residues (Callebaut et al., 2002). 
1.36.3 The Artemis endonuclease 
 
Artemis is a mammalian endonuclease that functions during V(D)J recombination and a subset 
of DSB repair. Nucleases can be grouped into two main families either exo or endo – nucleases. 
Exonucleases are typically sequence independent. Endonucleases can be further divided into 
those which are sequence independent (i.e. restriction enzymes) or structure specific. The 
nuclease activity of Artemis is conferred by a β-lactamase (aa1-135) and β-CASP (aa155-385) 
domains within its N-terminus (Ma et al., 2005a). On association with DNA-PK, Artemis cleaves 
5’ and 3’ overhangs and nicks DNA hairpins (Ma et al., 2005b). Using varying radiolabelled DNA 
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substrates Artemis was found to have activity on a wide range of DNA structures including 3’ 
flaps, pseudo Y structures, stem loop structures, symmetrical bubbles, heterologous loops and 
gapped DNA (Ma et al., 2005b). Y structures and nicked DNA were not cleaved by the Artemis 
DNA-PK complex. All of the substrates for endonuclelytic action by Artemis and DNA-PK had ss 
to ds DNA transitions. Un-cleaved substrates included blunt duplex DNA, nicked DNA, perfect Y 
structures and perfect ss DNA. Therefore unlike some endonucleases which are structure and 
sequence specific, Artemis on association with DNA-PK is functional on a wide range of end 
substrates.  
 In response to DSBs, Artemis is rapidly phosphorylated by ATM (Poinsignon et al., 2004; 
Riballo et al., 2004).  However, the functional relevance of this phosphorylation event remains 
unclear. Artemis contains 10 ST/Q PIKK target phosphorylation sites, 8 of which are contained 
within its C-terminus (Goodarzi et al., 2006). Artemis cDNA mutated for 7 of these sites is still 
able to complement the radiosensitivity of Artemis defective cells (Poinsignon et al., 2004). 
Expression of WT or Artemis protein mutated for all potential C-terminal PIKK phosphorylation 
sites (referred to as 9A) in a Artemis defective (CJ179) hTERT cell line was still able to restore 
mutant Artemis cells to a WT phenotype, as monitored by 53BP1 foci disappearance after 10 
Gy IR (Goodarzi et al., 2006). This suggested that Artemis activity was not dependent on 
phosphorylation at these PIKK target sites. Further mutation of all 10 PIKK target SQ sites 
found the same phenotype as the 9A mutant. Therefore loss of every SQ/TQ site in Artemis did 
not compromise Artemis’s function in vivo (Goodarzi et al., 2006). In addition, Artemis MEFs 
transfected with V(D)J coding joint substrate plasmids, Rag1 and Rag2 and WT or 9A mutants 
were still capable of cleaving the hairpin substrate. Therefore Artemis phosphorylation by ATM 
is dispensable for its nuclease activity in both DSB repair and V(D)J recombination (Goodarzi et 
al., 2006). DNA-PK defective cells, like Artemis cells, have a DSB repair defect after IR and are 
V(D)J recombination compromised (Le Deist et al., 2004). DNA-PKcs undergoes 
autophosphorylation within two distinct regions known as the ABCDE and PQR clusters 
(Merkle et al., 2002). Phosphorylation site mutants for the ABCDE cluster fail to rescue the DSB 
repair or V(D)J recombination defect of DNA-PK mutants. Goodarzi et al (2006) subsequently 
established that DNA-PK autophosphorylation is a prerequisite for Artemis activity. Different in 
vivo experiments which incubated either: Artemis, DNA-PK (unphosphorylated) and 
Wortmannin or Artemis, DNA-PK (phosphorylated) and PIKK inhibitor Wortmannin found 
Artemis was still functional in the presence of Wortmannin if DNA-PK had already undergone 
autophosphoryltion (Goodarzi et al., 2006). Additionally incubating Artemis and DNA-PK with 
non-hydrolysable ATPγS, no ATP or PIKK inhibitor Wortmannin were unable to support Artemis 
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activity on radiolablled DNA overhangs. This suggested that DNA-PK autophosphorylation was 
required for Artemis nuclease activity. At relevant salt concentrations Ku is also required for 
Artemis endonuclease activity (Goodarzi et al., 2006). DNA-PK but not Ku dissociates from 
blunt DNA after autophosphorylation. However, if DNA overhangs persist, DNA-PK remains 
stably associated with DNA even after autophosphorylation (Goodarzi et al., 2006). The 
addition of Artemis removed DNA-PK from the DNA end (Goodarzi et al., 2006). This was 
established in vivo by adding Ku + DNA-PK or Ku, DNA-PK + Artemis. Immunoprecipitation for 
Ku and immunoblotting for bound proteins established that only when Artemis was present 
did DNA-PK dissociate from Ku. The authors then tested whether DNA-PK autophosphorylation 
site mutants could support Artemis activity. In this scenario, no Artemis cleavage was found. 
The authors concluded that autophosphorylation at DNA-PK ABCDE cluster is required for 
Artemis nuclease activity. A model was suggested in which DNA-PK autophosphorylation may 
alter the holoenzyme conformation which facilitates exposure of ss to ds DNA junction to 
enable Artemis cleavage (Goodarzi et al., 2006). Therefore ATM dependent Artemis 
phosphorylation is dispensable for Artemis activation.  
 
 
1.36.4 Artemis and DSB repair 
 
Around 10% of DSBs remain unjoined for up to 14 days in CJ179 (Art) primary cells after 80 Gy 
when monitored by Pulse Field Gel Analysis (PFGA) (Riballo et al., 2004). This phenotype is 
identical to A-T cells. A-T and Artemis cells both loose γH2AX foci with similar kinetics as WT 
cells up to 4 hours after IR. At later time points (> 8 hours up to 14 days) A-T and Artemis cells 
have persistent γH2AX foci. This defect can be rescued following over-expression with Artemis 
cDNA. A mutant (D37N) Artemis cDNA with disrupted overhang endonucleolytic and hairpin 
cleavage activities (Pannicke et al., 2004) fails to rescue the DSB defect of CJ179 (Art) cells. This 
demonstrated that the function of Artemis in DSB repair requires its endonuclease activity. 
Since mutations in core NHEJ factors results in a marked DSB repair defect at early time points 
after IR (Kuhne et al., 2004), ATM and Artemis are not considered core components of NHEJ, 
but rather are required for the repair of a subset of DSBs at later time points (Riballo et al., 
2004). 
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 The addition of ATM inhibitor (ATMi) to CJ179 (Art) cells was shown to have no 
additive effect on γH2AX foci loss after 2 Gy IR, which suggested that ATM and Artemis 
function in the same repair pathway (Riballo et al., 2004). Previously the dependency for ATM 
and Artemis in DSB repair was proposed to be a consequence of end complexity since an 
increased reliance for these proteins was observed for repair of lesions generated by densely 
ionizing α particles (Riballo et al., 2004). In this model ATM was thought to phosphorylate and 
activate Artemis. However as mentioned earlier, ATM dependent Artemis phosphorylation is 
dispensable for Artemis activity (Goodarzi et al., 2006). Further analysis of damage complexity 
and ATM dependency using varying damage inducing agents such as neocarzinostatin (NCS) 
which produces defined DSB possessing phosphoglycolate or 3’-phospho termini refractory to 
ligation, and carbon K which induces clustered DSBs both generated a DSB repair fraction 
dependent on ATM which was similar to X-rays. Therefore the DSB repair fraction dependent 
on ATM did not exceed 20-25%. Therefore ATM dependency is not a consequence of increased 
damage complexity (Goodarzi et al., 2008). This finding necessitated a re-think for the role of 
ATM and Artemis in DSB repair. Using NIH 3T3 cell which have easily identifiable regions of 
heterochromatin, at 30 minutes after 0.25 – 2 Gy IR, the percentage of heterochromatin 
associated DSBs is roughly 25%, which is consistent with stochastic DSB induction (Goodarzi et 
al., 2008). By contrast, the percentage of heterochromatin associated DSBs at 24 hours after 1 
– 3 Gy IR with ATMi is roughly 60 – 70% (Goodarzi et al., 2008). Analysis of ATM dependent 
repair in Klinefeter syndrome cell lines, which have an XXXY genotype and consequently more 
silenced heterochromatin, found a greater number of persisting DSBs in the Klinefelter 
syndrome cells after ATMi than control cells (Goodarzi et al., 2008). Similarly analysis of γH2AX 
foci in ATMi treated HGPS cells which have reduced chromatin organization found only half the 
number of foci remaining after 24-48 hours after IR compared to ATMi treated WT cells. This 
suggested that ATM dependent DSBs reside within or are located at regions of 
heterochromatin (Goodarzi et al., 2008). 
 KAP-1 phosphorylation has been shown to correlate with global chromatin relaxation 
as measured by micrococcal nuclease digestion of genomic DNA (Ziv et al., 2006). Increased 
nucleosome compaction, as caused by heterochromatin formation, is more resistant to salt 
solublization and MNase digestion (Yoda and Ando, 2004). KAP-1, HP1 and HDAC1 are found in 
greatest abundance in fractions most resistant to nuclease digestion. IR induced DNA damage 
induces a reduction of KAP-1 in the most nuclease resistant chromatin fractions. A small 
fraction of KAP-1 remains chromatin bound even after 80 Gy IR (Goodarzi et al., 2008). The 
reduction of KAP-1 in nuclease resistant chromatin fractions was reversed within several hours, 
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mirroring the loss of γH2AX and indicative of a dynamic equilibrium with repair. KAP-1 release 
from chromatin enriched protein fractions does not occur with ATMi treatment (Goodarzi et 
al., 2008). This suggested that ATM dependent phosphorylation of KAP-1 was required to 
mediate nucleasomal relaxation. Further experiments established that heterochromatin 
relaxation mediated by either: KAP-1, HDAC1/2 or HP1 knockdown overcomes the 
requirement for ATM in DSB repair. Given that ATM and Artemis have epistatic repair defects 
following exposure to IR, in this chapter I wish to address whether the dependency for Artemis 
in DSB repair could also be overcome following heterochromatin relaxation. 
 
 
1.36.5 Aims of this chapter 
 
Both ATM and Artemis have epistatic repair defects and are required for the repair of a subset 
of DSBs that are repaired with slow kinetics in G1 (Riballo et al., 2004). ATM functions at this 
subfraction to mediate nucleasomal remodelling via phosphorylation of the heterochromatin 
building factor KAP-1, thereby facilitating access to other wise inaccessible DSBs (Goodarzi et 
al., 2008). Based on these findings, I wished to address in this chapter whether Artemis also 
functions like ATM to mediate or participate in nucleasomal remodelling. Firstly, I examine 
whether Artemis dependent DSBs localize to regions of heterochromatin. I further examined 
whether these DSBs are enriched for heterochromatin associated markers such as 
phosphorylated KAP-1 and Tri-Me K9 Histone H3. Following DSB induction KAP-1 dissociates 
from nuclease resistant chromatin enriched protein fractions, and the reestablishment of KAP-
1 at these fractions directly correlates with DSB repair (Goodarzi et al., 2008). I next wished to 
address whether Artemis dependent DSBs would prolong the duration that KAP-1 remained 
dissociated from heterochromatin enriched fractions. Following siRNA mediated 
heterochromatin relaxation the requirement for ATM in DSB repair can be alleviated (Goodarzi 
et al., 2008). Finally I addressed whether heterochromatin relaxation could alleviate the 
requirement for Artemis in DSB repair. 
1.37 Results 
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1.37.1 DSBs dependent on Artemis for repair are visibly associated with DAPI dense 
chromocenters. 
 
The heterochromatic content of the human genome is known to be in the range of 10-25% 
(Miklos and John, 1979). This percentage correlates with the DSB repair fraction that is 
dependent upon Artemis for repair. It has recently been reported by Goodarzi et al (2008) that 
DSBs dependent upon ATM signalling localize to regions of heterochromatin. To determine 
whether Artemis dependent breaks localize to regions of heterochromatin, I examined, by 
immunoflorescence, whether γH2AX foci that persist in Artemis siRNA transfected cells localize 
with regions of heterochromatin. I utilized contact inhibited G1 phase NIH3T3 mouse cells to 
rule out any complication posed by cell division or replication. These cells also offer the 
advantage of having easily identifiable heterochromatic regions following dense DAPI staining 
(Guenatri et al., 2004), thus enabling regions of heterochromatin to be imaged under the 
microscope. NIH 3T3 cells were treated with either control, Artemis oligo A and B, or 53BP1 
siRNA for 48 hours as a control for HC-DSB repair deficiency. Since specific antibodies against 
the mouse Artemis protein are unavailable to confirm successful knockdown, cells were 
selected on the basis of those which maintained a DSB repair fraction of 10-20% 24 hours after 
recovery following 3 Gy IR (Figure 5.1).  The estimated transfection efficiency was monitored 
using 53BP1 knockdown by immunoflorescence alongside the system employed to transfect 
the Artemis siRNA. γH2AX foci were scored in non-expressing cells (Figure 5.1). Like ATM 
inhibited cells, γH2AX foci persisting in the presence of Artemis siRNA localized to regions of 
heterochromatin. To quantify these findings, I enumerated the total number of γH2AX foci and 
the total number of those foci that localized to regions of heterochromatin (Figure 5.2).  
Strikingly, more than 70% of unrepaired IR induced DSBs were found to be visibly associated 
with regions of heterochromatin in Artemis defective cells (Figure 5.2). 
 
 
1.37.2 Late repairing Artemis dependent γH2AX foci co-localize with pKAP-1 foci 
 
Unrepaired DNA DSBs that reside within heterochromatin signal to ATM. This signalling event 
maintains the phosphorylation of KAP-1 until the completion of repair (Goodarzi et al., 2008). 
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Therefore, I postulated that DSBs dependent on Artemis that localize with regions of 
heterochromatin should also localize with pKAP-1 foci. To investigate this, 1BR (WT) and 
Artemis primary fibroblasts were irradiated with 3 Gy IR, fixed and immunostained at the 
indicated time points post IR for pKAP-1, γH2AX and DAPI. As expected, increased γH2AX foci 
in Artemis defective human cells highly contain pKAP-1 signal at DSBs (Figure 5.3).  
 
 
1.37.3 Artemis dependent DSBs are enriched for the heterochromatic marker Tri-Me K9 
Histone H3. 
 
Finally, I utilized a method other than microscopy to observe the correlation between 
heterochromatin and Artemis dependent repair. I reasoned that if Artemis dependent DSBs 
reside at regions of heterochromatin then γH2AX containing nucleosomes should be enriched 
for heterochromatin associated modifications such as Tri-Me K9 histone H3. To test this, I 
immunoprecipitated for γH2AX containing nucleosomes after IR in CJ179 (Art) primary cells 
and blotted for Tri-Me K9 Histone H3. First Artemis defective CJ hTERT cells were irradiated 
with either 10 Gy IR with a recovery time of 30 minutes (early time point) or 80 Gy with a 48 
hour recovery (late time point). The early time point should represent stochastic DSB’s 
distributed evenly throughout euchromatin and heterochromatin. At this time point there is 
enough time for repair foci to form but no actual repair to proceed. The late time point should 
represent only those DSBs dependent on Artemis for repair. Isolated protein samples were 
sonicated for 1 minute and DNA was extracted and resolved on a DNA agarose gel to ensure 
the same range of polynucleosomes were isolated for each sample (Figure 5.4). Following IR, I 
used γH2AX antibodies to immunoprecipitate (IP) nucleosomes which localize with DSBs and 
blotted for γH2AX and the heterochromatic marker Tri-Me K9 Histone H3 (Figure 5.4). Using 
these conditions similar amounts of γH2AX were IP’d for early and late time points. Where 
equivalent levels of γH2AX were IP’d, late repairing Artemis dependent DSBs were associated 
with roughly four times more histone H3 K9 trimethylation than cells with stochastically 
incurred DSBs (Figure 5.4). This data strongly suggested that Artemis plays a role in repair of 
DSBs associated with heterochromatin. Wildtype cells were not used during this analysis 
because at late time points after IR, all DSBs are repaired.  
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1.37.4 KAP-1 remains dissociated from chromatin enriched fractions following IR for longer 
in Artemis defective cells. 
 
As mentioned in the introduction, global chromatin relaxation has been shown to correlate 
with KAP-1 phosphorylation (Ziv et al., 2006). KAP-1 retention at micrococcal nuclease (MNase) 
resistant chromatin enriched protein fractions is reduced following IR, and the reestablishment 
of KAP-1 in these fractions directly correlates with DSB repair (Goodarzi et al., 2008). Here I 
want to address what affect Artemis deficiency has on IR induced KAP-1 dynamics at 
heterochromatin enriched chromatin fractions. If Artemis dependent DSBs reside at 
heterochromatin, then one would expect ATM signalling from these breaks to maintain KAP-1 
phosphorylation (pKAP-1) and subsequently prolong the duration that nucleosomes remain in 
a dynamic configuration. Therefore chromatin enriched fractions in Artemis defective cells 
would be expected to have less KAP-1 associated at later times after IR compared to WT cells. 
To test this, Artemis and WT MEFs were irradiated with 40 Gy IR and harvested 2 hours later. 
Protein extracts were subjected to increasing concentrations of salt and nuclease treatments 
to separate extracts into fractions of increasingly compacted chromatin. Under conditions of 
no IR, KAP-1 and HDAC1 protein levels were similar between WT and Artemis MEFs. 
Importantly, KAP-1 was only soluble in the chromatin enriched C3 protein fractions. Similarly 
HDAC1 was only found in increasingly compacted chromatin fractions (C2 and C3). Importantly 
the same volume of histones were collected between WT and Artemis MEFs for each fraction 
as monitored by Histone H3 (Figure 5.5). Strikingly, 8 hours after 40 Gy IR, KAP-1 remained 
dissociated from nuclease resistant fractions prepared from Artemis MEFs, whereas WT cells 
had re-established WT levels of KAP-1 association (Figure 5.5). This result suggested that 
Artemis dependent DSBs are located at KAP-1 enriched heterochromatin and that delayed DSB 
repair dependent on Artemis prolongs chromatin relaxation.  
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1.37.5 KAP-1 knockdown does not relieve the dependency for Artemis in DSB repair. 
 
ATM is known to phosphorylate the heterochromatic building factor, KAP-1. Following reports 
that phosphorylation of KAP-1 by ATM results in global chromatin relaxation (Goodarzi et al., 
2008; Ziv et al., 2006), it has been postulated that this relaxation may facilitate access to DSB’s 
that would otherwise remain inaccessible. Artemis and ATM deficiency cause epistatic repair 
defects and both function in the slow repair component of NHEJ. Therefore, it is possible that 
Artemis, like ATM, may play a role in chromatin relaxation. To test this, I examined whether 
Artemis-dependent repair was alleviated by KAP-1 knockdown using the siRNA in 48BR (WT) 
and CJ (Art) hTERT human cells. To confirm successful knockdown, cells were stained for KAP-1 
and γH2AX (Figure 5.6). Following KAP-1 knockdown (Figure 5.7), the Artemis-dependent 
repair fraction was not alleviated. This suggested that Artemis, unlike ATM, does not play a 
direct role in heterochromatic modulation that is associated with KAP-1 phosphorylation. To 
confirm functionally successful siRNA mediated knockdown of KAP-1, 48BR (WT) and CJ (Art) 
hTERT cells were transfected with KAP-1 siRNA and treated with ATMi inhibitor (ATMi) 30 
minutes before IR. The ATM-dependent repair defect of A-T cells is known to be relieved by 
siRNA mediated knockdown of KAP-1 (Goodarzi et al., 2008). Therefore, if siRNA mediated 
knockdown of KAP-1 is successful, hTERT cells treated with ATMi and KAP-1 siRNA should show 
a phenotype similar to cells transfected with KAP-1 siRNA only.  If, however, KAP-1 siRNA 
mediated knockdown is unsuccessful, 48BR (WT) hTERT cells will have a repair defect which is 
phenotypically similar to A-T cells i.e. a 10-20% DSB repair fraction that remains un-repaired 
after 24 hours post IR. Following KAP-1 siRNA transfection in combination with ATMi, both 
48BR (WT) and CJ (Art) hTERT cells showed a phenotype which was comparable to cells treated 
with KAP-1 siRNA only (Figure 5.7). 48BR (WT) hTERT cells showed no increased repair fraction 
after 24 hours following 3 Gy IR compared to untreated cells. Therefore it can be concluded 
that siRNA mediated knock down of KAP-1 was successful.  
 
 
1.37.6 KAP-1 or HDAC1 and HDAC2 knockdown also does not alleviate the DSB repair defect 
of Artemis defective mouse embryonic fibroblasts (MEFs).  
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To confirm our findings obtained with KAP-1 siRNA in human cells, I repeated these 
experiments in mouse embryonic fibroblasts (MEFs). Knockdown was verified by 
immunofluorescence (Figure 5.8), and γH2AX foci were scored specifically in KAP-1 depleted 
cells. As expected, the Artemis dependent DSB repair defect was not alleviated following KAP-1 
knockdown in Artemis defective mouse cells. To further consolidate this result, the histone 
deacetylases 1 and 2 (HDAC1 and HDAC2) were also knocked down. Histone deacetylases are a 
class of enzymes that remove acetyl groups from histone tails. Removal of these acetyl groups 
re-establishes the binding between the negative DNA phosphate backbone and positive 
histone tails, and is often associated with transcriptional silencing. HDAC1 and HDAC2 also act 
as a component of NuRD chromatin remodelling complex and a subunit of which interacts with 
KAP-1 to initiate transcriptional silencing (Feng and Zhang, 2003). γH2AX foci were scored 
specifically in cells successfully knocked down for  HDAC1 and HDAC2 (Figure 5.9).The Artemis 
dependent repair fraction persisted following knockdown, therefore, heterochromatic 
relaxation, via knockdown of HDAC1 and HDAC2, was also unable to relieve the repair defect 
associated with Artemis defective cells. 
 
 
1.38 Discussion 
 
1.38.1 The role of Artemis in ATM dependent DSB repair 
 
ATM and Artemis are required for a subset of DSB repair that occurs with slow kinetics by NHEJ 
in G0/G1 phase (Riballo et al., 2004). In this chapter, I focused on addressing the role of 
Artemis in ATM dependent DSB repair following IR. I demonstrate that DSBs that persist in the 
absence of Artemis localize to dense DAPI staining chromocenters and that Artemis dependent 
repair foci localize with heterochromatin associated repair foci, such as pKAP-1 foci. Moreover, 
Artemis dependent DSBs were found to be associated with roughly 4 times more histone H3 
K9 trimethylation (a heterochromatic marker) than repair fractions with stochastically incurred 
DSBs. Additionally, KAP-1 remains dissociated from chromatin enriched fractions for longer in 
Artemis defective cells compared to WT. These results suggest that Artemis dependent DSBs in 
133 
 
G1 reside at HC regions, and incomplete repair of these DSBs promotes the dissociation of 
KAP-1 and presumably HC relaxation at these DSBs for longer. However, unlike ATM deficient 
cells, perturbing the heterochromatin structure through KAP-1 or HDAC1/2 knockdown does 
not alleviate the dependency of Artemis in DSB repair. 
 The data thus far suggests that Artemis is unlikely to function like ATM to induce 
heterochromatic relaxation, and is likely to function downstream of this process. Given that 
Artemis is known to function during V(D)J recombination to remove hair-pin intermediate 
structures, and DSBs dependent on Artemis for repair do appear to associate with 
heterochromatin, I therefore propose that the repetitive nature of heterochromatic DNA may 
have a higher dependency on Artemis for repair to relive secondary structures or hairpins that 
form at damaged termini. Given that Artemis can cleave a variety of end substrates (Ma et al., 
2002) it is possible that other nucleases which are more substrate specific cannot recognise 
these complex structures as substrates. Therefore heterochromatin associated DSBs could 
possibly have a specificity for Artemis over other nucleases. A related endonuclease known as 
Apollo, functions at repetitive telomeric DNA to generate a protective 3’ ss overhang at leading 
strand telomeres after replication to prevent NHEJ of telomere ends. It is possible that Artemis 
endonuclease activity functions at other repetitive regions elsewhere in the genome.  Repair of 
DSBs by HR in G2 requires the known HR proteins, BRCA2, Rad51 and Rad54, and also Artemis 
and ATM (Beucher et al., 2009). The dependency for ATM in G2 is relieved by KAP-1 
knockdown, suggesting that repair by HR in G2 is associated with HC DSBs. The requirement 
for Artemis is reliant on it’s nuclease function. However not all HR associated repair is 
dependent on Artemis, because spontaneous SCEs and I-Sce1 induced HR repair do not require 
Artemis, therefore resection can occur without Artemis. These results suggest that Artemis is 
required for early steps of HR repair to function as an endonuclease possibly during processing 
which is necessary to enable resection of IR induced DSBs. Highly repetitious DNA sequences, 
such as centromeric satellite repeats, have been shown to from hairpins (Oritz-Lombardia et 
al., 1998). Additionally, repeating DNA units in disease genes, such as those found in 
Alzheimer's disease, are also capable of forming hairpins (Gacy et al., 1995).  A model has been 
proposed that Artemis is required to remove secondary structures which arise as HC DSBs that 
might be refractory to resection in G2. I propose that in G1, Artemis carries out a similar 
function to remove structures refractory to DSB repair by NHEJ. Future approaches to address 
Artemis’s function in DSB repair will likely be based on identifying the end structure or lesion 
which is dependent on Artemis processing.  
134 
 
 
 
 
 
 
Chapter 6: Analysis of G2/M 
checkpoint arrest after heavy ion 
irradiation 
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Heavy ions 
 
 
1.39 Introduction 
 
Charged particle radiotherapy using protons and heavier ions was first proposed for clinical 
application by Robert Wilson in 1946 (Wilson, 1946). In the early 1950s, the clinical use of 
proton and helium ion beams was first initiated at the Lawrence Berkeley National Laboratory 
in the United States. In Japan, the decision was made in 1984 to build the Heavy Ion Medical 
Accelerator in Chiba (HIMAC) at the National Institute of Radiological Sciences (NIRS). The 
accelerator complex was completed by the end of 1993. A year later clinical studies with 
carbon ions for cancer therapy were initiated, and to date more than 5196 patients have been 
treated with Carbon ions (Okada et al., 2010). Currently the availability of heavy ion 
radiotherapy (RT) is limited. Worldwide only 3 facilities offer Carbon ion RT: two hospital based 
facilities in Japan, the HIMAC and the Hyogo Ion Beam Medical Center (HIBMC), and a physic 
research facility at Gesellschaft fur Schrrerionedforschung Institute (GSI), Darmstadt in 
Germany. At the HIMAC a number of studies are ongoing using RT treatments of tumors of the 
head and neck, prostate, lung, liver as well as sarcomas of soft tissue and bone carcinomas. 
Patients are treated in 3 different treatment rooms, which are equipped with a vertical beam 
line, a horizontal beam line and the third with a vertical and a horizontal beam line.  
 Exposure to heavy ions also occurs naturally during space exploration. Space travel 
encompasses exposure to a broad spectrum of radiation ranging from infrared rays to galactic 
cosmic rays (GCR). GCR are composed of protons (85%), alpha particles (14%) and highly 
energized protons and iron nuclei (Simpson & Shapiro, 1983). Developments of efficient 
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countermeasures are key issues for manned space exploration. Therefore a better 
understanding of how cells respond to heavy ion irradiation is important for both radiotherapy 
and space exploration. In this chapter I will focus on how the G2/M checkpoint responds 
following irradiation with Carbon and Iron (Fe) ions. Also I will establish how many heavy ions 
induced DSBs are required to maintain G2/M checkpoint arrest.   
 
 
 
1.39.1 Linear energy transfer (LET) 
 
Various types of ionizing radiation exist such as those produced by radioactive decay (such as γ 
rays), particle accelerators (such as X-rays and Carbon ions) and those found in cosmic rays 
(such as Fe ions). When radiation is absorbed in biological material, ionizations and excitations 
occur that are not distributed at random but are localized along the tracks travelled by the 
individual charged particles in a pattern that depends on the type of radiation. X-rays are fast 
moving electrons with very small mass and are said to be sparsely ionizing. Densely ionizing 
radiations such as Carbon and Fe ions have a greater biological effectiveness than sparsely 
ionizing X-rays or γ rays. Because heavy ions are densely ionizing they are described as having a 
high linear energy transfer (LET). LET is the energy transferred per unit length of a track, and is 
a measure of the energy transferred to material as an ionizing particle travels through it. LET is 
measured in Kiloelectron volt per micrometer (KeV/μm) of unit of density material (see table 
6.1 for X-ray, Carbon ions and Fe ions LET values). Therefore high LET ionizing radiations 
deposit energy in high density pockets along its trajectory track. Complex DSBs are those 
described as having damaged bases or sugars at damaged end termini or with multiple 
damaged sites in close proximity (Goodarzi et al., 2008; Riballo et al., 2004). Simple DSBS are 
those with directly ligatable damaged ends which are sparsely distributed. Heavy ions can 
produce a complex mixture of both low and high complexity DNA damage. The complexity of 
DNA damage has been shown to increase with increasing LET values (Anderson et al., 2010) 
(See 6.1.4 for further discussion on clustered DNA damage).  Moreover the generation of small 
DNA fragments induced after IR also increases with increasing LET (Lobrich et al., 1996). In 
addition to the direct track of ionization from a high LET particle, δ rays also emanate from the 
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main track. δ rays produce simpler DNA damage similar to X-rays (Cucinotta et al., 1998). High 
LET produces more complex irreparable DSBs, and as a result a greater biological consequence 
than compared to X-rays. 
 
 
1.39.2 Relative biological effectiveness (RBE) 
 
Absorbed dose is a measurement of the energy absorbed per unit mass of tissue, and is 
expressed in units of Gy or Rad. Despite giving the same dose, equal doses of different types of 
radiation do not produce equal biological effect. For example 1Gy of Fe ions produces greater 
biological effect than 1 Gy of X-rays. The difference lies in the energy deposition, whether it is 
sparsely as for X-ray or densely as for heavy ions. Consequently, heavy ions have high relative 
biological effectiveness (RBE). High LET produces more complex slowly repairing and possibly 
irreparable DSBs, which result in a greater biological consequence in comparison to X-rays. 
Analysis of chromosome break rejoining by premature chromosome condensation (PCC) 
analysis showed that rejoining decreases with increasing complexity (Kawata et al., 2001a; 
Kawata et al., 2001b; Kawata et al., 2001c) again likely contributing to the high RBE of heavy 
ion irradiation. For radiation with optimal LET of 100 KeV/μm, the average separation between 
ionizing events is similar to the diameter of the DNA double helix (2 nm). At this dose, the IR 
track can most sufficiently produce DSBs in a single track.  RBE depends on the radiation 
quality (LET), radiation dose, dose rate and the biological system or end point. 
 
 
1.39.3 Braggs peak 
 
The advancement in Carbon ion radiotherapy was not only a consequence of their greater RBE 
but also because unlike X-rays, Carbon ions do not deposit their maximum energy on contact 
with skin. Instead Carbon ions are capable of penetrating through tissue to deposit their 
maximum radiation dose to a given point in the body. This is because charged particles slow 
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down as they travel through a material as a result of electromagnetic interactions (forces that 
cause the interactions between electrically charged particles). The slower they move, the more 
efficient they are at ionizing atoms in their path and the more likely they are to interact with 
atomic nuclei. This means that the highest radiation dose is delivered at the point in the body 
at which they stop - the so-called Bragg peak - while the dose elsewhere is low (Figure 6.1). 
Carbon ions have a sharp Bragg peak (a pronounced rise in energy deposition of radiation 
during its travel through matter); with a steep dose fall off downstream. This is particularly 
useful because tissue surrounding the tumor will not be hit by radiation. Before treating a 
patient, radiation oncologists identify the precise location of the tumour by imaging it. This is 
often done using modern imaging techniques such as - X-ray computed tomography (CT), 
magnetic resonance imaging (MRI) or positron emission tomography (PET). The energy of the 
Carbon ion beam is then adjusted to match the tumour depth. Moreover the Bragg peak can 
be modulated into a plateau that deposits a high dose of radiation throughout the depth of the 
tumour, known as a spread out Bragg peak (SOBP). A SOBP is normally achieved by magnetics 
which scatter the beam to a defined field.  Because the human body has effective repair 
mechanisms, it can tolerate some collateral damage. And since cancer cells often divide more 
rapidly than healthy cells and so are particularly vulnerable to DNA damage – targeted DNA 
damage at the tumor is often successful in destroying the tumor.   
 
 
1.39.4 Clustered DNA damage 
 
Clustered DNA damage was first described by Ward as locally multiple damaged sites (LMDS) 
which describes several closely spaced damages within a short DNA segment (Ward, 1981). 
Clustered DNA lesions were proposed to account for the increased lethality induced by IR, 
which cannot be fully explained by the amount of DSBs formed. IR induces DNA damage by 
direct ionization and through generation of hydroxyl radicals that attack DNA. Two or more 
DNA lesions of the same or different nature may be produced in close proximity to each other 
on opposite DNA strands. To establish the complexity of DNA damage that is produced after 
heavy ion IR, Michael Huels and colleagues at the University of Sherbrooke decided to look 
into this issue in more detail. They fired low-energy ions onto a film of biomolecules in an 
ultrahigh vacuum and analyzed the ions that desorb from the film with a mass spectrometer. 
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The results showed that the initial damage caused by the ions at their track ends is significantly 
more complex, clustered and lethal than that induced by X- or gamma-rays (Deng et al., 2006). 
Severe damage can be caused by energies as low as 0.25 eV per nucleon -- which is very low 
when compared with the energy of a typical heavy-ion beam. Using the Monte Carlo algorithm 
Semenenko & Stewart, established that Low LET radiations can create clusters with as many as 
10 lesions (Semenenko and Stewart, 2004), and ~30% of DSBs after low energy electrons are 
expected to contain clustered DSBs (Nikjoo et al., 1997). High LET is capable of producing 
damage with up to 25 lesions per cluster(Semenenko and Stewart, 2004), and ~70% of DSBs 
after high LET particles are expected to be clustered (Nikjoo et al., 1997). Local clustered DNA 
damage is expected to be more prone to misrepair, and therefore could account for the higher 
RBE associated with increasing LET values.  
 
 
1.39.5 Heavy ions 
 
High LET radiations are a critical component of space travel and are increasingly being used as 
an alternative for radiotherapy during cancer treatment. Heavy ions can be forced to deliver a 
much greater dose to the tumor while sparing normal tissue (Halperin, 2006). Newer than 
protons on the particle-therapy scene is ion therapy. Heavy ions, such as carbon, have a higher 
RBE than protons and are thought to provide more effective treatment for certain, deep-
seated tumours that are often "radioresistant". This is because the rate at which a charged 
particle loses energy in a material - which is quantified by its linear energy transfer (LET) - 
increases with the mass of the particle. 
 
 
1.39.6 Aims of this chapter 
 
Previous analysis of DSB repair after heavy ion irradiation has been monitored by PCC in G1 
which showed slower rejoining following irradiation with heavy ions compared to X-rays 
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(Okayasu et al., 2006). Recently high resolution microscopy has been used to analyze γH2AX 
foci after vertical Fe ion irradiation, which is a more sensitive DSB assay able to monitor DSB 
repair in individual cells and at physiologically relevant doses (Nakajima et al., manuscript 
submitted). However vertical irradiation can be problematic as not all underlying γH2AX foci in 
a track can be identified, therefore there is potential to underestimate the number of γH2AX 
induced. To overcome this issue, in this chapter I have analyzed DSB repair after horizontal Fe 
ion irradiation. After horizontal irradiation it is possible to identify all DSBs in a track by using 
γH2AX as a biomarker for DSB repair.  
 DSB complexity increases with radiation ionization density (Anderson et al., 2010). 
Therefore heavy ion irradiation is expected to produce DSBs with various complexities and 
clustering. The speed of repair after heavy ion irradiation has been shown to be determined by 
cluster complexity (Nakajima et al., manuscript submitted). The rate of repair has also been 
shown to directly influence the duration of checkpoint arrest (Shibata et al., 2010). Given that 
heavy ion irradiation induces complex clustered DNA damage, in this chapter I wished to 
address whether heavy ion induced DNA damage would maintain a prolonged G2/M 
checkpoint arrest. Additionally I wanted to establish how many clustered DSBs would be 
required to maintain G2/M checkpoint arrest.  
 
1.40 Results 
 
1.40.1 Fe ion induced DSBs are repaired with slower kinetics than X-ray induced DSBs. 
 
Heavy ion irradiation is known to induce DSBs that are more complex and clustered in 
comparison to X-ray. This is because heavy ions have a higher LET in comparison to X-rays, 
meaning the rate of energy loss along a heavy ion ionizing trajectory is denser than compared 
to lower LET sources such as X-rays. The nature of heavy ion induced DSB repair is largely 
unknown. Given that the DNA damage induced after heavy ion irradiation is more complex 
than that after X-ray, it is unknown whether the rate of repair is slower after heavy ion 
irradiation when using γH2AX as a monitor for DSB repair. To address this question I first 
selected a method of radiation which was optimal for γH2AX analysis. At the NIRS HIMAC 
facility, there are two directional methods available for administering heavy ion irradiation, 
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these being either horizontal or vertical (Figure 6.2). Vertical irradiation is problematic as 
underlying foci in an ionizing track can be missed when scoring foci, therefore an 
underestimation of the number of γH2AX in a track is possible. However, irradiating at low 
doses vertically ensures all cells are hit with the ion beam. Horizontal irradiation is problematic 
at lower doses IR because not all the cells in a sample are hit with the beam, and the variation 
in damaged induced between hit cells is large. However, irradiating horizontally enables all foci 
to be visualized in a track, which allows for a more accurate quantification of the number of 
DSBs induced. Taking these points into consideration, horizontal irradiation was selected 
because as mentioned above, all DSB foci can be visualized. To analyze γH2AX foci after 
horizontal Fe IR, 1BR hTERT cells were irradiated with either 1 Gy X-ray or 1Gy horizontal Fe 
ion IR, fixed at indicated time points after IR, and immunostained for γH2AX, CENP-F (G2 phase 
marker) and DAPI. γH2AX foci were counted in G1 phase cells. Because of the variation in 
damage induced between cells after horizontal Fe ion IR (Figure 6.3), to quantify DSB repair 
foci numbers were normalized to the 1 hour time point. As expected, DSB repair after Fe ion 
irradiation was greatly reduced in comparison to X-ray (Figure 6.4), with ~65% of DSBs still 
remaining 8 hours after Fe ion IR. At the equivalent time point after X-ray only ~10% of DSBs 
remained unrepaired. 24 hours post irradiation, more than 95% of DSBs had been repaired 
after X-ray, whereas only ~55% after Fe ion IR. I next analyzed DSB repair in G2 phase cells 
under the conditions described above. In G2 phase, very little repair was observed after Fe ion 
IR, with ~70% of DSBs remaining unrepaired up until 24 hours (Figure 6.5). In G2 phase, both 
NHEJ and HR can function to repair DSBs. NHEJ repairs DSBs with faster kinetics compared to 
HR (Beucher et al., 2009; Shibata et al., 2010). Therefore the slower repair kinetics observed 
after Fe ion IR in G2 is likely because complex lesions such as those produced after heavy ion 
irradiation are being repaired by HR (Shibata et al., 2011).  
 
 
1.40.2 Heavy ion irradiation initiates G2/M checkpoint arrest at lower doses IR in 
comparison to X-ray.  
 
As discussed in chapter 3, while ATM is a very sensitive DSB response kinase, its role in G2/M 
checkpoint activation requires a minimum number of DSBs i.e. 15-25 DSBs are required to 
initiate and maintain checkpoint arrest (Deckbar et al., 2007). Since heavy ion irradiation 
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induces DNA damage which is clustered and complex, I wished to determine whether lower 
doses of heavy ion IR could initiate a G2/M checkpoint arrest in comparison to X-ray. 1BR 
hTERT or 48BR primary cells were irradiated with either X-ray, Fe ion (horizontal or vertical) or 
Carbon ion irradiation at various doses of IR. Prior to IR cells were treated with aphidicolin, a 
replication polymerase inhibitor which prevents S phase cells progressing into G2 phase during 
analysis. One hour after treatment, cells were fixed and immunostained for serine 10 
phosphorylated histone H3 (pH3). pH3 is a biomarker for mitosis, which can be used to identify 
mitotic cells from an asynchronous population (Ajiro et al., 1996). The number of mitotic cells 
were counted and normalized to the unirradiated control. Irradiating cells with 0.25 Gy X-ray 
(which is roughly 10 DSBs in G2) resulted in ~30% of the cycling 1BR hTERT cell population 
arresting in G2 (Figure 6.6). An equivalent dose after Carbon ion irradiation resulted in ~55% of 
cycling 48BR primary cells arresting in G2. The same dose after both horizontal and vertical Fe 
ion irradiation resulted in roughly 90% of the cycling 1BR hTERT cell population arresting in G2, 
with only 10% of cells still progressing into mitosis. Of note, quantification of the mitotic 
population after horizontal Fe IR was calculated to take into consideration non-hit cells. 
Similarly, after 0.5 Gy IR, ~95% of cells were arrested after heavy ion irradiation, but only 50% 
after X-ray. These results demonstrate that heavy ion induced DNA damage can initiate a 
G2/M checkpoint arrest at lower doses IR compared to X-ray. A mentioned in the introduction, 
equal doses of different types of radiation do not produce equal biological effect. Therefore 
high LET ionizing radiations would be expected to produce greater biological effect than lower 
LET ionizing radiations at equivalent doses.  
 
 
1.40.3 Heavy ion induced DNA damage maintains a prolonged G2/M checkpoint arrest. 
 
1.40.3.1 Horizontal Fe ion irradiation 
 
Having demonstrated that after Fe ion irradiation DSB repair is extremely slow in comparison 
to X-ray in G2 (Figure 6.5), I next wanted to address what impact slow repair kinetics had on 
G2/M checkpoint maintenance. Additionally I wanted to establish how many Fe ion induced 
DSBs were required to maintain G2/M checkpoint arrest. To test this, 1BR hTERT cells were 
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irradiated with either 1 Gy X-ray or 1 Gy horizontal Fe ion irradiation. Prior to IR, cells were 
treated with aphidicolin, a DNA polymerase inhibitor, which prevents S phase cells progressing 
into G2. Every subsequent 24 hours after IR, aphidicolin was re-added to the samples. Cells 
were harvested at indicated time points after IR and immunostained for pH3, CENP-F, γH2AX 
and DAPI. This enabled me to monitor both mitotic index and the number of DSBs remaining at 
each time point. As mentioned earlier, horizontal irradiation doesn’t hit all cells and the 
variation in DNA damage between each cell is large. Therefore when scoring mitotic cells after 
horizontal IR, it was not possible to distinguish between non-hit cycling mitotic cells and hit 
mitotic cells that were released from the G2/M checkpoint. Since non-hit cells remained 
cycling, full checkpoint arrest was not observed after horizontal Fe ion IR (Figure 6.7). To 
establish how many Fe ion induced DSBs/clusters are required to maintain checkpoint arrest I 
scored γH2AX foci in mitotic cells rather than G2 phase cells. This was because if a mitotic cell 
contained γH2AX foci at later time points after IR I could be sure that this cell was a hit G2 
phase cell now released into mitosis. After 16 hours recovery following 1 Gy horizontal Fe IR, 
mitotic cells containing γH2AX foci had on average 7 γH2AX clustered foci (Figure 6.7 & 6.10). 
This resulted indicated that ≥7 clustered γH2AX foci induced after Fe ion irradiation are 
required to maintain G2/M checkpoint arrest. Analysis of the G2 phase cell population 
indicated that after Fe ion irradiation depletion of G2 phase cells is slower than after X-ray 
(Figure 6.7). This result implies that DSB repair is slower after Fe ion irradiation as previously 
shown (Figure 6.4 & Figure 6.5).  
 
 
1.40.3.2 Vertical Fe ion irradiation 
 
To establish whether cells maintain a prolonged checkpoint arrest after heavy ion irradiation, I 
next irradiated vertically with Fe ion. 1BR hTERT cells were irradiated with 1 Gy X-ray or 
vertical Fe ion IR. Prior to irradiation, cells were treated with aphidicolin to prevent S phase 
cells progressing into G2. Cells were fixed at indicated time points after IR and immunostained 
for pH3, CENP-F, γH2AX and DAPI. After vertical Fe ion IR, all cells are hit. Therefore, a full 
checkpoint arrest was observed (Figure 6.8C). Cells irradiated with X-rays began to release 
from the G2/M checkpoint 4 hours after IR, with around ~30% of cells reentering mitosis. Fe 
ion irradiated cells were still completely arrested at the G2/M checkpoint 4 hours after IR.  A 
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full checkpoint release was observed 8 hours after X-ray, implying that the DSB induced DDR 
signaling was below the threshold of 15-25 DSBs. Fe ion irradiated cells emerged from the 
G2/M checkpoint 16 hours post IR; however at this time point only ~30% of cells had started to 
recycle. This result implied that Fe ion induced DSBs maintain a prolonged checkpoint arrest. It 
was also important to establish that at later time points after IR there are still sufficient G2 
phase cells remaining to enter mitosis. Scoring CENP-F positive staining cells (G2 phase marker) 
revealed that the G2 phase population was only marginally reduced after Fe ion irradiation 
compared to X-ray irradiation. This result implied that after Fe ion irradiation some of the DNA 
damage is irreparable and some cells remain permanently arrested (>16 hours). To establish 
how many Fe ions IR induced DSBs were required to maintain arrest, γH2AX foci clusters were 
scored in mitotic cells at 16 and 24 hours after IR. At 16 hours after IR, mitotic cells contained 
on average ≥ 6 clustered γH2AX foci (Figure 6.8 & 6.10). This resulted implied that at least 7 
clustered γH2AX foci are required to maintain G2/M checkpoint arrest after Fe ion irradiation.  
 
 
1.40.3.3 Carbon ion irradiation 
 
I next analyzed G2/M checkpoint arrest after Carbon ion irradiation. 1BR hTERT cells were 
irradiated with 1 Gy X-ray or 1 Gy Carbon ions. Prior to irradiation cells were treated with 
aphidicolin to prevent S phase cells progressing into G2 during analysis. Cells were fixed at 
indicated time points post IR and immunostained for pH3, CENP-F, γH2AX and DAPI. Carbon 
ion irradiated cells remained completely arrested 4 hours after IR, whereas 30% of cells 
irradiated with X-rays had already started to recycle at this time point (Figure 6.9). A staggered 
checkpoint release was observed between 8 and 24 hours after Carbon ion irradiation, 
whereas X-ray irradiated cells were observed to have a sharp peak in checkpoint released cells 
at 8 hours post IR. This staggered release after Carbon ions could reflect different lesions with 
varying complexity repairing at different rates. Around 60% of cells irradiated with Carbon ions 
were able to reenter mitosis which was distinct to only 30% of cells after Fe ion irradiation. 
Carbon ions have a lower LET value compared to Fe ions (See table 6.1). Consequently the DNA 
damage produced after Carbon ions is less complex and expected to be easier to repair. This 
might explain why cells are able to release from the G2/M checkpoint after carbon ions but 
less so after Fe ions. To establish how irradiated cells were progressing through the cell cycle, 
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G1 (CENP-F negative), S (pan-nuclear γH2AX) and G2 (CENP-F positive) cells were scored. From 
this analysis it appeared that cells released from the G2/M checkpoint progressed through G1 
phase slowly (Figure 6.9). Despite NHEJ being a fast repair pathway, slower repair kinetics have 
been observed if the DNA damage is clustered (Nakajima et al., manuscript submitted). To 
establish how many clustered DSBs were required to maintain G2/M checkpoint arrest after 
Carbon IR, γH2AX foci were scored in mitotic cells at 16 and 24 hours post IR. 16 hours after IR, 
mitotic cells contained around 6-7 clustered γH2AX foci (Figure 6.9 & 6.10). This result implied 
that at least 7 Carbon ion clustered γH2AX foci are required to maintain G2/M checkpoint 
arrest.  
 
 
1.41 Discussion 
 
Analysis of DSB repair after heavy ion irradiation has predominantly been monitored by PCC 
analysis, a technique which involves the fusion of mitotic cells with interphase cells. Fusion 
induces the immediate condensation of the interphase chromatin into discrete chromosomes 
resembling compacted mitotic chromosomes. However this technique is limiting because 
physiologically relevant doses of IR cannot be used. Here I have employed a more sensitive 
DSB biomarker, γH2AX, to monitor DSB repair in both G1 and G2 phase of the cell cycle and at 
physiologically relevant doses of IR. As expected the rate of DSB repair was greatly reduced 
after Fe ion IR compared to X-rays in both G1 and G2 (Figure 6.4 & 6.5). Interestingly repair of 
heavy ion induced DSBs in G2 phase was extremely reduced with as little as 10% repair 24 
hours post IR (Figure 6.5). Given that in G2 phase both NHEJ and HR can function to repair 
DSBs and that HR is a slower repair mechanism (Beucher et al., 2009; Shibata et al., 2010), I 
propose that complex clustered DSBs induced by Fe ions are predominantly repaired by HR in 
G2. In line with this, >80% of G2 phase heavy ion induced DSBs have been observed to co-
localize with RPA foci (Jeggo laboratory, unpublished finding). It would be of interest to 
establish whether there is an absolute requirement for heavy ion induced DSBs to be repaired 
by HR in G2 by using a HR deficient cell line. However heavy ion induced DSBs in G1 have 
recently been shown to be predominantly repaired by NHEJ (Nakajima et al, manuscript 
submitted). Therefore if heavy ion induced DSBs do not produce end termini which are 
sufficiently single stranded to mediate RPA binding without the necessity of resection; it is 
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likely that G2 phase heavy ion induced DSBs could be repaired by NHEJ in G2, but this requires 
further consolidation. 
 The activation of ATM has been shown not to strictly correlate with the 
phosphorylation of Chk2 (Buscemi et al., 2004). Fewer DSBs are required to activate ATM than 
Chk2, which was indicative of a threshold of DDR signaling being required to initiate G2/M 
checkpoint arrest. Later it was shown that a threshold of between 15-25 DSBs is required to 
initiate and sustain G2/M checkpoint arrest (Deckbar et al., 2007). Given that heavy ion 
irradiation produces DSBs with increased end complexity and clustering, I wished to address 
whether these complex clustered DSBs would either generate more DDR signaling than a 
typical X-ray induced γH2AX foci or whether the clustering of foci would impede DDR signaling. 
Analysis of cells arresting at the G2/M checkpoint following IR with low doses of heavy ions 
revealed that cells were able to checkpoint arrest at doses as low as 0.25 Gy, whereas after X-
rays, cells do not respond until doses of at least 0.5 Gy (Figure 6.6). This result indicated that 
heavy ion induced DSBs are able to signal sufficiently to activate a full DDR which is capable of 
activating a full checkpoint arrest. Therefore DSBs in close proximity (clusters) can still 
proficiently signal to the checkpoint machinery and fewer clustered γH2AX foci are required to 
initiate checkpoint arrest than compared to individual foci.  
 Maintenance of checkpoint arrest is directly correlated with the rate of DSB repair 
(Shibata et al., 2010). Therefore a greater persistence of a fraction of DSBs after exposure to 
high LET radiation would be expected to maintain a prolonged G2/M checkpoint arrest. Indeed 
analysis of G2/M checkpoint release showed that after heavy ion IR, irradiated cells were 
arrested for at least a further 2 hours compared to X-rays (Figure 6.7, 6.8, & 6.9). After Fe ion 
irradiation only ~30% of cells enter mitosis before 8 hours, whereas 100% of cells enter after X-
ray (Figure 6.8). The difference in checkpoint release between Fe ions and X-rays could be 
explained by the different LET values between the two types of IR.  The high LET value of Fe 
ions means DSBs induced are highly clustered and are likely to be difficult to repair. It has been 
suggested that clustered DSBs could be resistant to processing by glycosylases or 
endonucleases, as shown for synthetic oligonucleotides containing clusters of specific 
compositions or configurations (Lomax et al., 2004). Repair resistant clusters could persist for a 
substantial time after IR (Tsao et al., 2007). The greater persistence of a fraction of DSBs after 
exposure to high LET radiation is likely related to their increased complexity. Carbon ion 
irradiated cells also maintained checkpoint arrest for a further 2 hours more than cells 
irradiated with X-rays. When cells were released 8 hours after IR with Carbon ions, up to 60% 
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of cells were capable of reentering mitosis, which contrasted to only 30% of cells after Fe ions. 
This result likely reflects differences in energy deposition (LET) between Carbon and Fe ions. Fe 
ions deposit nearly twice as much energy per unit track compared to Carbon ions. Therefore 
DSBs induced after Fe ions would be expected to be more complex and clustered than Carbon 
ion induced DSBs. Therefore repair of Fe ion induced DSBs would be expected to be less 
efficient compared to Carbon and therefore checkpoint arrest maintained for longer. As 
mentioned previously, 15-25 DSBs are required to maintain checkpoint arrest after low LET 
radiations such as γ rays or X-rays. After higher LET radiation around 7 clustered DSBs were 
required to maintain G2/M checkpoint arrest (Figure 6.7, 6.8, & 6.9). On average each 
clustered DSB contains ~5 γH2AX foci 16 hours after IR with heavy ions. Therefore 7 clustered 
DSBs at 16 hours after IR would be expected to contain 35 single γH2AX foci. Therefore in 
consideration of individual foci, single γH2AX foci are able to activate the DDR more sufficiently 
than compared to clustered foci to maintain G2/M checkpoint arrest. Clinically this is very 
important because cells still manifesting up to 7 clustered DSBs can be released from the G2/M 
checkpoint and progress into mitosis. In conclusion, heavy ion induced DSBs are repaired with 
slow kinetics which is related to their increased complexity. These DSBs maintain a prolonged 
G2/M checkpoint arrest and some cells with irreparable DSBs remain arrest for more than 96 
hours after IR. Therefore the duration of G2/M checkpoint arrest increases with increasing LET 
values.  
 
 
1.41.1 Implications for heavy ion radiotherapy 
 
Late effects of high LET are arguably a health risk for both space exploration and cancer 
patients undergoing heavy ion radiotherapy. Unrepaired DNA lesions such as those observed 
in response to Fe ions, would presumably result in persistent DNA damage signaling 
culminating in senescence and apoptosis, both processes constituting both bone fide barriers 
to carcinogenesis (Bartkova et al., 2006). One interesting point is whether cells in senescence 
evade cell death by remaining arrested, then at later times after IR re-enter G1 phase and 
begin recycling. This is of particular importance when considering whether senescent cancer 
cells can re-enter the cell cycle after radiotherapy. A recycling cancer stem cell which evaded 
death would then be able to repopulate a cancer tumor cell population thereby re-establishing 
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the cancer. Also a senescent cell population has the ability to alter its microenvironment 
through paracrine signaling (Ewald et al., 2008). These secretions can alter and adapt 
neighboring cells inducing them to divide. This has the potential to stimulate un-regulated cell 
growth and ultimately cancer. Therefore cells manifesting irreparable heavy ion induced 
clustered DSBs, have the potential to enter senescence and at a later time induce cellular 
changes which could lead to cancer.  
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Discussion  
 
1.42 Major aims 
 
Whilst the majority of DSB repair is ATM dependent, a subset of slow repairing DSBs, 
representing those located at regions of heterochromatin require ATM and the mediator 
proteins (Goodarzi et al., 2008; Riballo et al., 2004). Heterochromatin poses a barrier to DSB 
repair which is now known to be relieved by ATM dependent phosphorylation of the 
heterochromatin building factor KAP-1 (Goodarzi et al., 2008). This process requires the 
tethering of ATM at the DSB via a 53BP1-dependent process to achieve localized and 
concentrated KAP-1 phosphorylation (Noon et al., 2010). Chromatin configuration has been 
demonstrated to also affect the magnitude of DDR signalling. Previous studies have shown that 
an overall reduction in chromatin structure following depletion of the linker histone H1 
enhances the strength of the DDR (Murga et al., 2007). However the effect of HC 
superstructure specifically on DDR signalling has yet to be investigated. This is of particular 
importance because human syndromes exist which have disordered heterochromatin.  One 
major aim of my thesis was to investigate how HC influences damage response signalling 
focussing on the impact of disordered HC found in human syndromes.  
 The fraction of DSBs that remain unrepaired in the absence of ATM also require the 
endonuclease Artemis. This initial model proposed that a requirement for Artemis correlated 
with damage end complexity (Riballo et al., 2004). However, induction of more complex DSBs 
such as those after Carbon-K X-rays did not increase the dependency for Artemis in DSB repair 
(Goodarzi et al., 2008). My next aim was to establish whether like ATM, Artemis dependent 
DSBs are those which reside within HC. 
 Arrest of the cell cycle at the G2/M checkpoint following DNA damage infliction is a 
fundamental endpoint for ATM signalling. A threshold of ATM signalling has been defined 
whereby 10-25 DSBs are required to initiate and sustain checkpoint arrest (Deckbar et al., 
2007). From the results obtained in chapter 3 and 4 it became apparent that under conditions 
where the cellular HC content was reduced, the DDR amalgamating from each DSB was 
enhanced and consequently the G2/M checkpoint could be arrested when less than the 
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previously established threshold of DSBs were present.  My next aim was to establish what 
affect increased damage complexity has on G2/M checkpoint arrest. To address this question 
cells were irradiated with Carbon and Iron heavy ions at the NIRS in Chiba, Japan.  
 
1.43 The impact of higher order chromatin structure on ATM signalling and G2/M 
checkpoint arrest. 
1.43.1 Major conclusions 
 Reducing the HC content of a cell by knocking down either: KAP-1, DNMT3B or MeCP2 
enhances the rate and size of IR induced γH2AX foci formation at regions of HC. 
 ATM signalling is hyperactive in cells deficient for MeCP2 and DNMT3B after IR. 
 MeCP2 and DNMT3B deficient cells are capable of initiating a G2/M checkpoint arrest 
after low doses of IR, which in wildtype cells are insufficient to meet the threshold of 
DDR signalling normally required to initiate checkpoint arrest.  
 Despite responding to DSBs hyperactively, MeCP2 and DNMT3B deficient cells repair 
DSBs with normal kinetics. 
 Like KAP-1 mediated HC relaxation, MeCP2 and DNMT3B knockdown can overcome 
the requirement for ATM in DSB repair.  
 Cells deficient for HC associated factors: MeCP2, DNMT3B or Lamin A, maintain a 
prolonged G2/M checkpoint arrest. 
 Chk1 phosphorylation is hyperactive in MeCP2 deficient cells. 
 The signal intensity for RPA foci is enhanced in MeCP2 deficient cells.  
 
1.43.2 ATM dependent DDR in the context of reduced HC organization 
1.43.3 γH2AX foci expansion and DDR signalling 
 
In chapters 3 and 4, I demonstrated that by reducing the HC content of a cell the IR induced 
ATM dependent response to a DSB can be amplified, resulting in greater encroachment of 
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γH2AX foci into HC regions, faster γH2AX foci formation at HC associated DSBs and a 
hypersensitive and prolonged G2/M checkpoint arrest. I have shown that HC relaxation also 
results in increased ATM, Chk2 and Chk1 activation, indicating that by relieving the HC 
superstructure, IR induced signalling can be enhanced. Importantly DSB repair as monitored by 
γH2AX foci analysis was normal in HC relaxed cells. Therefore amplified DDR signalling could be 
not be accounted for by defective DSB repair.  In a HC relieved cell one could envision that 
firstly γH2AX is phosphorylated by ATM. MRN is recruited to γH2AX. Nbs1 binds and 53BP1 
indirectly tethers ATM (Noon et al., 2010) at the site of a DSB, resulting in an auto-activatory 
loop of recruitment and tethering. γH2AX expansion can then spread over megabases at HC 
regions. As a result, ATM can phosphorylate and activate more Chk2 at the site of a DSB. 
Therefore, increased foci expansion would lead to increased amounts of pATM localized at 
DSBs and in turn elevated levels of pChk2. This leads to a more efficient G2/M checkpoint 
arrest. This can also be applied to checkpoint maintenance, where ATM at the site of a DSB 
maintains Chk2 phosphorylation. Therefore HC relaxation not only facilitates repair (Riballo et 
al., 2004), but also assists optimal signalling from these breaks to enhance foci expansion 
(Figure 7.1).  
 Loss of HDAC 1 and 2 has previously been demonstrated to result in a hyperactive 
response to IR induced DSBs (Miller et al., 2010). γH2AX signalling is also enhanced as 
monitored by western blot in HDAC inhibited cells. Chk1, Chk2 and p53 are likewise increased 
and sustained for longer in HDAC1 and 2 depleted cells. However, analysis of DSB repair in 
these cells either by monitoring rejoining of a linearized plasmid or by the neutral comet assay 
revealed that DSB repair, particularly NHEJ, was reduced in HDAC1 and 2 knockdown cells 
(Miller et al., 2010). GFP-Ku70 and GFP-Art localized to sites of microirradiation for longer in 
HDAC inhibited cells (Miller et al., 2010). However this result could fit with chromatin 
remodelling signalling the end of DSB repair rather than the completion of repair (Polo et al., 
2006). Another difference between the results observed with MeCP2 loss and HDAC1/2 loss is 
that HDAC1/2 cells have a reduced survival rate after IR (Miller et al., 2010), whereas MeCP2 
deficient Rett syndrome cells have normal survival after IR. Given that survival after IR is 
reflective of DSB repair capacity, it is likely that MeCP2, unlike HDAC1/2, does not have a direct 
role in DSB repair.  
 CHD4 (Chromodomain helicase DNA-binding protein 4) is an ATPase chromatin 
remodelling protein that complexes with the NuRD complex and is involved in chromatin 
remodelling. Knockdown of CHD4 results in an increase of γH2AX as monitored by WB and a 
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prolonged checkpoint arrest after IR (Polo et al., 2010). CHD4 knockdown cells accumulate p21 
in unstressed conditions. IR induced p21 induction was p53 dependent, and was more robust 
and occurred earlier in CHD4 cells (Larsen et al., 2010). Importantly Rett cells express normal 
p53 levels, therefore hyperactive checkpoint responses in Rett syndrome cells is unlikely to be 
a result of endogenously active p53. Larsen et al, 2010, reported an increased level of DSBs in 
CHD4 deficient cells immediately after IR when monitoring damage by PFGE. The authors 
suggest that HC relaxation following CHD4 loss may result in a chromatin configuration which 
is more susceptible to IR. Analysis of DSBs by γH2AX foci analysis in KAP-1, MeCP2 and 
DNMT3B knockdown cells revealed that γH2AX foci form with faster kinetics in these cells but 
that the number of DSBs induced was similar between knockdown and control cells. 
Discrepancies between these results may perhaps be a consequence of different assays being 
used to monitor DSB induction. Here, I have used γH2AX analysis, which is a more sensitive 
assay compared to PFGE that can be used at lower and more physiologically relevant doses of 
IR. Nonetheless, CHD4 loss might have a greater impact on chromatin configuration than 
compared to KAP-1, MeCP2 or DNMT3B loss, and therefore could make chromatin more 
amenable to DNA damage.  
 DNA damage complexity and chromatin complexity affect speed of DSB repair, and 
slowly repairing DSBs undergo resection in G2 (Shibata et al., 2011). After exposure to X-rays, 
in both G1 and G2 phase, DSB repair proceeds with a fast and slow component. The fast 
component in G1 represents DSBs which reside within EC regions being repaired by core NHEJ 
factors. The slow component in G1 represents DSBs that reside within HC which require ATM, 
Artemis and the mediator proteins, in addition to the core NHEJ factors. In G2, fast repairing 
DSBs are repaired by NHEJ, and slow component represents repair of HC associated DSBs by 
HR, which requires resection (Beucher et al., 2009; Shibata et al., 2010). In G2 phase cells, 
knockdown of CIP does not affect DSB repair kinetics at 0.5 and 2 hours after IR. However DSB 
repair kinetics at later time points after IR (between 4 and 8 hours) is, surprisingly, accelerated 
in comparison to control cells (Shibata et al., 2011). This result suggested that by eliminating 
resection DSB repair is channelled through the faster NHEJ pathway (Shibata et al., 2011). Thus, 
by preventing resection, which normally occurs at HC regions, repair can be accelerated. From 
this result, it might be expected that the requirement for resection would be removed in a HC 
reduced cell because DSBs would be expected to be more accessible and hence faster to repair. 
Importantly, in the Rett syndrome cells in G2 phase, I observed an enhanced RPA response. 
This suggests that at HC, even if the time dependent barrier is removed, DSBs at these regions 
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still undergo resection, suggesting that the same component of the HC barrier remains. 
Further analysis is required to understand the impact of chromatin structure on resection 
 It is unclear whether the overall density of compaction or some fine detail of histone 
positioning is inhibitory to repair and signalling. Other NuRD complex components such as 
CHD4/Mi-2β and HDAC1/2 have been observed to be recruited to laser track induced lesions at 
early times (< 15 minutes) and promote re-joining of rapidly repairing lesions. Therefore the 
remodelling capabilities of these factors are not solely required for the repair of slow repairing 
HC associated DSBs (Murga et al., 2007; Polo et al., 2006; Riballo et al., 2004). It is possible to 
speculate that non HC regions may require tightening or additionally nucleosomes may require 
modification before repair can occur at some or all EC DSBs. Nucleosomes have been shown to 
act as a barrier to Ku sliding on DNA (Roberts and Ramsden, 2007). It has been suggested that 
HDAC1 and 2 may restrain unproductive Ku sliding to promote NHEJ (Miller et al., 2010). 
Therefore a certain chromatin configuration may be required for DSB repair not solely a 
relaxed one.  
 
1.43.4 The effect of HC protein loss on gene transcription 
 
The impact of heterochromatin relaxation on transcription remains unclear. p53 cell cycle 
regulation and apoptosis have been shown to be regulated by KAP-1 SUMOylation (Li et al., 
2007). KAP-1 SUMOylation is important for recruitment of silencing complex NuRD and the 
SETDB1 HMT (Ivanov et al., 2007). ATM mediated phosphorylation of KAP-1 on Ser824 is able 
to inhibit KAP-1 SUMOylation. SUMOylated KAP-1 decreases H3-K9 and H3-K14 Ac and 
increases H3-K9 methylation at the p21 promoter. KAP-1 binding motifs have been found at a 
number of genes including gadd45α, bax, puma and noxa (Elkon et al., 2003; Zheng et al., 
2000), which are involved in cell cycle regulation and apoptosis. However the on-going 
requirement for 53BP1 and ATM for HC DSB repair (Noon et al., 2010) suggests that the HC 
superstructure is not completely abolished and HC associated markers such as tri-methylation 
remain relatively unchanged Furthermore gross changes to the HC superstructure, KAP-1 
mobility or in vivo association with nucleosomes are not evident after IR (Goodarzi et al., 2008; 
Noon et al., 2010; Ziv et al., 2006). Although these studies do not preclude a highly localized 
effect below the threshold of detection by these techniques, it seems unlikely that KAP-1 
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containing HC becomes completely dismantled after ATM phosphorylation. It is more likely 
that KAP-1 dependent remodelling is sufficient for DSB repair but not adequate to invoke 
expression of KAP-1 dependent genes. Transcriptional regulation of proteins involved in cell 
cycle progression, such as p21, by KAP-1 might offer an evolutionary advantage to survival, 
given that KAP-1 associated DSBs take longer to repair, and therefore require longer 
checkpoint arrest. Hence, KAP-1 dissociation from a DSB might dictate the length of checkpoint 
arrest.  
 The role of DNMT3B in transcriptional regulation is also unclear as previous studies 
have failed to separate the function of DNMT3B from DNMT31. Previously, depletion of 
DNMT1 and 3B has been shown to increase transcription of cyclin B2 (Tschop and Engeland, 
2007). Cyclin B acts as a central regulator during the G2/M transition of the cell cycle. The 
down regulation of cell cycle regulators CDC25C and CDK2 after DNA damage in DNMT1-null or 
DNMT1 or 3B null cells is diminished (Le Gac et al., 2006). Zebularine, a drug that selectively 
traps and depletes nuclear DNMT1 and 3B, relieves p53 mediated repression of endogenous 
CDC25C and CDK2 (Le Gac et al., 2006). These results suggest that DNMT3B and or DNMT31 
have a regulatory role in turning the G2/M checkpoint off. IP experiments have shown that 
DNMT1, p53 H3K9me2 and HDAC1 are associated at the CDC25C and CDK2 promoters (Tschop 
and Engeland, 2007). Therefore it is likely that DNMT31, rather than DNMT3B has a more 
central role in regulating this promoter. Further work is required to determine the impact of 
KAP-1, MeCP2 and DNMT3B loss on protein expression profiles. 
 
1.43.5 Implications 
 
Rett syndrome is an X-linked neurological disorder which results from mutations in the MeCP2 
gene. Patients typically develop normally until two years of age, thereafter learned skills such 
as speech and purposeful hand-movements begin to regress. The neurological defects 
associated with Rett syndrome likely reflect disordered expression of neuronal specific genes 
as a consequence of MeCP2 loss. MeCP2 controls expression of several genes involved in 
neuron maturation including brain derived neurotrophic factor (BDNF) (Chen et al., 2003). 
BDNF is essential for neural plasticity, learning and memory. Following membrane 
depolarization, calcium ions influx resulting in MeCP2 phosphorylation and release from BDNF 
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promoter region. As a consequence, BDNF expression is transcriptionally up-regulated (Chen et 
al., 2003). MeCP2 also functions to regulate distal-less homeobox 5 (DLX5) expression. DLX5 is 
an important imprinted gene that regulates the production of enzymes that synthesize GABA 
(γ-aminobutyric acid). GABA is a mammalian neurotransmitter which controls neuron 
excitability and muscle contraction (Watanabe et al., 2002). DLX5 expression was found to be 
five times greater in MeCP2 null mice. Similarly, DLX5 imprinting in Rett syndrome 
lymphocytes is lost (Horike, 2005; Horike et al., 2005). Rett syndrome patients have no 
increased incidence of cancer. This could possibly be attributable to hypersensitive DNA 
damage detection which enables G2/M checkpoint arrest to be initiated when less than 20 
DSBs are present. Excessive signalling during brain development in response to oxidative stress 
could potentially interfere with normal brain development. Irregular chromatin organization 
could account for some of the brain defects associated with Rett and ICF syndrome.   
 ICF syndrome is a rare autosomal recessive disease characterized by facial 
dysmorphism, immunodeficiency and irregular centromeric satellite DNA at chromosomes 1, 9 
and 16. Immunodeficiency associated with ICF syndrome results after translocations involving 
chromosome 14, 15 and/or 16 which encode for the human immunoglobin V(D)J segments. In 
particular translocations often involve chromosome 16 which is disorganized at the 
centromeric regions in ICF patients as a result of DNMT3B loss. ICF syndrome patients have an 
increased incidence of cancer, which could be attributable to DNMT3B being involved in 
centromere chromatin organization, consequently ICF patients have irregular centromeres 
which makes chromosomal segregation during mitosis prone to error. This leads to genomic 
instability and chromosomal fragmentation eventually leading to cancer.  
 
1.44 The role of Artemis in DSB repair 
1.44.1 Major conclusions 
 DSBs dependent on Artemis for repair are visibly associated with DAPI dense 
chromocentres and co-localize with HC associated repair foci such as pKAP-1 foci. 
 Artemis dependent breaks reside at regions of HC enriched for TriMeK9 histone H3.  
 The dissociation of KAP-1 from chromatin following IR is prolonged in Artemis deficient 
cells. 
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 The dependency for Artemis in DSB repair cannot be overcome by KAP-1 or HDAC1/2 
knockdown. 
 
1.44.2 Artemis dependent DSBs reside within regions of heterochromatin 
 
ATM and Artemis are required for the repair of a subset of IR induced DSBs (Goodarzi et al., 
2008; Riballo et al., 2004). This subcomponent of DSB repair is repaired with slow kinetics and 
earlier studies suggested that DSB complexity determines the speed of repair. However this 
model was not consolidated by further studies examining the repair of DSBs with varying end 
complexities. For example the repair of DSBs induced by neocarzinostatin (NCS), a drug which 
produces a homogeneous population of relatively simple DSBs, were repaired with similar 
kinetics as IR induced DSBs (Goodarzi et al., 2008). This advocated for an alternative model and, 
given that ATM dependent DSBs have been shown to reside with HC (Goodarzi et al., 2008), it 
was proposed that chromatin complexity rather than damage complexity might influence DSB 
repair kinetics. In chapter 5, I demonstrated that DSBs persisting in Artemis deficient cells also 
localize to regions of HC. However in contrast to ATM, loss of Artemis has no effect on the 
induction or localization of pKAP-1. Depletion of HC associated factors such as KAP-1 or HDAC 
1/2 did not rescue the Artemis dependent DSB repair defect, suggesting that Artemis does not 
function like ATM to mediate HC relaxation and is likely to function downstream of this process. 
This model is consistent with Artemis functioning as an endonuclease on DSB termini. Given 
that heterochromatic DNA is often highly repetitious with complex secondary structures (Yunis 
et al., 1971), it is conceivable that Artemis which functions to remove hairpins during V(D)J 
recombination, may also operate at HC to remove complex secondary structures which are 
refractory to repair. However the precise role of Artemis in DSB repair is still unclear and 
requires further investigation.  
 KAP-1 phosphorylation has been demonstrated to increase the accessibility of MNase 
digestibility, and this accessibility is dependent on ATM (Ziv et al., 2006). I have demonstrated 
that in Artemis defective cells KAP-1 remains dissociated from HC enriched chromatin fractions 
for longer after IR. This result suggests that chromatin surrounding an Artemis dependent DSB 
remains relaxed for longer. Therefore despite Artemis and ATM harbouring an identical repair 
defect, the nature of the chromatin alterations surrounding these DSBs is distinct. What affect 
prolonged relaxation at Artemis dependent DSBs has on transcription is unclear, but KAP-1 has 
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been suggested to function as a transcriptional repressor for some HC associated genes (Li et 
al., 2007). 
 The examination of Artemis’s function is clinically valuable since patients display 
severe combined immunodeficiency (SCID) (Moshous et al., 2001). Despite this phenotype 
patients can survive into adulthood following bone marrow transplantation (Neven et al., 
2009).   
 
1.45 Heavy ion irradiation and checkpoint arrest 
1.45.1 Major conclusions 
 Heavy ion induced DSBs are repaired with slower kinetics than X-ray induced DSBs, 
particularly in G2 phase.  
 Single heavy ion tracks can induce a G2/M checkpoint arrest. 
 Heavy ion induced DSBs maintain a prolonged G2/M checkpoint arrest. 
 DDR signalling from 7 heavy ion induced DSBs/clusters is sufficient to maintain G2/M 
checkpoint arrest.  
 
In chapter 6, I have demonstrated that DSB repair after heavy ion irradiation is extremely 
slowed, in particular in G2 phase, where as little as 10% DSB repair is observed 24 hours after 
IR. In G2 phase two pathways of DSB repair exist, one with fast kinetics involving NHEJ the 
other with slow kinetics involving HR proteins, ATM and Artemis (Beucher et al., 2009; Shibata 
et al., 2010). The slower repair kinetics in G2 after heavy ion IR would suggest that complex 
clustered lesions are repaired by HR in G2. After X-rays, a threshold of 15-25 DSBs is required 
to initiate and sustain G2/M checkpoint arrest (Deckbar et al., 2007). Heavy ion induced DNA 
damage produces DSBs that are in close proximity (clusters). I have shown that signalling from 
these clusters is sufficient to initiate a G2/M checkpoint arrest. High resolution imaging after 
vertical IR suggests that a single cluster/track is sufficient to induce checkpoint arrest 
(Nakajima et al., manuscript submitted). Therefore clustered DSBs are able to proficiently 
signal to the checkpoint machinery and fewer clustered γH2AX foci are required compared to 
individual foci to satisfy arrest. The duration of DSB repair dictates the length of checkpoint 
arrest (Shibata et al., 2010). As expected, after heavy ion irradiation G2/M checkpoint arrest 
159 
 
was maintained for at least a further 4 hours compared to X-ray treated cells. Cells released 
from the checkpoint were found to still manifest ~7 clustered γH2AX foci. Therefore cells can 
enter mitosis while harbouring DNA damage induced after heavy ion irradiation.  
 Previously nearly 100% of carbon ion induced DSBs have been shown co-localize with 
RPA, whereas only 20-30% of X-ray induced DSBs undergo resection (Shibata et al., 2011). The 
speed of DSB repair correlates with DSB end resection (Shibata et al, 2011). As mentioned 
earlier, in G2 phase CtIP KD cells, normal repair kinetics are observed 0.5 and 2 hours after IR, 
but at later times after IR (between 4 and 8 hours) DSB repair proceeds with faster repair 
kinetics compared to control cells (Shibata et al., 2011). This result suggested that by 
preventing resection DSB repair is channelled through the faster NHEJ pathway. However 
BRCA2 siRNA treated cells still maintain a DSB repair defect. CtIP knockdown alleviates the 
BRCA2 dependent repair defect in G2. Therefore in the absence of resection all DSBs can be 
repaired by NHEJ. Given that HR is associated with the repair of complex DSBs which normally 
require resection to mediate end ligation (Shibata et al., 2011); it would be of interest to 
establish whether repair of heavy ion induced DSBs was still possible in BRCA2 and CtIP 
knockdown cells.  
 
1.46 Final summary  
 
To facilitate repair of DSBs residing at regions of HC, ATM is required to mediate relaxation by 
phosphorylating the C-terminus of KAP-1 at Ser824 (Goodarzi et al., 2008). This posed the 
question as to whether HC also acts as a barrier to IR induced γH2AX expansion particularly at 
HC associated DSBs. The work presented here has demonstrated that by reducing the HC 
content of a cell by removing KAP-1, MeCP2 or DNMT3B, the expansion of γH2AX can be 
enhanced. DDR signalling including ATM and Chk2 is also heightened in these cellular contexts, 
which is reflected in a hypersensitive and prolonged G2/M checkpoint arrest. Therefore HC 
relaxation not only facilitates repair of HC associated DSBs, but also assists in optimal signalling 
from these breaks. Artemis and ATM are both required for repair of a subset of slow repairing 
DSBs in G1. Here I have demonstrated that like ATM, Artemis is required for repair of HC 
associated DSBs. However, unlike ATM, Artemis is likely to function downstream of the process 
of HC relaxation.  In G1, chromatin complexity rather than damage complexity confers a 
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slowing on DSB repair kinetics. In G2, both NHEJ and HR can repair DSBs. Slow repairing DSBs 
in G2 represent those which reside within HC being repaired by HR. I have presented work 
here which demonstrates that heavy ion induced DSBs are repaired with extremely slow 
kinetics, particularly in G2 phase, suggesting that complex DSBs are also repaired by HR despite 
not necessarily being HC associated. Heavy ion induced DSBs are produced in close proximity 
and produce clustered γH2AX foci. I have demonstrated that the DDR signalling emanating 
from these clusters is sufficient to mediate checkpoint arrest at lower doses IR compared to X-
ray. Importantly cells can enter mitosis still manifesting up to 7 clustered heavy ion induced 
γH2AX foci.  
 Overall G2/M checkpoint arrest can be initiated and prolonged at lower dose IR when 
either the chromatin content of a cell is reduced or when the clustering of damage increases 
(i.e. the rate of repair prolonged as a result of increased damage complexity). In relation to 
DSB repair, the kinetics γH2AX formation can be enhanced in HC reduced cells, and the 
duration of DNA repair prolonged with increasing damage complexity.  
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Abstract  
Heterochromatin (HC) poses a barrier to H2AX foci expansion and DNA double strand break 
(DSB) repair, the latter being relieved by ATM-dependent KAP-1 phosphorylation. Using high 
resolution imaging, we show that the HC superstructure markedly restricts ATM signalling to 
cell cycle checkpoint proteins. The impact of HC is greater than anticipated from the 
percentage of HC-DNA and, in distinction to DSB repair, ATM only partly overcomes the 
constraints posed by HC. Importantly, we examine ATM signalling in human syndromes with 
disordered HC. Following depletion of MeCP2 and DNMT3B, proteins defective in Rett and 
Immunodeficiency with Centromere instability and Facial anomalies (ICF) Syndromes, 
respectively, we demonstrate enhanced H2AX signal expansion at HC-chromocentres in 
mouse NIH3T3 cells, which have visible HC-chromocentres. Previous studies have shown that 
the G2/M checkpoint is inefficient requiring multiple DSBs to initiate arrest. MeCP2 and 
DNMT3B depletion leads to hypersensitive radiation-induced G2/M checkpoint arrest despite 
normal DSB repair. Cell lines from Rett, ICF and Hutchinson Guildford Progeria Syndrome 
patients similarly showed hyperactivated ATM signalling, hypersensitive and prolonged G2/M 
checkpoint arrest. Collectively, these findings reveal that heterochromatin contributes to the 
previously described inefficient G2/M checkpoint arrest and demonstrate how the signalling 
response can be uncoupled from DSB repair.  
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Introduction 
The DNA damage response (DDR) to the presence of DNA double strand breaks (DSBs) 
encompasses pathways of DSB repair and a signal transduction response that includes the 
activation of cell cycle checkpoint arrest and/or apoptosis. ATM-dependent signalling is the 
most significant signal transduction pathway activated by DSBs (19). An early step in the 
signalling pathway is the phosphorylation of H2AX, a step that can be affected by either ATM 
or DNA-PKcs. The damage response mediator proteins, MDC1, RNF8, RNF168 and 53BP1, 
localise to the DSB generating irradiation-induced foci (IRIF) (25-26, 34). The precise function 
of IRIF remains unclear; cells lacking IRIF activate checkpoint arrest normally except at low 
doses where IRIF appear to function to amplify the signal. Most DSB repair occurs 
independently of ATM signalling but, critically, a subset of DSBs requires ATM and IRIF proteins 
for their repair (15, 28).  
 Over the past few years, a range of studies have demonstrated that chromatin 
structure exerts a significant impact on the DDR. For example histone H1 restricts DDR signal 
amplification and reduced H1 levels confer hypersensitive G2/M checkpoint arrest (23). This 
study provided initial evidence that the size of H2AX foci determines the magnitude of the 
ATM signal and the sensitivity of G2/M checkpoint arrest. Additionally, studies have shown 
that both transcription and higher order chromatin structure can impact upon the expansion 
of H2AX foci (8, 15, 17-18). Of relevance to this work, it has been shown that H2AX foci 
expansion is restricted by heterochromatin (HC) and that IRIF expand on the periphery rather 
than within HC regions (8, 15, 18). Further, despite the expansion of IRIF at the HC periphery, 
ATM-dependent signalling is required for the repair of HC-DSBs in contrast to DSBs located 
within euchromatic (EC) regions. Such repair requires ATM-dependent phosphorylation of the 
HC building factor, Kruppel-associated box (KRAB)-associated protein-1 (KAP-1) (24). Thus, the 
sub-set of DSBs that specifically require ATM for repair represent HC-DSBs. Interestingly, 
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recent findings have also shown the HC restricts DSB repair by homologous recombination in 
Drosophila, although there are differences to the situation in mammalian cells (7). Firstly, HC-
DSB repair in Drosophila is predominantly ATR-dependent. Further, the phosphorylation site 
on KAP-1 does not appear to be conserved in Drosophila. Thus, whilst HC represents a barrier 
to repair in both organisms, the way of overcoming this may differ to some extent. In 
mammalian cells, although H2AX foci do not expand within the centre of densely staining 
DAPI-chromocentres, they appear to expand normally at their periphery albeit with restricted 
encroachment into the HC superstructure. Indeed, no difference in the size of H2AX foci at EC 
and HC DSBs is apparent or has been reported. Thus, although ATM-dependent KAP-1 
phosphorylation is required to enable repair of HC-DSBs, it is unclear whether the HC 
superstructure actually impacts upon ATM signalling to the checkpoint machinery.  
G2/M checkpoint arrest, a crucial endpoint of ATM signalling, co-ordinates DSB 
formation and repair with cell cycle progression. The G2/M checkpoint has a defined sensitivity 
and as a consequence is not activated by low radiation doses (10, 13). The same concept also 
results in the release of cells from checkpoint arrest prior to completion of DSB repair. The 
magnitude of ATM signalling and the impact on the initiation and maintenance of checkpoint 
arrest is thus responsive to the progress of DSB repair; hence defects that impair DSB repair 
result in prolonged ATM signalling and checkpoint arrest. The recent analysis of factors that 
influence chromatin modifications such as HDAC1/2 and CHD4 have shown that they can 
impact upon both DSB repair and signal expansion with enhanced signalling likely being a 
consequence of impaired DSB repair (22, 27). In the first part of this study, we examine 
whether HC superstructure modulates the magnitude of ATM signalling to cell cycle checkpoint 
arrest. In contrast to the situation above where DSB repair is impaired, we examine situations 
where the rate of DSB repair is unperturbed. We observed that depletion of factors required 
for the building of the HC superstructure confers enhanced ATM signal expansion at HC-DSBs 
compared to that arising at EC-DSBs. Unexpectedly, this resulted in hypersensitive and 
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prolonged G2/M checkpoint arrest. These findings provide the first evidence that HC 
superstructure exerts a significant impact upon checkpoint arrest independently of any impact 
on DSB repair, uncoupling checkpoint signalling from repair. 
How HC superstructure influences the DDR is important to evaluate, not least because 
the HC content can differ between tissues and cell types. Further, human syndromes with 
disordered HC structure have been reported. These syndromes include Rett Syndrome, which 
harbours mutations in MeCP2, a methyl CpG-binding protein, Immunodeficiency with 
Centromere instability and Facial anomalies (ICF), Syndrome which is mutated in the DNA 
methyl transferase, DNMT3B and Hutchinson Gilford Progeria Syndrome (HGPS), which has 
mutations in Lamin A and displays progressive HC loss (3, 5, 9, 31). The HC superstructure 
involves a self-reinforcing web of histone and DNA modifications constructed with additional 
factors or complexes that have chromatin remodelling activity. KAP-1 functions as a scaffold 
protein and targets the KRAB-ZFP superfamily, thereby co-ordinating histone methylation and 
the deposition of HP1 (4). Methylation at CpG islands contributes to gene silencing due, in part, 
to the recruitment of methyl-CpG-binding protein 2 (MeCP2) (33), which interacts with 
HDAC1/2 and additional co-repressor proteins (1). MeCP2 also directly interacts with HP1 (2).  
In the second part of our study, we examine whether disordered HC in patient cells impacts 
upon ATM signalling to cell cycle checkpoint arrest. Importantly, in these syndromes, the rate 
of DSB repair is identical to that observed in control, although the requirement for ATM is 
partly overcome. Strikingly, despite a normal rate of DSB repair in these syndrome cells, we 
observe hypersensitive and prolonged G2/M checkpoint arrest. Our findings show that HC 
exerts a substantial impact on the magnitude of ATM signalling and contributes to the 
previously described inefficient G2/M checkpoint response.  
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Materials and methods 
Cell culture, drug treatment and irradiation 
48BR (wild type) and GM16548, GM11271 and GM11272 (Rett/MeCP2) primary human 
fibroblasts, 1BR hTERT and PT3 (ICF/DNMT3B) hTERT cells were cultured in DMEM with 15% 
FCS. GM02188 (wild type), GM16548 (Rett/MeCP2), GM08714 (ICF/DNMT3B) and AG10801 
(HGPS/Lamin A) are lymphoblastoid cell lines (LBLs) and were cultured in RPMI with 10% FCS. 
NIH 3T3, MEFs and A549 cells were cultured in MEM with 10% FCS. All culture medium are 
supplemented with L-glutamine, penicillin and streptomycin. 10 μM ATM inhibitor 
(Calbiochem) and 2.5 M Chk1/Chk2 inhibitor, SB218078 (Tocris Bioscience, USA), were added 
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30 min before IR. Cells were irradiated in medium using either a 137Cs gamma-source (dose 
rate, 7.5 Gy/min) or 250 kV X-rays delivered at 12 mA (dose rate, 0.5 Gy/min). 
 
siRNA knockdown and MeCP2 expression 
siRNA transfection of 48BR, 1BR hTERT, A549 and NIH 3T3 cells was undertaken using 
Metafectene Pro (Biotex, Germany) or Hiperfect (Qiagen, Hilden, Germany) according to the 
manufacture’s instructions. Scramble control, mouse MeCP2 and mouse DNMT3B were from 
Dharmacon SMART pool siRNA. Two distinct human MeCP2 and DNMT3B siRNA 
oligonucleotides were obtained from Invitrogen. The sequence of human and mouse KAP-1 
siRNA is as described previously (15). siRNA knockdown was carried out in suspended cells 
after trypsinization. After 24 hr, cells were trypsinized and retransfected with siRNA. Cells were 
incubated for 48 hr after the second transfection prior to analysis. The MeCP2 expressing 
vector (pEGFP-MeCP2) was kindly provided by Dr. Adrian Bird. Wild type (WT) EGFP-MeCP2 
was expressed in Rett LBL cells using GeneJuice (Novagen, MERCK, Germany) according to the 
manufacture’s instructions. To express WT MeCP2 in MeCP2 siRNA cells, three mutations 
within the siRNA target sequence were introduced in MeCP2 cDNA using QuikChangeTM Site-
Directed Mutagenesis Kit (Invitrogen). pEGFP-MeCP2 plasmid was transfected into cells for 6 
hours, 24 hours after siRNA knock down of 1BR hTERT cells. Following incubation at 37 oC for 
16-24 hour, cells were irradiated and analysed. 
 
Immunofluorescence and immunoblotting  
Immunofluorescence and immunoblotting were performed using antibodies against H2AX 
(Upstate Technology, UK), 53BP1 (Bethyl Laboratories, Montgomery, USA), p-histone H3 (p-H3) 
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Ser10 (Upstate Biotechnology, Buckingham, UK), Chk2 pThr68 (Cell signalling technology, 
Beverly, MA, USA), Chk2 (Abcam, Cambridge, UK or Cell signalling technology, Beverly, MA, 
USA), KAP-1 (Abcam, Cambridge, UK), Ku70 (Sata Cruz, CA, USA), ATM pSer1981 (Epitomics, CA, 
USA), ATM (Cell signalling technology, Beverly, MA, USA), ATR (Santa Cruz, CA, USA), Chk1 (Cell 
signalling technology, Beverly, MA, USA), p53 (Santa Cruz, CA, USA), Ku80 (polyclonal rabbit 
antibody), Actin (Abcam, Cambridge, UK) and CENP-F (Abcam, Cambridge, UK). For 
immunofluorescence, cover-slips were visualized using the Zeiss Axioplan microscope and 
simple PCI software. An Applied Precision® DeltaVision® RT Olympus IX70 deconvolution 
microscope and softWoRx® Suite software was used for high resolution and three dimensional 
imaging of deconvolved z-stacks.  
 
Analysis of signal intensity by ImageJ and softWoRx® Suite software 
The signal intensity of FITC and DAPI per H2AX focus was quantified with ImageJ in Fig. 2C and 
4C. In the pChk2 and pATM signal intensity analyses in Fig. 3C and 6D, the untreated nuclear 
intensity was subtracted from the IR induced nuclear signal intensity. The images were taken 
by the Zeiss Axioplan microscope with identical exposure time. The size of H2AX foci at 
chromocentre in Fig. 2E and 4E was quantified with ImageJ after deconvolution with 
softWoRx® Suite software. Quantitative measurements of H2AX and DAPI overlap were 
obtained and visualized as a red signal using softWoRx® Suite software. The size of overlapping 
regions per cell was quantified by ImageJ. The number of chromocentres was analysed and 
showed similar between cell lines (data not shown). The size of overlap per chromocentre was 
normalized following these analyses. The volume of the interior signal was visualized and 
measured by Huygens Professional, Scientific Volume Imaging. Similar to the analysis of 
overlap, the volume per chromocentre was normalized to the number of chromocentres (Fig. 
2F and 4F). 
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H2AX foci and G2/M checkpoint analysis 
DSB repair was monitored by disappearance of H2AX foci (21). G1 and G2 phase cells were 
identified using the cell cycle marker, anti-CENPF in human cells and anti-p-H3 Ser10 in mouse 
cells, respectively (6). S phase cells show a mild CENPF signal whereas G2 cells shows 
substantially greater signal. M phase cells are identified by their morphological changes, i.e. 
condensed chromatin by DAPI. For DSB repair in cycling cells and maintenance of G2/M 
checkpoint analysis, 4 M aphidicolin (APH) was added immediately after IR to block entry of 
irradiated S phase cells into G2 during analysis. Replication in the presence of APH induces 
extensive H2AX signalling, which helps the identification of S phase cells during H2AX foci 
analysis. APH does not impact upon DSB repair and signalling in G1 and G2 phase (6, 21, 30). 
For initiation of G2/M checkpoint analysis, cells were fixed 1 or 2 h after IR, and stained for p-
H3 Ser10 and DAPI. p-H3 Ser10 positive and condensed chromatin cells were counted as 
mitotic index. >400 cells were scored per condition. 
 
Trimethylated K9 of histone H3 IP 
After IR, 5x106 LBL cells were washed with PBS and then with low-salt buffer (LSB) [10 mM 
HEPES [pH 7.4], 25 mM KCl, 10 mM NaCl, 1 mM MgCl2 , 0.1 mM EDTA]. Pelleted cells were 
resuspended in LSB + phosphatase and a protease inhibitor cocktail (Sigma-Aldrich, UK) and 
snap frozen in liquid nitrogen. Cells were quick thawed and immediately centrifuged for 10 min 
at 10,000 rpm. The pellet was resuspended and treated with 100 U/ml MNase in nuclease 
buffer [10 mM HEPES [pH 7.9], 10 mM KCl, 1.0 mM CaCl2 , 1.5 mM MgCl2 , 0.34 M sucrose, 10% 
glycerol, 1 mM DTT, 0.1% [v/v] Triton X-100]. After incubation at 37 oC for 45 min, an equal 
volume of solubilization buffer [nuclease buffer + 2% [v/v] NP-40, 2% [v/v] Triton X-100, 600 
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mM NaCl] was added. Samples were then briefly sonicated and centrifuged at 10,000 rpm for 
10 min. The resulting supernatant, containing solubilized nucleosomes (50 g) was incubated 
with 2 g of ChIP grade -TriMe K9 histone H3 monoclonal antibody (Abcam, Cambridge, UK) 
overnight at 4 oC. Immunocomplexes were pulled down by adding protein G and A-sepharose 
(1:1) for 30 min at 4 oC. Samples were boiled for 3 min before electrophoresis in SDS-PAGE. 
 
Pulsed-field gel electrophoresis (PFGE) 
Cells were exposed to 20 Gy IR and trypsinised at the times indicated, then washed twice with 
PBS and embedded in 0.75% low melting agarose gel plugs (SeaPlaque agarose, Cambrex 
Bioproducts) at a concentration of 0.75 × 105 cells/plug. Plugs were placed in buffer containing 
20 g/ml proteinase K, 0.5 M EDTA, and 1% sarkosyl (pH 9.0) and incubated at 50°C for 24 
hours in the dark. Plugs were washed with 50 mM EDTA at room temperature for 1 hour and 
stored at 4°C. PFGE was carried out using a CHEF Mapper (Bio-Rad), with a cooling module 
(Model 1000 Mini Chiller, Bio-Rad) in 1% agarose gels (Pulsed Field Certified Agarose, Bio-Rad) 
in 0.5 × TBE. The forward and reverse voltage gradients were 5.4 V/cm and 3.6 V/cm, 
respectively for 5 to 60 seconds for a total of 20 h at 14°C. After PFGE, gels were stained with 
ethidium bromide and photographed under UV transillumination. The signal intensity of the 
smear was quantified by ImageJ at each time point and normalized to the intensity at 15 min 
after IR. 
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Results 
KAP-1 depletion enhances the expansion of HC-associated H2AX foci  
Previous studies have shown that H2AX foci do not expand into HC regions and that HC can 
restrict DSB repair (8, 15, 18). siRNA mediated depletion of KAP-1, which is a HC building factor, 
does not affect the rate of DSB repair in control cells but bypasses the requirement for ATM 
(15). Here, we examined how depletion of KAP-1 and other HC factors impact upon H2AX 
signal expansion at HC-DSBs. Firstly, we compared the kinetics of IR-induced H2AX foci 
formation at HC and EC regions using NIH3T3 cells, which have readily visualised dense DAPI 
staining chromocentres that correspond to pericentromeric and centromeric HC (15-16). We 
defined H2AX foci that overlap/juxtapose or do not overlap with chromocentres as HC and EC 
associated foci, respectively (Fig. 1A). To directly compare the speed of foci formation at EC 
versus HC-DSBs, we enumerated H2AX foci up to 20 min post IR when foci numbers become 
maximal (Fig. 1B-D). Significantly, we show that the kinetics of H2AX formation is dose 
independent and occurs more rapidly at EC than at HC-DSBs (Fig. 1E).  
We next examined whether loss of KAP-1 temporally affects the appearance of H2AX 
foci formation after IR. Although KAP-1 siRNA does not significantly change the size or 
structure of chromocentres (data not shown), it specifically enhances the rate of foci 
formation at HC-DSBs (Fig. 2A and B). To assess the size of H2AX foci, we monitored the signal 
intensity at foci of different DAPI signal intensity following control or KAP-1 siRNA at 30 min 
post IR, a time when maximal foci numbers have been reached. We arbitrarily defined regions 
of high and low DAPI signal as representing HC or EC regions. Although an inexact definition, it 
allows the impact of chromatin compaction to be assessed. Initially, we carried out a two-
dimensional analysis of the size of individual foci. In control cells, the foci size at 30 min post IR 
was independent of DAPI signal intensity. Thus, despite their slower rate of formation, foci at 
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HC-DSBs reach a similar size to those at EC-DSBs by 30 mins. KAP-1 siRNA significantly 
increased the H2AX signal intensity at DAPI regions of higher density relative to those of 
lower density, where no significant impact of KAP-1 siRNA was observed (Fig. 2C). Surprisingly, 
the signal intensity at regions of high DAPI signal following KAP-1 depletion was greater than in 
the regions of lower DAPI signal and greater than observed in control cells (see discussion for 
possible explanations). This suggests that ATM signalling either does not fully relieve the 
barrier posed by HC to foci expansion or does so inefficiently. To engineer loss of ATM 
signalling specifically at HC-DSBs, we examined the impact of 53BP1 knockdown, since we have 
previously shown that 53BP1 increases the retention of ATM at DSBs specifically promoting 
pKAP-1 foci formation at KAP-1-rich HC-DSBs; it does not impair pan-nuclear pKAP-1 since 
53BP1 only slightly reduces overall ATM signalling (24). Significantly, 53BP1 siRNA resulted in a 
greater decrease in size of H2AX foci at HC compared to EC regions (Fig. 2C). This suggests 
that ATM-dependent pKAP-1 accumulation at HC-DSBs enhances H2AX foci size but does not 
fully overcome the barrier posed by the HC superstructure. In contrast, ATM inhibitor (ATMi) 
treatment reduced H2AX foci size irrespective of DAPI density (Fig. 2C).  
Thus, global HC relaxation following KAP-1 knockdown provides a greater level of foci 
expansion than observed in control cells despite ATM activation. This is likely because in 
control cells pKAP-1 formation around a DSB only causes HC relaxation in the DSB vicinity 
whereas KAP-1 knockdown causes more extensive HC relaxation. 
 To assess further the impact of HC on H2AX foci expansion, we quantified the 
magnitude of H2AX-chromocentre overlap using high resolution deconvolved z-stacked 
images in KAP-1 depleted cells (this also represents a two dimensional analysis) (Fig. 2D) (N.B. 
we did not perform this analysis in 53BP1 siRNA or ATMi treated cells because of the tiny size 
of the foci at HC regions). We observed a > 3 fold increase in the magnitude of H2AX foci-
chromocentre overlap following KAP-1 siRNA (Fig. 2E). To examine whether this represents 
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expansion of foci on the surface of chromocentres or into the HC interior, we measured the 
volume of H2AX signal within the HC interior using three dimensional modelling software (Fig. 
2F). Strikingly, we observed substantially greater H2AX-DAPI overlap within the interior of 
chromocentres following KAP-1 siRNA. Collectively, these findings show that HC confers a 
substantial barrier to both the speed of formation and expansion of H2AX foci and ATM 
signalling partly but not fully overcomes this barrier. Despite this, H2AX foci formed at HC and 
EC regions are similar size largely due to the expansion of HC-foci into the neighbouring EC 
region.  
 
Depletion of KAP-1 enhances ATM signalling and G2/M checkpoint sensitivity. 
We next examined whether the enhanced H2AX foci expansion at chromocentres which we 
observe following KAP-1 siRNA correlates with enhanced checkpoint signalling and arrest. To 
monitor checkpoint signalling, we examined IR-induced Chk2 phosphorylation (pChk2) by 
Western blotting and observed increased pChk2 following KAP-1 depletion (Fig. 3A). The ATM 
dependency of Chk2 activation was confirmed using ATMi (Fig. 3B). By immunofluorescence 
(IF), KAP-1 depleted cells showed a 2-3 fold increase in pChk2 levels compared to control after 
IR (Fig. 3C). We also examined the sensitivity of G2/M checkpoint arrest following KAP-1 siRNA, 
exploiting our previous findings that checkpoint arrest is not initiated after low IR doses (10). 
Cells were transfected with control or KAP-1 siRNA in WT or ATM-/- MEFs and G2/M checkpoint 
arrest monitored by scoring phospho-histone H3 Ser10 positive cells 1 hr after IR. G2/M arrest 
was abolished in ATM-/- MEFs irrespective of KAP-1 status (Fig. 3D), confirming that G2/M 
checkpoint arrest is ATM dependent. Importantly, KAP-1 depleted cells showed hypersensitive 
checkpoint arrest at lower doses compared to control cells. We consolidated this result in 
human A549 cells using a different KAP-1 siRNA oligonucleotide ± ATMi addition (Fig. 3E). 
Similar to the results in MEFs, KAP-1 siRNA treated cells were fully-arrested after low doses, 
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whereas control cells do not fully activate checkpoint arrest (Fig. 3E). We also observed similar 
hypersensitive checkpoint arrest following combined HDAC1&2 siRNA (Fig. 3E). Collectively, 
these results demonstrate that the increased H2AX signal expansion following KAP-1 siRNA 
correlates with more sensitive G2/M checkpoint arrest. In contrast, KAP-1 siRNA does not 
influence the kinetics or extent of DSB repair in control cells but merely overcomes the need 
for ATM (15). Since KAP-1 siRNA could exert multiple impacts leading to abnormal checkpoint 
arrest, we next examined whether a similar effect was observed following loss of other factors 
required for the HC superstructure. 
  
Depletion of MeCP2 and DNMT3B causes faster H2AX foci formation and increased signal 
expansion in NIH3T3 cells. 
DNA methylation at CpG islands (CGIs) is an important epigenetic modification that regulates 
gene silencing and chromatin compaction. DNA methylation at CGIs recruits the methyl 
binding domain (MBD) proteins which recruit additional chromatin remodellers to silence 
chromatin (35). Here, we focused on changes in methylation-dependent chromatin 
compaction caused by loss of methyl CpG binding protein 2 (MeCP2) or DNA 
methyltransferease 3B (DNMT3B), since they represent components mutated in human 
syndromes (see below). Prior to examining patient cell lines, we examined the impact of 
siRNA-mediated knockdown since the mutations in patients are likely hypomorphic and may 
be less impacting. 
 Firstly, we found that neither depletion of MeCP2 nor DNMT3B by siRNA impacted 
upon the rate of DSB repair in mouse and human cells (data not shown and see Fig. 5). Next, 
we used siRNA-treated NIH3T3 cells to examine whether methylation-dependent chromatin 
compaction affects IR-induced H2AX foci formation at HC regions. Similar to the results 
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following KAP-1 siRNA, depletion of either MeCP2 or DNMT3B resulted in more rapid 
HCH2AX foci formation after IR (Fig. 4A and B). Moreover, MeCP2 and DNMT3B siRNA caused 
a statistically significant increase in H2AX signal intensity with the effect being greater on the 
foci associated with higher density DAPI regions (Fig. 4C). In somewhat distinction to the 
findings following KAP-1 loss, the impact, particularly following MeCP2 siRNA, was also upon 
regions of intermediate DAPI density possibly due to the role of methylation as a 
transcriptional repressor at CGIs at both constitutive and facultative HC. In contrast, KAP-1 is 
primarily enriched within constitutive HC. We also analysed the extent of H2AX and DAPI 
overlap in high resolution deconvolved z-stacked images (Fig. 4D). Although we observed 
minor changes in the number of chromocentres in MeCP2 and DNMT3B depleted cells (data 
not shown), computational analysis of H2AX and DAPI overlap per chromocentre revealed a 
~3 fold increase in H2AX foci expansion following MeCP2 or DNMT3B siRNA (Fig. 4E). 
Additionally, three dimensional image analyses revealed a greater volume of overlap between 
H2AX and HC within the interior of chromocentres (Fig. 4F). Collectively, these data 
demonstrate that MeCP2 and DNMT3B dependent chromatin organization also creates a 
barrier to IR induced H2AX foci expansion at HC regions since depletion of MeCP2 or DNM3T 
enhances foci expansion into the HC core. 
 
Loss of MeCP2/DNMT3B alleviates the ATM dependency of DSB repair. 
We observed that, despite the impact on ATM signalling (Fig. 4), IR-induced DSBs are repaired 
with normal kinetics following MeCP2 or DNMT3B siRNA using H2AX foci analysis and Pulsed-
field gel electrophoresis (Fig. 5A and B). We also observed normal DSB repair kinetics after IR 
in three primary G0/G1 fibroblasts derived from Rett Syndrome patients (Fig. 5C). We 
previously reported that loss of HC building factors (e.g. KAP-1, HP1 or HDAC1/2) overcomes 
the requirement for ATM for DSB repair (15). We, therefore, examined whether MeCP2 
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deficiency in Rett cells alleviates the DSB repair defect conferred by addition of ATMi. 
Surprisingly, loss of MeCP2 activity in Rett cell lines does not affect DSB repair kinetics in the 
presence of ATMi (Fig. 5C). In contrast, MeCP2 siRNA, whilst not affecting DSB repair in the 
absence of ATMi, almost entirely alleviated the DSB repair defect conferred by ATMi addition 
in WT and Rett cell lines in G1 and G2 phase (Fig. 5D and E). These findings suggest MeCP2 
contributes to the barrier that HC poses to DSB repair but that the hypomorphic mutations in 
MeCP2 patient cells do not sufficiently change the HC superstructure to overcome this barrier. 
An ICF Syndrome fibroblast cell line also showed normal DSB repair (Fig. 5F). Addition of ATMi 
also resulted in the DSB repair defect observed in control cells. DNMT3B depletion partly 
relieved the repair defect conferred by ATMi addition in control and ICF Syndrome cells, 
although the magnitude was smaller than that observed following MeCP2 depletion (Fig. 5F).  
 
Cell lines from Rett and ICF Syndrome patients exhibit hyperactive IR-induced ATM signalling. 
Since human fibroblasts do not display the well defined chromocentres present in MEFs, we 
could not readily examine H2AX signal expansion at HC-DSBs in patient cells. We instead 
examined downstream events that might be influenced by enhanced H2AX foci expansion and 
examined the IR-induced activation of two ATM-dependent phosphorylation events (i.e. ATM 
autophosphorylation (pATM) and pChk2). To avoid difficulties due to cell cycle stage (e.g. S 
phase cells have different chromatin superstructure compared to G0/G1 phase cells), we 
examined contact inhibited primary cells. Although several Rett Syndrome cell lines were 
available to us, only one line (GM11272) met the criterion of having sufficiently good growth 
and undergoing contact inhibition to permit this analysis (data not shown). First, we confirmed 
that Rett cell lines have normal levels of damage response protein expression and ATM 
dependent phosphorylation without DNA damage (Fig. 6A and B). Following exposure to 0.5 
and 3 Gy IR, we observed enhanced levels of pATM and pChk2 in GM11272 (Rett) cells 
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compared to 48BR (WT) fibroblasts (Fig. 6C), despite similar numbers of H2AX foci (Fig. 5C). 
To substantiate these findings in cycling cells (excluding S phase cells), we quantified pATM 
levels in G1 or G2 phase GM11272 (Rett) cells and in MeCP2 siRNA treated cells using IF and 
cell cycle markers. Consistent with the results obtained following immunoblotting, GM11272 
(Rett) cells and MeCP2 siRNA treated cells showed a >2 fold increase in pATM in both G1 and 
G2 phase compared to 48BR (WT) cells (Fig. 6D-E and MeCP2 siRNA data is not shown). We 
further consolidated the notion that ATM signal expansion is enhanced at HC-DSBs in Rett 
Syndrome cells using a co-immunoprecipitation (IP) procedure. Following IP using, -TriMe K9 
histone H3 antibody to immunoprecipitate HC-DNA regions and immunoblotting using H2AX 
antibody, we observed that the H2AX signal in the HC-enriched fraction was substantially 
greater in Rett compared to control cells (Fig. 6F). Direct immunoblotting with H2AX antibody 
showed that the signal was only 2 fold enhanced in Rett Syndrome compared to control cells 
(Fig. 6G). These findings are consistent with our IF analysis in NIH3T3 cells (Fig. 4) and 
demonstrate that loss of MeCP2 specifically enhances the encroachment of ATM signalling into 
HC regions.  
Additionally, we examined DNMT3B-mutated ICF Syndrome cells for their ability to 
activate ATM signalling after IR. Although ICF cells have a higher endogenous level of pATM 
consistent with a previous finding (14), we observed substantially greater pATM levels after IR 
in ICF compared to control cells (Fig. 6H). Taken together with the previous section, our results 
suggest that the disordered chromatin present in Rett and ICF Syndromes leads to enhanced 
ATM activation after IR. 
 
Rett Syndrome and other disorders with disorganised chromatin show hypersensitive and 
prolonged G2/M checkpoint arrest. 
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To investigate whether increased ATM activation has a functional impact, we examined the 
efficacy of G2/M checkpoint arrest after IR. Consistent with previous findings, we observed 
that WT fibroblasts do not fully activate G2/M checkpoint arrest after low doses (Fig. 7A). In 
striking contrast, three different Rett Syndrome primary fibroblast lines showed hypersensitive 
arrest 1 hr after IR (Fig. 7A). Full checkpoint arrest was observed in both WT and Rett cells after 
3 Gy since a signal sufficient to activate checkpoint arrest is likely achieved. Addition of a 
Chk1/Chk2 inhibitor abolished G2/M checkpoint arrest in control and Rett cells (Fig. 7B), 
demonstrating that hypersensitive checkpoint arrest in Rett cells is dependent on ATM-
Chk1/Chk2 signalling. Similar analysis of an hTERT immortalised ICF Syndrome cell line also 
revealed hypersensitive checkpoint arrest, which was also abolished by addition of a 
Chk1/Chk2 inhibitor (Fig. 7C). Further, MeCP2 and DNMT3B siRNA in 1BR (WT) hTERT cells 
gave a similar result and MeCP2 siRNA in Rett cells did not show any additivity (Fig. 7D and 
data not shown). Similar results were also obtained using a lymphoblastoid cell line (LBL) 
derived from HGPS, another disorder impacting on the HC superstructure (Fig. 7E). The control 
LBL showed more sensitive arrest compared to the fibroblast cell lines but nonetheless 
enhanced sensitivity was observed in the HGPS LBL.  
Finally, we also examined the maintenance of G2/M checkpoint arrest. We reasoned 
that, based on our previous analysis, checkpoint arrest is released when DDR signalling 
decreases as DSB repair ensues (10). Thus, we predicted that hyperactive checkpoint signalling 
might manifest as prolonged checkpoint arrest despite a normal rate of DSB repair. Strikingly, 
cell lines from the patients with impaired HC displayed prolonged G2/M checkpoint arrest up 
to 8 hr after 2 Gy IR (a dose which fully activates checkpoint arrest in all cells), whereas control 
cells are released by 6 hr (Fig. 7F). Addition of a Chk1/Chk2 inhibitor at 30 min post IR, when 
cells have initiated checkpoint arrest (30), resulted in immediate release from checkpoint 
arrest in all cell lines, demonstrating that the enhanced arrest observed in HC disordered 
patient cells represents hyperactivation of an ATM-Chk1/Chk2 dependent pathway (Fig. 7F). 
224 
 
Taken together, our findings demonstrate that loss of methylation dependent HC compaction 
in Rett and ICF Syndrome leads to increased signal expansion at HC-DSBs, enhanced ATM 
activation and hypersensitive G2/M arrest and maintenance. 
 
MeCP2 expression restores normal G2/M checkpoint signalling and arrest in MeCP2 
defective cells. 
To consolidate that the hypersensitive G2/M checkpoint response in MeCP2 depleted cells is 
due to loss of MeCP2 activity, we examined whether the effect could be complemented by 
expression of siRNA resistant MeCP2 cDNA. Whilst MeCP2 expression in control cells did not 
affect G2/M checkpoint sensitivity, MeCP2 expression in MeCP2 depleted cells restores normal 
G2/M checkpoint sensitivity (Fig. 8A). A similar, though less marked impact, was also observed 
when MeCP2 cDNA was expressed in Rett Syndrome LBLs (Fig. 8B). The less significant 
complementation could be due to the reduced transfection efficiency in LBLs compared to 
hTERT cells or could be the consequence of a dominant negative impact of the mutant protein. 
Further, MeCP2 expression restored the requirement for ATM for DSB repair to MeCP2 siRNA 
treated cells (Fig. 8C). 
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Discussion 
Previous studies have shown that histone H1 restricts DNA damage response (DDR) signalling 
and that reduced H1 levels confer hypersensitive G2/M checkpoint arrest (23). Here, we focus 
on the impact of HC superstructure on the DDR since the magnitude of HC can substantially 
differ between cell types and because patients with disordered HC have been described (3, 5, 
9). Previous studies have demonstrated that HC restricts H2AX expansion and DSB repair (8, 
15, 18). ATM signalling overcomes the barrier posed by HC to DSB repair (Goodarzi et al., 2008). 
However, the downstream consequences that HC poses to H2AX expansion have not been 
previously examined. Given that only 15-20 % of DNA is heterochromatic and that, although 
H2AX foci only expand on the periphery of HC regions, they rapidly become similar in size to 
H2AX foci at EC regions, it might have been anticipated that any impact would be modest. In 
fact, the impact of HC on DDR signalling is marked and only partly relieved by ATM signalling. 
In control cells (with functional ATM), we observe faster formation of H2AX foci at EC 
versus HC-DSBs, consistent with previous findings that H2AX foci rarely form within the core 
HC region but rather expand on the periphery (8, 15, 18). These previous studies have shown 
limited overlap between H2AX foci and HC, consistent with the notion that ATM confers 
localised HC relaxation in the DSB vicinity sufficient to enable HC-DSB repair. Interestingly, by 
30 min post IR, the size of foci at EC and HC regions is similar.  
Depletion of KAP-1, MeCP2 or DNMT3B enhanced the speed and size but not the 
number of H2AX foci. For analysis, we divided the DAPI-signal intensity into a low and high 
category, broadly distinguishing EC- and HC-DSBs, respectively. However, it has to be 
appreciated that there is a range of heterochromatinisation and this represents a somewhat 
crude division. KAP-1 siRNA impacted primarily at DSBs with the highest DAPI-density 
consistent with KAP-1 being predominantly localised at highly compacted HC; the impact for 
MeCP2 was broader, possibly reflecting the presence of methylated CpGs in a wider range of 
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compacted regions (although predominantly in HC-DNA). Surprisingly, under these conditions 
H2AX foci size at HC-DSBs became even larger than EC-DSBs. One possibility is that dynamic 
but distinct chromatin changes occur at EC versus HC regions. At HC-DSBs, it is necessary to 
achieve relaxation since HC is a barrier to repair, whilst there may be processes that actually 
restrict H2AX foci expansion at EC-DSBs. For example, several recent studies have reported 
that CHD4, a global chromatin remodelling component associated with HDAC activity, is 
recruited to DSBs after IR (20, 27, 32). Additionally, recent studies have suggested that 
transcription is silenced at transcriptionally active DSBs and/or restricts H2AX foci expansion 
(17, 29). These dynamic changes may tend to diminish signalling at EC-DSBs but enhance it at 
HC-DSBs. Our analysis of cells lacking 53BP1, which promotes concentrated pKAP-1 at HC-DSBs 
but does not affect pan-nuclear pKAP-1 (24), shows specific restriction in the expansion of HC-
DSBs strongly suggesting that one function of ATM is to enhance signalling from HC-DSBs (ATM 
may, however, additionally perturb expansion at EC-DSBs). Thus, the end result of perturbed 
HC superstructure when ATM signalling is active may be elevated signal expansion at HC-DSBs 
relative to EC-DSBs. Our analysis of the overlap between H2AX foci and regions of high DAPI-
density by two and three dimensional modelling was particularly informative. These findings 
show that knockdown of HC components (KAP-1, MeCP2 and DNMT3B) enhances H2AX foci 
expansion into the HC core to a greater extent than observed in control cells, consistent with 
the notion that ATM signalling only relaxes HC in the DSB vicinity and that most H2AX foci 
expansion occurs into the neighbouring EC region (15). Thus, ATM only minimally and locally 
overcomes the barrier posed by HC to H2AX foci expansion. Hence H2AX expansion following 
depletion of core HC factors is greater and progresses further into the HC core than in control 
cells. 
H2AX acts as a scaffold to recruit MDC1, MRN and 53BP1, which together aid ATM 
retention at the DSB (25). Thus, it might be anticipated that foci size correlates with the 
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magnitude of the downstream response. Yet cells lacking H2AX show efficient DDR signalling 
and checkpoint arrest except at low IR doses (12). We, therefore, examined checkpoint 
signalling at early times after low doses and observed enhanced ATM signalling following KAP-
1 or MeCP2 depletion most evident from 10 to 60 min post IR. Previously, we reported that 
the G2/M checkpoint is insensitive and is not activated by low IR doses (10). Strikingly, we 
observed that depletion of KAP-1, MeCP2 or DNMT3B by siRNA permits hyperactivation of 
checkpoint arrest at low doses that fail to arrest control cells. Thus, the impact of HC provides 
one explanation for the lack of sensitivity of the G2/M checkpoint. Our findings described 
above are consistent with a recent report that HC can be induced by oncogenic stress and that 
such HC formation can restrict activation of the DNA damage response and, most importantly, 
signalling to apoptosis (11). This important finding consolidates our results and shows that HC 
arising in a distinct manner can exert a similar dampening impact on the damage response. 
A major focus of our work is the examination of disorders with aberrant HC. We 
focused on Rett Syndrome partly because we observed the most dramatic impact in these cells 
and because they grew well, had low endogenous H2AX foci numbers and DDR signalling. Rett 
Syndrome cells show an ~ two fold increase in ATM phosphorylation, hypersensitive 
checkpoint activation and prolonged checkpoint maintenance, all features consolidated using 
siRNA-mediated depletion of MeCP2. We did not examine downstream steps of ATM signalling 
(e.g. Chk2 phosphorylation) in ICF or HGPS cells due to difficulties in obtaining sufficient G0/G1 
cells. However, the checkpoint analysis verified hypersensitive arrest and prolonged G2/M 
checkpoint activation, consistent with enhanced IR-induced ATM activation. A previous study 
reported elevated endogenous pATM in ICF LCLs without obvious changes in the response to 
IR (14). However, different methodologies were used and the subtle response to low doses 
was not examined. Collectively, these findings provide a clinical relevance to our work and 
show that disorders with impaired HC structure can display enhanced DDR signalling.  
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A range of studies have shown that the sensitivity and duration of checkpoint arrest 
reflects the status of DSB repair. Changes to chromatin structure including epigenetic histone 
modifications have been shown to influence checkpoint arrest via an impact on DSB repair (22, 
27). Here, we observed normal DSB repair. Thus, our findings provide a novel example of 
prolonged checkpoint arrest despite normal DSB repair and demonstrate that the checkpoint 
response can be markedly affected by the level and degree of HC compaction. We identify 
syndromes with disordered HC as displaying an abnormal checkpoint response despite normal 
DSB repair. 
A significant question is whether enhanced DDR signalling impacts clinically. We did 
not observe any significant change in IR sensitivity in primary Rett Syndrome fibroblasts (data 
not shown). However, in primary fibroblasts survival is likely determined predominantly by 
DSB repair, which was normal in Rett Syndrome cells. Prolonged arrest may simply lead to 
delayed cell cycling without a significant impact on survival. However, the response may 
depend upon cell type; for example in cells that activate apoptosis (which does not occur 
following IR in primary fibroblasts) elevated signalling may enhance cell death. Further, 
enhanced signalling from uncapped telomeres could manifest as early-onset senescence 
following telomere erosion. Significantly, premature ageing is a phenotype of syndromes with 
disordered chromatin. Finally, the magnitude of HC compaction may differ between stem and 
differentiated cells, potentially influencing the magnitude of ATM signalling. More specific 
studies are required to address these questions. 
In summary, we have shown an unexpectedly large impact on DDR signalling following 
loss of proteins that impact upon HC superstructure. The results reveal that the HC 
superstructure is a barrier to DDR signalling that is partly, but not totally, relieved by ATM 
signalling. We show that HC relaxation conferred by patient mutations or by knockdown of HC 
proteins has downstream consequences including hyperactive ATM signalling and checkpoint 
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arrest which cannot be attributed to impaired DSB repair. Thus, the barrier that HC 
superstructure poses to checkpoint signalling provides one explanation for the insensitivity of 
G2/M checkpoint arrest. 
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Figure legends 
Figure 1. The rate of H2AX foci formation at HC and EC regions. 
(A) The typical images of H2AX foci formation after IR in NIH3T3 cells. HC H2AX (red) 
represents regions of H2AX and dense-DAPI chromocentre overlap as determined by 
softWoRx® Suite software.  
(B-D) The rate of total- (B), EC- (C) and HC- (D) H2AX foci formation were enumerated after 
0.25, 0.5 and 1 Gy IR.  
(E) H2AX foci formation is normalized to the 20 min post IR signal. Similar results have been 
obtained in more than three independent experiments.  
 
Figure 2. Depletion of KAP-1 enhances the speed and expansion of H2AX signal at HC 
regions 
(A) KAP-1 siRNA increases the speed of HC H2AX foci formation. KAP-1 siRNA treated NIH3T3 
cells were irradiated with 1 Gy. The number of H2AX foci overlapping/juxtaposing and non-
overlapping with chromocentres was enumerated as HC and EC foci. 
(B) The rate of H2AX foci formation shown in (A) was normalized to the number of foci at 20 
min. The knockdown efficiency is shown in right panel. 
(C) Greater H2AX signal intensity at higher dense DAPI regions in KAP-1 siRNA treated cells 
after IR. KAP-1 siRNA treated NIH3T3 cells were irradiated with 3 Gy IR and fixed 30 min later. 
The signal intensity of H2AX and DAPI per focus was quantified using ImageJ. Typical images 
and values are shown in the right panel. Black bars represent the median. Statistical 
significance was determined using Student’s two-tailed t test. 
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(D, E) Increased H2AX signal expansion at HC regions following KAP-1 siRNA. High resolution 
deconvolved z-stacked images in KAP-1-depleted NIH3T3 cells are shown in D. H2AX signal 
overlap of with dense DAPI (blue+green) was visualized as red signal determined by softWoRx® 
Suite software computer analysis. The magnitude of overlap of H2AX per chromocentre was 
quantitatively measured by ImageJ and shown in E. 
(F) Depletion of KAP-1 enhances signal expansion into the HC interior. The H2AX signal 
expansion into the HC interior is shown by three dimensional modelling in NIH3T3 cells. The 
volume of the interior signal per chromocentre was measured by Huygens Professional, 
Scientific Volume Imaging. The quantification is shown in the right panel. In panel A-F, G1 cells 
with p-H3 Ser10 negative were analysed. S phase cells, which show extensive H2AX signal, 
were excluded. Error bas represent the S.D. from two independent experiments (A, B, E and F). 
n; the number of chromocentres analysed (E and F). 
 
Figure 3. KAP-1 depletion enhances ATM signalling and G2/M checkpoint sensitivity.  
(A) Increased pChk2 is observed following KAP-1 depletion after IR. 1BR (WT) hTERT cells +/- 
KAP-1 siRNA were exposed to 0.5 Gy IR and harvested at the indicated time points. The 
quantification of pChk2 bands normalised by total Chk2 is shown in right panel. Similar results 
have been observed in 2 additional experiments. 
(B) IR-induced pChk2 is ATM dependent irrespective of KAP-1 status. 1BR (WT) hTERT cells +/- 
KAP-1 siRNA were exposed to 3 Gy IR with or without 10 M ATM inhibitor and harvested 2 hr 
post IR.  
(C) Enhanced pChk2 signal is observed in KAP-1 depleted cells by IF. 1BR (WT) hTERT cells +/- 
KAP-1 siRNA were fixed and stained with pChk2, CENPF and DAPI, 30 min after IR. The signal 
238 
 
intensity was analysed using ImageJ. G2 phase cells were identified by CENP-F. -pChk2 
antibody specificity was confirmed as in (30). Results represent the mean +/- S.D. from two 
experiments. 
(D) KAP-1 siRNA knockdown causes hypersensitive G2/M checkpoint arrest. WT and ATM-/- 
MEFs were subjected to KAP-1 siRNA. After IR, cells were fixed 1 hr later and stained with -p-
H3 Ser10 and DAPI. The number of p-H3 Ser10+ cells were scored and normalized to the non-
irradiated control. >400 cells were scored.  
(E) KAP-1 and HDAC1&2 depletion increase the sensitivity of G2/M checkpoint arrest. A549 
cells were subjected to KAP-1 siRNA with or without ATM inhibitor or HDAC1/2 double siRNA. 
The % mitotic cells 2 hr after IR were scored as described in (D). Results represent the mean 
and S.D. from three experiments (D and E). 
 
Figure 4. Depletion of MeCP2 and DNMT3B allows increased H2AX signal expansion. 
(A) Depletion of MeCP2 and DNMT3B increases the speed of HC H2AX foci formation. MeCP2 
and DNMT3B siRNA treated NIH3T3 cells were irradiated with 1 Gy and fixed at the indicated 
times. H2AX foci formation was analysed as described in Fig. 2. 
(B) The rate of H2AX foci formation shown in (A) was normalized to foci numbers counted at 
20 min. The knockdown efficiencies are shown in right panel. 
(C) MeCP2 and DNMT3B depletion with siRNA enhances H2AX signal intensity at HC regions. 
NIH3T3 cells subjected to siRNA irradiated with 3 Gy, fixed 30 min later and stained with -
H2AX and DAPI. The signal intensity of H2AX and DAPI per focus was quantified using ImageJ. 
The black bars represent the median. Statistical significance was determined using Student’s 
two-tailed t test. 
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(D, E) Increased H2AX signal expansion at HC regions following MeCP2 and DNMT3B siRNA. 
The regions of H2AX-chromocentre overlap were analysed as described in Fig. 2.  
(F) Depletion of MeCP2 and DNMT3B enhances the H2AX signal expansion into the HC interior 
in NIH3T3 cells. The H2AX signal expansion within DAPI chromocentres in MeCP2 and 
DNMT3B siRNA treated cells was measured as described in Fig. 2. G1 cells with p-H3 Ser10 
negative were analysed (A-F). Results represent the mean and S.D. from two experiments (A, B, 
E and F). n; the number of chromocentres analysed (E and F). 
 
Figure 5. Rett and ICF Syndrome cell lines show a normal rate of DSB repair; MeCP2 and 
DNMT3B depletion alleviates the DSB repair defect conferred by ATMi treatment.  
(A) Depletion of MeCP2 and DNMT3B does not influence DSB repair kinetics in 1BR (WT) hTERT 
cells. To assess the impact of ATM on DSB repair, ATMi was added 30 min prior to IR. Similar 
result was observed in MeCP2 and DNMT3 depleted NIH 3T3 cells (data not shown). 
(B) DSB repair was analysed by neutral PFGE after 20 Gy IR. P2 (XLF) hTERT cells show a 
substantial DSB repair defect, whereas MeCP2, DNMT3B siRNA treated 1BR (WT) hTERT cells 
show normal DSB repair. 
(C) Rett primary fibroblasts show normal DSB repair in G1 phase. The hypomorphic MeCP2 
mutations in Rett cells do not overcome the DSB repair defect in ATMi treated cells.  
(D) Depletion of MeCP2 with siRNA alleviates the DSB repair defect conferred by ATMi 
treatment in Rett G1 cells. MeCP2 siRNA was undertaken in control and Rett primary 
fibroblasts.  
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(E) Depletion of MeCP2 does not affect DSB repair in G2 phase cells but rescues the repair 
defect conferred by ATMi addition. 1BR (WT) hTERT cells were subjected to MeCP2 siRNA. G2 
cells were identified with CENPF.  
(F) ICF fibroblast cells show normal DSB repair. Depletion of DNMT3B partly alleviates the DSB 
repair defect in the presence of ATMi in ICF G1 cells. DSB repair was measured by H2AX foci 
analysis after 3 Gy IR (A and C-F). 4 M Aphidocolin was added immediately after IR to prevent 
S phase cells progressing into G2 phase and to identify S phase cells because of extensive 
H2AX signalling (A, C-F). Error bas represent the S.D. from three independent experiments (A-
F). 
 
Figure 6. Rett Syndrome cell lines exhibit enhanced ATM signalling after IR. 
(A) Rett fibroblast cells have normal levels of damage response protein expression. Whole cell 
protein extracts were obtained from exponentially growing 48BR (WT) and GM16548, 
GM11272 and GM11272 (Rett/MeCP2) primary human fibroblast cells. 
(B) Rett fibroblast cells show normal pATM level without DNA damage. As a positive control, 
48BR (WT) cells were irradiated with 0.5 and 3 Gy and the signallings were examined at 30 min 
after IR. 
(C) G0/G1 arrested Rett fibroblast cells exhibit increased pATM /pChk2 compared with control 
fibroblasts. Primary 48BR and Rett cells were synchronized in G0/G1 with contact inhibition 
for >10 days. G0/G1 arrest was confirmed by FACS (data not shown). 
(D) Enhanced IR-induced pATM in G1 and G2 phase cycling Rett fibroblast cells compared to 
control fibroblasts. Cycling 48BR and Rett fibroblast cells were irradiated with indicated doses. 
Cells were fixed and stained with pATM, CENPF and DAPI, 30 min after IR. The signal intensity 
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was analysed using ImageJ. G2 phase cells were identified by CENP-F. S phase cells, which 
show intermediate CENPF levels, were excluded from analysis. -pATM antibody specificity 
was confirmed as in (24). Results represent the mean +/- S.D. from three experiments.  
(E) The typical images of pATM signal in cycling 48BR and Rett fibroblast cells are shown (40x).  
(F) Enhanced H2AX signal in an HC enriched fraction in Rett compared to control cells after IR. 
Lymphoblastoid cell lines (LBLs) were harvested at 30 min after 10 or 20 Gy IR. To enrich for 
HC-DNA, the nucleosome fraction was subjected to IP using -TriMe K9 histone H3 antibody.  
(G) Enhanced global H2AX signalling in Rett cells after IR. Levels of total trimethylated K9 of 
histone H3 were similar between Rett and control LBLs.  
(H) ICF fibroblast cells exhibit greater pATM after IR compared to control cells. PT3 
(ICF/DNMT3B) cells were arrested in G0/G1 following contact inhibition. >90% of cells were in 
G1 phase (data not shown). Cells were irradiated with 0.5 Gy, harvested at 1 hr after IR and 
processed as described above.  
 
Figure 7. Cell lines from Rett, ICF and HGPS patients show hypersensitive IR-induced G2/M 
checkpoint arrest. 
(A) Hyperactive G2/M checkpoint arrest was observed at lower doses in Rett fibroblasts. Two 
control (48BR and 1BR) and three Rett Syndrome (GM16548, GM11271 and GM11272) 
primary fibroblast lines were analysed for G2/M checkpoint arrest.  
(B) Enhanced initiation of checkpoint sensitivity in Rett fibroblast cells was abolished by adding 
the Chk1/Chk2 inhibitor. The Chk1/Chk2 inhibitor, SB218078, was added 30 min prior to IR. 
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(C) ICF fibroblast cells show hypersensitive G2/M checkpoint arrest. 1BR (WT) and PT3 
(ICF/DNMT3) hTERT cells were analysed for G2/M checkpoint arrest. The inhibitor was added 
30 min prior to IR.  
(D) Depletion of MeCP2 and DNMT3B confers hypersensitive G2/M checkpoint arrest. 1BR (WT) 
hTERT cells were subjected to MeCP2 and DNMT3B siRNA. Two distinct siRNA oligonucleotides, 
#1 and #2, were used for each MeCP2 and DNMT3B knockdown. 
(E) A LBL cell line from an HGPS patient (AG10801) shows hypersensitive G2/M checkpoint 
arrest.  
(F) Prolonged IR-induced G2/M checkpoint maintenance in patient with HC disorder LBLs. The 
maintenance of G2/M checkpoint arrest was examined in control (GM02188), Rett (GM16548), 
ICF (GM08714) and HGPS (AG10801) LBLs. LBLs were used for this analysis to allow direct 
comparison between all patient lines, because efficiently growing HGPS cells were only 
available as LBLs. Consistent with fibroblast cell lines, patient LBLs showed hypersensitive 
initial G2/M checkpoint arrest after low dose IR (data not shown). 4 M Aphidicolin (APH) was 
added immediately after 2 Gy IR. We have not examined 12 hr time point in the inhibitor 
treated cells because of cellular toxicity by the drug. Mitotic index was measured using p-H3 
Ser10 at 1 hr after irradiation (A-E). Error bas represent the S.D. from three independent 
experiments (A-F). 
 
Figure 8. MeCP2 expression restores normal G2/M checkpoint signalling and arrest in MeCP2 
defective cells. 
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(A) MeCP2 expression in MeCP2 depleted cells restores normal G2/M checkpoint arrest. siRNA 
resistant WT MeCP2 was expressed in 1BR (WT) hTERT cells with or without knocking down 
endogenous MeCP2 proteins.  
(B) MeCP2 expression in Rett LBL cells partially rescues the hypersensitive G2/M checkpoint 
arrest.  
(C) MeCP2 expression in MeCP2 depleted cells restored the requirement for ATM for DSB 
repair to MeCP2 siRNA treated cells. DSB repair in G1 cells was measured by 53BP1 foci 
analysis after 3 Gy IR. Mitotic index was measured using p-H3 Ser10 at 1 hr after irradiation (A 
and B).  Error bas represent the S.D. from two or three independent experiments (A-C). 
gH2AX cluster foci analysis using high resolution decomboluted image after high 
LET irradiation  
 
Nakako Nakajima, Atsushi Shibata, Ryuichi Okayasu, Penny Jeggo. 
 
Results 
Delta vision deconvolution analysis in complex gH2AX cluster foci following 
exposure to vertical heavy ions irradiation. 
gH2AX form foci at the site of DSBs. ATM and DNA-PK is activated by DSB ends and 
phosphorylate H2AX. To consolidate whether heavy ion induced gH2AX foci 
formation is depended on DSB, we examined gH2AX foci formation in the presence of 
ATMi and DNA-PKi(Figure 1A). Consistent with the observations after X-rays (Stiff, 
Can Res), the treatment with ATMi/DNA-PKi diminished gH2AX foci formation in 
G0/G1 cells following exposure to heavy ions.  
Interestingly, we reproducibly observed greater size of gH2AX foci after heavy 
ions compare to that after X-rays (Figure 1B). To investigate gH2AX foci structure with 
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higher resolution microscope imaging, we utilized DeltaVision microscope with 
deconvolution following exposure to vertical Fe ions irradiation (Figure 1C, top panel). 
Interestingly, high resolution deconvoluted image analysis revealed that the larger size 
of gH2AX focus contains multiple gH2AX foci cluster (We named a complex gH2AX 
foci as gH2AX cluster foci, and individual foci at cluster region as gH2AX foci). Since 
it is know that heavy ions induce complex DNA damages, we examined gH2AX cluster 
foci after heavy ion irradiation with different levels of LET, i.e. we irradiated cells with 
1 Gy Fe (200 keV/m), 1 Gy Carbon (70 keV/m) and 1 Gy X-ray (~0.1 keV/m). 
Following exposure to irradiations, gH2AX cluster foci was frequently observed after 
heavy ions although levels of cluster foci were largely different between heavy ions and 
X-rays (Figure 1D, quantification is shown in Figure 2).  
We next investigated DSB repair using gH2AX cluster foci analysis by Delta 
Vision deconvolution. Human fibroblast cells are arrested in G0/G1 with contact 
inhibition and are irradiated, since DNA damages in S phase might be more 
complicated, and also DSBs in S/G2 phase are repaired by HR as well as NHEJ. To 
monitor gH2AX foci complexity, we classified complexity of gH2AX cluster according 
to the number of foci per cluster (Figure 2A). Using this classification, we analyzed rate 
of DSB repair in 48BR (WT) primary fibroblast cells following exposure to Fe and X-
rays. To examine repair rate in each gH2AX cluster foci, we plotted the % of repair. 
Consistent with the notion that high LET irradiation causes complex DNA damage, we 
observed highly cluster foci after Fe ions whereas there are a few >4 cluster foci after 
X-rays (Figure 2B). Interestingly, we observed slower DSB repair in higher complex 
gH2AX cluster foci (Figure 2B), especially >7 gH2AX foci per cluster, after Fe ions. 
Similar tendency, i.e. complex gH2AX cluster foci (>3-4 foci per cluster) are repaired 
slowly, was observed after X-rays although the incidence of highly-complex gH2AX 
cluster foci is significantly lower than heavy ion irradiation (Figure 2B). To examine 
whether DSB repair is required for NHEJ following heavy ions as well as X-rays 
(Ahnesorg, Buck), we carried out gH2AX cluster foci analysis in NHEJ defective, XLF 
cells. XLF cells show a substantial repair defect in all categories of cluster foci after Fe 
ions (Figure 2C). The slightly higher XLF dependency was observed after Fe ions 
compared to X-rays. This is consistent with the observation in our previous work (ref), 
although the mechanistic insight in this difference is unclear. Thus, our results 
demonstrate that DSBs, which form a simple gH2AX cluster foci, are repaired with 
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faster kinetics whereas highly complex gH2AX cluster foci are repaired with slower 
kinetics. Also, following exposure to heavy ions as well as X-rays, DSBs are 
predominantly repaired by NHEJ in G0/G1 cells, suggesting that NHEJ is a major DSB 
repair pathway in G0/G1 irrespective of damage complexity. 
 
 
In vivo track structure analysis using high resolution gH2AX foci following 
exposure to horizontal Fe irradiation. 
In the analysis following exposure to vertical irradiation (Figure 1-2), we consider that 
we might underestimate or miss gH2AX foci behind a cluster foci as we discussed 
above. In Figure 1 and 2, we analyzed structure of gH2AX cluster foci by two 
dimensional visualizations after stucking z-axis images. This also might misestimate 
size of expansion in gH2AX cluster foci at the region of the particulate passage. 
Therefore, we next irradiated primary 48BR (WT) G0/G1 cells with Fe ions 
horizontally and analysed gH2AX foci with Delta vision deconvolution. After 
horizontal Fe irradiation, gH2AX foci track on a line, which Fe is passed through 
nucleus, is shown at 30 min (Figure 3A) (N.B. we measured foci stack structure at 30 
min since a track begins to bend >2 hr post irradiation, and chose cell with a single 
track). To examine the size of gH2AX foci expansion at track, we measured the width 
of gH2AX cluster foci from edge to edge in track (named as width per track) and the 
width of cluster foci from edge to edge in cluster (named as width per cluster) at 30 min 
after Fe ions. The average width of per track at 30 min after Fe ions is shown in Figure 
3B. Interestingly, the width per cluster after Fe ions is approximately 5-fold wider than 
that after X-rays (Figure 3C). It has been proposed that heavy ion irradiation causes 
penumbra effect around core irradiation region (ref; physics). Therefore, we estimated 
the energy levels at core and penumbra region following exposure to Fe ions irradiation 
(200 keV/m = 418 MeV/n) (Figure 3D). brabrabra… 
To assess this estimation in in vivo using gH2AX foci analysis, we measured the 
distance to the gH2AX foci at non-track region. Interestingly, we observed 
approximately 3 gH2AX foci at non-track region when cell has a single track and the 
average of the distance is ~3.5 m from the middle of track (Figure 3E, top). We further 
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analysed the relationship between the distance and gH2AX foci cluster (Figure 3E, 
bottom). We next examined the rate of repair at non-track region in primary 48BR (WT) 
and XLF hTERT cells (Figure 3F and G).  
 
Comparison of gH2AX cluster foci analysis between vertical and horizontal Fe ions 
irradiation 
As we discussed above, since DNA is continuously moving in nuclei, gH2AX cluster 
foci might change its structure especially at later time points. To compare the 
consequent differences in damage structure between vertical and horizontal irradiation, 
we measured the gH2AX cluster foci in 48BR (WT) cells at 24 hr post irradiation. Since, 
after horizontal Fe ions, we cannot select cell with a single track at later time points due 
to DNA movement, we compared the percentage of cluster per cell (Figure 4). 
Surprisingly, similar type of cluster damages was observed after both horizontal and 
vertical irradiation, suggesting that the fundamental damage structure is similar 
irrespective of direction of irradiation.  
 
Rate of gH2AX cluster foci disappearance following exposure to Fe ions and X-
rays irradiation 
To examine the rate of DSB repair with longer time course, we enumerated the number 
of gH2AX cluster foci by eyes. Consistent with the previous observation and the data 
from the time course experiments up to 24 hr (Figure 2), the slower DSB repair kinetics 
was observed after Fe ions compared to X-rays in 48BR (WT) primary cells (Figure 
5A). We also examined the rate of DSB repair in XLF hTERT cells. To directly 
compare the repair kinetics between cell lines with distinct type of damages, we 
normalized the gH2AX cluster foci disappearance as a percentage of the repair (Figure 
5B, the actual number of gH2AX cluster foci in XLF as well as 48BR cells is shown in 
Figure 5B). The similar percentage of DSB repair defect was observed in XLF cells 
after Fe ions and X-rays. We further investigated the repair rate in these cell lines after 
horizontal Fe ions irradiation. Since cells irradiated with horizontal Fe ions show a 
variable length and number of tracks between individual cells, e.g. diameter and shape 
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of a cell and direction of ions largely affect length of track, we monitored the rate of 
foci disappearance only >8 hr after irradiation.  
 
 
Discussions 
We previously reported that analysis of prematurely condensed choromosomes in G1 
showed the slower rejoining following exposure to heavy ions than X-rays (Okayasu, 
Rad. Res., 2006). In this study, we investigated the DSB repair after heavey ions 
irradiation using gH2AX foci analysis, which is a sensitive DSB assay and able to 
monitor DSB repair in individual cells using physiological doses. Furthermore, we 
developed the assay with high resolution microscope with deconvolution, which has a 
strong advantage to analyse structure and size of gH2AX foci within a cluster.  
 
 
Novel gH2AX foci analysis within cluster lesion using high resolution microscope 
with denovolution. 
Advantage:  
We revealed that greater size of gH2AX focus visualized by conventional microscope is 
actually including gH2AX cluster foci using Delta Vision microscope denovolution. 
Limitations; 
The analysis of gH2AX cluster foci after vertical heavy ions irradiation has technical 
limitations. At 2 hr, slightly greater % of complex cluster foci formation was observed 
compared to that at 30 min post irradiation. This could be explained by some reasons, 
i.e. i) smaller foci can not grow until detectable levels up to 30 min post irradiation. ii) 
Individual foci merge at later time points since DNA is moving in nucleus (Aten JA, 
science, 2004) and/or due to recruitment of foci at repair centre (I don’t believe repair 
centre model in yeast though). iii) foci behind cluster foci might appear due to DNA 
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movement and rotation in two dimension analysis after vertical irradiation. We currently 
cannot entirely verify these possibilities because of technical limitations, i.e. it might be 
resolved if gH2AX foci were monitored with Live cell imaging analysis with delta 
vision microscope, however importantly, we observed that the percentage of complex 
gH2AX cluster foci in repair defective, XLF, cells was not increased up to 24 hr, 
suggesting that these possibilities are negligible small.  
On the other hand, the analysis after horizontal irradiation has other technical 
limitations when rate of repair is monitored, i.e. there is huge variation between 
individual cells because of a variable length of diameter. Also, the issue of DNA 
movement could be happened after horizontal irradiation as well. Further, as shown in 
Figure 4, we show the similar percentage of cluster distribution between vertical and 
horizontal irradiation at 24 hr after damage. This might be dependent on type of cell 
lines. Since the depth of nuclei is ~<4 m in primary fibroblast cells and the distance 
between each cluster is ~3 m, we estimate the number of cluster per track after vertical 
irradiation is approximately <1-2. Therefore, we probably did not largely underestimate 
cluster behind cluster foci even after vertical irradiation Thus, we suggest that this 
cluster analysis is available for both vertical and horizontal irradiation in fibroblast cells.  
 
b) Higher complex gH2AX cluster foci after heavy ions. In contrast, significantly lower 
percentage of cluster foci after X-ray, but there are a few cluster and it remains.  
 
c) Speed of repair is determined by the cluster complexity. 
 
Thus we propose that our novel gH2AX cluster foci analysis is useful approach to 
investigation of type of clustering damage. 
 
-electron effect 
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From the analysis after horizontal irradiation, we demonstrate that the main heavy ion 
particle causes highly gH2AX cluster foci at main track, and also produce less complex 
foci around the main track by d-electron effect. These analyses suggested the possibility, 
i.e. after vertical irradiation, the less cluster gH2AX foci might be due to the d-electron 
effects. However, we cannot distinguish the main track from the other damages after 
vertical irradiation.  
 
Physics View 
Heavy ions, nuclei of atoms, are accelerated until getting a 60-70% of light speed under 
vacuum after removing electrons. After releasing from the vacuum condition, nuclei of 
atoms have to be passed in air. In air, our estimations revealed that heavy ions ~<50% 
iron nuclears are collapsed until they get a target (can we show this estimation by 
physics calculations?), e.g. cells. We cannot distinguish the damage by original Fe 
particle from other collapsed atoms, nevertheless importantly, we demonstrate that the 
heavy ions at main track lead to gH2AX cluster foci high-frequently compared to X-
rays. 
 
Complex gH2AX cluster foci is repaired by NHEJ with slower kinetics. 
In mammalian cells, NHEJ is a major pathway in G1 phase. In this study, we show that 
highly complex gH2AX cluster foci are repaired with slower kinetics and the substantial 
repair defect in the absence of XLF. It is known that NHEJ is a faster repair pathway, 
nevertheless surprisingly, we observed significantly slower repair kinetics if DSBs at 
damaged region form highly complex gH2AX cluster foci. In our work, we did not find 
the obvious merge the individual clusters since the similar number of foci was observed 
in XLF cell up to 24 hr post irradiation. Thus we speculate that DSBs are repaired 
within the cluster if DSBs are repaired by either contact-first model or break-first model. 
However importantly, if high complex gH2AX cluster foci are induced at a certain 
region, it might make it difficult to find the partner end, leading to reducing the speed of 
repair, and also it increases the frequency of miss-rejoining and translocation.  
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In addition, the reason why we chose XLF cell lines as a NHEJ defective cell is we 
previously found a fewer contribution of alternative DSB repair in XLF defective cell 
lines compared to Ku80-/- and LigaseIV-/- cell lines after X-rays (Loser et al. and data 
not shown). Although further work will be required to verify a contribution of 
alternative end joining pathway in DSB repair after heavy ions, our study strongly 
demonstrate that NHEJ is a major repair pathway in Fe ions induced DSBs. 
 
Does slower repair kinetics affect relative biological effectiveness?   
As we discussed, it is likely that complex cluster fraction with slower repair might lead 
to miss-rejoining and translocation. This might contribute to the higher RBE ratio after 
heavy ions compare to X-rays. Also, since we show that the significant number of DSBs 
within cluster foci has not been repaired until 72-96 hr in non-cycling G0/G1 cells even 
after low dose, 1 Gy, we speculate that a sever chromosomal instability might be 
occurred in M phase if cells could not be sustained by G2/M checkpoint arrest and 
released with cluster damage.  
 
 
 
 
 
 
 
Materials and Methods 
Cell culture and irradiation 
48BR (Wild type) primary and 2BN (XLF-defective) hTERT human fibroblasts were 
cultured in DMEM supplemented with 15% fetal calf serum, 100 U/ml penicillin and 
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100 µg/ml streptomycin at 37°C in a humidified mixture of 95% air 5% CO2. Cells were 
seeded into Nunc chamber glass slides and grown to confluence for irradiation. 
Exposures to carbon (290 MeV/nucleon, LET 70 keV/μm) and iron (500 MeV/nucleon, 
LET 200 keV/μm) beams were performed at the Heavy Ion Medical Accelerator 
(HIMAC) facility of the National Institute of Radiological Sciences (NIRS), Chiba, 
Japan. Chamber slides were set up in vertical or horizontal position with the cell layers 
perpendicular to the incident horizontal beam. X-ray irradiation was performed at 200 
kVp and 20 mA (Shimadzu, TITAN-320). Dose rates were set at 1 Gy/min for heavy 
ions and 0.5 Gy/min for X-rays. Cells expected to receive about 1 Gy/min of X-rays, 
because glass slides on which cells reflect X-rays (Lobrich, add ref).  
 
Immunofluorescence staining 
Cells were washed in cold PBS and fixed for 10 min in 4% w/v paraformaldehyde at 
room temperature. Afterwards, the cells were permeabilized for 2 min in 0.2% v/v 
Triton X-100 in PBS, washed in PBS. Antibodies were diluted with 4% w/v BSA in 
PBS. Cells were incubated with mouse anti-γ-H2AX antibody (Millipore) for 1 h at 
37°C, washed three times in PBS and incubated with FITC-conjugated rabbit anti-
mouse IgG antibody (Sigma) for 1 h at room temperature. Slides were washed twice in 
PBS and once for 5 min in PBS containing DAPI to stain the DNA, mounted using 
Vectashield. 
Sample analysis and image processing 
Microscopic images were captured with An Applied Precision Delta Vision RT Lympus 
IX70 deconvolution microscope and a Zeiss Axioplan microscope. Images taken by 
Delta Vision were deconvoluted and processed using softWoRx.  Evaluation of foci 
numbers and cluster numbers, measurement of length and width of track was performed 
with ImageJ v1.35p.  
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Figure 1. Development of novel gH2AX cluster foci analysis with high resolution 
deconvoluted image 
A) ATMi and DNA-PKi if anyone has done this expt. 
B) gH2AX form bigger foci after heavy ions compared to X-rays.  
Cells are irradiated 1 Gy vertical Fe and X-rays and fixed at 30 min post irradiation. 
Cover-slips were visualized using the Zeiss Axioplan microscope and simple PCI 
software. 
C) Visualisation of gH2AX foci after heavy ions using conventional microscope.  
48BR (WT) primary human fibroblast cells were fixed at 2 hr after with 1 Gy vertical 
Fe ions and stained with gH2AX and DAPI. Cover-slips were visualized using the Zeiss 
Axioplan microscope and simple PCI software. Two typical cells from the field (x 40) 
shown in left panel are enlarged with 100x magnification in right panel.  
D) Visualisation of gH2AX foci using high resolution microscope Delta Vision with 
deconvolution. 
48BR (WT) primary human fibroblast cells shown in panel C were also taken by an 
Applied Precision® DeltaVision RT Olympus IX70 deconvolution microscope. After z-
sectioning, the images were stuck and deconvoluted with softWoRx Suite software. 
E) Comparison of gH2AX cluster foci after Fe, Carbon and X-ray irradiation using 
Delta Vision deconvolution. 
48BR (WT) primary human fibroblast cells were irradiated with 1 Gy vertical Fe, 1 Gy 
vertical Carbon and 1 Gy X-rays and fixed at 2 hr. Typical gH2AX foci cluster was 
enlarged in right panel. Greater number of gH2AX cluster foci was observed after 
higher LET heavy ions compare to X-rays. The quantification of Fe ions and X-rays 
was shown in Figure 2. 48BR primary human fibroblast cells were arrested in G0/G1 
for >7 days after 100% confluent (A-D). 
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Figure 2. gH2AX cluster foci analysis in WT and NHEJ defective, XLF, cells after 
Fe ions irradiation.   
A) Classification of gH2AX cluster foci.  
48BR primary human fibroblast cells were irradiated with 1 Gy Fe ions vertically and 
stained with gH2AX and DAPI. gH2AX cluster foci was visualized with Delta vision 
microscope. gH2AX cluster foci were categorised as 1-2, 3-4, 5-6 and >7 foci per 
cluster as shown in left panel. The original images without labelling are shown in right 
panel.  
B) Higher complex gH2AX cluster foci are repaired with slow kinetics.  
48BR (WT) primary human fibroblast cells were irradiated with 1 Gy vertical Fe and 1 
Gy X-ray. Cells were fixed at 30 min and 24 hr post irradiation and stained with 
gH2AX and DAPI. To measure % of repair, the number of remaining cluster was 
normalized with that at 30 min post irradiation. DSB repair with lower complex gH2AX 
cluster foci (1-2 gH2AX foci per cluster) shows faster kinetics compared to higher 
complex cluster. *gH2AX cluster foci with 5-6 and >7 foci were not observed at 30 min 
after X-rays. 
C) DSB repair requires NHEJ in G0/G1 cells following exposure to Fe ions as well as 
X-rays. 
48BR (WT) primary human fibroblast and P2 (XLF) hTERT cells were irradiated with 
1 Gy vertical Fe and 1 Gy X-rays. gH2AX cluster foci analysis was carried out at 0.5, 2 
and 24 hr after irradiation. 48BR primary human fibroblast and XLF (P2) hTERT cells 
were arrested in G0/G1 for >7 days after 100% confluent (A-C). >100 foci in two 
independent experiments was analysed (B-C). 
 
Figure 3. Analysis of in vivo track structure after horizontal Fe ions irradiation. 
A) Typical image of gH2AX foci track after horizontal Fe ions. 
Cells were irradiated with 1 Gy Fe ions horizontally. Cells were fixed at 30 min and 
stained with gH2AX and DAPI.  
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B) Measurement of width of track after horizontal Fe ions. 
48BR (WT) primary human fibroblast cells were irradiated with 1 Gy Fe ions 
horizontally. Cells were fixed at 30 min and stained with gH2AX and DAPI. The width 
of gH2AX cluster foci from edge to edge in track was measured using ImageJ software. 
C) Measurement of width per cluster after horizontal Fe ions. 
The width of cluster foci from edge to edge in cluster in 48BR (WT) cells was measured 
at 30 min after horizontal Fe ions irradiation. The longest diameter in gH2AX foci was 
measured at 30 min after 1 Gy X-rays. 
D) Physics graph. 
E) Distribution of gH2AX cluster foci at non-track region. 
48BR (WT) primary human fibroblast cells were irradiated with 1 Gy Fe ions 
horizontally. Cells were fixed at 30 min and stained with gH2AX and DAPI. The 
distance of gH2AX foci from the main track is shown in the box and plots. The middle 
bar indicates the median in the top panel. The relationship between the distance from 
the main track and the number of gH2AX foci per cluster is shown in the scatter plot in 
the bottom panel. >100 foci at non-track region were analysed from two independent 
experiments.  
F) The rate of repair in gH2AX foci at non-track region. 
gH2AX foci were enumerated in 48BR (WT) primary and XLF hTERT cells following 
exposure to 1Gy horizontal Fe ions irradiation. Error bars represent the standard error of 
the mean (SEM) from 2 independent experiments. The quantification was carried out 
with combining two independent experiments (B-C and E-F). Cell with a single track 
were chosen for gH2AX track analysis (B-C and E-F). 
 
Figure 4. Comparison of gH2AX foci cluster between horizontal and vertical Fe 
ions irradiation. 
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48BR (WT) primary human fibroblast and P2 (XLF) G0/G1 arrested cells were 
irradiated with 1 Gy Fe ions horizontally and vertically. gH2AX foci were analysed 
with Delta Vision deconvolution imaging and with categorization as shown in Figure 2. 
The quantification was performed with combining two independent experiments 
  
Figure 5. Rate of DSB repair after Fe ions irradiation in 48BR and XLF cells. 
A) The number of gH2AX cluster foci after Fe ions and X-rays. 
gH2AX foci were enumerated in 48BR (WT) primary and XLF hTERT cells following 
exposure to 1 Gy X-rays, vertical and horizontal 1 Gy Fe ions. After horizontal Fe ions, 
the number of gH2AX foci was enumerated from 8 to 96 hr, since it is too difficult to 
distinguish individual cluster at earlier time points. To verify the similar levels of 
induction between cell lines after horizontal Fe ions, the track length per cell was 
measured in 48BR and XLF cells (Supplemental Figure). 
B) Percentage of rate of gH2AX cluster foci disappearance after Fe ions and X-rays. 
The number of gH2AX cluster foci, which is obtained in panel A, was normalized with 
the number at 30 min post irradiation. Error bars represent the standard error of the 
mean (SEM) from 2 independent experiments (A-B). 
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Damaging agent Type of lesion/DNA
alteration
Repair mechanism
Endogenous DNA damage
Depurination AP site NER
Alkylation Base modification NER
Cytosine deamination Base transition BER
Oxidation 8oxoG BER
dNTP misincorporation
during replication
Base transition BER
Replication fork stalling SSB
DSB
SSB repair
HR
Meiosis DSB HR
V(D)J recombination DSB NHEJ
Exogenous DNA damage
MMS (Alkylating agent) Alkylating agent
MMC Covalently crosslinks bases ICL, FA
CPT Topoisomerase I inhibitor SSB repair or HR
Etoposide Topoisomerase II inhibitor HR
IR Various DNA lesions SSB, DSB, plus others
UV Thymine dimers, 6-4 photo-
products, cyclobutane dimers
NER, HR
Table 1.1: DNA lesions generated by endogenous and exogenous sources of DNA
damage, and the main repair pathway employed to deal with each lesion type. AP:
apurine/apyrimidine, NER: nucleotide excision repair, BER: base excision repair, SSB:
single strand break repair, DSB: double strand break repair, HR: homologous
recombination, NHEJ: non-homologous end joining, MMS: methyl methanesulfonate,
MMC: mitomycin C, CPT: camptothecin, ICL: interstrand crosslink repair, FA: fanconi
anaemia pathway, IR: ionizing radiation, UV: ultra violet light.
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DDR mechanism Type of lesion Repair proteins
Mismatch repair 
(MMR)
DNA mismatches, 
insertions and 
deletions arising 
from DNA replication
MSH2 (recognises mismatch),
MLH1 (binds hemimethylated daughter and nicks DNA)
EXO1 (5’-3’ exonuclease)
Polymerase δ and ε
RFC (Replication Factor C, is a 5 subunit complex that binds 3’ 
termini DNA  and using ATP loads PCNA)
PCNA (Proliferating Cell Nulcear Antigen acts as a processivity 
factor for DNA pol δ)
RPA (Replication Protein A, protects ss DNA ends)
Ligase I
Base excision repair 
(BER)
Abnormal DNA 
bases, base adducts,
Oxidative damage
Abortive 
topoisomerase I 
damage
DNA glycosylase (recognizes damaged base and removes base to 
form an AP site (a site that has neither a purine or pyrimidine base),
APE1 endonulcease (cleaves at AP site)
DNA polymerases β, δ, ε
Flap endonulcease FEN1 (long patch repair generates a flap which 
is removed by FEN1)
Ligase I or III
Single strand break 
repair (SSBR)
Single stranded 
breaks
PARP-1,2 (recognise SSB and adds poly ADP-ribose chains)
DNA glycosylase 
APE1 endonuclease
DNA polymerases β, δ, ε
FEN1 (Flap endonulcease )
XRCC1 (accessory factor that interacts with PARP2, DNA ligase III & 
pol β)
PNK (Polynucleotide Kinase - transfers a phosphate to the free 
hyroxyl end of 5’ DNA to ready the DNA for ligation)
APTX (Apratxin)
Ligase I or III
Nucleotide excision  
repair (NER)
Bulky base adducts
UV photo products
RNA polymerase II
XPC, DDB1/2 recognise distorted base
CSA & CSB bind some lesions during TC-NER
TFIIH subunits XPB & XPD (helicases) unwind DNA
XPG (3’ endonuclease
XPF & ERCC1 (generate a 5’ nick)
Removal of ss DNA with a 25-30 nucleotide gap
DNA polymerases δ or ε fill the gap & PCNA
RPA
Ligase I
Non Homologous
End Joining (NHEJ)
DSBs
V(D)J recombination
CSR
Ku (recognizes end termini)
DNA-PKcs (binds and autophosphorylates at DSB inducing end 
termini exposure to processing enzymes or ligases)
Artemis (endonclease that processes ends refractory to ligation)
XRCC4, XLF, Ligase IV (ligation complex)
Homologous 
recombination (HR)
DSBs
Stalled replication
forks
Meiotic 
recombination
Abortive topo II 
damage
DNA cross links
MRN, CtIP (exonucleases that generate ss DNA end termini)
RPA
RAD51, RAD52(protein filament which invades sister chromatid in 
search of homologous template)
BRCA1/2
FEN1
DNA polymerases
Fanconi anaemia 
(FA)
DNA cross links FANC-A,B,C,E,F,G,L&M (core complex which catalyzes the mono-Ub 
and subsequent activation of FANCD2 & FANC1)
FANCD2 & FANC1 (Following Ub these proteins are recruited to 
chromatin where they interact with BRCA1/2 and channel repair 
through HR)
HR proteins
Table 1.2: DNA repair pathways and components.
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Syndrome Mutated genes DDR defect Phenotype
LIG 4 syndrome LIG4 NHEJ Radiosensitive
Microcephaly
Immunodeficiency 
Delayed growth
Radiation severe –
combined 
immunodeficiency 
disorder (RS-SCID)
ARTEMIS NHEJ Immunodeficiency
Radiosensitive
Ataxia telangiectasia (A-T) ATM Damage signalling
DSB repair
Ataxia
Cerebellar degeneration
Immunodeficiency
Ataxia telangiectasia like 
disorder (A-TLD)
MRE11 Damage signalling
DSB repair
Ataxia
Cerebellar degeneration
Immunodeficiency
Nijmegen breakage 
syndrome (NBS)
NBS1 Damage signalling
DSB repair
Microcephaly
Growth retardation
Immunodeficiency
Nijmegen breakage like 
disorder  (NBSLD)
RAD50 Damage signalling
DSB repair
Microcephaly
Growth retardation
Immunodeficiency
Seckel syndrome (SS) ATR
PCNT
Damage signalling
DSB repair
Microcephaly
Severe primordial  
proportionate growth 
retardation
Table 1.3: Human disorders associated with defective DDR.
LIG 4 syndrome is caused by hypomorphic mutations in the NHEJ ligase, ligase
IV (O’Driscoll et al., 2001). LIG 4 patients display severe immunodeficiency due
to an inability to repair DSBs induced during V(D)J recombination (Taccioli et
al., 1993). LIG 4 patients are also radiosensitive as a consequence of
incomplete DSB ligation during NHEJ repair. Like LIG 4 syndrome, RS-SCID
patients ,which have mutations in Artemis, are also radiosensitive and
immunodeficient, which is reflective of a role of Artemis in NHEJ (Taccioli et
al., 1993). A-T is a neurodegenerate disorder caused by mutations in ATM
(Chun & Gatti, 2004). Progressive loss of Purkinje neurons in the cerebellum
(the region of brain involved in balance and co-ordination) of A-T patients
results in ataxia (Borghesani et al., 2000). A-TLD is caused by mutation in the
MRN component, MRE11. A-TLD patients show a delayed onset of ataxia
compared to A-T patients, with no cancer predisposition (Stewart et al., 1999).
Mutations in another component of the MRN complex, NDB1, results in NBS.
NBS is characterized by microcephaly and growth retardation (Mutations in
RAD50, a further component of the MRN complex, results in NBSLD, which is
phenotypically similar to NBS. SS is caused by mutations in ATR or PCNT, and is
characterized by proportionate growth retardation, severe microcephaly and
skeletal abnormalities (Seckel & Thomas, 1960).
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Figure 1.1 : The major DSB repair pathways
(A) NHEJ: The heterodimer Ku rapidly binds DSB ends. Ku promotes repair by NHEJ by recruiting DNA-
PKcs. Autophosphorylation of DNA-PKcs at multiple DNA-PKcs amino clusters induces remodelling at
the DSB end, which exposes the damage termini for end processing. Ends refractory to direct ligation
are processed by the endonuclease Artemis. The ligation complex composed of XRCC4, Ligase 4 and XLF
mediate DNA ligation. (B) HR: The MRN complex competes with Ku for the DSB end. MRN binding
initiates resection together with CtIP to promote HR in S and G2 phase (You & Bailis, 2010. The
endonuclease CtIP interacts with BRCA1 and the MRN complex (Huen et al., 2010). BRCA1 ubiquitinates
CtIP and facilitates CtIP’s association with damage sites (Huen et al., 2010). ATM controls resection by
activating CtIP via phosphorylation. 53BP1 has an inhibitory role on resection possibly by blocking end
termini (Bunting et al., 2010). Resection generated 3’ ssDNA ends are coated with RPA. ATRIP binds RPA
and localizes ATR at the site of the DSB. ATR phosphorylates and activates Chk1, which contributes to
checkpoint arrest. RPA is displaced from 3’ ss ends by BRCA2, and RAD51 filaments are assembled
(West, 2003). Rad51 filaments invade the homologous DNA strand in search for a homologous template
to use for repair. D loop structures or Holiday junctions formed after strand invasion can be cleaved by
a host of nucleases.
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Figure 1.2: Protein domain architecture and phosphomotifs for DDR proteins 
and checkpoint kinases. Forkhead associated domain (FHA), SQ/TQ clustered 
(SCD), kinase domain (KINASE), BRCA1 C-terminus domain (BRCT). See 1.4 for 
details.
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Figure 1.3: The ubiquitination system
Step one in the ubiquitination reaction involves the transfer of ubiquitin to the
active site cysteine residue of an E1 ubiquitin ligase, a reaction which requires
ATP. In this reaction, the C-terminus of ubiquitin becomes linked to the E1
cysteine sulfhydryl group by a thioester linkage. Step two involves the transfer of
ubiquitin from the E1 ubiquitin enzyme to the active site of the E2 ubiquitin
conjugating enzyme via a transesterification reaction. Next a E3 ubiquitin enzyme
bridges the association of the E2 enzyme with its target substrate. Finally an
isopeptide bond is formed between a lysine residue on the target protein and the
C-terminal glycine of ubiquitin (reviewed in Hershko & Ciechanover, 1998).
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Figure 1.4: ATM dependent signalling events in response to IR.
1. After IR, H2AX is phosphorylated by ATM at Ser139. 2. MDC1 directly binds
H2AX via it’s BRCT domain. 3. MRN is recruited via association with the FHA
and BRCT domains of Nbs1 with MDC1. 4. Nbs1 also interacts with ATM,
leading to further recruitment of ATM, which results in an auto-activatory loop.
5. ATM phosphorylates MDC1, which recruits the E3 ubiquitin ligase RNF8 via
its FHA domain. HERC2 mediates RNF8 and UBC13 association which promotes
further K63 Ub chain synthesis. 6. RNF168-UBC13 recognises RNF8 mediated
ubiquitin (Ub) chains. RNF168 acts with UBC13 to amplify the RNF8 dependent
histone ubiquitination by targeting H2A histones and promoting further
formation of lysine 63 linked Ub conjugates. 7. RAP80 binds K63 ubiquitin
chains via a ubiquitin interacting motif (UIM). RAP80 recruits abraxas which
interacts with BRCA1 via its BRCT domain. PIAS1/4 on association with UBC9
mediates the SUMOylation of BRCA1, which stimulates BRCA1’s Ub ligase
activity to further promote Ub chain synthesis. 8. Recruitment of BRCA1 leads
to BACH1 recruitment (DNA helicase) and CtIP (exonuclease), both which
channel for DSB repair. 9. 53BP1 is subsequently recruited following chromatin
ubiquitination. However 53BP1 contains no ubiquitin interacting motifs. It’s
recruitment is likely dependent on chromatin remodelling events initiated after
chromatin ubiquitination which expose residues required for 53BP1 binding.
53BP1 binds methyl residues via it’s tudor domain. 53BP1 recruitment
channels signalling towards DSB repair.
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Figure 1.5: ATR dependent Chk1 activation
1. ssDNA is coated by RPA. 2. ATR recognises these regions through ATRIP. 3. Rad17
binds and recruits the Rad9-Rad1-Hus1 (9-1-1) complex (Cortez et al., 2001). 4. The
9-1-1 complex brings TOPBP1 which is required for optimal ATR activation (Kumagou
et al., 2006). 5. ATR phosphorylates Chk1 at Ser317 and Ser345 via claspin (Kumagai
and Durphy, 2000). 6. Phosphorylated Chk1 is released from chromatin where it can
then phosphorylate CDC25 (protein phosphatase) proteins inhibiting their activity
and marking them for ubiquitin mediated proteolysis by β-TrCP. Loss of CDC25
activity induces cell cycle checkpoint arrest. ATM and ATR function together in
response to DSBs in G2. ATM and the MRN complex are required to initiate
resection in G2 to form ssDNA substrate to initiate ATR activation (Jazayer et al.,
2006).
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Function Phase Protein
Cyclin dependent kinases 
(CDKs)
Protein kinases that 
control cell cycle 
progression on association 
with cyclins
G1 Cdk4, Cdk6
G1/S, S Cdk2
G2/M Cdk1
Cyclins Proteins that control CDK 
activity
G1 Cyclin D1, D2, D3
(bind Cdk4 or Cdk6)
G1/S Cyclin E
(binds Cdk2)
S Cyclin A1 & A2
(Bind Cdk2, Cdk1)
M Cyclin B1 & B2
(bind Cdk1)
Figure 1.6: The cell cycle checkpoints
G1: In the absence of DNA damage (black arrows), CDC25A removes the inhibitory phosphorylation on CDK4. This
enables Rb and E2F to dissociate, allowing E2F to function as a transcription factor, and ready the cell for DNA
synthesis. In the presence of DNA damage (red arrows), two distinct pathways function to initiate checkpoint
arrest. One pathway involves the phosphorylation p53 and its negative regulator MDM2 by ATM and Chk2,
causing p53 stabilization and activation. p53 up-regulates the transcription of the CDK inhibitor p21. p21 inhibits
activation of CDK complexes. Without active CDK complexes, the transcription factor E2F remains sequestered by
Rb and cell cycle progression is halted. Since this pathway is dependent on transcription it likely takes several
hours before fully activated and is likely to be important for maintenance of G1 arrest. The second pathway is
dependent on posttranslational modifications such as phosphorylation and is activated more rapidly. During this
pathway, Chk2 phosphorylates CDC25A targeting it for degradation. The inhibitory phosphorylation on CDK4
remains, and E2F remains sequestered by Rb, therefore halting cell cycle progression. S: In the absence of DNA
damage (black arrows), CDC25A removes the inhibitory phosphorylations on CDK2. This enables CDK2/cyclin A to
mediate the loading of Ori binding factor CDC45 to origins to initiate DNA synthesis. In response to DNA damage
(red arrows), CDC25A is phosphorylated at Ser123, Ser178, Ser276 and Ser292 by ATM, Chk1 or Chk2, marking
CDC25A for degradation. Degradation of CDC25A means the inhibitory phosphorylations at Thr14 and Tyr15 on
CDK2 remain, which prevents loading of CDC45 to origins and prevents DNA synthesis. G2/M: For transition into
mitosis (black arrows), the inhibitory phosphorylations at Thr14 and Tyr15 on CDK1 which are carried out by wee1
and Myt kinases must be removed by CDC25. Following removal of these phosphorylations, CDK1 can associate
with cyclin B and drive cell cycle progression. In the presence of DNA damage (red arrows), Chk1 and Chk2
phosphorylate CDC25 at Ser216, which induces the binding of 14-3-3 proteins to CDC25 sequestering it in the
cytoplasm and inhibiting cell cycle progression.
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P
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Complex Function
Subfamily INO80
INO80 ATP dependent nucleosome remodeller that restores chromatin architecture after 
UV damage by removing bulky photo-products (Sarkar et al, 2010). Involved in 
nucleosomal spacing (Udugama et al, 2010).
Arp5, Arp8
(Actin related proteins)
Form part of the cytoskeleton. Involved in ATP dependent chromatin remodelling
Subfamily SWRI
Tip60 Acetyltransferase – adds acetyl groups to histones. Has been shown to be  important 
for ATM activation (Sun et al, 2009). 
P400 Contains an ATPase chromatin remodelling subunit. Forms complexes with other 
remodelling complexes.
TTRAP
(TRAF & TNF receptor 
associated protein)
Cation dependent phosphodiesterase. On association with CD40, TNF & TRAFs 
inhibits nuclear factor kappa β (NFKβ) activation. Structurally similar to APE1 
endonulcease and functions in DNA repair (Hu et al, 2000). Also associates with 
Tip60.
ING3
(Inhibitor of growth 
family, member 3)
Contains a PHD finger, a common motif often involved in chromatin remodelling
Subfamily ACF/CHARAC
ACF
(Asymmetric crying faces)
ATP dependent chromatin remodeller. Has a role in nucleosome spacing (Racki et al, 
2009).
SNF2H Has helicase and ATPase activity, regulates transcription by altering chromatin 
structure. 
Subfamily Mi-2/CHD
NuRD
(Nucleosome 
remodelling & histone 
deactylation)
A complex containing histone deactylation activity and ATP dependent chromatin 
remodelling (Kunert & Brehm, 2009).
CHD3 (Mi-2α)
CHD4 (Mi-2β)
(Chromodomain-
helicase-DNA binding)
Contains an ATPase domain followed by two chromodomains (a chromatin binding 
domain that often binds methylated residues and is often associated with  
heterochromatin building factors). Important for differentiation and development. 
HDAC1
HDAC2
(Histone deacetylase 1/ 
2)
Enzymes that remove acetyl groups from lysine residues on histones.
RbAp46
(Rb-associated protein 
46)
Component of the histone deacetylase complex that  physically interacts with Rb. 
Also interacts with the NuRD complex. Regulatory subunit that links cell cycle 
progression, DNA repair and chromatin remodelling. 
Subfamily SWI/SNF
BRG1
(brahma related gene 1)
A protein containing helicase and ATPase activity. Can bind BRCA1 and HP1 (Nielsen 
et al,  2002). Regulates chromatin structure. 
Table 1.4: Chromatin remodelling complexes.
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KRAB
Zn
NuRD
HDAC1/2
KAP-1
PHD
Bromo SUMO
SUMO
CHD3
SETDB1
AcMeMeMeMe
Figure 3.1: KAP-1 and heterochromatin formation
KAP-1 is a HC associated protein that acts as a scaffold for the recruitment of
repressor machinery. The associated KRAB-Zinc finger domain facilitates the binding of
KAP-1 to DNA. The C-terminus of KAP-1 contains an HP1 interaction domain, a PHD
domain and a bromodomain. Bromodomains recognise acetylated lysines on Histone
H3 and H4 (Mujtaba et al., 2007). The PHD domain binds the SUMO E3 ligase Ubc9,
and directs SUMO conjugation of the bromodomain. SUMOylation at the
bromodomain of KAP-1 is recognized by the histone deacetylase complex NuRD via
CHD3 and the histone methyltransferase SETDB1. SETDB1 and CHD3 bind the SUMO
modified KAP-1 via SUMO interacting motifs (SIMs). These proteins modify chromatin
with repressive marks to establish a silenced heterochromatin superstructure.
Mutations in either the PHD or bromodomain compromises the association of KAP-1
with CHD3 and SETB1, and relieves transcriptional repression (Ivanov et al., 2007).
Repression is relieved by phosphorylation of KAP-1 by ATM. ATM phosphorylates the
C-terminus of KAP-1, which impedes the interaction between the SUMOylated
bromodomain of KAP-1 and CHD3 (Goodarzi et al., manuscript submitted).
RING B box B box Coiled-Coil PHD Bromodomain
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MBD TRD
NLS
730 C>T (1) 1155 del (2)
(1) GM16548 (Rett, primary fibroblast): non sense mutation
(2) GM11272 (Rett, primary fibroblast): frame shift mutation
A) MeCP2
PWWP Cy3-rich 
ATRX
Domain PHD I IV VI VIII XI X
Regulatory N-terminal domain Catalytic C-terminal domain
B) DNMT3B
1807 
G>A (1)
744 
G>A (1)
(1) GM08714 (ICF, B-lymphocyte):         744   = novel splice acceptor site + 9 bp insertion
1807 = point mutation
Figure 3.2: Schematic representation of MeCP2 and DNMT3B gene structures.
A: MeCP2: MeCP2 maps to the long arm of the X chromosome on position q28 and undergoes X
inactivation. The gene has 4 exons. MeCP2 is an abundant, ubiquitously expressed nuclear protein
of 486 aa most frequently encoded by exon 2,3 and 4. A second isoform also exists, MeCP2B,
which encodes exon 1,3 and 4. MeCP2 protein contains 4 functional domains: an 85 aa methyl
binding domain (MBD), an 104 aa transcriptional repressor domain (TRD) which interacts with the
co-repressor Sin3A, a nuclear localization sequence (NLS) for nuclear export and a C-terminal
segment which facilitates binding to the nucleosome core (reviewed in Matarazzo et al., 2009).
Rett syndrome cell line GM16548 contains a non-sense mutation located in the catalytic domain.
Rett syndrome cell line GM11272 contains a deletion at aa 1155 resulting in frame shift mutation.
Details on Rett syndrome patient GM11271 mutation are unavailable. B: DNMT3B: DNMT3B maps
to the long arm of chromosome 20 at position q11.2 (Xie et al., 1999). DNMT3B spans
approximately 47 kb and contains 24 exons, 6 of which are alternatively spliced (Xie et al., 1999).
DNMT3B is composed of two large regulatory domains. The first being the N-terminal domain
which is composed of a chromatin binding PWWP, a zinc finger DNA binding cy3-rich ATRX
domain, and also a polybromo homology domain (PHD) like motif. The second domain is the
catalytic C-terminal which is composed of 6 motifs (I – X) (reviewed in Ehrlich et al., 2008). ICF
syndrome cell line GM08714 is a compound heterozygote. One allele has a G>A transition at 1807,
which results in a Ala to Thr substitution at codon 603. The second allele has a G>A substitution
which results in generation of a novel splice acceptor site and a 9 bp insertion in the mRNA.
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MeCP2
Me
Sin3A
HDAC
Me
MeCP2
Sin3A
HDAC
Me
Me
Ac AcAcAc
Figure 3.3: MeCP2 and transcriptional silencing
Transcription is suppressed in promoter regions containing methylated CpGs that are
bound by MeCP2 (methyl-CpG-binding protein 2). MeCP2 binds methylated DNA and
recruits chromatin-remodelling complexes that contain Sin3A (a transcriptional co-
repressor) and histone deacetylases (HDACs). This leads to chromatin condensation
owing to histone deacetylation, which results in a limited accessibility of the
transcriptional machinery to promoter regions. When MeCP2 is not bound to
methylated DNA the complex(es) that usually contains MeCP2, SIN3A and/or HDACs
are not recruited, and the chromatin remains in a transcriptionally active
configuration.
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N-terminal 
head
Prelamin A
Coiled-coil rod domain C-terminal tail
CAAX
Progerin
NLS
C     O     CH3
O
Progerin
2034 G>A (1)
(1) AG10801 (HGPS, B-lymphocyte):  cryptic splice site activation
Figure 3.4: A schematic representation of prelamin A maturation into progerin. Lamin
A is synthesized as a 664 aa precursor protein called prelamin A. Prelamin A contains a C-
terminal CAAX aa motif that undergoes farnesylation. Mature lamin A contains no
farnesyl modification. Progerin, the mutant form of prelamin A, retains the C-terminal
CAAX motif either due to aberrant splicing as a consequence of splice site loss through
mutation or mutations in Zmpste24, which is the endopeptiase encoding gene which
encodes the protease responsible for farnesyl production (reviewed in Kudlow et al.,
2007). HGPS cell line AG10801 contains a de novo single base substitution G>A change at
nucleotide 2034, which results in a change in exon 11 of the lamin A gene. This
substitution creates a cryptic splice site which results in skipping 150 bp of the LMNA
mRNA leading to deletion of 50 amino acids from the protein (Erikson et al., 2003).
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Figure 3.5: A schematic overview representing DNA damage signalling responses that function to initiate
G2/M checkpoint arrest. DSBs generated following exposure to IR, oxidative stress or alkalayting agents
activate ATM. Active ATM associated with DSBs via the MRN complex (Shiloh et al., 2003). ATM
phosphorylates Chk2 on residue Thr68 which stimulates Chk2 autophosphorylation at residues Thr383 and
Thr387, subsequently resulting in Chk2 kinase activation. ATM specifically and exclusively activates Chk2 at the
damage site (Lukas et al., 2003). Active Chk2 phosphorylates CDC25C at Ser216, creating a binding site for 14-
3-3 proteins. 14-3-3 bound CDC25C is catalytically inhibited or sequestered in the cytoplasm, where it is unable
to activate cdc2/cyclin B. As a consequence cdc2/cyclin B remains phosphorylated and inactive. The G2/M
checkpoint is then arrested. DSBs generated by replication associated damage such as stalled or collapsed
replication forks or following treatment with crosslinking agents such as HU or CPT, generate ssDNA overhangs
which ssDNA binding protein RPA can bind. RPA coated DNA recruits ATRIP along with ATR to the site of a
lesion. Active ATR phosphorylates Chk1 at Ser317, resulting in Chk1 autophosphoryaltion at Ser345 and Ser296
and subsequent activation. Chk1 can also function like Chk2 to phosphorylate CDC25C at ser216 and mediate
G2/M checkpoint arrest via inhibiting the dephosphorylation of cdc2/cyclin B. DSBs which undergo resection
prior to RPA binding require ATM activity upstream of this process. Here ATM can phosphorylate either or
both the MRN complex (Gatei et al., 2000, Stewart et al., 2001) and CtIP (Li et al., 2000) to initiate resection. In
this pathway of G2/M arrest, ATM acts up stream of ATR in the activation of Chk1. For sufficient signalling
mediated by Chk2 and Chk1 to initiate G2/M checkpoint arrest at least 15 DSBs are required.
RPA
ATR
cdc2/
cyclin B
(HU, CPT, stalled fork)
UV lesion/ replicative stress
Chk1
P
P
P
S317
S345
S296
CDC25C
P
S216
MRN
ATM
(IR, alkalating agent)
DSB
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NIH 3T3 cell
Figure 3.6: Visualization of heterochromatin by immunoflorescence
NIH 3T3 cells were immunostained for the heterochromatin marker TriMeK9
histone H3 (red) and DAPI (blue). DAPI dense chromocenters co-localize with
regions of heterochromatin identified by TriMeK9 staining. MeCP2 also co-
localizes with DAPI dense chromocenters.
TriMeK9 H3 MeCP2
DAPI DAPI
Region of 
heterochromatin 
identified by TriMeK9 
H3 enriched staining 
Chromocenter
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Figure 3.7: The size of IR induced γH2AX foci expansion at regions of heterochromatin
increases following KAP-1 knockdown. (A) NIH 3T3 murine cells were transfected with
control or KAP-1 siRNA for 48 hours. Cells were irradiated with 3 Gy IR and 30 minutes
later immunostained for γH2AX (green) and DAPI (blue). Using the Delta Vision
microscope, high resolution, deconvolved Z stack images were obtained. To analyze
quantitatively regions of γH2AX and DAPI overlap, the co-localization tool on Sorftworx
suite software was used. Red represents regions of strong DAPI (blue) and FITC (green)
overlap. (B) Picture panel represents a close up of the region outlined in yellow in (A).
(C) The relative size of γH2AX foci at regions of heterochromatin was assessed using
ImageJ software. (D) Image of knockdown efficiency. NIH 3T3 cell were treated with
KAP-1 siRNA as described in (A) and immunostained for KAP-1 (red) and DAPI (blue).
Results are representative of 3 independent experiments.
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Figure 3.8: The volume of γH2AX signal expansion at regions of heterochromatin increases
following KAP-1, MeCP2 or DNMT3B knockdown. (A) Representative images of NIH 3T3 cells
following treatment with either control, KAP-1 or MeCP2 siRNA for 48 hours. 3D images were
generated using the Delta vision softworx software. Pink represents regions of strong γH2AX and
DAPI co-localization. γH2AX (green) and DAPI (blue) (B) Quantification of the volume of strong
γH2AX and DAPI overlap was performed using Huygens co-localization analyzer software in cells
treated as in (A). Values were normalized to the maximum volume of over-lap which was
observed following MeCP2 knockdown. 100 chromocenters were analyzed per cell type. Results
are representative of 3 independent experiments.
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Figure 3.9: IR induced γH2AX signal intensity increases following KAP-1 knockdown.
(A) To analyze γH2AX and DAPI signal intensity the Zeiss Axioplane microscope was used
and exposure times kept constant. To measure signal intensity, each γH2AX foci and
corresponding DAPI region was analyzed using ImageJ software. (B) NIH 3T3 cells were
treated with either control or KAP-1 siRNA for 48 hours. 30 minutes post 3 Gy IR, cells
were fixed and immunostained for γH2AX and DAPI. The x axis represents DAPI signal
intensity and the y axis represents γH2AX signal intensity.
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Figure 3.10: IR induced γH2AX foci form with faster kinetics in NIH 3T3 cells
following KAP-1 knockdown. NIH 3T3 cells were treated with either control or KAP-1
siRNA for 48 hours. Following transfection, cells were irradiated with 1 Gy IR and
fixed and immunostained for γH2AX at indicated time points. γH2AX foci co-localizing
with DAPI dense regions (chromocenters) were scored as heterochromatin (HC) DSBs.
γH2AX foci not co-localizing with DAPI dense regions were scored as euchromatin
(EC) DSBs. Results are representative of 3 independent experiments.
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Figure 3.11: MeCP2 knockdown significantly affects the size of DAPI dense
chromocentres in NIH 3T3 cells. (A) Representative delta vision images of NIH 3T3 cells
following 48 hour incubation with either control, KAP-1, MeCP2 or DNMT3B siRNA. Cells
were stained with DAPI (blue). (B) DAPI dense chromocentre intensity was analyzed
using high resolution Delta vision images using Image J software. P values were
calculated using a two sample t test assuming unequal variances. KAP-1: P(T<=t) =
0.073, MeCP2: P(T<=t) = 0.007, DNMT3B: P(T<=t) = 0.921.
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Figure 3.12: The size of IR induced γH2AX foci expansion at regions of
heterochromatin increases following MeCP2 knockdown. (A) NIH 3T3 murine cells
were transfected with control or MeCP2 siRNA for 48 hours. Cells were irradiated
with 3 Gy IR and 30 minutes later immunostained for γH2AX (green) and DAPI (blue).
Using the Delta Vision microscope, high resolution, deconvolved Z stack images were
obtained. To analyze quantitatively regions of γH2AX and DAPI overlap, Sorftworx
suite software was used. Red represents regions of strong DAPI (blue) and FITC
(green) overlap. (B) Picture panel represent a close up of the region outlined in yellow
in (A). (C) The relative size of γH2AX foci at regions of heterochromatin was assessed
using ImageJ software. (D) Image showing knockdown efficiency. NIH 3T3 cell were
treated with MeCP2 siRNA as described in (A) and immunostained for MeCP2 (red)
and DAPI (blue). Results are representative of 3 independent experiments.
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Figure 3.13: The size of IR induced γH2AX foci expansion at regions of
heterochromatin increases following DNMT3B knockdown. (A) NIH 3T3 murine cells
were transfected with control or DNMT3B siRNA for 48 hours. Cells were irradiated with
3 Gy IR and 30 minutes later immunostained for γH2AX (green) and DAPI (blue). Using
the Delta Vision microscope, high resolution, deconvolved Z stack images were
obtained. To analyze quantitatively regions of γH2AX and DAPI overlap, Sorftworx suite
software was used. Red represents regions of strong DAPI (blue) and FITC (green)
overlap. (B) Picture panel represent a close up of the region outlined in yellow in (A). (C)
The relative size of γH2AX foci at regions of heterochromatin was assessed using ImageJ
software. (D) NIH 3T3 cell were treated with DNMT3B siRNA as described in (A) and
immunostained for DNMT3B (red) and DAPI (blue). Results are representative of 3
independent experiments.
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Figure 3.14: IR induced γH2AX foci form with faster kinetics in NIH 3T3 cells
following MeCP2 or DNMT3B knockdown. NIH 3T3 cells were treated with either
control, MeCP2 or DNMT3B siRNA for 48 hours. Following transfection, cells were
irradiated with 1 Gy IR and fixed and immunostained for γH2AX at indicated time
points. γH2AX foci co-localizing with DAPI dense regions (chromocenters) were
scored as heterochromatin (HC) DSBs. γH2AX foci not co-localizing with DAPI dense
regions were scored as euchromatin (EC) DSBs. Results are representative of 3
independent experiments.
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Figure 3.15: IR induced γH2AX signal intensity increases following MeCP2 or DNMT3B
knockdown. NIH 3T3 cells were treated with either control, MeCP2 or DNMT3B siRNA
for 48 hours. Following transfection, cells were fixed and immunostained for γH2AX 30
minutes post 3 Gy IR. To analyze γH2AX and DAPI signal intensity the Zeiss xeoplane
microscope was used and exposure times kept constant. To measure signal intensity,
each γH2AX foci and corresponding DAPI region was analyzed using ImageJ software.
Black lines represent the median values. Statistical significance was determined using
Student’s two-tailed t test.
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Figure 3.16: Protein expression of ATM, ATR, Chk2, Chk1, Ku80 and p53 in Rett
syndrome patient GM16548 (Rett/MeCP2), GM11271 (Rett/MeCP2) and GM11272
(Rett/MeCP2) is normal. (A) Cycling populations of 48BR (WT), GM16548
(Rett/MeCP2), GM11271(Rett/MeCP2) and GM11272(Rett/MeCP2) primary fibroblast
cells were harvested for whole cell protein extract. 50 µg of extract was resolved on a
8% denaturing SDS gel. Larger molecular weight proteins (ATM and ATR) were
transferred to a nitrocellulose membrane at 12V overnight at 4 . The other molecular
weight proteins were transferred as described in materials and methods. Membranes
were immunoblotted for indicated antibodies. (B) Cell cycle profile analysis of
GM16548 (Rett/MeCP2) GM11271 (Rett/MeCP2) and GM11272 (Rett/MeCP2).
Cycling and contact inhibited (more than 10 days confluent) G1 arrested 48BR (WT),
and Rett syndrome (MeCP2) primary fibroblasts were prepared for FACS analysis as
described in materials and methods. Results are representative of three independent
experiments.
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Figure 3.17: (A) Rett syndrome patient cells display hyperactive ATM activation in
cycling cell populations following DNA damage. Cycling 48BR (WT), GM16548
(Rett/MeCP2), GM11271 (Rett/MeCP2) and GM1172 (Rett/MeCP2) primary fibroblasts
were irradiated with either 0 or 0.5 Gy IR and harvested 0.5 hr later. Whole cell extracts
were prepared and immunoblotted for indicated antibodies. (B) ATM and Chk2 activation
is also increased in G1 arrested Rett syndrome patient cells compared to WT cells
following DNA damage. G1 arrested, more than 10 days confluent, 48BR (WT) and
GM11272 (Rett/MeCP2) primary fibroblasts were irradiated with either 0, 0.5 or 3 Gy IR
and harvested at indicated time points post IR. Whole cell extracts were prepared and
immunoblotted for indicated antibodies. Blots are representative of 3 independent
experiments. 0 = no IR treatment.
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Figure 3.18: Rett syndrome cell lines exhibit enhanced ATM signalling after IR in G1
and G2 phase cells. Cycling 48BR (WT) and Rett syndrome (MeCP2) fibroblasts were
irradiated with indicated doses IR. 30 minutes post IR cells were fixed and
immunostained for pSer1981 ATM (red), DAPI (blue) and the G2 marker CENP-F
(green). Pan nuclear pSer1981 ATM signal intensity in G1 phase (CENP-F negative) cells
was analyzed using ImageJ software. (B) 48BR (WT) and Rett syndrome (MeCP2)
fibroblast cells were treated as in (A). Pan nuclear pS1981 ATM signal intensity in G2
phase (CENP-F positive) cells was analyzed using ImageJ software. Results are
representative of +/- SD of three independent experiments.
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Figure 3.19: ATM phosphorylation is hyperactive in G1 and G2 phase 48BR (WT)
primary cells knocked down for MeCP2. 48BR (WT) fibroblast cells were transfected
with either control or MeCP2 siRNA for 48 hours. Cell were irradiated with indicated
doses IR. 30 minutes post IR cells were fixed and immunostained for pSer1981 ATM
(red), DAPI (blue) and the G2 marker CENP-F (green). Pan nuclear pSer1981 ATM signal
intensity in G1 phase (CENP-F negative) cells was analyzed using ImageJ software. (B)
48BR (WT) fibroblast cells were treated as in (A). Pan nuclear pSer1981 ATM signal
intensity in G2 phase (CENP-F positive) cells was analyzed using ImageJ software.
Results are representative of +/- SD of three independent experiments.
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Figure 3.20: ATM activation is hyperactive in ICF (DNMT3B) syndrome
hTERT cells. Contact inhibited G1 arrested 1BR (WT) and ICF (DNMT3B) hTERT
cells were irradiated with either 0 or 0.5 Gy IR. Whole cell extracts were
prepared and immunoblotted with the indicated antibodies. Of note, when
over exposed the 0 hr signal for pSer1981 ATM activation in the ICF
(DNMT3B) hTERT cells was as pronounced as that observed in the 1BR (WT)
hTERT cells after 0.5 Gy IR.
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Figure 3.21: Rett syndrome patient cells initiate G2/M checkpoint arrest hyper-
sensitively following IR. (A) 48BR (WT), GM16548 (Rett/MeCP2), GM11271
(Rett/MeCP2) and GM11272 (Rett/MeCP2) primary fibroblast cells were grown on
cover slips for 48 hours and irradiated with indicated doses IR. 1 hour post IR, cells
were fixed and immunostained for pS10 histone H3 (mitotic marker). The number of
pS10 histone H3 positive cells were counted and normalized to the un-irradiated
control. (B) 48BR (WT) and GM11272 (Rett/MeCP2) fibroblasts were treated with
either control or MeCP2 siRNA for 24 hours, retransfected, and incubated with siRNA
for a further 48 hours. Cells were irradiated with indicated doses and IR and fixed and
immunostained for pS10 histone H3 1 hour later. No additive effect on checkpoint
sensitivity was observed following MeCP2 knockdown in GM11272 (Rett/MeCP2)
fibroblasts. Results represent the +/- SD of three experiments.
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Figure 3.22: MeCP2 and DNMT3B knockdown confers a hypersensitive G2/M
checkpoint arrest in NIH 3T3 cells following IR. (A) NIH 3T3 cells were transfected with
MeCP2 siRNA for 48 hours. Cells were irradiated with indicated doses IR. 1 hour post IR
cells were fixed and immunostained for pS10 histone H3. pS10 histone H3 positive cells
were scored and normalized to the un-irradiated control. Representative
immunofluorescent images of knockdown efficiency are shown: MeCP2 (red) and DAPI
(blue). (B) NIH 3T3 cells were treated with DNMT3B siRNA for 48 hours, cells were
treated as in (A). Western blot showing knockdown efficiency. Protein extracts were
harvested from cells transfected with either control or DNMT3B siRNA. 60 μg of whole
cell extract was immunoblotted for DNMT3B and Actin (loading control). Representative
immunofluorescence images are shown of knockdown efficiency: DNMT3B (red) and
DAPI (blue). Results are representative of three independent experiments.
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Figure 3.23: ICF (DNMT3B) syndrome and HGPS (Lamin A) cell lines also exhibit a
hyperactive G2/M checkpoint response following IR. (A) 1BR (WT) and PT3 (ICF) hTERT
cells were grown on cover slips for 48 hours and irradiated with indicated doses IR. 1 hour
post IR cells were fixed and immunostained for pS10 histone H3. The number of pS10
histone H3 positive cell were counted and normalized to the un-irradiated control. (B)
GM02188 (WT) and GM08714 (ICF) lymphoblast cells were treated as in (A). The number
of pS10 histone H3 positive cells were scored and normalized to the un-irradiated control.
(C) GM02188 (WT) and HGPS lymphoblast cells were irradiated with indicated doses IR
and fixed and immunostained for pS10 histone H3 1 hour later. The number of pS10
histone H3 positive cells were counted and normalized to the un-irradiated control.
Results represent the +/- SD of three experiments.
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Figure 4.1: Model showing the mechanisms contributing to G2/M checkpoint
arrest. In G2 phase, two DSB repair mechanisms exists, these being Non-
Homologous end Joining (NHEJ) and Homologous Recombination (HR). Around 80%
of DSB in G2 are repaired with fast kinetics by the core NHEJ machinery (Beucher et
al., 2009). DSBs repaired by NHEJ are unresected and signal via ATM to Chk2 to
initiate checkpoint arrest. A subcomponent (~20%) of DSBs in G2 undergo ATM
dependent resection, generating RPA coated ssDNA that signals via ATR to Chk1 to
mediate checkpoint arrest (Jazayeri et al., 2006). Resected DSBs are repaired with
slow kinetics by HR (Beucher et al., 2009). Therefore at late time points after IR,
arrest is mainly dependent on HR repair (Shibata et al., 2010). Therefore checkpoint
arrest is maintained by ATR dependent Chk1 activation at resected DSBs and
sustained ATM to Chk2 signalling at unrepaired DSBs (Shibata et al., 2010)
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Figure 4.2: DSB repair is normal in G1 phase Rett syndrome primary cells and
MeCP2 knockdown rescues the ATM dependent repair defect. (A) 48BR, Rett
syndrome patient (GM16548, GM11271 & GM11272) primary fibroblasts were
treated with -/+ ATMi 30 minutes prior to IR. Cells were irradiated with 3 Gy IR and
fixed at indicated time points. Numbers of γH2AX foci were scored. (B) Cells were
treated as in (A) with the addition of either control or MeCP2 siRNA for 48 hours
prior to -/+ ATMi treatment. All results represent the +/- SD of three independent
experiments.
ATMi
+ siMeCP2
48BR + siControl
GM16548
GM11271
GM11272 
48BR
24 hr
0
4
6
8
10
2
N
o
. o
f 
γH
2
A
X
 f
o
ci
 in
 G
1
 c
e
lls
N
o
. o
f 
γH
2
A
X
 f
o
ci
 in
 G
1
 c
e
lls
0
10
20
30
40
50
60
240.5
Time after 2 Gy IR (hr)
GM16548 (Rett/MeCP2)
GM11271 (Rett/MeCP2)
GM11272 (Rett/MeCP2) 
48BR (WT)
ATMi
N
o
. o
f 
γH
2
A
X
 f
o
ci
 in
 G
1
 c
e
lls
0
10
20
30
40
50
60
0 0.5 2 24
Time after 2 Gy IR (hr)
A
B
 
 
 
 
 
 
 
 
 
 
 
291 
 
0
10
20
30
40
50
60
70
0 2 8
A
ve
ra
ge
 n
u
m
b
e
r 
o
f 
γH
2
A
X
 f
o
ci
 in
 G
2
Time after 3 Gy IR (hrs)
48BR (WT)
GM16548 (Rett/MeCP2)
GM11271 (Rett/MeCP2)
GM11272 (Rett/MeCP2)
Figure 4.3: DSB repair is normal in G2 phase Rett syndrome primary cells (A)
48BR, Rett syndrome patient (GM16548, GM11271 & GM11272) primary
fibroblasts were irradiated with with 3 Gy IR and fixed at indicated time points.
Numbers of γH2AX foci were scored. All results represent the +/- SD of three
independent experiments.
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Figure 4.4: Rett and MeCP2 knockdown cells have a prolonged G2/M checkpoint
arrest (A) 48BR and Rett syndrome patient (GM11272) primary fibroblasts were
irradiated with 2 Gy IR, treated with aphidicolin (4µM) and fixed at indicated time
points. Cells were immunostained for pS10 histone H3. pS10 histone H3 positive
mitotic cells were scored and expressed as a percentage of the control mitotic
population. (B) 1BR hTERT cells were treated with either control or MeCP2 siRNA
for 48 hours. Following transfection, cells were irradiated with 2 Gy IR, treated with
aphidicolin (APH) and harvested at indicated time points. (C) Table of the average
percentage of mitotic cells (without normalization) after IR for each cell type. All
results represent the +/- SD of three experiments
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Figure 4.5: Rett, ICF and HPGS lymphoblastiod cells maintain a prolonged G2/M
checkpoint arrest. (A) GM02188 (WT), GM08714 (ICF/DNMT3B), GM16548
(Rett/MeCP2) and AG10801 (HGPS/LaminA) lymphoblastiod cells were irradiated
with 2 Gy IR and treated with aphidicolin (4µM) immediately after IR. At indicated
times after IR cells were harvested by cytospin and immunostained for pS10 histone
H3. pS10 histone H3 positive cells were scored and expressed as a percentage of the
control mitotic population. (B) Table of the average percentage of mitotic cells
(without normalization) after IR for each cell type. All results represent the +/- SD of
three experiments
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Figure 4.6: Hyperactive Chk1 activation in Rett syndrome patient GM11272 is
ATM dependent. 48BR and Rett syndrome (GM12272) patient primary fibroblast
cells were treated -/+ ATMi 30 minutes prior to IR. 1 hour post irradiating with
either 0 or 10 Gy IR, cells were fixed and immunostained for pSer345 Chk1 (red)
and DAPI (blue). Cells were also stained for CENP-F to select for G2 phase cells. 20
G2 phase cells were analyzed per condition. Results are representative of +/- SD of
three independent experiments. a.u. = arbitrary units.
0
20
40
60
80
100
120
A
ve
ra
ge
 p
Se
r3
4
5
 C
h
k1
 s
ig
n
a
l i
n
te
n
si
ty
 
(a
.u
.)
10 Gy IR
48BR
Rett
p
C
h
k1
-IR
D
A
P
I
10 Gy
- ATMi
48BR Rett 48BR Rett 48BR Rett 48BR Rett 
-IR 10 Gy
+ ATMi
10 Gy IR + ATMi
 
 
 
 
 
 
 
 
 
 
 
295 
 
Figure 4.7: pSer345 Chk1 phosphorylation is hyperactive in 48BR primary cells
knocked down for MeCP2. 48BR (WT) fibroblast cells were transfected with either
control or MeCP2 siRNA for 48 hours. Cell were irradiated with indicated doses IR. 1
hour post IR cells were fixed and immunostained for pSer345 Chk1 (red), DAPI (blue)
and the G2 marker CENP-F (green). Pan nuclear pSer345 Chk1 signal intensity in G2
phase (CENP-F positive) cells was analyzed using ImageJ software. 20 G2 phase cells
were analyzed per condition. Results are representative of +/- SD of three
independent experiments. a.u. = arbitrary units.
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Figure 4.8: RPA foci signal intensity is enhanced in Rett syndrome patient
cells(A) 48BR (WT) and Rett syndrome (GM11272) primary fibroblasts were
irradiated with 3 Gy (IR). 1 hour following IR, cells were pre-extracted using 0.2%
trition for 1 minute before fixing. Cells were immunostained for RPA (green),
53BP1 (red) and DAPI (blue). (B) Cells were treated as in (A). RPA signal intensity
was analyzed for foci which co-localized with 53BP1 using Image J software.
a.u. = arbitrary units.
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Figure 4.9: Rett syndrome cells have normal survival IR.
Radiosensitivity was assessed by colony survival analysis. 48BR (WT) and
Rett syndrome (GM11272) cells were trypsinzed, irradiated with indicated
doses IR and plated onto feeder cells prepared 24 hours earlier then left to
form colonies for 3 weeks. The radiosensitivity of AT3153 (A-T/ATM) is also
shown (take from M’Kacher et al., 2003).
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Figure 5.1: DSBs dependent on Artemis for repair reside within regions of
heterochromatin. (A) NIH 3T3 cells were treated with either control or Artemis A & B
siRNA oligo’s for 48 hours before irradiating cells with 3 Gy IR and harvesting at time points
indicated. Cells were fixed and immunostained for γH2AX (red) and DAPI (green). (B)
53BP1 knockdown in NIH 3T3 cells was confirmed by immunoflourescence. Cells were fixed
and stained for 53BP1 (red) 48 hours following transfection. (C) NIH 3T3 cells were treated
as in (A) with the indicated siRNA oligo’s and harvested at indicated time points. Total
γH2AX foci numbers were enumerated. More than 30 cells were randomly selected for
each condition. All results represent the +/- SD of three experiments
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Figure 5.2: More than 70% of unrepaired IR induced DNA double stranded breaks
are visibly associated with regions of heterochromatin in Artemis siRNA transfected
NIH 3T3 cells. (A) NIH 3T3 cells were treated with Artemis A & B siRNA oligo’s for 48
hours before irradiating cells with 3 Gy IR. Cells were fixed and harvested at indicated
time points. Total γH2AX foci numbers were counted. (B) yH2AX foci localizing with
dense DAPI staining regions (heterochromatin) were also scored. (C) NIH 3T3 cells
were treated as in (A). The total number of γH2AX foci associated with regions of
heterochromatin was counted for a minimum of 30 cells and the average of 3
experiments is shown. The percentage of breaks associated with heterochromatin has
been calculated.
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Figure 5.3: Phospho-KAP-1 co-localizes with late repairing γH2AX foci in Artemis
defective human cells. 1BR (WT) and CJ179 (Art) primary cells were grown on
cover-slips until confluent, irradiated with 3 Gy IR and harvested and indicated
time points. Cells were fixed and stained for pKAP-1 (red), γH2AX (green) and DAPI
(blue).
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Figure 5.4: Artemis dependent DSBs are enriched for the heterochromatic marker
Tri-Me K9 Histone H3. (A) First a suitable fixation condition was optimized for the
IP. Protein extracts were prepared as described in materials and methods from
CJ179 (Art) primary cells. Extracts were treated with indicated doses of PFA and
fixed for 3 minutes prior to resolving on a 8% denaturing SDS gel, followed by
commassie staining. 0.1% PFA was selected on the basis that no protein sample was
fixed in the well after this concentration. (B) Next the size of DNA fragments
generated after sonication was analysed. CJ179 (Art) primary cells were irradiated
with either 10 Gy (30 minute recovery) or 80 Gy (48 hour recovery) IR. Whole cell
DNA extracts (5 μg) were prepared as described in materials and methods and
resolved on an agarose gel. (C) Quantification of 3 separate γH2AX
immunoprecipitations in CJ179 (Art) primary cells. (D) CJ179 (Art) primary cells
were irradiated and harvested at indicated time points. Cells were lysed and
nucleosomes solubilized as described in materials and methods. Soluble
nucleosome extracts (60 µg) were blotted for γH2AX and trimethylated K9 of
histone 3 (Tri-Me K9 H3). γH2AX was immunoprecipitated from soluble nucleosome
extract, and blotted for γH2AX and Tri-Me K9 H3 (IP Histone γH2AX sample). All
results represent the +/- SD of three independent experiments
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Figure 5.5: IR induced KAP-1 dissociation from chromatin enriched fractions is
prolonged in Artemis defective cells. Confluent, contact inhibited wildtype or
Artemis MEFs were irradiated with either 0 or 40 Gy IR and harvested 8 hours later.
Cells were processed for chromatin fractionation as described in the materials and
methods. Cell extracts were resolved on a split 7.5% and 17.5% denaturing SDS gel
and immunoblotted for the indicated antibodies. Results are representative of three
independent experiments.
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Figure 5.6: KAP-1 knockdown does not alleviate the requirement for Artemis in
DSB repair. (A) A representative image of a CJ hTERT (Art) cell selected on the basis
of successful knockdown. 24 hours post 3 Gy IR, following a 48 hour KAP-1 siRNA
transfection incubation, cells were fixed and stained for KAP-1 (red), γH2AX (green)
and DAPI (blue). Both a successful (faint red) and unsuccessful (bright red) KAP-1
knockdown cell is shown. 100x magnification is shown (B) 48BR (WT) hTERT and CJ
(Art) hTERT cells were transfected with control or KAP-1 siRNA. At 48 hours post
transfection, cells were harvested and stained for KAP-1 (red) and DAPI (blue). 40x
magnification is shown.
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Figure 5.7: KAP-1 knockdown does not alleviate the requirement for Artemis in
DSB repair. (A) Representative images of γH2AX foci (green) in successfully KAP-1
knocked down hTERT cells. (B) hTERT cells were transfected as in (A). Cells were fixed
and stained for KAP-1, γH2AX and DAPI. Cells treated with ATMi were incubated with
the drug 30 minutes prior to IR. Numbers of γH2AX foci were scored. All results
represent the +/- SD of three experiments.
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Figure 5.8: KAP-1 knockdown alleviates the DSB repair defect observed in AT MEFs
but not Artemis defective MEFs. 48 hours following siRNA transfection, cells were
irradiated with 3 Gy IR. Cells were harvested at time points indicated following IR,
fixed and immunostained for KAP-1, γH2AX and DAPI. γH2AX foci were counted in
cells successfully knockdown for KAP-1. All results represent the +/- SD of three
independent experiments
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Figure 5.9: HDAC1 and HDAC2 knockdown does not alleviate the requirement for
Artemis in DSB repair. (A) Art-/- MEFs were transfected with KAP-1 or HDAC1/2 siRNA
for 48 hours. Cells were fixed and stained for KAP-1 (red) or HDAC2 (red) and DAPI
(blue). (B) 48 hours following siRNA transfection cells were irradiated with 3 Gy IR.
Cells were harvested at time points indicated following IR, fixed and immunostained
for HDAC1, γH2AX and DAPI. γH2AX foci were counted in cells successfully knockdown
for HDAC1/2. Results represent the +/- SD of three independent experiments.
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Particle LET (keV/μm)
(ICRU Report 16,
1970)
Particle status after 
cellular absorption
(Sekine et al., 2008)
Chromosome 
exchange 
frequency
(Himada et al., 
2010)
DNA fragment 
frequency
(Himada et al., 
2010)
X-ray
Carbon
Iron
1.7
68.3 – 70.0
199.3 - 200.0
-
C: ~87% dose 
contribution (~50% 
original, other 
nucleotides: He and H)
Fe: over 90% dose 
contribution
(over 80% original)
0.23
0.45
0.61
0.16
0.71
0.88
Table 6.1: The frequency of chromosome aberrations increases with LET value.
Chromosome aberration frequency was measured by premature chromosome
condensation and fluorescence in situ hybridization (FISH) (Himada et al., 2010).
Secondary particles such as H and He (lighter fragments) also contribute to ion
induced damage after Fe ions (Sekine et al., 2008).
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Figure 6.1: Heavy ions such as protons and Carbon ions have a bragg peak. X-
rays (photons) lose energy rapidly by ionization as they travel through the body.
Charged particles such as protons and carbon ions deposit most of their energy
at a specific depth that depends on their energy (called the Bragg peak). This
means that they can deliver a high radiation dose at a tumour site, while sparing
the surrounding healthy tissue.
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Figure 6.2: Fe ion irradiation can be administered either vertically or horizontally.
(A) Photograph of the HIMAC at the NIRS. Yellow dashed arrow indicated direction of ion
beam. Solid yellow arrows indicate the directions that samples were loaded for
horizontal or vertical IR. (B) Schematic representation of the direction the ion beam will
hit cells when irradiating either vertically or horizontally. (C) 1BR hTERT cells irradiated
with 1 Gy Fe ions either vertically or horizontally. Cells were fix and immunostained for
γH2AX (red) 4 hours after IR.
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Figure 6.3: Heavy ion irradiation produces variation in the number of DSBs induced
between cells, and the type of γH2AX foci formed differs from that after X-rays. (A)
The number of DSBs induced after heavy ion irradiation varies between each cell. 1BR
hTERT cells were fixed 1 hour after irradiating with 1 Gy either X-ray, Fe ions
(horizontally or vertically) or Carbon ions and stained with γH2AX (red), DAPI (blue) and
CENP-F (not shown). Images were obtained using a Delta vision microscope with
deconvolution (60x). (B) The shape and size of heavy ion induced γH2AX foci differ
from that of X-ray induced foci. Cells were treated as in (A). G2 phase cells were
selected on the basis of staining positive for CENP-F.
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Figure 6.4: Horizontal Fe ion irradiation induces DSBs are repaired with slow kinetics
in G1. (A) A large variation in the number of DSBs induced between cells after Fe ion
irradiation is observed. Scatter blots represent the number of γH2AX foci per cell,
with more than 30 cells scored for each time point. 1BR hTERT cells were irradiated
with 1 Gy either X-ray or horizontal Fe ions. Cells were fixed at indicated time points
after IR and immunostained for γH2AX, CENP-F and DAPI. γH2AX foci were quantified
in G1 (CENP-F negative) cells. (B) Percentage rate of DSB repair after horizontal Fe ion
and X-ray irradiation. Cells were treated as in (A). The number of γH2AX foci were
normalized with the number of foci at 1 hour post IR. Error bars represent the
standard deviation of the mean from 2 independent experiments
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Figure 6.5: Horizontal Fe ion irradiation induces DSBs are repaired with slow
kinetics in G2. (A) A large variation in the number of DSBs induced after Fe ion
irradiation is observed. Scatter blots represent the number of γH2AX foci per cell,
with more than 30 cells scored for each time point. 1BR hTERT cells were irradiated
with 1 Gy either X-ray or horizontal Fe ions. Cells were fixed at indicated time
points after IR and immunostained for γH2AX, CENP-F and DAPI. γH2AX foci were
quantified in G2 (CENP-F positive) cells. (B) Percentage rate of DSB repair after
horizontal Fe ion and X-ray irradiation. Cells were treated as in (A). The number of
γH2AX foci were normalized with the number of foci at 1 hour post IR. Error bars
represent the standard deviation of the mean from 2 independent experiments
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Figure 6.6: G2/M checkpoint arrest is initiated at lower doses after heavy ion
irradiation. 48BR primary or 1BR hTRET cells were treated with APH and
irradiated with either X-rays, Fe ions (vertically or horizontally) or Carbon ions at
indicated doses of IR. One hour post IR, cells were fixed and immunostained for
the mitotic marker pH3. pH3 positive cells were counted and normalized to the un-
irradiated control. Error bars represent the standard deviation of the mean from 2
independent experiments
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Figure 6.7: 1BR hTERT cells are released from the G2/M checkpoint with ~7-8 Fe (horizontal)
ion induced DSBs. (A) Cell cycle progression after Fe ion irradiation is slowed. 1BR hTERT cells
were treated with APH and irradiated with 1 Gy either X-ray or Fe ions. Prior to IR cells were
treated with aphidicolin to prevent S phase cells progressing into G2 during analysis. Cells
were fixed at indicated time points post IR and immunostained for γH2AX, pH3, CENP-F and
DAPI. The percentage of G1 (CENP-F negative), G2 (CENP-F positive) and S (pan nuclear
γH2AX) phase cells was calculated for a cell population containing at least 300 cells. (B) Cells
released from the G2/M checkpoint manifest ~ 7 Fe ion induced DSBs. Cells were treated as in
(A). γH2AX foci were counted in G2 and M phase cells at indicated time points. (C) Cells were
treated as in (A). pH3 positive cells were counted and normalized to the un-irradiated control.
Error bars represent the standard deviation of the mean from 2 independent experiments
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Figure 6.8: 1BR hTERT cells are released from the G2/M checkpoint with ~7 Fe (vertical) ion
induced DSBs. (A) Cell cycle progression after Fe ion irradiation is slowed. 1BR hTERT cells
were irradiated with 1 Gy either X-ray or Fe ions. Prior to IR cells were treated with
aphidicolin to prevent S phase cells progressing into G2 during analysis. Cells were fixed at
indicated time points post IR and immunostained for γH2AX, pH3, CENP-F and DAPI. The
percentage of G1 (CENP-F negative), G2 (CENP-F positive) and S (pan nuclear γH2AX) phase
cells was calculated for a cell population containing at least 300 cells. (B) Cells released from
the G2/M checkpoint manifest ~ 7 Fe ion induced DSBs. Cells were treated as in (A). γH2AX
foci were counted in G2 and M phase cells at indicated time points. (C) Cells were treated as
in (A). pH3 positive cells were counted and normalized to the un-irradiated control. Error bars
represent the standard deviation of the mean from 2 independent experiments
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Figure 6.9: 1BR hTERT cells are released from the G2/M checkpoint with ~7 Carbon ion
induced DSBs. (A) Cell cycle progression after Carbon ion irradiation is slowed. 1BR hTERT cells
were irradiated with 1 Gy either X-ray or Carbon ions. Prior to IR cells were treated with
aphidicolin to prevent S phase cells progressing into G2 during analysis. Cells were fixed at
indicated time points post IR and immunostained for γH2AX, pH3, CENP-F and DAPI. The
percentage of G1 (CENP-F negative), G2 (CENP-F positive) and S (pan nuclear γH2AX) phase
cells was calculated for a cell population containing at least 300 cells. (B) Cells released from
the G2/M checkpoint manifest ~ 7 Carbon ion induced DSBs. Cells were treated as in (A).
γH2AX foci were counted in G2 and M phase cells at indicated time points. (C) Cells were
treated as in (A). pH3 positive cells were counted and normalized to the un-irradiated control.
Error bars represent the standard deviation of the mean from 2 independent experiments
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Figure 6.10: γH2AX foci 16 hours after irradiation with heavy ions.
1BR hTERT cells were irradiated with 1 Gy either X-ray, Fe ions (horizontal or
vertical), or Carbon ions. 16 hours after irradiation cells were fixed and
immunostained for γH2AX (red) and DAPI (blue)
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Figure 7.1: A model for hyperactive ATM signalling in the context of reduced higher order chromatin structure
(1) WILDTYPE CELL: Euchromatin (EC) - Sufficient γH2AX expansion occurs at EC-DSBs after IR which enables DSB repair with fast kinetics. However,
γH2AX expansion at these regions is not indefinite, possibly due to repressive histone marks or rapid turnover of H2AX. Heterochromatin (HC) -
Small localized chromatin relaxation occurs following H2AX phosphorylation. However, signalling from these DSBs at early times is modest until
sufficient KAP-1 phosphorylation has been pursued following 53BP1 mediated tethering of ATM. (2) KAP-1, MeCP2 or DNMT3B KD CELL:
Heterochromatin (HC) - More Chk2 signalling emanates from HC associated DSBs as a result of greater γH2AX expansion and hence more ATM
activation. The repressive EC associated histone modifications may be absent in HC, and therefore γH2AX expansion is greater at HC in comparison
to EC.  
